-- phpMyAdmin SQL Dump
-- version 4.1.14
-- http://www.phpmyadmin.net
--
-- Host: 127.0.0.1
-- Generation Time: Jan 02, 2018 at 02:30 PM
-- Server version: 5.6.17
-- PHP Version: 5.5.12

SET SQL_MODE = "NO_AUTO_VALUE_ON_ZERO";
SET time_zone = "+00:00";


/*!40101 SET @OLD_CHARACTER_SET_CLIENT=@@CHARACTER_SET_CLIENT */;
/*!40101 SET @OLD_CHARACTER_SET_RESULTS=@@CHARACTER_SET_RESULTS */;
/*!40101 SET @OLD_COLLATION_CONNECTION=@@COLLATION_CONNECTION */;
/*!40101 SET NAMES utf8 */;

--
-- Database: `drug_website_new2`
--

-- --------------------------------------------------------

--
-- Table structure for table `drg_generic_group`
--

CREATE TABLE IF NOT EXISTS `drg_generic_group` (
  `GN_GRP_ID` int(10) unsigned NOT NULL AUTO_INCREMENT,
  `GN_NAME` varchar(255) NOT NULL DEFAULT '',
  `GN_SL_NO` int(10) unsigned DEFAULT NULL,
  `GN_DESC` text,
  `TH_GRP_ID` int(10) unsigned NOT NULL DEFAULT '0',
  `ACTIVE_STATUS` enum('Y','N') NOT NULL DEFAULT 'Y',
  `CRE_BY` int(10) unsigned DEFAULT NULL,
  `CRE_DT` timestamp NOT NULL DEFAULT '0000-00-00 00:00:00',
  `UPD_BY` int(10) unsigned DEFAULT NULL,
  `UPD_DT` datetime DEFAULT NULL,
  PRIMARY KEY (`GN_GRP_ID`),
  KEY `FK_drg_generic_group_1` (`TH_GRP_ID`) USING BTREE
) ENGINE=InnoDB  DEFAULT CHARSET=utf8 AUTO_INCREMENT=324 ;

--
-- Dumping data for table `drg_generic_group`
--

INSERT INTO `drg_generic_group` (`GN_GRP_ID`, `GN_NAME`, `GN_SL_NO`, `GN_DESC`, `TH_GRP_ID`, `ACTIVE_STATUS`, `CRE_BY`, `CRE_DT`, `UPD_BY`, `UPD_DT`) VALUES
(3, ' Capecitabine USP', NULL, NULL, 36, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(4, '(Neomycin Sulphate+Polymyxin B-Sulphate+Nystatin+Metronidazole)BP', NULL, NULL, 38, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(5, 'Aceclofenac BP', NULL, NULL, 35, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(6, 'Aciclovir', NULL, NULL, 45, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(7, 'Albendazole', NULL, NULL, 43, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(8, 'Almitrine Bismesylate INN & Raubasine INN', NULL, NULL, 61, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(9, 'Amikacin USP', NULL, NULL, 38, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(10, 'Amoxycylline  Trihydrate USP with Clavulanate Acid USP', NULL, NULL, 38, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(11, 'Amoxycylline Trihydrate BP', NULL, NULL, 38, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(12, 'Azithromycin', NULL, NULL, 38, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(13, 'Azithromycin Dihydrate USP', NULL, NULL, 38, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(14, 'Azithromycin USP', NULL, NULL, 38, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(15, 'Baclofen USP', NULL, NULL, 55, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(16, 'Beclometasone Dipropionate  ', NULL, NULL, 53, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(17, 'Budesonide', NULL, NULL, 56, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(18, 'Carboplatin BP', NULL, NULL, 57, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(19, 'Cefadroxil Monohydrate USP', NULL, NULL, 38, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(20, 'Cefditoren Dihydrate INN', NULL, NULL, 38, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(21, 'Cefepime USP', NULL, NULL, 38, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(22, 'Cefixime Trihydrate USP', NULL, NULL, 38, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(23, 'Cefpodoxime USP', NULL, NULL, 38, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(24, 'Cefpodoxime USP with Clavulanic Acid USP', NULL, NULL, 38, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(25, 'Ceftazidime Pentahydrate USP', NULL, NULL, 38, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(26, 'Ceftriaxone Sodium USP', NULL, NULL, 38, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(27, 'Cefuroxime USP ', NULL, NULL, 38, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(28, 'Cefuroxime USP with Clavulanic Acid USP ', NULL, NULL, 38, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(29, 'Cephradine USP', NULL, NULL, 38, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(30, 'Cetrizine Dihydrochloride ', NULL, NULL, 41, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(31, 'Chloramphenicol BP', NULL, NULL, 49, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(32, 'Chloramphenicol BP & ', NULL, NULL, 34, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(33, 'Ciprofloxacin Hcl. USP ', NULL, NULL, 34, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(34, 'Ciprofloxacin USP', NULL, NULL, 38, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(35, 'Ciprofloxacin USP & Dexamethasone USP', NULL, NULL, 49, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(36, 'Ciprofloxacin USP & Hydrocortisone BP', NULL, NULL, 62, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(37, 'Cisplatin BP', NULL, NULL, 57, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(38, 'Citicoline', NULL, NULL, 48, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(39, 'Clarithromycin USP', NULL, NULL, 38, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(40, 'Clindamycin USP', NULL, NULL, 38, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(41, 'Coenzyme Q10  USP', NULL, NULL, 61, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(42, 'Dantrolene Sodium USP', NULL, NULL, 55, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(43, 'Desloratadine ', NULL, NULL, 41, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(44, 'Dexamethasone BP', NULL, NULL, 49, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(45, 'Dexamethasone USP,Neomycin sulphate USP&', NULL, NULL, 60, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(46, 'Dextran 70 USP + Hyorimellose USP ', NULL, NULL, 34, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(47, 'Diclofenac Potassium BP', NULL, NULL, 35, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(48, 'Diclofenac Sodium BP', NULL, NULL, 34, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(49, 'Diclofenac Sodium USP + Misoprostol BP ', NULL, NULL, 35, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(50, 'Diosmin BP+ Hesperidine BP', NULL, NULL, 61, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(51, 'Domperidone BP', NULL, NULL, 39, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(52, 'Doripenem Monohydrate INN', NULL, NULL, 38, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(53, 'Doxophylline ', NULL, NULL, 47, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(54, 'Doxorubicin HCL USP', NULL, NULL, 36, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(55, 'Dutasteride INN', NULL, NULL, 46, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(56, 'Entecavir', NULL, NULL, 45, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(57, 'Erythromycin BP ', NULL, NULL, 38, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(58, 'Esomeprazole INN', NULL, NULL, 37, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(59, 'Etoposide USP', NULL, NULL, 57, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(60, 'Famotidine USP', NULL, NULL, 37, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(61, 'Fexofenadine Hcl ', NULL, NULL, 41, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(62, 'Flucloxacillin Sodium BP', NULL, NULL, 38, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(63, 'Fluconazole', NULL, NULL, 40, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(64, 'Flunarizine Dihydrochloride BP', NULL, NULL, 42, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(65, 'Fluorometholone USP', NULL, NULL, 58, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(66, 'Fluorouracil USP', NULL, NULL, 36, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(67, 'Flupentixol & Melitracen', NULL, NULL, 48, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(68, 'Gabapentin', NULL, NULL, 48, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(69, 'Gemifloxacin INN', NULL, NULL, 38, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(70, 'Hydrocortisone Sodium Succinate', NULL, NULL, 63, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(71, 'Ibuprofen BP', NULL, NULL, 35, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(72, 'ketorolac Tromethamine USP', NULL, NULL, 34, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(73, 'Ketotifen BP', NULL, NULL, 34, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(74, 'Ketotifen Fumerate ', NULL, NULL, 41, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(75, 'Lactulose BP', NULL, NULL, 54, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(76, 'Lansoprazole USP', NULL, NULL, 37, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(77, 'Levocarnitine USP', NULL, NULL, 61, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(78, 'Levocetirizine Dihydrochloride ', NULL, NULL, 41, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(79, 'Levodopa & Carbidopa', NULL, NULL, 48, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(80, 'Levofloxacin INN', NULL, NULL, 38, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(81, 'Lomefloxacin INN ', NULL, NULL, 34, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(82, 'Loratadine ', NULL, NULL, 41, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(83, 'Mebeverine HCl BP', NULL, NULL, 44, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(84, 'Meclizine HCl USP', NULL, NULL, 39, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(85, 'Mefenamic Acid USP', NULL, NULL, 35, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(86, 'Meropenem Trihydrate USP ', NULL, NULL, 38, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(87, 'Mesalamine USP', NULL, NULL, 35, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(88, 'Methotrexate USP', NULL, NULL, 36, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(89, 'Methylprednisolone Acetate USP', NULL, NULL, 35, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(90, 'Mirtazapine ', NULL, NULL, 48, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(91, 'Mometasone Furoate', NULL, NULL, 56, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(92, 'Montelukast ', NULL, NULL, 47, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(93, 'Moxifloxacin BP ', NULL, NULL, 34, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(94, 'Moxifloxacin Hydrochloride BP', NULL, NULL, 38, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(95, 'Naproxen BP', NULL, NULL, 35, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(96, 'Naproxen USP + Esomeprazole USP', NULL, NULL, 35, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(97, 'Nitazoxanide', NULL, NULL, 43, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(98, 'Nitrofurantoin USP', NULL, NULL, 38, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(99, 'Ofloxacin INN', NULL, NULL, 38, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(100, 'Omeprazole BP', NULL, NULL, 37, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(101, 'Ondansetron USP', NULL, NULL, 39, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(102, 'Ornidazole', NULL, NULL, 43, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(103, 'Paclitaxel USP', NULL, NULL, 57, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(104, 'Palonosetron HCl INN', NULL, NULL, 39, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(105, 'Pantroprazole BP', NULL, NULL, 37, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(106, 'Paracetamol BP + Tramadol HCl USP', NULL, NULL, 35, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(107, 'Pefloxacin INN', NULL, NULL, 38, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(108, 'Phenytoin', NULL, NULL, 48, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(109, 'Piracetam', NULL, NULL, 48, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(110, 'Pizotifen BP', NULL, NULL, 42, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(111, 'Povidone BP', NULL, NULL, 34, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(112, 'Prednisolone', NULL, NULL, 63, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(113, 'Prednisolone Acetate USP', NULL, NULL, 34, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(114, 'Pregabalin', NULL, NULL, 48, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(115, 'pregabelin', NULL, NULL, 48, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(116, 'Rabeprazole Sodium INN ', NULL, NULL, 37, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(117, 'Ranitidine USP', NULL, NULL, 37, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(118, 'Ribavirin', NULL, NULL, 45, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(119, 'Rifaximin BP', NULL, NULL, 38, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(120, 'Risperidone', NULL, NULL, 48, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(121, 'Roflumilast ', NULL, NULL, 47, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(122, 'Rupatadine Fumarate ', NULL, NULL, 41, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(123, 'Salbutamol', NULL, NULL, 53, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(124, 'Salbutamol + Ipratropium Bromiide ', NULL, NULL, 53, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(125, 'Salmeterol ', NULL, NULL, 53, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(126, 'Salmeterol+Fluticasone Propionate', NULL, NULL, 53, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(127, 'Sertraline', NULL, NULL, 48, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(128, 'Simethicone USP', NULL, NULL, 37, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(129, 'Sodium Cromoglycate', NULL, NULL, 50, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(130, 'Sofosbuvir', NULL, NULL, 45, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(131, 'Sparfloxacin INN', NULL, NULL, 38, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(132, 'Sulfasalazine USP', NULL, NULL, 35, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(133, 'Sulindac USP', NULL, NULL, 35, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(134, 'Tamsulosin HCl USP', NULL, NULL, 46, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(135, 'Tamsulosin HCl USP & Dutasteride INN', NULL, NULL, 46, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(136, 'Tenofovir', NULL, NULL, 45, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(137, 'Terbinafine Hcl', NULL, NULL, 40, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(138, 'Theophylline ', NULL, NULL, 47, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(139, 'Tiemonium Methylsulfate INN', NULL, NULL, 44, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(140, 'Tobramycin + Dexamethasone', NULL, NULL, 59, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(141, 'Tofacitinib INN', NULL, NULL, 61, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(142, 'Tolfenamic Acid BP', NULL, NULL, 35, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(143, 'Tolperisone Hydrochloride INN', NULL, NULL, 55, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(144, 'Tramadol HCl BP', NULL, NULL, 35, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(145, 'Travoprost USP ', NULL, NULL, 34, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(146, 'Triamcinolone Acetonide', NULL, NULL, 56, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(147, 'Triamcinolone Acetonide USP', NULL, NULL, 35, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(148, 'Vincristine SulphateUSP', NULL, NULL, 57, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(149, 'Zolmitriptan INN', NULL, NULL, 42, 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(150, 'Dapoxetine Hydrochloride INN', NULL, 'Desc Of ', 61, 'Y', 1, '2017-11-07 04:35:24', NULL, NULL),
(151, 'GlucosamineBP+Chondroitin Sodium USP', NULL, 'Desc of', 61, 'Y', 1, '2017-11-07 04:36:09', NULL, NULL),
(152, 'GlucosamineBP+Diacerin INN ', NULL, 'desc of', 61, 'Y', 1, '2017-11-07 04:36:57', NULL, NULL),
(153, 'Omega-3-Acid Ethyl Esters BP', NULL, 'Desc Of', 61, 'Y', 1, '2017-11-07 04:37:21', NULL, NULL),
(154, 'Cilostazol USP', NULL, 'Desc Of', 61, 'Y', 1, '2017-11-07 04:38:17', NULL, NULL),
(155, 'Ursodeoxycholic Acid BP', NULL, 'Desc Of', 61, 'Y', 1, '2017-11-07 04:38:40', NULL, NULL),
(156, 'Diferipon INN', NULL, 'Desc Of ', 61, 'Y', 1, '2017-11-07 04:39:08', NULL, NULL),
(157, 'Allopurinol BP', NULL, 'Desc Of', 61, 'Y', 1, '2017-11-07 04:39:29', NULL, NULL),
(158, 'Metformin HCl BP', NULL, 'Desc Of', 64, 'Y', 1, '2017-11-07 05:08:16', NULL, NULL),
(159, 'Metformin HCl USP', NULL, 'desc Of', 64, 'Y', 1, '2017-11-07 05:08:42', NULL, NULL),
(160, 'Vildagliptin INN', NULL, 'Desc Of', 64, 'Y', 1, '2017-11-07 05:09:06', NULL, NULL),
(161, 'Vildagliptin INN + Metformin Hydrochloride USP', NULL, 'Desc Of', 64, 'Y', 1, '2017-11-07 05:09:35', NULL, NULL),
(162, 'Linagliptin INN ', NULL, 'Desc Of', 64, 'Y', 1, '2017-11-07 05:10:12', NULL, NULL),
(163, 'Saxagliptin Hydrochloride INN', NULL, 'Desc Of', 64, 'Y', 1, '2017-11-07 05:10:47', NULL, NULL),
(164, 'Sitagliptin INN', NULL, 'Desc Of', 64, 'Y', 1, '2017-11-07 05:11:21', NULL, NULL),
(165, 'Sitagliptin INN (immediate release) +Metformin HCl USP (extended release)  ', NULL, 'Desc Of', 64, 'Y', 1, '2017-11-07 05:11:50', NULL, NULL),
(166, 'Gliclazide BP', NULL, 'desc Of', 64, 'Y', 1, '2017-11-07 05:12:10', NULL, NULL),
(167, 'Glimepiride USP', NULL, 'Desc Of', 64, 'Y', 1, '2017-11-07 05:12:40', NULL, NULL),
(168, 'Dapagliflozin INN', NULL, 'Desc Of', 64, 'Y', 1, '2017-11-07 05:13:05', NULL, NULL),
(169, 'Canagliflozin INN', NULL, 'Desc Of', 64, 'Y', 1, '2017-11-07 05:13:22', NULL, NULL),
(170, 'Linagliptin INN + Metformin Hydrochloride USP', NULL, 'Desc Of', 64, 'Y', 1, '2017-11-07 05:36:51', NULL, NULL),
(171, 'Sitagliptin INN + Metformin Hydrochloride USP', NULL, 'desc Of', 64, 'Y', 1, '2017-11-08 02:28:01', NULL, NULL),
(172, 'Lisinopril USP', NULL, 'Desc Of', 65, 'Y', 1, '2017-11-08 03:26:37', NULL, NULL),
(173, 'Captopril USP', NULL, 'Desc Of', 65, 'Y', 1, '2017-11-08 03:27:01', NULL, NULL),
(174, 'Ramipril BP', NULL, 'Desc Of', 65, 'Y', 1, '2017-11-08 03:27:21', NULL, NULL),
(175, 'Ramipril BP+Hydrochlorothiazide USP', NULL, 'Desc Of', 65, 'Y', 1, '2017-11-08 03:27:46', NULL, NULL),
(176, 'Valsartan USP', NULL, 'Desc Of', 65, 'Y', 1, '2017-11-08 03:28:10', NULL, NULL),
(177, 'Valsartan USP + Hydrochlorothiazide USP', NULL, 'Desc Of', 65, 'Y', 1, '2017-11-08 03:28:31', NULL, NULL),
(178, 'Losartan Potassium USP', NULL, 'Desc Of', 65, 'Y', 1, '2017-11-08 03:28:56', NULL, NULL),
(179, 'Losartan Potassium USP +Hydrochlorothiazide USP', NULL, 'Desc Of', 65, 'Y', 1, '2017-11-08 03:29:17', NULL, NULL),
(180, 'Olmesartan Medoxomil BP', NULL, 'Desc Of', 65, 'Y', 1, '2017-11-08 03:29:38', NULL, NULL),
(181, 'Olmesartan Medoxomil BP +Hydrochlorothiazide BP', NULL, 'Desc Of', 65, 'Y', 1, '2017-11-08 03:30:01', NULL, NULL),
(182, 'Azilsartan Medoxomil Potassium INN', NULL, 'Desc Of', 65, 'Y', 1, '2017-11-08 03:30:20', NULL, NULL),
(183, 'Trimetazidine Dihydrochloride BP', NULL, 'Desc of', 65, 'Y', 1, '2017-11-08 03:30:40', NULL, NULL),
(184, 'Enoxaparin Sodium BP 4000 anti-Xa IU', NULL, 'Desc Of', 65, 'Y', 1, '2017-11-08 03:31:01', NULL, NULL),
(185, 'Enoxaparin Sodium BP 6000 anti-Xa IU', NULL, 'Desc Of', 65, 'Y', 1, '2017-11-08 03:31:28', NULL, NULL),
(186, 'Enoxaparin Sodium BP 8000 anti-Xa IU', NULL, 'Desc of', 65, 'Y', 1, '2017-11-08 03:31:46', NULL, NULL),
(187, 'Clopidogrel USP', NULL, 'Desc of', 65, 'Y', 1, '2017-11-08 03:32:05', NULL, NULL),
(188, 'Clopidogrel USP + Aspirin USP', NULL, 'Desc of', 65, 'Y', 1, '2017-11-08 03:32:26', NULL, NULL),
(189, 'Amiodarone HCl BP', NULL, 'Desc of', 65, 'Y', 1, '2017-11-08 03:32:42', NULL, NULL),
(190, 'Vinpocetine BP', NULL, 'Desc Of', 65, 'Y', 1, '2017-11-08 03:33:04', NULL, NULL),
(191, 'Dopamine Hydrochloride USP', NULL, 'Desc of', 65, 'Y', 1, '2017-11-08 03:33:25', NULL, NULL),
(192, 'Heparin Sodium BP', NULL, 'Desc of', 65, 'Y', 1, '2017-11-08 03:33:46', NULL, NULL),
(193, 'Ivabradine INN', NULL, 'Desc Of', 65, 'Y', 1, '2017-11-08 03:34:08', NULL, NULL),
(194, 'Prasugrel INN', NULL, 'desc of', 65, 'Y', 1, '2017-11-08 03:34:24', NULL, NULL),
(195, 'Ticagrelor INN', NULL, 'Desc Of', 65, 'Y', 1, '2017-11-08 03:34:47', NULL, NULL),
(196, 'Metoprolol Tartrate USP', NULL, 'Desc Of', 65, 'Y', 1, '2017-11-08 03:35:05', NULL, NULL),
(197, 'Carvedilol USP ', NULL, 'Desc Of', 65, 'Y', 1, '2017-11-08 03:35:23', NULL, NULL),
(198, 'Bisoprolol Fumarate USP', NULL, 'Desc of', 65, 'Y', 1, '2017-11-08 03:35:44', NULL, NULL),
(199, 'Bisoprolol Fumarate USP + Hydrochlorothiazide USP', NULL, 'Desc of', 65, 'Y', 1, '2017-11-08 03:36:17', NULL, NULL),
(200, 'Nebivolol Hydrochloride INN', NULL, 'Desc of', 65, 'Y', 1, '2017-11-08 03:36:38', NULL, NULL),
(201, 'Amlodipine BP', NULL, 'Desc Of', 65, 'Y', 1, '2017-11-08 03:36:56', NULL, NULL),
(202, 'Amlodipine BP + Atenolol BP', NULL, 'Desc Of', 65, 'Y', 1, '2017-11-08 03:37:18', NULL, NULL),
(203, 'Amlodipine BP + Valsartan USP', NULL, 'Desc of', 65, 'Y', 1, '2017-11-08 03:37:41', NULL, NULL),
(204, 'Diltiazem HCl USP', NULL, 'Desc Of', 65, 'Y', 1, '2017-11-08 03:38:01', NULL, NULL),
(205, 'Amlodipine BP + Olmesartan Medoxomil BP', NULL, 'Desc Of', 65, 'Y', 1, '2017-11-08 03:38:22', NULL, NULL),
(206, 'Amlodipine BP + Olmesartan Medoxomil BP', NULL, 'Desc Of', 65, 'Y', 1, '2017-11-08 03:39:02', NULL, NULL),
(207, 'Lacidipine BP', NULL, 'Desc Of', 65, 'Y', 1, '2017-11-08 03:39:21', NULL, NULL),
(208, 'Nifedipine USP', NULL, 'Desc Of', 65, 'Y', 1, '2017-11-08 03:39:44', NULL, NULL),
(209, 'Furosemide BP + Spironolactone USP', NULL, 'Desc Of', 65, 'Y', 1, '2017-11-08 03:40:09', NULL, NULL),
(210, 'Indapamide BP', NULL, 'Desc Of', 65, 'Y', 1, '2017-11-08 03:40:28', NULL, NULL),
(211, 'Indapamide BP +Perindopril Erbumine BP', NULL, 'Desc Of', 65, 'Y', 1, '2017-11-08 03:40:48', NULL, NULL),
(212, 'Spironolactone USP', NULL, 'Desc Of', 65, 'Y', 1, '2017-11-08 03:41:09', NULL, NULL),
(213, 'Atorvastatin BP', NULL, 'Desc Of', 65, 'Y', 1, '2017-11-08 03:41:26', NULL, NULL),
(214, 'Fenofibrate USP', NULL, 'Desc Of', 65, 'Y', 1, '2017-11-08 03:41:47', NULL, NULL),
(215, 'Pitavastatin INN', NULL, 'Desc of ', 65, 'Y', 1, '2017-11-08 03:42:05', NULL, NULL),
(216, 'Simvastatin USP', NULL, 'Desc OF', 65, 'Y', 1, '2017-11-08 03:42:21', NULL, NULL),
(217, 'Niacin USP', NULL, 'Desc OF', 65, 'Y', 1, '2017-11-08 03:42:38', NULL, NULL),
(218, 'Rosuvastatin INN', NULL, 'Desc Of', 65, 'Y', 1, '2017-11-08 03:43:22', NULL, NULL),
(219, 'Nitroglycerin USP', NULL, 'Desc OF', 65, 'Y', 1, '2017-11-08 03:43:39', NULL, NULL),
(220, 'Isosorbide-5-Mononitrate USP', NULL, 'Desc Of', 65, 'Y', 1, '2017-11-08 03:43:57', NULL, NULL),
(221, 'Nitroglycerin USP', NULL, 'Desc Of', 65, 'Y', 1, '2017-11-08 03:44:15', NULL, NULL),
(222, 'Glyceryl Trinitrate BP', NULL, 'Desc Of', 65, 'Y', 1, '2017-11-08 03:44:31', NULL, NULL),
(223, 'Adapalene INN', NULL, 'Desc Of', 66, 'Y', 1, '2017-11-08 03:46:22', NULL, NULL),
(224, 'Urea BP', NULL, 'Desc Of', 66, 'Y', 1, '2017-11-08 03:46:38', NULL, NULL),
(225, 'Benzoyl Peroxide BP', NULL, 'Desc OF', 66, 'Y', 1, '2017-11-08 03:46:55', NULL, NULL),
(226, 'Betamethasone (as 17-valerate) BP', NULL, 'Desc OF', 66, 'Y', 1, '2017-11-08 03:47:14', NULL, NULL),
(227, 'Betamethasone (as 17-valerate) BP + Neomycin Sulphate BP', NULL, 'Desc Of', 66, 'Y', 1, '2017-11-08 03:47:37', NULL, NULL),
(228, 'Camphor USP + Menthol USP + Methyl Salicylate BP', NULL, 'Desc Of', 66, 'Y', 1, '2017-11-08 03:47:57', NULL, NULL),
(229, 'Fluocinolone Acetonide BP', NULL, 'Desc Of', 66, 'Y', 1, '2017-11-08 03:48:15', NULL, NULL),
(230, 'Clobetasol Propionate BP', NULL, 'Desc Of', 66, 'Y', 1, '2017-11-08 03:48:32', NULL, NULL),
(231, 'Econazole Nitrate BP + Triamcinolone Acetonide BP', NULL, 'Desc Of', 66, 'Y', 1, '2017-11-08 03:48:52', NULL, NULL),
(232, 'Butenafine HCl INN', NULL, 'Desc Of', 66, 'Y', 1, '2017-11-08 03:49:10', NULL, NULL),
(233, 'Fusidic Acid BP + Hydrocortisone Acetate BP', NULL, 'Desc Of', 66, 'Y', 1, '2017-11-08 03:49:35', NULL, NULL),
(234, 'Nystatin BP + Neomycin BP +Gramicidin USP + Triamcinolone Acetonide BP', NULL, 'Desc of', 66, 'Y', 1, '2017-11-08 03:50:13', NULL, NULL),
(235, 'Permethrin INN ', NULL, 'Desc Of', 66, 'Y', 1, '2017-11-08 03:50:31', NULL, NULL),
(236, 'Miconazole Nitrate USP ', NULL, 'Desc Of', 66, 'Y', 1, '2017-11-08 03:50:50', NULL, NULL),
(237, 'Miconazole Nitrate BP + Hydrocortisone BP', NULL, 'Desc Of', 66, 'Y', 1, '2017-11-08 03:51:05', NULL, NULL),
(238, 'Terbinafine BP', NULL, 'Desc Of', 66, 'Y', 1, '2017-11-08 03:51:26', NULL, NULL),
(239, 'Acyclovir BP', NULL, 'desc of', 66, 'Y', 1, '2017-11-08 03:51:50', NULL, NULL),
(240, 'Acyclovir BP + Hydrocortisone BP', NULL, 'Desc Of', 66, 'Y', 1, '2017-11-08 03:52:07', NULL, NULL),
(241, 'Silver Sulfadiazine USP', NULL, 'Desc Of', 66, 'Y', 1, '2017-11-08 03:52:23', NULL, NULL),
(242, 'Triamcinolone Acetonide BP ', NULL, 'Desc OF', 66, 'Y', 1, '2017-11-08 03:52:40', NULL, NULL),
(243, 'Betamethasone (as 17-valerate) BP +Clotrimazole BP', NULL, 'Desc Of', 66, 'Y', 1, '2017-11-08 03:52:58', NULL, NULL),
(244, 'Clobetasol Propionate BP', NULL, 'Desc Of', 66, 'Y', 1, '2017-11-08 03:53:18', NULL, NULL),
(245, 'Calcipotriol BP', NULL, 'Desc Of', 66, 'Y', 1, '2017-11-08 03:53:58', NULL, NULL),
(246, 'Betamethasone BP + Calcipotriol BP', NULL, 'Desc Of', 66, 'Y', 1, '2017-11-08 03:54:15', NULL, NULL),
(247, 'Fluticasone Propionate BP', NULL, 'Desc Of', 66, 'Y', 1, '2017-11-08 03:54:44', NULL, NULL),
(248, 'Nystatin BP + Neomycin BP +Gramicidin USP + Triamcinolone Acetonide BP', NULL, 'Desc Of', 66, 'Y', 1, '2017-11-08 03:55:11', NULL, NULL),
(249, 'Zinc Oxide USP', NULL, 'Desc Of', 66, 'Y', 1, '2017-11-08 03:55:31', NULL, NULL),
(250, 'Mupirocin USP', NULL, 'Desc Of', 66, 'Y', 1, '2017-11-08 03:56:01', NULL, NULL),
(251, 'Neomycin Sulphate BP & Bacitracin Zinc BP', NULL, 'Desc Of', 66, 'Y', 1, '2017-11-08 03:56:21', NULL, NULL),
(252, 'Neomycin Sulphate BP + Bacitracin Zinc BP +Polymyxin B Sulphate BP', NULL, 'Desc OF', 66, 'Y', 1, '2017-11-08 03:56:42', NULL, NULL),
(253, 'Povidone lodine USP', NULL, 'Desc Of', 66, 'Y', 1, '2017-11-08 03:57:02', NULL, NULL),
(254, 'Betamethasone (as 17-valerate) BP +Phenylephrine Hydrochloride BP +Lignocaine Hydrochloride BP', NULL, 'Desc Of', 66, 'Y', 1, '2017-11-08 03:57:21', NULL, NULL),
(255, 'Cinchocaine HCl BP+ Hydrocortisone BP +Framycetin Sulphate BP + Esculin BP', NULL, 'Desc Of', 66, 'Y', 1, '2017-11-08 03:57:49', NULL, NULL),
(256, 'Adapalene BP + Benzoyl Peroxide BP', NULL, 'Desc Of', 66, 'Y', 1, '2017-11-08 03:58:09', NULL, NULL),
(257, 'Clindamycin USP + Benzoyl Peroxide BP', NULL, 'Desc Of', 66, 'Y', 1, '2017-11-08 03:58:29', NULL, NULL),
(258, 'Clindamycin Phosphate USP + Tretinoin USP', NULL, 'Desc Of', 66, 'Y', 1, '2017-11-08 03:58:52', NULL, NULL),
(259, 'Naproxen Sodium BP', NULL, 'Desc Of', 66, 'Y', 1, '2017-11-08 03:59:30', NULL, NULL),
(260, 'Miconazole base BP', NULL, 'Desc Of', 66, 'Y', 1, '2017-11-08 03:59:49', NULL, NULL),
(261, ' Triamcinolone Acetonide USP', NULL, 'Desc Of', 66, 'Y', 1, '2017-11-08 04:00:07', NULL, NULL),
(262, 'Astaxanthin INN ', NULL, 'Desc of', 67, 'Y', 1, '2017-11-08 04:06:46', NULL, NULL),
(263, 'Calcium Carbonate USP', NULL, 'Desc Of', 67, 'Y', 1, '2017-11-08 04:07:02', NULL, NULL),
(264, 'Calcium Carbonate USP + Vitamin D3 BP', NULL, 'Desc Of', 67, 'Y', 1, '2017-11-08 04:07:33', NULL, NULL),
(266, 'Vitamin D3 BP', NULL, 'Desc Of', 67, 'Y', 1, '2017-11-08 04:13:34', NULL, NULL),
(269, 'Calcitriol BP', NULL, 'Desc Of', 67, 'Y', 1, '2017-11-08 04:14:28', NULL, NULL),
(270, 'Calcium Citrate USP +Calcitriol USP ', NULL, 'Desc of', 67, 'Y', 1, '2017-11-08 04:14:46', NULL, NULL),
(271, 'Phytomenadion (Vitamin K1) BP/USP', NULL, 'Desc Of', 67, 'Y', 1, '2017-11-08 04:15:02', NULL, NULL),
(272, 'Vitamin E USP', NULL, 'Desc Of', 67, 'Y', 1, '2017-11-08 04:15:20', NULL, NULL),
(273, 'Vitamin E  USP+Vitamin C USP ', NULL, 'Desc Of', 67, 'Y', 1, '2017-11-08 04:15:41', NULL, NULL),
(274, 'Vitamin+Minerals', NULL, 'Desc Of', 67, 'Y', 1, '2017-11-08 04:15:54', NULL, NULL),
(275, 'Mecobalamin INN', NULL, 'Desc Of', 67, 'Y', 1, '2017-11-08 04:16:11', NULL, NULL),
(276, 'Paricalcitol USP ', NULL, 'DesC oF', 67, 'Y', 1, '2017-11-08 04:16:28', NULL, NULL),
(277, 'Vitamin A BP/USP ', NULL, 'Desc Of', 67, 'Y', 1, '2017-11-08 04:16:59', NULL, NULL),
(278, 'Calcium Carbonate USP ( From Coral Source)+ Vitamin D3 USP', NULL, 'Desc Of', 67, 'Y', 1, '2017-11-08 04:17:19', NULL, NULL),
(279, 'Multivitamin BP/USP', NULL, 'Desc Of', 67, 'Y', 1, '2017-11-08 04:17:52', NULL, NULL),
(280, 'Multivitamin + Minerals BP/USP', NULL, 'Desc Of', 67, 'Y', 1, '2017-11-08 04:18:06', NULL, NULL),
(281, 'Multivitamin with Cod Liver Oil ', NULL, 'Desc Of', 67, 'Y', 1, '2017-11-08 04:18:21', NULL, NULL),
(282, 'Vitamin B1+Vitamin B6+ Vitamin B12', NULL, 'Desc Of', 67, 'Y', 1, '2017-11-08 04:18:37', NULL, NULL),
(283, 'Multivitamin + Multi Minerals ', NULL, 'Desc Of', 67, 'Y', 1, '2017-11-08 04:18:52', NULL, NULL),
(284, '(Iron+Vitamin B Complex+ Zinc) INN/BP', NULL, 'Desc Of', 67, 'Y', 1, '2017-11-08 04:19:07', NULL, NULL),
(285, 'Multivitamin + Multi Minerals A-Z', NULL, 'Desc Of', 67, 'Y', 1, '2017-11-08 04:19:24', NULL, NULL),
(286, '(Antioxidant+Vitamins+Multimineral) BP/USP', NULL, 'Desc Of', 67, 'Y', 1, '2017-11-08 04:19:39', NULL, NULL),
(287, 'Zinc Sulphate USP', NULL, 'Desc Of', 67, 'Y', 1, '2017-11-08 04:19:53', NULL, NULL),
(288, 'Calcium Orotate INN', NULL, 'Desc Of', 67, 'Y', 1, '2017-11-08 04:36:49', NULL, NULL),
(289, 'Sharbat Amla', NULL, 'Desc Of', 68, 'Y', 1, '2017-11-09 04:17:31', NULL, NULL),
(290, 'Qurs Penitab', NULL, 'Desc Of', 69, 'Y', 1, '2017-11-09 04:17:58', NULL, NULL),
(291, 'Sharbat Gheekowar', NULL, 'Desc Of', 70, 'Y', 1, '2017-11-09 04:18:37', NULL, NULL),
(292, 'Syrup Hazmina', NULL, 'Desc Of', 71, 'Y', 1, '2017-11-09 04:19:12', NULL, NULL),
(293, 'Black Seed Oil ', NULL, 'Desc Of', 72, 'Y', 1, '2017-11-09 04:19:49', NULL, NULL),
(294, 'Syrup Musaffi', NULL, 'Desc Of', 73, 'Y', 1, '2017-11-09 04:20:16', NULL, NULL),
(295, 'Chirata', NULL, 'Desc Of', 74, 'Y', 1, '2017-11-09 04:20:43', NULL, NULL),
(296, 'Syrup Deenar', NULL, 'Desc Of', 75, 'Y', 1, '2017-11-09 04:21:08', NULL, NULL),
(297, 'Syrup Misali', NULL, 'Desc of', 76, 'Y', 1, '2017-11-09 04:21:39', NULL, NULL),
(298, 'Habbe Nishat', NULL, 'Desc Of', 77, 'Y', 1, '2017-11-09 04:22:04', NULL, NULL),
(299, 'Syrup Atfal', NULL, 'Desc of', 78, 'Y', 1, '2017-11-09 04:22:29', NULL, NULL),
(300, 'Syrup Niswan', NULL, 'Desc Of', 79, 'Y', 1, '2017-11-09 04:22:52', NULL, NULL),
(301, 'Syrup Buzuri', NULL, 'Desc of', 80, 'Y', 1, '2017-11-09 04:23:40', NULL, NULL),
(302, 'Aloe Vera Extract', NULL, 'Desc Of', 81, 'Y', 1, '2017-11-09 04:39:51', NULL, NULL),
(303, 'Andrographis', NULL, 'Desc Of', 82, 'Y', 1, '2017-11-09 04:40:39', NULL, NULL),
(304, 'Ginkgo Biloba', NULL, 'Desc Of', 83, 'Y', 1, '2017-11-09 04:41:12', NULL, NULL),
(305, 'Saccharomyces boulardii', NULL, 'Desc Of', 98, 'Y', 1, '2017-11-09 04:41:42', NULL, NULL),
(306, 'Dandelion', NULL, 'Desc Of', 85, 'Y', 1, '2017-11-09 04:42:07', NULL, NULL),
(307, 'Adhatoda Vasica & Other Ingredients', NULL, 'Desc Of', 86, 'Y', 1, '2017-11-09 04:42:37', NULL, NULL),
(308, 'St. John''s Wort', NULL, 'Desc Of', 87, 'Y', 1, '2017-11-09 04:43:04', NULL, NULL),
(309, 'Garlic oil', NULL, 'Desc Of', 88, 'Y', 1, '2017-11-09 04:43:39', NULL, NULL),
(310, 'Ginseng', NULL, 'Desc Of', 89, 'Y', 1, '2017-11-09 04:45:01', NULL, NULL),
(311, 'Silymarin', NULL, 'Desc of', 90, 'Y', 1, '2017-11-09 04:45:26', NULL, NULL),
(312, 'Ispaghula Husk', NULL, 'Desc Of', 92, 'Y', 1, '2017-11-09 04:46:26', NULL, NULL),
(313, 'Bitter Melon (korola)', NULL, 'Desc Of', 93, 'Y', 1, '2017-11-09 04:46:48', NULL, NULL),
(314, 'Peppermint Oil', NULL, 'Desc Of', 94, 'Y', 1, '2017-11-09 04:47:18', NULL, NULL),
(315, 'Echinacea Purpurea', NULL, 'Desc Of', 95, 'Y', 1, '2017-11-09 04:47:54', NULL, NULL),
(316, 'Saw Palmetto', NULL, 'Desc Of', 96, 'Y', 1, '2017-11-09 04:49:36', NULL, NULL),
(317, 'Evening Primrose Oil', NULL, 'Desc Of', 97, 'Y', 1, '2017-11-09 04:50:02', NULL, NULL),
(318, 'Probiotic Combination', NULL, 'Desc of', 98, 'Y', 1, '2017-11-09 04:50:52', NULL, NULL),
(319, 'Spirulina', NULL, 'Desc Of', 99, 'Y', 1, '2017-11-09 04:51:33', NULL, NULL),
(320, 'Ivy & Thyme Extract', NULL, 'Desc Of', 100, 'Y', 1, '2017-11-09 04:52:03', NULL, NULL),
(321, 'Ferrous Sulphate+Folic Acid BP', NULL, 'Desc Of', 101, 'Y', 1, '2017-11-09 22:51:49', NULL, NULL),
(322, 'Ferrous Sulphate+Folic Acid BP+Zinc Sulphate Monohydrate BP', NULL, 'Desc Of', 101, 'Y', 1, '2017-11-09 22:52:12', NULL, NULL),
(323, 'Elemental Iron (As Carbonyl Iron INN)+ Folic Acid USP+ Zinc Sulphate Monohydrate USP', NULL, 'Desc Of\r\n', 101, 'Y', 1, '2017-11-09 22:52:37', NULL, NULL);

-- --------------------------------------------------------

--
-- Table structure for table `drg_global_achivement`
--

CREATE TABLE IF NOT EXISTS `drg_global_achivement` (
  `ACHIVEMENT_ID` int(10) unsigned NOT NULL AUTO_INCREMENT COMMENT 'Primary Key',
  `INSERT_FILES` varchar(255) NOT NULL DEFAULT '' COMMENT 'Category name',
  `INSERTS_PDF` varchar(255) NOT NULL,
  `ACHIVEMENT_DESC` varchar(2000) NOT NULL DEFAULT '' COMMENT 'Category short description',
  `ACTIVE_STATUS` enum('Y','N') NOT NULL DEFAULT 'Y' COMMENT 'Y=Active, N=Inactive',
  `CRE_BY` int(10) unsigned NOT NULL DEFAULT '0' COMMENT 'Who Created the row',
  `CRE_DT` timestamp NOT NULL DEFAULT '0000-00-00 00:00:00' COMMENT 'Created  Date and Time',
  `UPD_BY` int(10) unsigned DEFAULT NULL COMMENT 'Who Updated the row',
  `UPD_DT` datetime DEFAULT NULL COMMENT 'Last Update Date and Time',
  `ORDER_NO` int(10) unsigned NOT NULL DEFAULT '0',
  PRIMARY KEY (`ACHIVEMENT_ID`)
) ENGINE=InnoDB  DEFAULT CHARSET=utf8 AUTO_INCREMENT=32 ;

--
-- Dumping data for table `drg_global_achivement`
--

INSERT INTO `drg_global_achivement` (`ACHIVEMENT_ID`, `INSERT_FILES`, `INSERTS_PDF`, `ACHIVEMENT_DESC`, `ACTIVE_STATUS`, `CRE_BY`, `CRE_DT`, `UPD_BY`, `UPD_DT`, `ORDER_NO`) VALUES
(25, 'uploads/achivement/1.jpg', 'uploads/achivementpdf/NAFDAC_Certificate_for_Unit2.pdf', 'Desc of', 'Y', 1, '2017-11-16 03:14:28', NULL, NULL, 0),
(26, 'uploads/achivement/2.jpg', 'uploads/achivementpdf/NAFDAC_Certificate_for_Unit1.pdf', 'Desc of', 'Y', 1, '2017-11-16 03:16:37', NULL, NULL, 0),
(29, 'uploads/achivement/3.jpg', 'uploads/achivementpdf/NAFDAC_Certificate_for_Unit2.pdf', 'desc of', 'Y', 1, '2017-11-16 03:20:22', NULL, NULL, 0),
(30, 'uploads/achivement/4.jpg', 'uploads/achivementpdf/Aclene_Plus_PDF.pdf', 'DESC oF', 'Y', 1, '2017-11-20 05:23:47', NULL, NULL, 0),
(31, 'uploads/achivement/1.JPG', 'uploads/achivementpdf/ALBASINE3.pdf', 'DESc OF', 'Y', 1, '2017-11-20 05:24:20', NULL, NULL, 0);

-- --------------------------------------------------------

--
-- Table structure for table `drg_medicine_cat`
--

CREATE TABLE IF NOT EXISTS `drg_medicine_cat` (
  `CAT_ID` int(10) unsigned NOT NULL AUTO_INCREMENT COMMENT 'Primary Key',
  `CAT_NAME` varchar(255) NOT NULL DEFAULT '' COMMENT 'Category name',
  `CAT_DESC` varchar(2000) NOT NULL DEFAULT '' COMMENT 'Category short description',
  `ACTIVE_STAT` enum('Y','N') NOT NULL DEFAULT 'Y' COMMENT 'Y=Active, N=Inactive',
  `PARENT_CAT_ID` int(10) unsigned NOT NULL DEFAULT '0' COMMENT 'Parent Category ID For Generating Category Tree',
  `CRE_BY` int(10) unsigned NOT NULL DEFAULT '0' COMMENT 'Who Created the row',
  `CRE_DT` timestamp NOT NULL DEFAULT '0000-00-00 00:00:00' COMMENT 'Created  Date and Time',
  `UPD_BY` int(10) unsigned DEFAULT NULL COMMENT 'Who Updated the row',
  `UPD_DT` datetime DEFAULT NULL COMMENT 'Last Update Date and Time',
  `ORDER_NO` int(10) unsigned NOT NULL DEFAULT '0',
  PRIMARY KEY (`CAT_ID`)
) ENGINE=InnoDB  DEFAULT CHARSET=utf8 AUTO_INCREMENT=8 ;

--
-- Dumping data for table `drg_medicine_cat`
--

INSERT INTO `drg_medicine_cat` (`CAT_ID`, `CAT_NAME`, `CAT_DESC`, `ACTIVE_STAT`, `PARENT_CAT_ID`, `CRE_BY`, `CRE_DT`, `UPD_BY`, `UPD_DT`, `ORDER_NO`) VALUES
(4, 'Pharmaceuticals', '', 'Y', 0, 0, '0000-00-00 00:00:00', NULL, NULL, 0),
(5, 'Unani', 'Desc of', 'Y', 0, 1, '2017-11-09 04:11:58', NULL, NULL, 0),
(6, 'Herbal', 'Desc of', 'Y', 0, 1, '2017-11-09 04:25:49', NULL, NULL, 0);

-- --------------------------------------------------------

--
-- Table structure for table `drg_medicine_img`
--

CREATE TABLE IF NOT EXISTS `drg_medicine_img` (
  `MED_IMG_ID` int(10) unsigned NOT NULL AUTO_INCREMENT,
  `MEDICINE_ID` int(10) unsigned NOT NULL DEFAULT '0',
  `IMAGE_URL` varchar(255) NOT NULL DEFAULT '',
  `IMG_DESC` text NOT NULL,
  `ACTIVE_STATUS` enum('Y','N') NOT NULL DEFAULT 'Y',
  `CRE_BY` int(10) unsigned NOT NULL DEFAULT '0',
  `CRE_DT` timestamp NOT NULL DEFAULT '0000-00-00 00:00:00',
  `UPD_BY` int(10) unsigned DEFAULT NULL,
  `UPD_DT` datetime DEFAULT NULL,
  PRIMARY KEY (`MED_IMG_ID`),
  KEY `FK_drg_medicine_img_1` (`MEDICINE_ID`)
) ENGINE=InnoDB  DEFAULT CHARSET=utf8 AUTO_INCREMENT=69 ;

--
-- Dumping data for table `drg_medicine_img`
--

INSERT INTO `drg_medicine_img` (`MED_IMG_ID`, `MEDICINE_ID`, `IMAGE_URL`, `IMG_DESC`, `ACTIVE_STATUS`, `CRE_BY`, `CRE_DT`, `UPD_BY`, `UPD_DT`) VALUES
(37, 717, 'uploads/images/ASLOR.jpg', 'uploads/images/ASLOR.jpg', 'Y', 0, '2017-11-02 00:16:51', NULL, NULL),
(38, 718, 'uploads/images/CETRIN.jpg', 'uploads/images/CETRIN.jpg', 'Y', 0, '2017-11-02 00:21:19', NULL, NULL),
(39, 719, 'uploads/images/CLARIGEN.jpg', 'uploads/images/CLARIGEN.jpg', 'Y', 0, '2017-11-02 00:23:42', NULL, NULL),
(40, 720, 'uploads/images/DIPA.jpg', 'uploads/images/DIPA.jpg', 'Y', 0, '2017-11-02 00:26:45', NULL, NULL),
(43, 723, 'uploads/images/FENAT.jpg', 'uploads/images/FENAT.jpg', 'Y', 0, '2017-11-02 00:39:06', NULL, NULL),
(47, 728, 'uploads/images/FEXOFAST-50ml.jpg', 'uploads/images/FEXOFAST-50ml.jpg', 'Y', 0, '2017-11-02 01:56:39', NULL, NULL),
(51, 732, 'uploads/images/LORAT.jpg', 'uploads/images/LORAT.jpg', 'Y', 0, '2017-11-02 02:35:38', NULL, NULL),
(52, 733, 'uploads/images/DOXOMA-200.jpg', 'uploads/images/O', 'Y', 0, '2017-11-02 02:41:21', NULL, NULL),
(54, 735, 'uploads/images/M-KAST-4.jpg', 'uploads/images/-', 'Y', 0, '2017-11-02 02:52:45', NULL, NULL),
(55, 736, 'uploads/images/ROFUMIL.jpg', 'uploads/images/ROFUMIL.jpg', 'Y', 0, '2017-11-02 02:55:49', NULL, NULL),
(56, 737, 'uploads/images/THEOVENT SR-200.jpg', 'uploads/images/H', 'Y', 0, '2017-11-02 02:58:14', NULL, NULL),
(57, 738, 'uploads/images/ventil.jpg', 'uploads/images/ventil.jpg', 'Y', 0, '2017-11-02 03:05:56', NULL, NULL),
(58, 739, 'uploads/images/VENTIL_ PLUS.jpg', 'uploads/images/VENTIL_ PLUS.jpg', 'Y', 0, '2017-11-02 03:08:50', NULL, NULL),
(61, 742, 'uploads/images/seraflo.jpg', 'uploads/images/e', 'Y', 0, '2017-11-02 04:10:47', NULL, NULL),
(62, 743, 'uploads/images/SERAVENT.jpg', 'uploads/images/SERAVENT.jpg', 'Y', 0, '2017-11-02 04:14:58', NULL, NULL),
(63, 744, 'uploads/images/BECOVENT.jpg', 'uploads/images/BECOVENT.jpg', 'Y', 0, '2017-11-02 04:17:31', NULL, NULL),
(64, 745, 'uploads/images/M-Son.jpg', 'uploads/images/M-Son.jpg', 'Y', 0, '2017-11-02 04:27:44', NULL, NULL),
(65, 746, 'uploads/images/Rhinocort.jpg', 'uploads/images/Rhinocort.jpg', 'Y', 0, '2017-11-02 04:31:00', NULL, NULL),
(66, 747, 'uploads/images/THEOVENT SR-200.jpg', 'uploads/images/THEOVENT SR-200.jpg', 'Y', 0, '2017-11-02 04:34:34', NULL, NULL),
(67, 748, 'uploads/images/Pednisol-5.jpg', 'uploads/images/e', 'Y', 0, '2017-11-02 04:39:12', NULL, NULL),
(68, 749, 'uploads/images/VENTIL_ PLUS.jpg', 'uploads/images/VENTIL_ PLUS.jpg', 'Y', 0, '2017-11-02 04:41:51', NULL, NULL);

-- --------------------------------------------------------

--
-- Table structure for table `drg_medicine_info`
--

CREATE TABLE IF NOT EXISTS `drg_medicine_info` (
  `MEDICINE_ID` int(10) unsigned NOT NULL AUTO_INCREMENT,
  `MEDICINE_NAME` varchar(255) NOT NULL DEFAULT '',
  `GN_GRP_ID` int(10) unsigned NOT NULL DEFAULT '0',
  `MEDICINE_DESC` text,
  `INSERT_FILE` varchar(45) DEFAULT NULL,
  `CRE_BY` int(10) unsigned DEFAULT NULL,
  `CRE_DT` timestamp NOT NULL DEFAULT '0000-00-00 00:00:00',
  `UPD_BY` int(10) unsigned DEFAULT NULL,
  `UPD_DT` datetime DEFAULT NULL,
  `IS_LATEST` enum('Y','N') NOT NULL DEFAULT 'N',
  `ACTIVE_STATUS` enum('Y','N') NOT NULL DEFAULT 'Y',
  `CAT_ID` int(10) unsigned NOT NULL DEFAULT '0',
  `PRODUCT_FET_PHOTO` varchar(255) DEFAULT NULL,
  PRIMARY KEY (`MEDICINE_ID`),
  KEY `FK_drg_medicine_info_1` (`GN_GRP_ID`),
  KEY `FK_drg_medicine_info_2` (`CAT_ID`)
) ENGINE=InnoDB  DEFAULT CHARSET=utf8 AUTO_INCREMENT=1185 ;

--
-- Dumping data for table `drg_medicine_info`
--

INSERT INTO `drg_medicine_info` (`MEDICINE_ID`, `MEDICINE_NAME`, `GN_GRP_ID`, `MEDICINE_DESC`, `INSERT_FILE`, `CRE_BY`, `CRE_DT`, `UPD_BY`, `UPD_DT`, `IS_LATEST`, `ACTIVE_STATUS`, `CAT_ID`, `PRODUCT_FET_PHOTO`) VALUES
(717, 'ASLOR ', 43, '<p><strong>Composition :</strong>Desloratadine 5mg Tablet. <strong></strong></p><p><strong>Indications :</strong>Allergic Rhinitis :\r\nDesloratadine is indicated for the relief of\r\nthe nasal and non-nasal symptoms of\r\nallergic rhinitis (seasonal and perennial)\r\nin patients 12 years of age or older.\r\nChronic Idiopathic Urticaria :\r\nDesloratadine is indicated for the\r\nsymptomatic relief of pruritus, reduction\r\nin the number of hives and size of hives\r\nin patients with Chronic Idiopathic\r\nUrticaria 12 years of age and older.initis :\r\nDesloratadine is indicated for the relief of\r\nthe nasal and non-nasal symptoms of\r\nallergic rhinitis (seasonal and perennial)\r\nin patients 12 years of age or older.\r\nChronic Idiopathic Urticaria :\r\nDesloratadine is indicated for the\r\nsymptomatic relief of pruritus, reduction\r\nin the number of hives and size of hives\r\nin patients with Chronic Idiopathic\r\nUrticaria 12 years of age and older.<strong><br></strong></p><p><strong>Contraindication :</strong>  Adults and\r\n12 years of age or older children 5mg\r\nonce daily. Child 6-11 years: 2.5mg once\r\ndaily, 1-5 years: 1.25mg once daily.\r\nPatients with liver or renal impairment : A\r\nstarting dose of one Aslor tablet\r\n(Desloratadine 5mg) every other day is\r\nrecommended. Or, as directed by the\r\nregistered physician.<br></p><p><strong>Use in pregnancy and lactation :</strong> </p><p>Desloratadine has been assigned to\r\npregnancy category C by the FDA.<br></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Aslor tablet : 10 x 10''s tablets\r\nin blister pack.</span><br></p>', 'uploads/images/49.jpg', 1, '2017-11-29 05:40:18', NULL, NULL, '', 'Y', 4, 'uploads/IMG/49.jpg'),
(718, 'CETRIN  ', 30, '<p><strong>Composition :</strong>Cetirizine Dihydrochloride 10mg Tablet.<strong></strong></p><p style="margin-bottom: 10px; color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;="" background-color:="" rgb(255,="" 255,="" 255);"=""><strong>Indication :  </strong><span class="redactor-invisible-space">Cetrin is indicated in -\r\nJ Allergic rhinitis for relief from nasal\r\ncongestion, sneezing, rhinorrhoea,\r\nocular symptoms like redness,\r\nlacrimation and itching. J Allergic\r\ndermatological conditions like urticaria,\r\ndermographism, atopic eczema and\r\ncontact dermatitis. J Acute allergic\r\nreactions due to drugs, foods insect\r\nbites, etc.</span><br></p><p style="margin-bottom: 10px; color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;="" background-color:="" rgb(255,="" 255,="" 255);"=""><strong>Dosage and administration :  </strong><span class="redactor-invisible-space">Cetrin\r\ntablet : Adults and children 12 years and\r\nolder : one Cetrin tablet (10mg) once\r\ndaily.</span><br></p><p style="margin-bottom: 10px; color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;="" background-color:="" rgb(255,="" 255,="" 255);"=""><strong>Use in pregnancy and lactation :</strong>  Pregnancy category B by FDA.<strong><br></strong></p><p><strong>Packing : </strong>10x10''s tablets in blister pack.</p>', 'uploads/images/26.jpg', 1, '2017-11-29 05:10:35', NULL, NULL, '', 'Y', 4, 'uploads/IMG/cetrin.jpg'),
(719, 'CLARIGEN ', 78, '<p><strong>Composition : </strong><span class="redactor-invisible-space">Levocetirizine\r\nDihydrochloride 5mg Tablet<strong>.</strong></span><strong></strong></p><p style="margin-bottom: 10px; color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;="" background-color:="" rgb(255,="" 255,="" 255);"=""><strong>Indication : </strong>Clarigen is indicated for\r\nthe treatment of Seasonal allergic\r\nrhinitis, Perennial allergic rhinitis, chronic\r\nidiopathic urticaria, Food allergy, Allergic\r\nbronchial asthma, Eczema.<strong><br></strong></p><p style="margin-bottom: 10px; color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;="" background-color:="" rgb(255,="" 255,="" 255);"=""><strong>Dosage and administration :  </strong><span class="redactor-invisible-space">Levocetirizine is indicated for all ages\r\nabove six years. It should be taken as a\r\nsingle dose with or without food. Adult :\r\nOne Levocetirizine 5mg tablet once daily.\r\nChildren &gt; 6 years : One Levocetirizine\r\ntablet (5mg) once daily. Dose adjustment\r\nis indicated in moderate or severe renal\r\nimpairment. A reduction in the dose of\r\nLevocetirizine by 50% should be\r\nconsidered in patients with moderate to\r\nsevere renal dysfunction. Or, as directed\r\nby the registered physician.</span><strong><br></strong></p><p style="margin-bottom: 10px; color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;="" background-color:="" rgb(255,="" 255,="" 255);"=""><strong>Use in pregnancy and lactation :</strong>Levocetirizine has been assigned to\r\nPregnancy Category B by the FDA.<strong><br></strong></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Clarigen Tablet : 10x10''s\r\ntablets in blister pack.</span><strong></strong></p>', 'uploads/images/CLARIGEN.jpg', 1, '2017-11-28 00:44:29', NULL, NULL, '', 'Y', 4, 'uploads/IMG/clarigen.jpg'),
(720, 'DIPA ', 122, '<p><strong></strong><strong>Composition : </strong>Rupatadine 10mg Tablet<strong></strong></p><p><strong>Indication : </strong>It is indicated for the\r\nsymptomatic treatment of allergic rhinitis and\r\nurticaria.</p><p><strong>Dosage and administration :  </strong><span class="redactor-invisible-space">Adults and\r\nadolescents (over 12 years of age) -The\r\nrecommended dose is 10 mg once daily, with\r\nor without food. Or, as directed by the\r\nregistered physician.</span><strong><br></strong></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Rupatadine has been assigned to Pregnancy\r\nCategory B by the FDA.</span></p><p><strong>Packing :</strong>  3x10''s tablets in blister pack.<span></span><br></p>', 'uploads/images/DIPA.jpg', 1, '2017-11-29 04:30:54', NULL, NULL, '', 'Y', 4, 'uploads/IMG/dipa.jpg'),
(723, 'FENAT ', 74, '<p><strong></strong><strong>Composition :</strong>Ketotifen 1mg Tablet &\r\n1mg/5ml Syrup.<strong></strong></p><p><strong>Indication :</strong>: 1. Bronchial asthma as a\r\nprophylactic treatment. 2. Symptomatic\r\ntreatment of allergic conditions including\r\nrhinitis and conjunctivitis.</p><p><strong>Dosage and administration</strong> :</p><p>Fenat Tablet :\r\nAdults- 1mg twice daily with food. If\r\nnecessary the dose may be increased to\r\n2mg twice daily. Children from 2 years-\r\n0.5mg to 1mg twice daily with food.\r\nElderly- Same as adults or as advised by\r\nthe registered physician. <strong></strong></p><p><strong>Use in pregnancy and lactation </strong>: Pregnancy category C by the FDA.<strong><br></strong></p><p><strong>Packing :</strong>Fenat Tablet : 10 x 10''s tablets\r\nin blister pack.<span></span><br></p>', 'uploads/images/FENAT.jpg', 1, '2017-11-26 06:03:28', NULL, NULL, '', 'Y', 4, 'uploads/IMG/fenat-1.jpg'),
(728, 'FEXOFAST', 61, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Fexofenadine Hydrochloride\r\n60mg, 120mg, 180mg Tablet & 30mg/5ml\r\nSuspension.</span><strong></strong></p><p><strong>Indication : </strong>Fexofenadine Hydrochloride is\r\nindicated for the relief from physical\r\nsymptoms associated with seasonal allergic\r\nrhinitis and treatment of chronic idiopathic\r\nurticaria. It is not cure totally but prevents the\r\naggravation of rhinitis and urticaria. It reduces\r\nthe severity of the symptoms and providing\r\nmuch relief from repeated sneezing, runny\r\nnose, itchy eyes and general body fatigue\r\ncaused by rhinitis and urticaria.</p><p><strong>Dosage and administration :  </strong><span class="redactor-invisible-space">Fexofast\r\ntablets: Seasonal allergic rhinitis and chronic\r\nidiopathic urticaria: Adults and Children 12\r\nYears and Older: The recommended dose of\r\nFexofenadine Hydrochloride is 60 mg twice\r\ndaily or 180 mg once daily with water. A dose\r\nof 60 mg once daily is recommended as the\r\nstarting dose in patients with decreased renal\r\nfunction. Children 6 to 11 Years: 30 mg twice\r\ndaily with water. A dose of 30 mg once daily\r\nis recommended as the starting dose in\r\npatients with decreased renal function.</span><strong><br></strong></p><p><strong>Use in pregnancy and lactation :  </strong><span class="redactor-invisible-space">Fexofenadine has been assigned to\r\npregnancy category C by the FDA.</span><strong><br></strong></p><p><strong>Packing : </strong></p><p><strong> </strong>Fexofast-60 : 5x 10''s tablets in blister pack.</p><p><span class="redactor-invisible-space">\r\nFexofast-120 : 3x 10''s tablets in blister pack.</span></p><p><span class="redactor-invisible-space">\r\nFexofast-180 : 2x10''s tablets in blister pack. </span></p><p>Fexofast Suspension : 50ml suspension.<span></span><br></p>', 'uploads/files/FEXOFAST-50ml.jpg', 1, '2017-11-29 03:30:34', NULL, NULL, '', 'Y', 4, 'uploads/IMG/fexofast-30.jpg'),
(732, 'LORAT ', 75, '<p><strong></strong><strong>Composition :</strong>: Loratadine 10mg Tablet.<strong></strong></p><p><strong>Indication : </strong>Lorat tablet is indicated in\r\nadults for the relief of symptoms\r\nassociated with seasonal and perennial\r\nallergic rhinitis, such as sneezing, nasal\r\ndischarge and itching and ocular itching\r\nand burning. Nasal and ocular signs and\r\nsymptoms are relieved rapidly after oral\r\nadministration. Lorat tablet is also\r\nindicated for the relief of symptoms\r\nassociated with idiopathic chronic urticaria</p><p><strong>Dosage and administration :</strong>Adults and\r\nchildren 12 years of age and over : One\r\nLorat 10mg tablet once daily or, as\r\ndirected by the physician.<strong><br></strong></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Loratadine has been assigned to\r\nPregnancy Category B by the FDA</span><strong><br></strong></p><p><strong>Packing :  </strong><span class="redactor-invisible-space">10 x 10''s tablets in blister\r\npack.</span><span></span><br></p>', 'uploads/files/LORAT.jpg', 1, '2017-11-27 23:52:07', NULL, NULL, '', 'Y', 4, 'uploads/IMG/lorat.jpg'),
(733, 'DOXOMA', 53, '<p><strong></strong><strong>Composition : </strong>Each Metered dose (Puff) contains Beclometasone Dipropionate 100 mcg.<strong></strong></p><p><strong>Indication : </strong>Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration,</p><p> where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. <strong><br></strong></p><p><strong>Dosage and administration : </strong>Becovent inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled Becovent appropriate to the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to individual response. Management of chronic asthma (Adults & Children over 12 years): 100-400 mcg twice daily. Maximum 1000 mcg twice daily. Children (5-12 years): 100-200 mcg twice daily. the dose may be adjusted as necessary.<strong><br></strong></p><p><strong>Use in pregnancy and lactation : </strong>Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.<strong><br></strong></p><p><strong>Packing : </strong>Becovent HFA Inhaler : Each box contains one inhaler of 200 Puffs<span></span><br></p>', 'uploads/images/DOXOMA_syr.jpg', 1, '2017-11-02 02:41:21', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/doxoma-400.jpg'),
(735, 'M-KAST', 92, '<p><strong></strong><strong><em></em>Composition : </strong><span class="redactor-invisible-space">Montelukast 4mg, 5mg,\r\n10mg & 10mg chewable tablet.</span><strong></strong></p><p><strong>Indication :</strong>M-Kast is indicated for the\r\nprophylaxis and chronic treatment of\r\nasthma.</p><p><strong>Dosage and administration :  </strong><span class="redactor-invisible-space">Adolescents & adults (15 years of age or\r\nover) : 10mg daily to be taken in the\r\nevening. Pediatric (6-14 years of age) :\r\n5mg daily to be taken in the evening.\r\nPediatric (2-5 years of age) : 4mg daily\r\nto be taken in the evening. Safety and\r\neffectiveness of Montelukast in pediatric\r\npatients less than 12 months of age with\r\nasthma have not been established. Or,\r\nas directed by the registered physician.</span><strong><br></strong></p><p><strong>Use in pregnancy and lactation :  </strong><span class="redactor-invisible-space">Montelukast has been assigned to\r\npregnancy category B by the FDA.</span><strong><br></strong></p><p><strong>Packing : </strong></p><p><strong></strong>M-Kast 4 : 2x14''s tablets in blister pack.</p><p><span class="redactor-invisible-space">\r\nM-Kast 5 : 2x14''s tablets in blister pack. </span></p><p><span class="redactor-invisible-space">M-Kast 10 : 2x10''s tablets in blister\r\npack. </span></p><p><span class="redactor-invisible-space">M-Kast 10-C : 2x14''s tablets in blister\r\npack.</span><span></span><br></p>', 'uploads/images/M-KAST-4.jpg', 1, '2017-11-28 03:22:11', NULL, NULL, '', 'Y', 4, 'uploads/IMG/M-Kast-Chewable-Tablet.jpg'),
(736, 'ROFUMIL', 121, '<p><strong></strong><strong>Composition : </strong>Roflumilast 500mcg Tablet.<strong></strong></p><p><strong>Indication : </strong>Roflumilast is indicated for\r\nthe maintenance treatment of severe\r\nCOPD associated with chronic bronchitis\r\nwith a history of frequent exacerbation.</p><p><strong>Dosage and administration :  </strong><span class="redactor-invisible-space">The\r\nrecommended dose of Roflumilast is one\r\n500 microgram(mcg) tablet once daily.\r\nThe tablet should be swallowed with\r\nwater and can be taken with or without\r\nfood. Or, as directed by the registered\r\nphysician.</span><strong><br></strong></p><p><strong>Use in pregnancy and lactation :  </strong><span class="redactor-invisible-space">Roflumilast is pregnancy category C by\r\nthe FDA.</span><strong><br></strong></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Rofumil : 2x10''s tablets in\r\nblister pack.</span><span></span><br></p>', 'uploads/images/ROFUMIL.jpg', 1, '2017-12-29 23:47:34', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/rofumil.jpg'),
(737, 'THEOVENT SR', 138, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Theophylline 200mg, 300mg\r\n& 400mg Tablet</span><strong></strong></p><p><strong>Indication :  </strong><span class="redactor-invisible-space">Theovent-SR tablet is\r\nindicated for the treatment of the symptoms\r\nand reversible airflow obstruction\r\nassociated with chronic asthma and other\r\nchronic lung diseases, e.g., emphysema\r\nand chronic bronchitis. Also indicated for\r\nthe treatment of left ventricular and\r\ncongestive cardiac failure.</span><strong><br></strong></p><p><strong>Dosage and administration :  </strong><span class="redactor-invisible-space">TheoventSR\r\ntablets can be taken once a day in the\r\nmorning or evening. It is recommended that\r\nTheovent-SR should be taken with meals.\r\nTheovent-SR 200 : Dose 200mg every 12\r\nhours. Increased according to response to\r\n400mg every 12 hours. Theovent-SR 300 :\r\nOne tablet every 12 hours. Or as directed\r\nby the registered physician.</span><strong><br></strong></p><p><strong>Use in pregnancy and lactation :  </strong><span class="redactor-invisible-space">Theophylline has been assigned to\r\npregnancy category C by the FDA.</span><strong><br></strong></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Theovent-SR tablet : 5 x 10''s tablets in\r\nblister pack.\r\nTheovent-SR 200 : 10 x 10''s tablets in\r\nblister pack.\r\nTheovent-SR 300 : 10 x 10''s tablets in\r\nblister pack.</span><span></span><br></p>', 'uploads/images/THEOVENT SR-200.jpg', 1, '2017-11-27 04:26:39', NULL, NULL, '', 'Y', 4, 'uploads/IMG/theovent-sr.jpg'),
(738, 'VENTIL ', 123, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">: Each Metered dose\r\n(Puff) contains Salbutamol 100 mcg as\r\nSalbutamol Sulphate.</span><strong></strong></p><p><strong>Indication :</strong> Ventil is\r\nindicated for the treatment of prevention\r\nof bronchospasm in patients 4 years of\r\nage and older with reversible obstructive\r\nairway disease.</p><p><strong>Dosage and administration :  </strong><span class="redactor-invisible-space">For\r\ntreatment of acute episods of\r\nbronchospasm or prevention of\r\nasthmatic symptoms, the usual dosage\r\nfor adults and children 4 years of age\r\nand older is 2 inhalations repeated every\r\n4 to 6 hours; in some patients, 1\r\ninhalation every 4 hours may be\r\nsufficient. More frequent administration\r\nor a larger number of inhalations is not\r\nrecommended. Exercise-Induced\r\nBronchospasm Prevention: The usual\r\ndosage for adults and children 4 years\r\nand older is 2 inhalations 15 to 30\r\nminutes before exercise. Or, as directed\r\nby the registered physician.</span><strong><br></strong></p><p><strong>Use in pregnancy and lactation :</strong> There are no\r\nadequate and well- Controlled studies of\r\nSalbutamol sulphate in pregnant women.\r\nSalbutamol inhaler should be used\r\nduring pregnancy only if the potential\r\nbenefit justifies the potential risk to the\r\nfetus. It is not known whether the\r\ncomponents of Salbutamol excreted in\r\nhuman milk.<strong><br></strong></p><p><strong>Packing :</strong><em><strong> </strong></em><span class="redactor-invisible-space"><em><strong>Ventil HFA Inhaler : </strong></em>Each box\r\ncontains one inhaler of 200 Puffs.</span><span></span><br></p>', 'uploads/images/ventil.jpg', 1, '2017-11-27 04:18:24', NULL, NULL, '', 'Y', 4, 'uploads/IMG/Ventil-HFA-Inhaler.jpg'),
(739, 'VENTIL PLUS ', 124, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Each metered dose\r\n(puff) contains Salbutamol 100 mcg as\r\nSalbutamol Sulphate and Ipratropium\r\nBromide 20 mcg as Ipratropium Bromide\r\nMonohydrate.</span><strong></strong></p><p><strong>Indication : </strong>This Inhaler is indicated for\r\npatients with chronic obstructive\r\npulmonary disease (COPD) on a regular\r\naerosol bronchodilator who continue to\r\nhave evidence of bronchospasm and\r\nwho require a second bronchodilator.</p><p><strong>Dosage and administration :  </strong><span class="redactor-invisible-space">The\r\nrecommended dose of this inhaler is two\r\ninhalations four times a day. Patients\r\nmay take additional inhalations as\r\nrequired; however, the total number of\r\ninhalations should not exceed 12 in 24\r\nhours. Or, as directed by the registered\r\nphysician</span><strong><br></strong></p><p><strong>Use in pregnancy and lactation :  </strong><span class="redactor-invisible-space">There are no adequate and wellcontrolled\r\nstudies of Ventil Plus in\r\npregnant women. This Inhaler should be\r\nused during pregnancy only if the\r\npotential benefit justifies the potential risk\r\nto the fetus. It is not known whether the\r\ncomponents of Ventil Plus are excreted\r\nin human milk, caution should be\r\nexercised when this Inhaler is\r\nadministered to a nursing mother.</span><strong><br></strong></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Each box contains one inhaler of 200\r\nPuffs.</span><span></span><br></p>', 'uploads/images/VENTIL_ PLUS.jpg', 1, '2017-11-28 02:23:32', NULL, NULL, '', 'Y', 4, 'uploads/IMG/Ventil-Plus-HFA-Inhaler.jpg'),
(742, 'SERAFLO', 126, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Each metered dose\r\n(Puff) contains Salmeterol 25 mcg as\r\nSalmeterol Xinafoate and Fluticasone\r\nPropionate 250 mcg.</span><strong></strong></p><p><strong>Indication : </strong>This Inhaler is indicated\r\nin the regular treatment of asthma\r\nwhere use of a combination product\r\n(long-acting beta-2-agonist and inhaled\r\ncorticosteroid) is appropriate:\r\nPatients not adequately controlled with\r\ninhaled corticosteroids and "as\r\nneeded" inhaled short acting beta-2-\r\nagonist or, Patients already adequately\r\ncontrolled on both inhaled corticosteroid\r\nand long-acting beta-2-agonist.</p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Adults\r\nand adolescents 12 years and older :\r\nTwo inhalations of 25 micrograms\r\nsalmeterol and 250 micrograms\r\nfluticasone propionate twice daily. Or\r\nas directed by the registered physician.</span><strong><br></strong></p><p><strong>Use in pregnancy and lactation :  </strong><span class="redactor-invisible-space">Administration of drugs during pregnancy\r\nand lactation should only be considered\r\nif the expected benefit to the mother is\r\ngreater than any possible risk to the\r\nfoetus or child. There is insufficient\r\nexperience of the use of Salmeterol\r\nXinafoate and Fluticasone Propionate in\r\nhuman pregnancy and lactation. There\r\nare no data available for human breast\r\nmilk.</span><strong><br></strong></p><p><strong>Packing :</strong> Each\r\nbox contains one inhaler of 120 Puffs.<span></span><br></p>', 'uploads/images/seraflo.jpg', 1, '2017-11-27 05:14:23', NULL, NULL, '', 'Y', 4, 'uploads/IMG/Seraflo-25-125-HFA-Inhaler.jpg'),
(743, 'SERAVENT', 125, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Each metered dose\r\n(puff) contains Salmeterol 25 mcg as\r\nSalmeterol Xinafoate.</span></p><p><strong>Indication :</strong>  Seravent is indicated for\r\nreversible airways obstruction (including\r\nnocturnal asthma and prevention of\r\nexercise-included bronchospasm) in\r\npatients requiring long term regular\r\nbronchodilator therapy.<br></p><p><strong>Dosage and administration :</strong>  Adults: 50\r\nmicrograms (two puffs) twice daily. More\r\nsevere cases: 100 micrograms (four\r\npuffs) twice daily. Children 5-12 years: 50\r\nmicrograms (two puffs) twice daily. Or, as\r\ndirected by the registered physician.<strong><br></strong></p><p><strong><br></strong></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Each\r\nbox contains one inhaler of 200 Puffs.</span><span></span><br></p>', 'uploads/images/SERAVENT.jpg', 1, '2017-11-28 05:27:55', NULL, NULL, '', 'Y', 4, 'uploads/IMG/Seravent-HFA-Inhaler.jpg'),
(744, 'BECOVENT ', 16, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Each Metered dose (Puff)\r\ncontains Beclometasone Dipropionate 100\r\nmcg.</span><span class="redactor-invisible-space"></span><strong></strong></p><p><strong>Indication : </strong><span class="redactor-invisible-space">Becovent is indicated in the\r\nmaintenance treatment of asthma as\r\nprophylactic therapy in patients 5 years of\r\nage and older. Becovent is also indicated\r\nfor asthma patients who require systemic\r\ncorticosteroid administration, where adding\r\nBecovent may reduce or eliminate the need\r\nfor the systemic corticosteroids.</span></p><p><strong>Dosage and administration :  </strong><span class="redactor-invisible-space">Becovent\r\ninhaler is for oral inhalation use only.\r\nPatients should be given a starting dose of\r\ninhaled Becovent appropriate to the\r\nseverity of their disease. The dose may\r\nthen be adjusted until control is achieved or\r\nreduced to the minimum effective dose\r\naccording to individual response.\r\nManagement of chronic asthma (Adults\r\n& Children over 12 years): 100-400 mcg\r\ntwice daily. Maximum 1000 mcg twice daily.\r\nChildren (5-12 years): 100-200 mcg twice\r\ndaily. the dose may be adjusted as\r\nnecessary</span><span class="redactor-invisible-space"></span><strong><br></strong></p><p><strong>Packing :  </strong><span class="redactor-invisible-space">Each\r\nbox contains one inhaler of 200 Puffs.</span><br></p>', 'uploads/images/BECOVENT.jpg', 1, '2017-11-29 05:28:42', NULL, NULL, '', 'Y', 4, 'uploads/IMG/Becovent-HFA-Inhaler.jpg'),
(745, 'M-Son', 91, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Each metered spray\r\ncontains Mometasone Furoate 50mcg.</span><strong></strong></p><p><strong>Indication :</strong>This nasal spray is indicated\r\nfor the treatment of the nasal symptoms of\r\nseasonal & perennial allergic rhinitis in\r\nadults and pediatric patients 2 years of age\r\nand older. It is indicated for the prophylaxis\r\nof the nasal symptoms of seasonal allergic\r\nrhinitis in adult and adolescent patients 12\r\nyears of age and older. It is also indicated\r\nfor the treatment of nasal polyps in patients\r\n18 years of age and older.</p><p><strong>Dosage and administration :</strong><em>  Allergic\r\nrhinitis:</em> Adults & children 12 years of\r\nage and older: The recommended dose for\r\nprophylaxis & treatment of the nasal\r\nsymptoms of seasonal allergic rhinitis and\r\ntreatment of the nasal symptoms of\r\nperennial allergic rhinitis is 2 sprays in each\r\nnostril once daily. In patients with a known\r\nseasonal allergen that precipitates nasal\r\nsymptoms of seasonal allergic rhinitis,\r\nprophylaxis with this nasal spray, 50mcg\r\n(200 mcg/day) is recommended 2 to 4\r\nweeks prior to the anticipated start of the\r\npollen season.<strong><br></strong></p><p><strong><br></strong></p><p><strong>Packing :  </strong><span class="redactor-invisible-space">Each bottle contains 120\r\nmetered doses for sprays.</span><span></span><br></p>', 'uploads/images/M-Son.jpg', 1, '2017-11-28 03:20:13', NULL, NULL, '', 'Y', 4, 'uploads/IMG/m-son.jpg'),
(746, 'Rhinocort', 17, '<p><strong></strong><strong>Composition : </strong>Each Metered dose (Puff) contains Beclometasone Dipropionate 100 mcg.<strong></strong></p><p><strong>Indication : </strong>Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, </p><p>where adding Becovent may reduce or eliminate the need for the systemic corticosteroids.<strong> </strong><strong><br></strong></p><p><strong>Dosage and administration :</strong> Becovent inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled Becovent appropriate to the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to individual response. Management of chronic asthma (Adults & Children over 12 years): 100-400 mcg twice daily. Maximum 1000 mcg twice daily. Children (5-12 years): 100-200 mcg twice daily. the dose may be adjusted as necessary.<strong><br></strong></p><p><strong>Use in pregnancy and lactation : </strong>Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.<strong><br></strong></p><p><strong>Packing : </strong>Becovent HFA Inhaler : Each box contains one inhaler of 200 Puffs<span></span><br></p>', 'uploads/images/Rhinocort.jpg', 1, '2017-11-02 04:31:00', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/rhinocort.jpg'),
(747, 'Trialon', 146, '<p><strong></strong><strong>Composition :</strong><span class="redactor-invisible-space"> Triamcinolone Acetonide\r\n40mg/1ml (IM) Injection.</span><strong></strong></p><p><strong>Indication : </strong>Trialon is\r\nindicated for alleviating the joint pain,\r\nswelling and stiffness associated with\r\nrheumatoid arthritis and osteoarthrosis\r\nwith an inflammatory component, also for\r\nbursitis, epicondylitis and tenosynovitis.</p><p><strong>Dosage and administration :  </strong><span class="redactor-invisible-space">The dose of\r\nTrialon is dependent on the size of the\r\njoint to be treated and on the severity of\r\nthe condition. Doses of 2.5-5mg (0.0625-\r\n0.1250ml) for smaller joint and 5-15mg\r\n(0.125-0.375ml) for larger joints usually\r\nalleviate the symptoms. Trialon 40mg/ml\r\nis available to facilitate administration of\r\nlarger doses. Or, as directed by the\r\nregistered physician.</span><strong><br></strong></p><p><strong><br></strong></p><p><strong>Packing :  </strong>Trialon Injection IM : 1 x 3''s vials.<span></span><br></p>', 'uploads/images/THEOVENT SR-200.jpg', 1, '2017-11-27 04:32:11', NULL, NULL, '', 'Y', 4, 'uploads/IMG/trialon_spray.jpg'),
(748, 'Pednisol', 112, '<p><strong></strong><strong>Composition : </strong>Each Metered dose (Puff) contains Beclometasone Dipropionate 100 mcg.<strong></strong></p><p><strong>Indication : </strong>Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, </p><p>where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. <strong><br></strong></p><p><strong>Dosage and administration : </strong>Becovent inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled Becovent appropriate to the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to individual response. Management of chronic asthma (Adults & Children over 12 years): 100-400 mcg twice daily. Maximum 1000 mcg twice daily. Children (5-12 years): 100-200 mcg twice daily. the dose may be adjusted as necessary.<strong><br></strong></p><p><strong>Use in pregnancy and lactation : </strong>Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.<strong><br></strong></p><p><strong>Packing : </strong>Becovent HFA Inhaler : Each box contains one inhaler of 200 Puffs<span></span><br></p>', 'uploads/images/Pednisol-5.jpg', 1, '2017-11-02 04:39:12', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/pednisol-20.jpg'),
(749, 'Hydrasone', 70, '<p><strong></strong><strong>Composition : </strong>Each Metered dose (Puff) contains Beclometasone Dipropionate 100 mcg.<strong></strong></p><p><strong>Indication : </strong>Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, </p><p>where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. <strong><br></strong></p><p><strong>Dosage and administration : </strong>Becovent inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled Becovent appropriate to the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to individual response. Management of chronic asthma (Adults & Children over 12 years): 100-400 mcg twice daily. Maximum 1000 mcg twice daily. Children (5-12 years): 100-200 mcg twice daily. the dose may be adjusted as necessary.<strong><br></strong></p><p><strong>Use in pregnancy and lactation : </strong>Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.<strong><br></strong></p><p><strong>Packing : </strong>Becovent HFA Inhaler : Each box contains one inhaler of 200 Puffs<span></span><br></p>', 'uploads/images/VENTIL_ PLUS.jpg', 1, '2017-11-02 04:41:51', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/hydrason-100.jpg'),
(752, 'AZIMEX', 13, '<p><strong></strong><strong>Composition :</strong>Azithromycin 250mg & 500mg Tablet,\r\n200mg/5ml Suspension.</p><p><strong>Indication :</strong>Azithromycin is indicated for the treatment of\r\nAcute bacterial exacerbations of chronic obstructive\r\npulmonary disease, Acute bacterial sinusitis, Community\r\nacquired pneumonia due to Chlamydia pneumoniae.\r\nHaemophilus influenzae, Mycoplasma pneumoniae or\r\nStreptococcus pneumoniae in patients appropriate for oral\r\ntherapy. It is also indicated for pharyngitis, tonsillitis,\r\nuncomplicated skin and skin structure infections, urethritis\r\nand cervicitis and Genital ulcer disease.<br></p><p><strong>Dosage and administration :</strong>Infections\r\nCommunity acquired pneumonia (mild\r\nseverity), Pharyngitis / tonsillitis (second line\r\ntherapy), Skin / Skin structure infections\r\n(uncomplicated)\r\nAcute bacterial exacerbations of Chronic\r\nobstructive pulmonary disease (mild to\r\nmoderate)\r\nAcute bacterial sinusitis\r\nGenital ulcer disease (Chancroid)\r\nNon gonococcal urethritis and cervicitis\r\nGonococcal Urethritis and cervicitis</p><p><strong>Use in pregnancy and lactation</strong> :</p><p>Azimex-250 Tablet : 1 x 10''s tablet in blister pack.\r\nAzimex-500 Tablet : 3 x 3''s tablet in blister pack.\r\nAzimex Suspension : 15ml, 30ml and 50ml suspension.<strong></strong></p>', 'uploads/images/azimex_500.jpg', 1, '2017-11-26 06:10:34', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/azimex.jpg'),
(762, 'CLARIN', 39, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Clarithromycin 250mg &\r\n500mg Tablet.</span></p><p><strong>Indication :</strong>Clarin is indicated for the\r\ntreatment of mild to moderate infections\r\nlike pharyngitis, tonsillitis, acute maxillary\r\nsinusitis, acute bacterial exacerbation of\r\nchronic bronchitis, pneumonia,\r\nuncomplicated skin and skin structure\r\ninfections, disseminated mycobacterial\r\ninfections.Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. </p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Usual dose\r\nis 250mg twice daily, may be increased\r\nto 500mg twice daily, if necessary in\r\nsevere infection. A course is usually for 7\r\nto 14 days. In patients with severe renal\r\nimpairment dosage may need to be\r\nhalved to 250mg once daily or 250mg\r\ntwice daily in severe infection or as\r\ndirected by a registered physician.</span></p><p><br></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Clarin-250 : 1 x 10''s tablets in blister\r\npack.\r\nClarin-500 : 1 x 10''s tablets in blister\r\npack.</span></p>', 'uploads/images/clarin_500.jpg', 1, '2017-11-28 00:45:42', NULL, NULL, '', 'Y', 4, 'uploads/IMG/clarin.jpg'),
(763, 'ERYBAC', 57, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Erythromycin 250mg,\r\n500mg Tablet & 125mg/5ml Suspension.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">Erythromycin has been\r\nused in the treatment of a wide variety of\r\ninfections caused by susceptible\r\norganism. Its uses include bronchitis,\r\nsevere campylobacter enteritis,\r\nchancroid, diphtheria, and legionella\r\ninfection. It is used as an alternative to\r\npenicillin in penicillin-allergic patients\r\nwith various conditions like anthrax,\r\nactinomycosis, leptospirosis, pelvic\r\ninflammatory disease, pharyngitis, the\r\nprevention of perinatal streptococcal\r\ninfection and rheumatic fever. It is used\r\nas an alternative to tetracycline in\r\npatients with Chlamydia infections.</span></p><p><strong>Dosage and administration :<em> </em></strong><em></em></p><p><span class="redactor-invisible-space"><em>Adults\r\nand Children (over 8 years) : </em>The usual\r\ndose is 1gm/day in divided doses. This\r\nmay be increased upto 4gm per day\r\naccording to the severity of the infection.\r\nChildren : ( upto 8 years) : 30 mg / kg /\r\nday in divided dose. In severe infection,\r\nup to 50mg/kg/day in divided doses. or\r\ndirected by the registered physician.</span></p><p><strong><br></strong></p><p><strong>Packing : </strong></p><p><strong></strong><span class="redactor-invisible-space">Erybac-250 : 5 x 10''s tablets in blister\r\npack.</span></p><p><span class="redactor-invisible-space">\r\nErybac-500 : 6 x 5''s tablets in blister\r\npack.</span></p><p><span class="redactor-invisible-space">\r\nErybac : 100ml suspension.</span></p>', 'uploads/images/Erybac_250.jpg', 1, '2017-11-29 03:37:09', NULL, NULL, '', 'Y', 4, 'uploads/IMG/erybac.jpg'),
(764, 'ERYBAC Suspension', 57, '<p><strong>Composition : </strong><span class="redactor-invisible-space">Erythromycin 250mg, 500mg Tablet & 125mg/5ml Suspension.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">Erythromycin has been used in the treatment of a wide variety of infections caused by susceptible organism. Its uses include bronchitis, severe campylobacter enteritis, chancroid, diphtheria, and legionella infection. It is used as an alternative to penicillin in penicillin-allergic patients with various conditions like anthrax, actinomycosis, leptospirosis, pelvic inflammatory disease, pharyngitis, the prevention of perinatal streptococcal infection and rheumatic fever. It is used as an alternative to tetracycline in patients with Chlamydia infections.</span></p><p><strong>Dosage and administration :<em></em></strong><em></em></p><p><span class="redactor-invisible-space"><em>Adults and Children (over 8 years) : </em>The usual dose is 1gm/day in divided doses. This may be increased upto 4gm per day according to the severity of the infection. Children : ( upto 8 years) : 30 mg / kg / day in divided dose. In severe infection, up to 50mg/kg/day in divided doses. or directed by the registered physician.</span></p><p><strong><br></strong></p><p><strong>Packing :</strong></p><p><strong></strong><span class="redactor-invisible-space">Erybac-250 : 5 x 10''s tablets in blister pack.</span></p><p><span class="redactor-invisible-space">Erybac-500 : 6 x 5''s tablets in blister pack.</span></p><p>Erybac : 100ml suspension.</p>', 'uploads/images/Erybac_sus.jpg', 1, '2017-11-29 03:37:35', NULL, NULL, '', 'Y', 4, 'uploads/IMG/erybac-250.jpg'),
(765, 'Perinem-500', 52, '<p><strong></strong><strong>Composition :</strong> Each Metered dose (Puff) contains Beclometasone Dipropionate 100 mcg.</p><p><strong>Indication : </strong>Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. </p><p><strong>Dosage and administration : </strong>Becovent inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled Becovent appropriate to the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to individual response. Management of chronic asthma (Adults & Children over 12 years): 100-400 mcg twice daily. Maximum 1000 mcg twice daily. Children (5-12 years): 100-200 mcg twice daily. the dose may be adjusted as necessary.</p><p><strong>Use in pregnancy and lactation : </strong>Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.</p><p><strong>Packing : </strong>Becovent HFA Inhaler : Each box contains one inhaler of 200 Puffs</p>', 'uploads/images/Perinem-500.jpg', 1, '2017-11-05 00:20:11', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/Perinem-500-Injection.jpg'),
(766, 'Ropenem-500mg Injection', 86, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Meropenem 500mg & 1gm\r\ninjection.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">Meropenem IV is indicated for the\r\ntreatment, in adults and children, of the following\r\ninfections caused by single or multiple bacteria\r\nsensitive to Meropenem. These are as follows:\r\nPneumonias and nosocomial pneumonias,\r\nUrinary tract infections, Intra-abdominal\r\ninfections, Gynaecological Infections, such as\r\nendometritis Skin and Skin structure infections,\r\nMeningitis, septicaemia, Empiric treatment,\r\nincluding monotherapy, for presumed infections\r\nin adult patient with febrile neutropenia.</span></p><p><strong>Dosage and administration :</strong><strong> </strong></p><p><span class="redactor-invisible-space"><strong>Adults: </strong>The\r\ndosage and duration of therapy shall be\r\nestablished depending on type and severity of\r\ninfection and condition of the patient. The\r\nrecommended daily dosage is as fallow. 500mg IV\r\nevery 8 hours in the treatment of pneumonia, UTI,\r\nGynaecological infections such as endometritis,\r\nskin and skin structure infections. 1g IV every 8\r\nhours in the treatment of nosocomial pneumonias,\r\nperitonitis, presumed infections in neutropenic\r\npatients, Septicaemia. In cystic fibrosis, doses up\r\nto 2g every 8 hours have been used. In meningitis\r\nthe recommended dosage is 2g every 8 hours<strong>.\r\n</strong></span></p><p><span class="redactor-invisible-space"><strong>Children: </strong>For children over 3 months and up to\r\n12 years of age, the recommended dose is 10 to\r\n20 mg/kg every 8 hours depending on type and\r\nseverity of infection, susceptibility of the\r\npathogen and the condition of the patient. In\r\nchildren over 50 kg weight, adult dosage should\r\nbe used. In meningitis the recommended dose\r\nis 40 mg/kg every 8 hours. Or, as directed by\r\nregistered physician.\r\nMethod of Administration: Ropenem to be used\r\nfor bolus intravenous injection should be\r\nconstituted with sterile water for injection (5ml\r\nper 250mg meropenem). This provides an\r\napproximate available concentration of 50mg/ml.\r\nConstituted solutions are clear or pale yellow.<br></span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">: Meropenem\r\nhas been assigned to pregnancy category B by\r\nthe FDA</span></p><p><strong>Packing : </strong>1 Combipack.</p>', 'uploads/images/Ropenem_500.jpg', 1, '2017-11-28 00:28:31', NULL, NULL, '', 'Y', 4, 'uploads/IMG/Ropenem-Injection.jpg'),
(768, 'DEMOXIL', 11, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">: Amoxycillin 250mg, 500mg\r\nCapsule, 125mg/5ml Suspension, 250mg /\r\n5ml DS Suspension</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">Urinary tract infections :\r\nnephritis, pyelonephritis, pyelitis, cystitis,\r\ngonorrhoea and non-gonococcal urethritis.\r\nSkin and soft tissue infections : cellulitis,\r\nwounds, carbuncles and furunculosis.\r\nGastro-intestinal infections : enteric fever,\r\near, nose and throat infections, meningitis.</span></p><p><strong>Dosage and administration</strong> :</p><p><em><strong></strong>Oral :\r\n</em>Standard adult dosage : 250mg three times\r\ndaily, increasing to 500mg three times daily\r\nfor more severe infections.\r\nChildren (2 to 10 years) : 125mg three\r\ntimes daily, increasing to 250mg three\r\ntimes daily for more severe infection.\r\nInfants (Up to 2 years) : 62.5 - 125mg\r\nthree times daily or as directed by the\r\nphysician. In case of severity the dosage\r\nmay safely be increased. Food does not\r\ninterfere with absorption of Demoxil.</p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Amoxycillin has been assigned to\r\npregnancy category B by the FDA</span></p><p><strong>Packing :</strong></p><p><strong> </strong><span class="redactor-invisible-space">Demoxil 250mg Capsule : 5x10 capsules\r\nin blister pack.</span></p><p><span class="redactor-invisible-space">\r\nDemoxil 500mg Capsule : 5x10 capsules\r\nin blister pack.</span></p><p><span class="redactor-invisible-space">\r\nDemoxil : 100ml suspension.</span></p><p><span class="redactor-invisible-space">\r\nDemoxil-DS : 100ml suspension.</span></p>', 'uploads/images/Demoxil_500.jpg', 1, '2017-11-29 04:27:26', NULL, NULL, '', 'Y', 4, 'uploads/IMG/demoxil-125.jpg'),
(769, 'FLUPEN', 62, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Flucloxacillin 250mg,\r\n500mg Capsule & 125mg/5ml Dry Syrup.\r\n</span></p><p><strong>Indication :</strong>Flupen is indicated for the\r\ntreatment of infections due to Grampositive\r\norganisms, including infections\r\ncaused by b-lactamase-producing\r\nstaphylococci. </p><p><br></p><p>Typical indications\r\ninclude:Skin and soft tissue infections : boils,\r\nabscesses, carbuncles, infected skin\r\nconditions, e.g. ulcer, eczema and acne,\r\nfurunculosis, cellulitis, infected wounds,\r\ninfected burns, protection for skin grafts,\r\notitis media and externa, impetigo.</p><p>\r\nRespiratory tract infections :\r\npneumonia, lung abscess, empyema,\r\nsinusitis, pharyngitis, tonsillitis, quinsy.\r\nOther infections caused by Flupensensitive\r\norganisms : osteomyelitis,\r\nenteritis, endocarditis, urinary tract\r\ninfection, meningitis, septicaemia. </p><p><strong>Dosage and administration :</strong><em></em></p><p><em> </em><span class="redactor-invisible-space"><em>Oral :\r\n</em>Adults and the elderly: In mild to\r\nmoderate infections, 250mg (1 capsule)\r\n4 times daily, half to one hour before\r\nmeal.\r\nChildren : Children up to 2 years of age\r\nmay be given 125mg (1 teaspoonful)\r\nevery 6 hrs and those aged 2 to 10\r\nyears, 250mg (2 teaspoonfuls) every 6\r\nhrs, half to one hour before meal or as\r\ndirected by a registered physician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Flucloxacillin has been assigned to\r\npregnancy category B by the FDA.</span></p><p><strong>Packing : </strong></p><p><span class="redactor-invisible-space">Flupen-250 Capsule : 10x7''s capsules\r\nin blister pack.</span></p><p><span class="redactor-invisible-space">\r\nFlupen-500 Capsule : 3x7''s capsules in\r\nblister pack. </span></p><p><span class="redactor-invisible-space">Flupen Dry Syrup : 100ml bottle.\r\n<br></span></p>', 'uploads/images/Flupen_250.jpg', 1, '2017-11-29 03:28:33', NULL, NULL, '', 'Y', 4, 'uploads/IMG/Flupen-Dry-Syrup.jpg'),
(770, 'FLUPEN Dry Syrup', 62, '<p><strong>Composition : </strong><span class="redactor-invisible-space">Flucloxacillin 250mg, 500mg Capsule & 125mg/5ml Dry Syrup.</span></p><p><strong>Indication :</strong>Flupen is indicated for the treatment of infections due to Grampositive organisms, including infections caused by b-lactamase-producing staphylococci.</p><p><br></p><p>Typical indications include:Skin and soft tissue infections : boils, abscesses, carbuncles, infected skin conditions, e.g. ulcer, eczema and acne, furunculosis, cellulitis, infected wounds, infected burns, protection for skin grafts, otitis media and externa, impetigo.</p><p>Respiratory tract infections : pneumonia, lung abscess, empyema, sinusitis, pharyngitis, tonsillitis, quinsy. Other infections caused by Flupensensitive organisms : osteomyelitis, enteritis, endocarditis, urinary tract infection, meningitis, septicaemia.</p><p><strong>Dosage and administration :</strong><em></em></p><p><em></em><span class="redactor-invisible-space"><em>Oral : </em>Adults and the elderly: In mild to moderate infections, 250mg (1 capsule) 4 times daily, half to one hour before meal. Children : Children up to 2 years of age may be given 125mg (1 teaspoonful) every 6 hrs and those aged 2 to 10 years, 250mg (2 teaspoonfuls) every 6 hrs, half to one hour before meal or as directed by a registered physician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Flucloxacillin has been assigned to pregnancy category B by the FDA.</span></p><p><strong>Packing :</strong></p><p><span class="redactor-invisible-space">Flupen-250 Capsule : 10x7''s capsules in blister pack.</span></p><p><span class="redactor-invisible-space">Flupen-500 Capsule : 3x7''s capsules in blister pack.</span></p><p>Flupen Dry Syrup : 100ml bottle. </p>', 'uploads/images/Flupen_dr.jpg', 1, '2017-11-29 03:29:05', NULL, NULL, '', 'Y', 4, 'uploads/IMG/flunac-150.jpg');
INSERT INTO `drg_medicine_info` (`MEDICINE_ID`, `MEDICINE_NAME`, `GN_GRP_ID`, `MEDICINE_DESC`, `INSERT_FILE`, `CRE_BY`, `CRE_DT`, `UPD_BY`, `UPD_DT`, `IS_LATEST`, `ACTIVE_STATUS`, `CAT_ID`, `PRODUCT_FET_PHOTO`) VALUES
(771, 'Butibac ', 20, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Ceftibuten 400mg\r\nCapsule.</span></p><p><strong>Indication :</strong>Ceftibuten is used to treat\r\nacute bacterial exacerbations of chronic\r\nbronchitis (ABECB), acute bacterial otitis\r\nmedia, pharyngitis and tonsillitis. It is\r\nalso indicated for pneumonia, infections\r\nof the urinary tract, enteritis and\r\ngastroenteritis.Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. </p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">The usual\r\ndose of Ceftibuten is 400mg once\r\ndaily.Or, as directed by the registered\r\nphysician.</span></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Butibac 1 x 7''s capsules in\r\nblister pack.</span></p>', 'uploads/images/Butibac_cap.jpg', 1, '2017-11-29 05:27:39', NULL, NULL, '', 'Y', 4, 'uploads/IMG/butibac-400.jpg'),
(774, 'CEFORAN', 23, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Cefpodoxime 100mg, 200mg\r\nTablet, 40mg/5ml & 80mg/5ml Suspension. </span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">Cefpodoxime is indicated for the\r\ntreatment of- *Upper respiratory-tract infections,\r\n*Lower respiratory-tract infections, *Skin and\r\nsoft tissue infections, *Uncomplicated urinarytract\r\ninfections, *Sexually transmitted diseases.</span> </p><p><strong>Dosage and administration :</strong></p><p><strong></strong>Upper\r\nrespiratory-tract infections (but in pharyngitis\r\nand tonsillitis reserved for infections which are\r\nrecurrent, chronic, or resistant to other\r\nantibacterial), 100mg twice daily (200mg twice\r\ndaily in sinusitis) 14 days. *Lower respiratorytract\r\ninfections (including bronchitis and\r\npneumonia), 100mg to 200mg twice daily 10\r\ndays. *Skin and soft tissue infections, 200mg\r\ntwice daily 7 to 14 days. *Uncomplicated\r\nurinary-tract infections 100mg twice daily 7\r\ndays. (200mg twice daily in uncomplicated\r\nupper urinary-tract infections) *Uncomplicated\r\ngonorrhea & rectal gonococcal infection in\r\nwomen: 200mg as a single dose Children : 15\r\ndays to 6 months: 4mg/kg every 12 hours, 6\r\nmonths to 2 years : 40mg every 12 hours, 3 to 8\r\nyears : 80mg every 12 hours. Over 9 years :\r\n100mg every 12 hours. Patients with renal\r\ndysfunction: For patients with severe renal\r\nimpairment (creatinine clearance&lt;30ml/min) the\r\ndosing interval should be increased to 24 hourly.\r\nOr, as directed by the registered physician. </p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Cefpodoxime has been assigned to pregnancy\r\ncategory B by the FDA.</span></p><p><strong>Packing : </strong></p><p>Ceforan-100 : 2 x 7''s tablets in blister pack. </p><p>Ceforan-200 : 2 x 7''s tablets in blister pack. </p><p><span class="redactor-invisible-space">Ceforan Suspension : 50ml and 100ml\r\nsuspension. </span></p><p>Ceforan-DS Suspension : 50ml suspension.</p>', 'uploads/images/ceforan_ds.jpg', 1, '2017-11-29 05:11:56', NULL, NULL, '', 'Y', 4, 'uploads/IMG/ceforan-100.jpg'),
(775, 'Clavuran', 24, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Cefpodoxime + Clavulanic Acid;\r\n(100mg+62.5mg) & (200mg+125mg) Tablet.</span></p><p><strong>Indication :</strong>It is indicated in the following\r\ninfections when caused by susceptible\r\norganisms: Acute bacterial exacerbations of\r\nchronic bronchitis, Acute community\r\nacquired pneumonia, Upper and lower\r\nrespiratory tract infections, Skin and soft\r\ntissue infections, Urinary tract infections,\r\nPharyngitis and/or tonsillitis, General\r\ngonorrhea (men and women) and rectal\r\ngonococcal infections (women), Acute\r\nmaxillary sinusitis. </p><p><strong>Dosage and administration :</strong></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Cefpodoxine has been assigned to\r\npregnancy category B by the FDA.</span></p><p><strong>Packing : </strong></p><p><strong></strong>Clavuran-100 : 2x7''s tablets in blister pack.</p><p><span class="redactor-invisible-space">\r\nClavuran-200 : 2x7''s tablets in blister pack.</span></p>', 'uploads/images/Clavuran_100.jpg', 1, '2017-11-29 05:09:03', NULL, NULL, '', 'Y', 4, 'uploads/IMG/clavuran-200.jpg'),
(776, 'Dicef', 29, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Cephradine 250mg &\r\n500mg Capsule, 125mg/5ml, 250mg/5ml\r\nSuspension & 1.25mg/ml Paediatric\r\nDrops.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">In the treatment of infections\r\nof the urinary, respiratory and gastrointestinal\r\ntracts and of the skin and soft\r\ntissues. These include : </span></p><p><span class="redactor-invisible-space">Upper respiratory tract infections :\r\npharyngitis, sinusitis, otitis media,\r\ntonsillitis, laryngo-tracheo bronchitis.\r\nLower respiratory tract infections :</span></p><p><span class="redactor-invisible-space">\r\nacute and chronic bronchitis, lobar and\r\nbronchopneumonia.\r\nUrinary tract infections : cystitis,\r\nurethritis, pyelonephritis.\r\nSkin and soft tissue infections : </span></p><p><span class="redactor-invisible-space">abscess, cellulitis, furunculosis, impetigo.\r\nGastro-intestinal tract : bacillary dysentery,\r\nenteritis, peritonitis.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Oral : Adults : For urinary tract\r\ninfections the usual dose is 500mg four\r\ntimes daily or 1g twice daily, severe or\r\nchronic infections may require larger\r\ndoses.\r\nFor respiratory tract infections and skin\r\nand soft tissue infections the usual dose is\r\n250mg or 500mg four times daily or\r\n500mg or 1g twice daily depending on the\r\nseverity and site of infections.\r\nFor gastro-intestinal tract infections,\r\n500mg three or four times daily may be\r\nemployed.\r\nChildren : The usual dose is from 25 to\r\n50mg/kg/day total, given in two or four\r\nequally divided doses or as directed by the\r\nregistered physician. For otitis media daily\r\ndoses from 75-100 mg/kg/every 6 to 12\r\nhours are recommended to a maximum\r\ndaily dose of 4g or advised by the\r\nregistered physician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Cephradine has been assigned to\r\npregnancy category B by the FDA.</span></p><p><strong>Packing : </strong></p><p>Dicef 500 Capsule : 6 x 5''s capsules.</p><p><span class="redactor-invisible-space">\r\nDicef 250 Capsule : 5 x 10''s capsules .</span></p><p><span class="redactor-invisible-space">\r\nDicef Suspension : 100 ml. Suspension. </span></p><p><span class="redactor-invisible-space">Dicef Forte Suspension : 100ml\r\nSuspension.</span></p><p><span class="redactor-invisible-space">\r\nDicef Paediatric Drops : 15ml drops with\r\na plastic dropper.</span></p>', 'uploads/images/Dicef_500.jpg', 1, '2017-11-29 04:25:33', NULL, NULL, '', 'Y', 4, 'uploads/IMG/Dicef-Capsule.jpg'),
(777, 'Dicephin', 26, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Ceftriaxone 250mg (IV/IM),\r\n500mg (IV/IM), 1gm (IV/IM) & 2gm (IV)\r\nInjection.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">Dicephin is indicated for the\r\ntreatment of the following infections when\r\ncaus ed by sus ceptible organisms: lower\r\nrespiratory tract infections, s kin and s kin\r\nstructure infections, urinary tract infections,\r\nuncomplicated gonorrhea, pelvic inflammatory\r\ndisease, intra-abdominal infections, bacterial\r\nsepticemia, bone and joint infections, meningitis\r\nand surgical prophylaxis.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Dicephin may\r\nbe administered intra venously or\r\nintramuscularly.\r\nAdults : The usual adult daily dose is 1 to 2\r\ngrams given once a day (or in equally divided\r\ndoses twice a day) depending on the type and\r\nseverity of infection. The total daily dose should\r\nnot exceed 4 grams. For surgical prophylaxis, a\r\nsingle dos e of 1 gram administered\r\nintravenously 1/2 to 2 hours before surgery is\r\nrecommended.\r\nChildren : For the treatment of skin and skin\r\nstructure infections, the recommended total\r\ndaily dose is 50 to 75 mg/kg given once a day\r\n(or in equally divided doses twice a day). The\r\ntotal daily dose should not exceed 2 grams. In\r\nthe treatment of meningitis, it is recommended\r\nthat the initial therapeutic dose be 100mg/kg\r\n(not to exceed 4 grams) or as directed by the\r\nregistered physician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Ceftriaxone has been assigned to pregnancy\r\ncategory B by the FDA.</span></p><p><strong>Packing :</strong>1 Combipack / Injection. </p>', 'uploads/images/Dicephin_250.jpg', 1, '2017-11-29 04:23:58', NULL, NULL, '', 'Y', 4, 'uploads/IMG/dicephin.jpg'),
(778, 'Fuclav', 24, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Cefuroxime+Clavulanic Acid\r\n(125mg+31.25mg), (250mg+62.5mg)\r\n(500mg+125mg) Tablet &\r\n(125mg+31.25mg)/5ml Suspension.</span></p><p><strong>Indication :</strong>It is indicated for the treatment of\r\npatients with mild to moderate infections caused\r\nby susceptible strains of the designated\r\nmicroorganisms in the conditions listed below :\r\nPharyngitis/tonsillitis, Acute bacterial otitis media,\r\nAcute bacterial maxillary sinusitis, Acute bacterial\r\nexacerbations of chronic bronchitis and secondary\r\nbacterial infections of acute bronchitis,\r\nUncomplicated skin and skin-structure infections,\r\nUncomplicated urinary tract infections,\r\nUncomplicated gonorrhea, Early lyme disease. </p><p><strong>Dosage and administration : </strong></p><p><strong>Packing :</strong></p><p><strong> </strong>Fuclav-125 : 2x7''s tablets in blister pack. </p><p>Fuclav-250 : 2x7''s tablets in blister pack.</p><p><span class="redactor-invisible-space">\r\nFuclav-500 : 2x7''s tablets in blister pack. </span></p><p>Fuclav suspension : 70 ml suspension.</p>', 'uploads/images/Fuclav_500.jpg', 1, '2017-11-29 03:26:34', NULL, NULL, '', 'Y', 4, 'uploads/IMG/fuclave.jpg'),
(779, 'Furex', 23, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Cefuroxime 250mg & 500mg Tablet,\r\n750mg/vial & 1.5gm/vial Injection and 125mg/5ml\r\nSuspension.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">Furex is indicated in the\r\ntreatment of :</span></p><p><span class="redactor-invisible-space">\r\nl	Upper respiratory tract infections : Ear, nose, throat\r\ninfections, such as otitis media, sinusitis, tonsillitis\r\nand pharyngitis.\r\nl	Lower respiratory tract infections : Acute and chronic\r\nbronchitis and pneumonia.\r\nl Genito-urinary tract infections : Pyelonephritis, cystitis\r\nand urethritis, gonorrhoea, acute uncomplicated\r\ngonococcal urethritis and cervicitis.\r\nl	Skin and soft tissue infection : Impetigo.\r\nl	Lyme disease : Erythema marginatum.</span></p><p><strong>Dosage and administration : </strong></p><p><span class="redactor-invisible-space"><strong>Tablet & Suspension :</strong> Adults : Most\r\ninfections will respond to 250mg b.d. in mild to\r\nmoderate lower respiratory tract infections e.g.\r\nbronchitis for more severe lower respiratory tract\r\ninfections, or if pneumonia is suspected then 500mg b.\r\nd. should be given. For urinary tract infections a dose\r\nof 125mg b. d. A single dose of 1gm is recommended\r\nfor the treatment of uncomplicated gonorrhoea. Lyme\r\ndisease in adults and children over the age of 12\r\nyears; the recommended dose is 500mg b. d. for 20\r\ndays.<strong> </strong></span></p><p><span class="redactor-invisible-space"><strong>Children : </strong>The usual dose is 125mg b. d. or 10mg/kg\r\nb. d. to a maximum of 250mg daily. For otitis media, in\r\nchildren less than 2 years of age the usual dosage is\r\n125mg b. d. or 10mg/kg b. d. to a maximum of 250mg\r\ndaily and in children over 2 years of age, 250mg b. d.\r\nor 15mg/kg b. d. to a maximum of 500mg daily. There\r\nis no experience in children under three months of\r\nage.\r\nThe usual course of therapy is seven days.\r\nCefuroxime should be taken after food for optimum\r\nabsorption.\r\nInjection : Adults : Many infections will respond to\r\n750mg 8 hourly by i.m. or i.v. injection. For more\r\nsevere infection, this dose should be increased to 1.5g\r\n8 hourly i.v. The frequency of i.m. or i.v. injections can\r\nbe increased to six-hourly if necessary, giving total\r\ndoses of 3g to 6g daily.\r\nChildren : Doses of 30 to 100mg/kg/day given as\r\nthree or four divided doses. A dose of 60mg/kg/day will\r\nbe appropriate for most infections.\r\nNeonates : Doses of 30 to 100mg/kg/day given as two\r\nor three divided doses.\r\nOr, as directed by the registered physician.\r\nAdministration : Intramuscular : Add 1ml water for\r\ninjection to 250mg Furex & 3ml water for injection to\r\n750mg Furex. Shake gently to disperse.\r\nIntravenous : Dissolve Furex in water for injection\r\nusing at least 2ml for 250mg, at least 8ml for 750mg at\r\nleast16ml for 1.5 gm.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Cefuroxime has\r\nbeen assigned to Pregnancy category B by the FDA.</span></p><p><strong>Packing :</strong></p><p><strong> </strong><span class="redactor-invisible-space">Furex Tablet : 2 x 7''s tablets in blister\r\npack.</span></p><p><span class="redactor-invisible-space">\r\nFurex-500 Tablet : 2 x 7''s tablets in blister pack.</span></p><p><span class="redactor-invisible-space">\r\nFurex Suspension : 70ml suspension.</span></p><p><span class="redactor-invisible-space">\r\nFurex-750mg (IM/IV) & 1.5gm (IV) Injection :\r\nCombipack.</span></p>', 'uploads/images/Furex_500.jpg', 1, '2017-11-29 03:25:25', NULL, NULL, '', 'Y', 4, 'uploads/IMG/furex-1.5.jpg'),
(780, 'SEFANID ', 19, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Cefadroxil 500mg\r\nCapsule & 125mg/5ml Suspension</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">Cefadroxil is indicated for\r\nthe treatment of patients with urinary\r\ntract infection caused by Escherichia\r\ncoli, Proteus mirabilis and Klebsiella\r\nspecies. Skin and skin structure\r\ninfections caused by staphylococci,\r\nPharyngitis and Tonsillitis caused by\r\nstreptococcus pyogenes (Group A betahemolytic\r\nstreptococci).</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Administered orally and with food.\r\nAdults : Urinary Tract Infections : The\r\nusual dosage is 1gm (2 capsules) or\r\n2gm (4-capsules) per day in single or\r\ndivided doses.\r\nSkin and Skin Structure Infections :\r\nThe usual dosage is 1gm (2 capsules)\r\nper day in single or divided doses.\r\nPharyngitis and Tonsillitis : The usual\r\ndosage is 1gm (2 capsules) per day in\r\nsingle or divided doses.\r\nFor urinary tract infections, the\r\nrecommended daily dosage for children\r\nis 30mg/kg/day in divided doses every\r\n12 hours.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Cefadroxil has been assigned to\r\npregnancy category B by the FDA.</span></p><p><strong>Packing :</strong> <span class="redactor-invisible-space">Sefanid Capsule : 5''s x10 capsules in\r\nblister pack.\r\nSefanid Suspension : 100ml\r\nSuspension.</span></p>', 'uploads/images/sefanid_sus.jpg', 1, '2017-11-27 05:51:33', NULL, NULL, '', 'Y', 4, 'uploads/IMG/sefanid125.jpg'),
(781, 'T-CEF', 22, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Cefixime 200mg & 400mg\r\nCapsule. 25mg/ml Paediatric Drops, 100mg/5ml &\r\n200mg/5ml Suspension.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">Cefixime is generally classified as a\r\nthird-generation cephalosporin antibiotic and is\r\ngiven by mouth in the treatment of susceptible\r\ninfections, including gonorrhoea, otitis media,\r\npharyngitis, lower respiratory-tract infections such\r\nas bronchitis and urinary tract infections and\r\nShigellosis, caused by Shigella flexneri (54%), S.\r\nboydii (30%), S. dysenteriae non-type 1 (6%) and\r\nS. Sonnei (10%).</span></p><p><strong>Dosage and administration :</strong>Adults : The recommended dose of T-cef is 400mg\r\ndaily. This may be given as 200mg capsule every\r\n12 hours. For the treatment of uncomplicated\r\ncervical/urethral gonococcal infections, a single\r\noral dose of 400mg is recommended.\r\nPaediatric (6 Months or older) : The recommended\r\ndose is 8mg/kg/day of the suspension. This may\r\nbe administered as a single daily dose or may be\r\ngiven in two divided doses, as 4mg/kg every 12\r\nhours.\r\nTyphoid fever : Oral T-cef 5mg/kg 12 hourly for\r\n14 days.\r\nShigellosis : 8mg/kg/day as a single dose or in 2\r\ndivided doses for 5 days. Or, as directed by the\r\nregistered physician.</p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">: Cefixime has\r\nbeen assigned to pregnancy category B. by the\r\nFDA.</span></p><p><strong>Packing : </strong><span class="redactor-invisible-space">T-cef Capsule : 2 x 7''s capsules in blister pack.\r\nT-cef 400 Capsule : 1 x 7''s capsules in blister\r\npack.\r\nT-cef Paediatric Drops : 21ml suspension.\r\nT-cef Suspension : 30ml, 50ml suspension.\r\nT-cef DS : 50ml suspension.</span></p>', 'uploads/images/T-cef_400.jpg', 1, '2017-11-27 03:18:15', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/t-cef25.jpg'),
(782, 'Trum 3(IV/IM)', 25, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Ceftazidime 250mg, 500mg &\r\n1gm Injection.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">It is indicated for the treatment of\r\nsingle infections and for mixed infections caused\r\nby susceptible organisms. S evere infections in\r\ngeneral : for example septicaemia, bacteraemia,\r\nperitonitis, meningitis, infections in\r\nimmunosuppressed patients and in patients in\r\nintensive care units with specific problems.\r\nR espiratory tract infections : for example,\r\npneumonia, bronchopneumonia, infected\r\npleuris y, empyema, lung abs cess, infected\r\nbronchiectasis, bronchitis and lung infections in\r\npatients with cystic fibrosis. E ar, nose and throat\r\ninfections : otitis media, otitis externa,\r\nmastoiditis, sinusitis and other severe ear and\r\nthroat infections. Urinary tract infections: acute\r\nand chronic pyelonephritis, pyelitis, prostatitis,\r\ncystitis, urethritis, renal abscess. S kin and soft\r\ntissue infections: abscess, cellulitis, infected burn\r\nand wounds, skin ulcers etc. Gastrointestinal\r\nbiliary and abdominal infections : cholangitis,\r\ncholecystitis, intraabdominal abscess, peritonitis\r\netc. Bone and joint infections : Osteomyelitis,\r\nseptic arthritis etc.\r\n</span></p><p><strong>Dosage and administration </strong><em "="">:</em><em>Adults : </em>The adult dosage range for\r\nCeftazidime is 1gm to 6gm per day 8 or 12 hourly\r\n(IM or IV). In the majority of infections, 1gm 8\r\nhourly or 2gm 12 hourly should be given. In\r\nurinary tract infections and many less serious\r\ninfections, 250mg or 500mg or 1gm 12 hourly is\r\nusually adequate. In very severe infections,\r\nespecially immunocompromis ed patients,\r\nincluding those with neutropenia, 2gm 8 or 12\r\nhourly or 3gm 12 hourly should be administered\r\nor as directed by the registered physician.\r\nInfants and children : The usual dosage range for\r\nchildren aged over 2 months is 30 to\r\n100mg/kg/day, given as two or three divided\r\ndoses.</p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">C eftazidime has been assigned to pregnancy\r\ncategory B by the FDA.</span></p><p><strong>Packing : </strong>Combipack.</p>', 'uploads/images/Trum_3_500.jpg', 1, '2017-11-27 04:29:47', NULL, NULL, '', 'Y', 4, 'uploads/IMG/Trum-3-Injection.jpg'),
(783, 'Unipim', 21, '<p><strong></strong><strong>Composition : </strong>: Cefepime 500mg & 1gm injection.</p><p><strong>Indication : </strong><span class="redactor-invisible-space">It is indicated for moderate to severe\r\nPneumonia caused by Pseudomonas aeruginosa,\r\nKlebsiella pneumoniae, Streptococcus pneumoniae,\r\nand other Gram negative organisms; Empiric\r\ntherapy for Febrile Neutropenia; Treatment of\r\nUncomplicated and Complicated Urinary Tract\r\nInfections, including pyelonephritis caused by\r\ntypical urinary tract pathogens; Uncomplicated Skin\r\nand Skin structure infections caused by\r\nStaphylococcus aureus or Streptococcus pyogenes;\r\nIt is also used for Complicated Intra-abdominal\r\ninfections used in combination with metronidazole.</span></p><p><strong>Dosage and administration :</strong><em><strong> </strong></em><span class="redactor-invisible-space"><em><strong>Adult :\r\n</strong></em>Recommended Dosage Schedule\r\nv	Moderate to severe Pneumonia : 1-2gm IV every\r\n12hr for 10 days.\r\nv	Empiric therapy for febrile Neutropenia : 2gm IV\r\nevery 8hr for 7 days.\r\nv	Mild to moderate Complicated or Uncomplicated\r\nUrinary Tract Infection, including pyelonephritis :\r\n500mg-1gm IV every 12hr for 7-10 days.\r\nv	Severe Complicated or Uncomplicated Urinary\r\nTract Infection, including pyelonephritis : 2gm IV\r\nevery 12hr for 10 days.\r\nv	Moderate to severe Uncomplicated skin and skin\r\nstructure infections : 2gm IV every 12hr for 10 days.\r\nv	Complicated Intra-abdominal Infections used in\r\ncombination with Metronidazole : 2gm IV every 12hr\r\nfor 7-10 days.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">: Cefepime has\r\nbeen assigned to pregnancy category B by the\r\nFDA.</span></p><p><strong>Packing :</strong><em> </em><span class="redactor-invisible-space"><em></em><em>Unipim-500 (IV/IM) injection : </em>1 Combipack.<strong><em>\r\nUnipim-1gm (IV/IM) injection : </em></strong>1 Combipack</span></p>', 'uploads/images/azimex_15ml.jpg', 1, '2017-11-27 04:24:18', NULL, NULL, '', 'Y', 4, 'uploads/IMG/unipim-1.jpg'),
(784, 'CIPROZID', 34, '<p><strong></strong><strong>Composition : </strong>Ciprofloxacin 3 mg/ml.</p><p><strong>Indication : </strong><span class="redactor-invisible-space">Eye : Ciprofloxacin is\r\nindicated for the treatment of corneal\r\nulcers and superficial infections of the\r\neye and adnexa caused by suceptible\r\nstrains of bacteria.\r\nEar : Otitis Externa</span></p><p><strong>Dosage and administration : </strong></p><p><strong></strong><span class="redactor-invisible-space">Eye : Adults : Superficial ocular\r\ninfection: The usual dose is one or two\r\ndrops in the affected eye (s) four times a\r\nday. In severe infections, the dosage for\r\nthe first two days may be one or two\r\ndrops every two hours during waling\r\nhours.</span></p><p><span class="redactor-invisible-space">\r\nBacterial corneal ulcer : Two drops into\r\nthe affected eye every 15 minutes for the\r\nsix hours and then two drops into\r\naffected eye every 30 minutes for the\r\nremainder of the first day. On the second\r\nday, instill two drops in the affected eye\r\nhourly. On the third to the fourteenth day,\r\nplace two drops is the affected eye every\r\nfour hours. Treatment may be continued\r\nafter 14 days if corneal reepithelialization\r\nhas not occured. </span></p><p><span class="redactor-invisible-space">Children : The safety & efficacy of\r\nCiprofloxacin in children under the age of\r\n11 years has not been established.</span></p><p> Ear : One or two drops is instilled into\r\nthe infected ear every four hours. Or, as\r\ndirected by the registered physician.</p><p><strong>Packing : </strong><span class="redactor-invisible-space">10 ml in plastic dropper bottle.\r\n</span></p>', 'uploads/images/Ciprozid_750.jpg', 1, '2017-11-29 04:59:05', NULL, NULL, '', 'Y', 4, 'uploads/IMG/ciprozid.jpg'),
(785, 'Floxalone ', 94, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Moxifloxacin 5mg/ml as\r\nMoxifloxacin Hydrochloride.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">Floxalone eye\r\ndrop is indicated for the treatment of\r\nbacterial conjunctivitis caused by\r\nsusceptible strains of the following\r\norganisms: </span></p><p><span class="redactor-invisible-space">Aerobic Gram-positive microorganisms:\r\nCorynebacterium species, Micrococcus\r\nluteus, Staphylococcus aureus,\r\nStaphylococcus epidermidis,\r\nStaphylococcus haemolyticus,\r\nStaphylococcus hominis, Staphylococcus\r\nwarneri, Streptococcus pneumoniae,\r\nStreptococcus viridans group. </span></p><p><span class="redactor-invisible-space">Aerobic Gram-negative microorganisms:\r\nAcinetobacter lwoffii, Haemophilus\r\ninfluenzae, Haemophilus parainfluenzae.\r\nOther microorganisms: Chlamydia\r\ntrachomatis.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">The\r\nrecommended dose is one drop in the\r\naffected eye every 8 hours (3 times) daily\r\nfor 7 days. Or, as directed by the registered\r\nphysician.</span></p><p><strong>Packing : </strong>5ml in plastic dropper bottle.</p>', 'uploads/images/Floxalone.jpg', 1, '2017-11-29 03:03:40', NULL, NULL, '', 'Y', 4, 'uploads/IMG/floxalone-400.jpg'),
(786, 'Gelcin', 69, '<p><strong></strong><strong>Composition : </strong>Gemifloxacin 320mg Tablet.</p><p><strong>Indication : </strong><span class="redactor-invisible-space">Gemifloxacin is indicated for\r\nthe treatment of - Acute bacterial\r\nexacerbations of chronic bronchitis and\r\ncommunity-acquired pneumonia (including\r\nmulti-drug resistant strains).</span></p><p><strong>Dosage and administration :</strong>The dosage and administration of Gemifloxacin is given below:\r\nIndication	Dose	Duration\r\nAcute bacterial exacerbation of chronic bronchitis	One 320mg tablet daily	5 days\r\nCommunity acquired pneumonia [mild to moderate severity]\r\nDue to known or suspected S. pneumoniae, H.		5 days\r\ninfluenzae, M. pneumoniae,or C. pneumoniae\r\ninfection	One 320mg tablet daily\r\nDue to known or suspected Multi-drug resistant		7 days\r\nStreptococcus pneumonie including\r\nK. pneumoniae, or M. catarrhalis infection.</p><p><strong>Use in pregnancy and lactation :</strong>Gemifloxacin has been assigned to\r\npregnancy category C by the FDA.\r\nCaution should be exercised when\r\nGemifloxacin is administered to a nursing\r\nmother.Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.</p><p><strong>Packing </strong>: 1 x 7''s tablets in blister pack.</p>', 'uploads/images/Gynomix.jpg', 1, '2017-11-28 02:38:47', NULL, NULL, '', 'Y', 4, 'uploads/IMG/gelcin.jpg'),
(787, 'Levoflox', 80, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Levofloxacin 500mg & 750mg\r\nTablet.</span></p><p><strong>Indication :</strong>Levofloxacin is indicated for the\r\ntreatment of mild, moderate, and severe\r\ninfections caused by susceptible strains of the\r\ndesignated micro-organisms in the condition\r\nlisted below: l Acute maxillary sinusitis due to\r\nStreptococcus pneumoniae, Haemophilus\r\ninfluenzae, or Moraxella catarrhalis. l Acute\r\nbacterial exacerbation of chronic bronchitis due\r\nto Staphylococcus aureus, Streptococcus\r\npneumoniae, Haemophilus influenzae, or\r\nMoraxella catarrhalis. l Community-acquired\r\npneumonia due to Staphylococcus aureus,\r\nStreptococcus pneumoniae, Haemophilus\r\ninfluenzae, Klebsiella pneumoniae, Moraxella\r\ncatarrhalis, Chlamydia pneumoniae, Legionella\r\npneumophila, or Mycoplasma pneumoniae. l\r\nUncomplicated & complicated urinary tract\r\ninfections due to Escherichia coli, Klebsiella\r\npneumoniae, or Staphylococcus saprophyticus. l\r\nAcute pyelonephritis caused by Escherichia coli.\r\nl Uncomplicated & complicated skin and soft\r\ntissue infections including abscesses, cellulitis,\r\nfuruncles, impetigo, pyoderma, wound infections,\r\ndue to Staphylococcus aureus, Streptococcus\r\npyogenes, Proteus mirabilis or Enterococcus\r\nfaecalis. l Enteric infections caused by\r\nEnterobacter sp., Escherichia coli,\r\nCampylobacter sp., Vibrio cholerae, Shigella sp.,\r\nSalmonella sp. </p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">: l Acute sinusitis: 500mg once daily for\r\n10-14 days or 750mg once daily for 5 days. l\r\nExacerbation of chronic bronchitis: 500mg once\r\ndaily for 7 days, or 750mg once daily for 3 days\r\n(Uncomplicated), 750mg once daily for 5 days\r\n(Complicated). l Community-acquired\r\npneumonia: 500mg once daily for 7-14 days, or\r\n750mg once daily for 5 days. l Uncomplicated\r\nurinary-tract infections: 250mg once daily for 3\r\ndays. l Complicated urinary-tract infections and\r\nacute pyelonephritis: 250mg once daily for 7-10\r\ndays. l Uncomplicated skin and soft-tissue\r\ninfections: 500mg once daily for 7-10 days. l\r\nComplicated skin and soft-tissue infections:\r\n750mg once daily for 7-14 days. l Enteric fever:\r\n500mg once daily for 7-14 days. l Diarrhea,\r\ncholera, shigellosis & enteritis: Mild to moderate\r\ncase: 500mg (single dose), Moderate to sever\r\ncase: 500mg once daily for 3 days. Or, as\r\ndirected by the registered physician.</span></p><p><strong>Use in pregnancy and lactation :</strong>: Levofloxacin\r\nhas been assigned to pregnancy category C by\r\nthe FDA. It can be presumed that Levofloxacin\r\nwill be excreted in human milk. Because of the\r\npotential for serious adverse reaction from\r\nLevofloxacin in nursing infants, a decision should\r\nbe made whether to discontinue nursing or to\r\ndiscontinue the drug, taking into account the\r\nimportance of the drug to the mother.</p><p><strong>Packing : </strong><span class="redactor-invisible-space">Levoflox-500 : 2 x 10''s tablets in blister pack.\r\nLevoflox-750 : 2 x 5''s tablets in blister pack.</span></p>', 'uploads/images/Levoflox_750.jpg', 1, '2017-11-27 23:54:06', NULL, NULL, '', 'Y', 4, 'uploads/IMG/Levoflox-Sterile-Eye-Drops.jpg'),
(788, 'Oflacin', 99, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Ofloxacin 200mg & 400mg\r\nTablet.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">The following infections caused\r\nby Ofloxacin susceptible Staphylococcus,\r\nStreptococcus pyogenes, Hemolytic\r\nstreptococci, Streptococcus pneumoniae,\r\nPeptostreptococcus sp., Neisseria\r\ngonorrhoeae, Escherichia coli, Citrobacter sp.,\r\nShigella sp., Klebsiella pneumoniae,\r\nEnterobacter sp., Serratia sp., Proteus sp.,\r\nPseudomonas aeruginosa, Haemophilus\r\ninfluenzae, Acinetobacter sp., and\r\nCampylobacter sp.,\r\na) 	Pneumonia, Chronic Bronchitis, Diffuse\r\npanbronchiolitis, Bronchiectasis with\r\ninfection, Secondary infections of chronic\r\nrespiratory diseases.\r\nb)	Pharyngolaryngitis, Tonsillitis and Acute\r\nbronchitis.\r\nc)	Pyelonephritis, Cystitis, Prostatitis,\r\nEpididymitis, Gonococcal urethritis, Nongonococcal\r\nurethritis.\r\nd)	Intrauterine infection, Adnexitis,\r\n	Bartholinitis.\r\ne)	Folliculitis, Furuncle, Furunculosis,\r\nCarbuncle, Erysipelas phlegmon,\r\nLymphangitis, Felon, Subcutaneous\r\nabscess, Spiradenitis, Acne conglobata,\r\nInfectious atheroma, Perianal abscess.\r\nf)	Mastadenitis, Superficial secondary\r\ninfections after traumas, Burns, Surgery,\r\nTraumas.\r\ng)	Cholecystitis, Cholangitis.\r\nh)	Otitis media, Sinusitis.\r\ni) 	Blepharitis, Hordeolum, Dacryocystitis,\r\nTarsadenitis, Keratohelcosis.\r\nj)	Bacillary dysentery, Enteritis.\r\nk)	Periodontitis, Pericoronitis, Gnathitis.\r\nl)	Skin & soft tissue infections.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">General dosage\r\nrecommedation : The dose of OFLACIN is\r\ndetermined by the type and severity of the\r\ninfection. The dosage range of adults is 200mg\r\nto 800mg daily. Up to 400mg may be given as a\r\nsingle dose, preferably in the morning, larger\r\ndoses should be given as two divided doses.\r\nOFLACIN should not be taken within two hours of\r\nmagnesium/aluminium containing antacids or iron\r\npreparations since reduction of absorption of\r\nofloxacin can occur.\r\nLower Urinary Tract Infections : 200-400mg\r\ndaily preferably in the morning.\r\nUpper Urinary Tract Infections : 200-400mg\r\ndaily preferably in the morning, increasing, if\r\nnecessary, to 400mg twice daily.\r\nLower Respiratory Tract Infections : 400mg\r\ndaily preferably in the morning increasing, if\r\nnecessary, to 400mg twice daily.\r\nUncomplicated Urethral and Cervical\r\nGonorrhoea : A single dose of 400mg.\r\nNon Gonococcal Urethritis and Cervicitis :\r\n400mg daily in single or divided doses.\r\nImpaired renal function : 100mg should be\r\ngiven every 48 hours, when creatinine clearance\r\nis less than 20ml/minute (serum creatinine\r\ngreater than 5mg/dl).\r\nElderly : No adjustment of dosage is required in\r\nthe elderly.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Ofloxacin has\r\nbeen assigned to pregnancy category C by the\r\nFDA.</span></p><p><strong>Packing :</strong> <span class="redactor-invisible-space">Oflacin 200 : 2x10''s tablets in blister pack.\r\nOflacin 400 : 2x10''s tablets in blister pack</span></p>', 'uploads/images/Oflacin_400.jpg', 1, '2017-11-28 00:08:44', NULL, NULL, '', 'Y', 4, 'uploads/IMG/oflacin.jpg'),
(789, 'Peflox', 107, '<p><strong></strong><strong>Composition : </strong>: Pefloxacin 400mg Tablet.</p><p><strong>Indication : </strong><span class="redactor-invisible-space">Pefloxacin is a synthetic,\r\n4-quinolone derivative with bactericidal\r\nactivity against a wide range of gramnegative\r\nand gram-positive organisms.\r\nPefloxacin is indicated for the treatment\r\nof the following infections caused by\r\nsensitive bacteria :\r\nJ	Severe systemic infections\r\nJ	Respiratory tract infections\r\nJ	Ear, nose and throat infections\r\nJ	Urinary tract infections\r\nJ	Skin & soft tissue infections\r\nJ	Gastro-intestinal infections\r\nJ	Eye infections\r\nJ	Biliary tract infections\r\nJ	Intra abdominal infections\r\nJ	Bone and joint infections\r\nJ	Pelvic infections and gonorrhoea\r\nJ	Prostate infections</span></p><p><strong>Dosage and administration :  </strong><span class="redactor-invisible-space">General dosage recommendation :\r\nThe dosage for adults is 400mg twice\r\ndaily.\r\nGonorrhoea : 800mg (2 tablets) once.\r\nInfections of the lower and upper\r\nurinary tract : 400mg twice daily.\r\nIn respiratory tract infections : 400mg\r\ntwice daily.\r\nImpaired renal function : Dosage\r\nadjustments are not usually required.\r\nDuration of treatment : 5-10 days or as\r\ndirected by a registered physician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Pefloxacin has been assigned to\r\npregnancy category C by the FDA.</span></p><p><strong>Packing : </strong> 2 x 10''s tablets in blister pack.</p>', 'uploads/images/peflox.jpg', 1, '2017-11-28 00:03:13', NULL, NULL, '', 'Y', 4, 'uploads/IMG/peflox.jpg'),
(790, 'Sparonex', 131, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Sparfloxacin 200mg\r\nTablet.</span></p><p><strong>Indication :</strong>Sparfloxacin is indicated\r\nfor the treatment of adults with following\r\ninfections caused by susceptible strains\r\nof the designated microorganisms:\r\nCommunity Acquired Pneumonia, Acute\r\nbacterial exacerbations of chronic\r\nbronchitis, Sinusitis, Bronchitis, Chronic\r\nObstructive Pulmonary Disease (COPD),\r\nLung abscess, all other RTIs. Sparonex\r\ncan also be indicated in Skin and Soft\r\nTissue Infections, Urinary Tract\r\nInfections. </p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">The\r\nrecommended daily adult dose is two\r\ntablets (400mg) on first day as a loading\r\ndose, followed by one tablet (200mg)\r\ndaily as a maintenance dose. Duration of\r\nmaintenance treatment is 5 to 10 days. It\r\ncan be taken with or without food. or as\r\ndirected by a registered physician.</span></p><p><strong>Use in pregnancy and lactation :</strong>Sparfloxacin has been\r\nassigned to pregnancy category C by the\r\nFDA.</p><p><strong>Packing :</strong>2 x 10''s tablets in blister\r\npack.</p>', 'uploads/images/Sparonex.jpg', 1, '2017-11-27 05:53:16', NULL, NULL, '', 'Y', 4, 'uploads/IMG/Sparonex-Tablet.jpg'),
(791, 'Dalacin', 40, '<p><strong>Composition : </strong><span class="redactor-invisible-space">Clindamycin Phosphate 1.2% and Tretinoin 0.025%. Indications : This gel is indicated for the topical treatment of acne vulgaris in patients 12 years or older.</span></p><p><br></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Clindamycin & tretinoin gel should be applied once daily in the evening, gently rubbing the medication to lightly cover the entire affected area. Approximately a pea sized amount will be needed for each application. Avoid the eyes, lips, and mucous membranes. Clindamycin & tretinoin gel is not for oral, ophthalmic or intravaginal use. Or, as directered by registered physician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">There are no controlled data in women pregnancy. It can be used in pregnancy if potential benefits outweigh the risk or as directed by the registered physician. Clindamycin is likely to be excreted into the breast milk. A decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the benefit of the drug to the mother. Pregnancy Category B.</span></p><p><strong>Packing : </strong><span class="redactor-invisible-space" style="background-color: initial;">Dalacin Plus Gel : 15gm in a tube.</span></p>', 'uploads/images/Dalacin_cap.jpg', 1, '2017-11-29 03:58:12', NULL, NULL, '', 'Y', 4, 'uploads/IMG/dalacin.jpg'),
(792, 'Faxan', 119, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Rifaximin 200mg &\r\n550mg Tablet.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space"> <span class="redactor-invisible-space">Faxan 200 tablets are\r\nused to treat traveler''s diarrhea by\r\nnoninvasive strains of E. coli in adults\r\nand children at least 12 years of age.\r\nFaxan 550 tablets are used to prevent\r\nepisodes of hepatic encephalopathy in\r\npeople at least 18 years of age who have\r\nliver disease. Rifaximin tablet is used to\r\ntreat bacterial over growth of irritable\r\nbowel syndrome</span></span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Traveler''s\r\nDiarrhea: The recommended dose of\r\nRifaximin is one 200mg tablet taken\r\norally three times a day for 3 days.\r\nRifaximin can be administered orally,\r\nwith or without food. Hepatic\r\nEncephalopathy: The recommended\r\ndose of Rifaximin is one 550mg tablet\r\ntaken orally two times a day for 1 to 3\r\nweeks. Rifaximin can be administered\r\norally, with or without food. Bacterial over\r\ngrowth of irritable bowel syndrome\r\nRifaximin 400mg, 3 times daily for 10\r\ndays. Or, as directed by the registered\r\nphysician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Rifaximin has been assigned to\r\npregnancy category C by the FDA.</span></p><p><strong>Packing :</strong></p><p><strong> </strong><span class="redactor-invisible-space">Faxan-200 : 2x7''s tablets in alu-alu\r\nblister pack. </span></p><p><span class="redactor-invisible-space">Faxan-550 : 1x7''s tablets in alu-alu\r\nblister pack.</span></p>', 'uploads/images/Faxan_550.jpg', 1, '2017-11-29 03:13:07', NULL, NULL, '', 'Y', 4, 'uploads/IMG/faxan-200.jpg'),
(793, 'Gynomix', 4, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Neomycin Sulphate		35,000 I.U.\r\nPolymyxin B Sulphate		35,000 I.U.\r\nNystatin		1,00,000 I.U.\r\nMetronidazole		200 mg.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">Gynomix is indicated for\r\nthe treatment of Vaginal mixed\r\ninfections, Vaginal leucorrhoeas, Vaginal\r\ntrichomoniasis if whatever their origin\r\n(Mycotic or Bacterial).</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Use in\r\nVagina 1 capsule at night for 6 days. Or,\r\nas directed by the physician.</span></p><p><br></p><p><strong>Packing : </strong>: 6 capsules in a box.</p>', 'uploads/images/Gynomix.jpg', 1, '2017-11-28 02:34:57', NULL, NULL, '', 'Y', 4, 'uploads/IMG/gynomix.jpg'),
(794, 'Psudonil', 9, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Amikacin 100mg, 250mg &\r\n500mg injection.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">Amikacin Sulfate\r\ninjection is indicated in the short-term\r\ntreatment of serious infections due to\r\nsusceptible strains of gram negative\r\nbacteria, including Pseudomonas species,\r\nEscherichia coli, species of indole-positive\r\nand indole-negative Proteus, providencia\r\nspecies, Klebsiella-Enterobacter-Serratia\r\nspecies and Acinetobacter species.\r\nClinical Studies have shown Amikacin,\r\nsulfate Injection to be effective in bacterial\r\nsepticemia; in serious infections of the\r\nrespiratory tract, bones and joints, central\r\nnervous system and skin and soft tissue,\r\nintra-abdominal infections; and in burns\r\nand post operative infection. Clinical\r\nstudies have shown Amikacin also to be\r\neffective in serious complicated and\r\nrecurrent urinary tract infections due to\r\nthese organisms.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Serious\r\ninfection caused by susceptible organisms:\r\nAdults & Children''s: 15mg/kg/day in two\r\nequally divided doses every 8 to 12 hours\r\nIM or IV (if IV, diluted in 100 or 200 ml\r\ninfusion solution or normal saline given\r\nover 30 to 60 minutes) the dose may be\r\nincreased maximum 500 mg every 8\r\nhours. Neonates with normal renal\r\nfunction: Initially\r\nloading 10 mg/kg daily divided dosage by\r\nIM or IV (if given by IV an infusion period\r\nof 1 to 2 hours recommended) than 7.5\r\nmg/kg every 18 to 24 hours.\r\nUncomplicated UTI: Adults 250mg I.M or\r\nIV b.i.d. Clinical Tuburculosis: Adults,\r\nchildren''s and infants 15mg/kg I.M daily\r\nfive times weekly as an adjunct to other\r\nantitubercular durgs. Or as directed by the\r\nregistered physician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Amikacin has been assigned to pregnancy\r\ncategory D by the FDA.</span></p><p><strong>Packing : </strong></p><p><strong></strong><span class="redactor-invisible-space">Psudonil-100mg Injection : 1 x 5\r\nampoules in a blister pack. </span></p><p><span class="redactor-invisible-space">Psudonil-250mg Injection : 1 x 5\r\nampoules in a blister pack.</span></p><p><span class="redactor-invisible-space">\r\nPsudonil-500mg Injection : 1 x 5\r\nampoules in a blister pack.</span></p>', 'uploads/images/Psudonil_500.jpg', 1, '2017-11-28 04:53:11', NULL, NULL, '', 'Y', 4, 'uploads/IMG/Psudonil-Injection.jpg'),
(795, 'Rantoin', 98, '<p><strong></strong><strong>Composition : </strong>Each Metered dose (Puff) contains Beclometasone Dipropionate 100 mcg.</p><p><strong>Indication : </strong>Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. </p><p><strong>Dosage and administration : </strong>Becovent inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled Becovent appropriate to the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to individual response. Management of chronic asthma (Adults & Children over 12 years): 100-400 mcg twice daily. Maximum 1000 mcg twice daily. Children (5-12 years): 100-200 mcg twice daily. the dose may be adjusted as necessary.</p><p><strong>Use in pregnancy and lactation : </strong>Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.</p><p><strong>Packing : </strong>Becovent HFA Inhaler : Each box contains one inhaler of 200 Puffs</p>', 'uploads/images/Rantoin.jpg', 1, '2017-11-05 03:41:18', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/30.jpg'),
(797, 'LANSEC', 76, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Lansoprazole 15mg & 30mg\r\nCapsule.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">Healing and long term management of\r\ngastroesophageal reflux disease. Healing and\r\nmaintenance therapy for patients with duodenal\r\nulcer. Relief of reflux-like symptoms (eg. Heartburn)\r\nand/or ulcer-like symptoms (eg. upper epigastric\r\npain) associated with acid-related dyspepsia. Healing\r\nof benign gastric ulcer. Lansec is also effective in\r\npatients with benign peptic lesions, including reflux\r\noesophagitis, unresponsive to H2 receptor\r\nantagonists. Eradication of H.pylori from the upper\r\ngastro-intestinal tract in patients with duodenal ulcer\r\nor gastritis when used in combination with\r\nappropriate antibiotics.	</span></p><p><strong>Dosage and administration : </strong></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Lansoprazole has\r\nbeen assigned to pregnancy category B by the FDA.</span></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Lansec-15 : 6 x 10''s capsules in blister pack.\r\nLansec-30 : 6 x 10''s capsules in blister pack.</span></p>', 'uploads/images/azimex_15ml.jpg', 1, '2017-11-28 02:55:35', NULL, NULL, '', 'Y', 4, 'uploads/IMG/lansec30.jpg'),
(798, 'PANSEC ', 105, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Pantoprazole 20mg, 40mg\r\nTablet & 40mg Injection.</span></p><p><strong>Indication :</strong></p><p><strong> </strong><span class="redactor-invisible-space">Pansec is registered for the\r\nfollowing indications : </span></p><p>1) Duodenal ulcer </p><p>2) Gastric ulcer</p><p><span class="redactor-invisible-space"> 3)\r\nModerate to severe reflux esophagitis</span></p><p><span class="redactor-invisible-space"> 4)\r\nEradication of Helicobacter pylori </span></p><p><span class="redactor-invisible-space">5)\r\nTreatment of ulcers resistant to H2\r\nantagonists</span></p><p><span class="redactor-invisible-space"> 6) Maintenance of ulcer\r\nremission </span></p><p>7) Zollinger Ellison syndrome </p><p><span class="redactor-invisible-space">8)\r\nTreatment of ulcers induced by non-steroidal\r\nanti-inflammatory drugs (NSAIDs).</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">The dose of\r\npantoprazole will be different for different\r\npatients.\r\nTreatment of erosive esophagitis adult oral\r\ndose is 40mg given once daily for upto 8\r\nweeks. Maintenance of healing of erosive\r\nesophagitis the recommended adult oral dose\r\nis one tablet daily (40mg).\r\nZollinger- Ellison syndrome : the\r\nrecommended adult dose is 40mg twice\r\ndaily.\r\nTo treat gastroesophageal reflux disease :\r\n40mg once a day, preferably in the morning\r\nfor 4 to 8 weeks.\r\nTo treat gastric ulcers : 40mg once a day,\r\npreferably in the morning for 4 to 8 weeks.\r\nTo treat duodenal ulcers : 40mg once a day,\r\npreferably in the morning for 2 weeks.\r\nEradication of Helicobacter pylori : Triple\r\ntherapy of Pansec 40mg twice daily plus\r\nclarithromycin 500mg and metronidazole\r\n500mg both three times daily.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Pantoprazole has been assigned to\r\npregnancy category B by the FDA.</span></p><p><strong>Packing : </strong></p><p>Pansec-20 : 4 x 14''s Tablet in blister pack.</p><p><span class="redactor-invisible-space">\r\nPansec-40 : 4 x 14''s Tablet in blister pack. </span></p><p>Pansec-40 Injection : Combipack.</p>', 'uploads/images/Pansec_20.jpg', 1, '2017-11-28 04:51:21', NULL, NULL, '', 'Y', 4, 'uploads/IMG/pansec-40.jpg');
INSERT INTO `drg_medicine_info` (`MEDICINE_ID`, `MEDICINE_NAME`, `GN_GRP_ID`, `MEDICINE_DESC`, `INSERT_FILE`, `CRE_BY`, `CRE_DT`, `UPD_BY`, `UPD_DT`, `IS_LATEST`, `ACTIVE_STATUS`, `CAT_ID`, `PRODUCT_FET_PHOTO`) VALUES
(799, 'PRONEX ', 58, '<p><strong></strong><strong>Composition :</strong>Esomeprazole 20mg & 40mg\r\nTablet/Capsule & 40mg (IV) Injection.</p><p><strong>Indication :</strong>  </p><p><span class="redactor-invisible-space">1) Treatment of Gastroesophageal Reflux Disease\r\n(GERD)</span></p><p><span class="redactor-invisible-space">2) H. Pylori eradication to reduce the risk of\r\nduodenal ulcer recurrence.</span></p><p><strong>Dosage and administration : </strong></p><p><strong></strong><span class="redactor-invisible-space">Direction for use of IV injection : The\r\nEsomeprazole powder should be reconstituted with\r\n5ml or 0.9% Sodium Chloride Injection, USP. The\r\nreconstituted solution should be administered as an\r\nintravenous injection over no less than 3 minutes.\r\nThe reconstituted solution should be stored at room\r\ntemperature up to 30oC (86oF) and administered\r\nwithin 12 hours after reconstitution. No refrigeration\r\nis required. </span></p><p><span class="redactor-invisible-space">Direction for use of IV infusion : A solution for\r\nintravenous infusion is prepared by first\r\nreconstituting the contents of one vial with 5ml of\r\n0.9% Sodium Chloride Injection, USP, Lactated\r\nRinger''s Injection, USP or 5% Dextrose Injection,\r\nUSP and further diluting the resulting solution to a\r\nfinal volume of 50ml. The solution should be\r\nadministered as an intravenous infusion over a\r\nperiod of 10 to 30 minutes. The admixture solution\r\nshould be stored at room temperature up to 30o\r\nC\r\nand should be administered within 12 hours when\r\nreconstituted with 0.9% Sodium Chloride Injection\r\nor Lactated Ringer''s Injection and 6 hours when\r\nreconstituted with 5% Dextrose injection. Or, as\r\ndirected by the registered physician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Pregnancy\r\ncategory B by the FDA.</span></p><p><strong>Packing :</strong></p><p><strong> </strong>Pronex-20 : 5 x 10''s capsules in blister pack.</p><p>\r\nPronex-40 : 4 x 7''s capsules in blister pack. </p><p>Pronex-20 : 4 x 14''s tablets in blister pack.</p><p>\r\nPronex-40 : 4 x 14''s tablets in blister pack.</p><p>\r\nPronex-40 Injection : Combipack.</p>', 'uploads/images/azimex_15ml.jpg', 1, '2017-11-28 04:47:37', NULL, NULL, '', 'Y', 4, 'uploads/IMG/pronex-40.jpg'),
(800, 'RABESEC ', 116, '<p><strong></strong><strong>Composition :</strong> Each Metered dose (Puff) contains Beclometasone Dipropionate 100 mcg.</p><p><strong>Indication :</strong> Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. </p><p><strong>Dosage and administration : </strong>Becovent inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled Becovent appropriate to the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to individual response. Management of chronic asthma (Adults & Children over 12 years): 100-400 mcg twice daily. Maximum 1000 mcg twice daily. Children (5-12 years): 100-200 mcg twice daily. the dose may be adjusted as necessary.</p><p><strong>Use in pregnancy and lactation : </strong>Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.</p><p><strong>Packing :</strong> Becovent HFA Inhaler : Each box contains one inhaler of 200 Puffs</p>', 'uploads/images/Rabesec.jpg', 1, '2017-11-05 03:57:06', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/rabesec20.jpg'),
(801, 'FAMOTID ', 60, '<p><strong></strong><strong>Composition : </strong>Each Metered dose (Puff) contains Beclometasone Dipropionate 100 mcg.</p><p><strong>Indication : </strong>Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. </p><p><strong>Dosage and administration : </strong>Becovent inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled Becovent appropriate to the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to individual response. Management of chronic asthma (Adults & Children over 12 years): 100-400 mcg twice daily. Maximum 1000 mcg twice daily. Children (5-12 years): 100-200 mcg twice daily. the dose may be adjusted as necessary.</p><p><strong>Use in pregnancy and lactation : </strong>Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.</p><p><strong>Packing : </strong>Becovent HFA Inhaler : Each box contains one inhaler of 200 Puffs</p>', 'uploads/images/azimex_30ml.jpg', 1, '2017-11-05 03:59:00', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/famotid-20.jpg'),
(802, 'ULCAR ', 117, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Ranitidine 150mg &\r\n300mg Tablet.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">Ulcar is indicated for the\r\ntreatment of duodenal ulcer and benign\r\ngastric ulcer, including that associated\r\nwith non-steroidal anti-inflammatory\r\nagents.\r\nUlcar tablet is also indicated for the\r\ntreatment of post-operative ulcer,\r\noesophageal reflux disease and\r\nZollinger-Ellison Syndrome. Other\r\npatients with chronic episodic dyspepsia,\r\ncharacterised by pain (epigastric or\r\nretrosternal) which is related to meals or\r\ndisturbs sleep but is not associated with\r\nthe preceding conditions may benefit\r\nfrom Ranitidine treatment. Ulcar is\r\nindicated for conditions where reduction\r\nof gastric secretion and acid output is\r\ndesirable such as: the prophylaxis of\r\ngastro-intestinal haemorrhage from\r\nstress ulceration in seriously ill patients,\r\nthe prophylaxis of recurrent haemorrhage\r\nin patients with bleeding peptic ulcers\r\nand before general anaesthesia in\r\npatients considered to be at risk of acid\r\naspiration (Mendelson''s Syndrome),\r\nparticularly obstetric patients during\r\nlabour.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Ulcar\r\nTablet : The recommended oral dosage\r\nof Ulcar for adults is 150mg tablet twice\r\ndaily. An alternate dosage of 300mg daily\r\nat bed time can be used for patients in\r\nwhom dosing convenience is important.\r\nOr as directed by a registered physician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Ranitidine has been assigned to\r\npregnancy category B by the FDA.</span></p><p><strong>Packing : </strong></p><p><span class="redactor-invisible-space">Ulcar 150mg Tablet : 10x10''s tablets in\r\nformed pack.</span></p><p><span class="redactor-invisible-space">\r\nUlcar 300mg Tablet : 5x10''s tablets in\r\nformed pack.</span></p>', 'uploads/images/Ulcar_150.jpg', 1, '2017-12-04 01:49:01', NULL, NULL, '', 'Y', 4, 'uploads/IMG/ulcar-300.jpg'),
(803, 'Semecon', 128, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Simethicone 67mg/ml\r\nPaediatric Drop.</span></p><p><strong>Indication :</strong></p><p><span class="redactor-invisible-space">Flatulence,\r\nabdominal distention, fullness, </span></p><p><span class="redactor-invisible-space">gas and\r\nwindy colic: Semecon is an excellent and\r\neffective antiflatulent. It is used for relief\r\nof the painful symptoms of excess gas in\r\nthe digestive tract. Semecon drop is\r\nespecially used in infants. </span></p><p><span class="redactor-invisible-space">Large bowel preparation : Addition of\r\nSemecon to a polyethylene glycol bowel\r\npreparation produces symptomatic\r\nimprovement prior to investigation in\r\npatients undergoing colonoscopy.</span></p><p><span class="redactor-invisible-space">\r\nTreatment of poisoning : Semecon has\r\nan anecdotal use as an antifoaming\r\nagent in the management of accidental\r\ningestion of foaming detergents.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Take after\r\nmeals and at bedtime. Can be given with\r\ninfant''s feeds. Shake the bottle well\r\nbefore each use.\r\nChildren less than 2 years of age : 20mg\r\n(0.3ml Semecon drops) 4 times daily up\r\nto 240mg (3.6ml Semecon drops)/day.\r\nChildren 2 - 12 years of age : 40mg\r\n(0.6ml Semecon drops) 4 times daily.\r\nAdults : 40 - 80mg (0.6 - 1.2ml Semecon\r\ndrops) 4 times daily, up to 500mg (7.5ml\r\nSemecon drops)/day.</span></p><p><strong>Use in pregnancy and lactation : </strong>Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.</p><p><strong>Packing : </strong><span class="redactor-invisible-space">Semecon Paediatric Drops :\r\n15ml drops with a plastic dropper.</span></p>', 'uploads/images/azimex_15ml.jpg', 1, '2017-11-28 05:26:40', NULL, NULL, '', 'Y', 4, 'uploads/IMG/semecon.jpg'),
(817, 'Anilic', 142, '<p><strong></strong><strong>Composition : </strong>Tolfenamic Acid 200mg\r\nTablet.\r\nIndication</p><p><strong>Indication :</strong>It is indicated for the\r\ntreatment of acute migraine.</p><p><strong>Dosage and administration :</strong>Adults :\r\n200 mg when the first symptoms of\r\nmigraine appear. The treatment can be\r\nrepeated once after 1-2 hours if a\r\nsatisfactory response is not obtained.\r\nChildren : A paediatric doses regimen\r\nhas not yet been established.\r\nOr, as directed by the registered\r\nphysicians.</p><p><strong>Use in pregnancy and lactation :</strong>There are no adequate and wellcontrolled\r\nstudies in pregnant women.\r\nDuring the first and second trimester of\r\npregnancy, Tolfenamic acid should not\r\nbe given unless clearly necessary. Like\r\nother NSAIDs, Tolfenamic acid should\r\nnot be given in the last trimester.\r\nTolfenamic acid can appear in breast\r\nmilk in very low concentrations. It should\r\nbe avoided when breast feeding.</p><p><strong>Packing : </strong><span class="redactor-invisible-space">Anilic 3 x 10''s tablets in blister\r\npack.</span></p>', 'uploads/images/anilic.jpg', 1, '2017-11-26 06:21:34', NULL, NULL, '', 'Y', 4, 'uploads/IMG/01.jpg'),
(819, 'Bufen SR', 71, '<p><strong></strong><strong>: Bufen-SR : 6 x 5''s capsulesComposition : </strong><span class="redactor-invisible-space">lbuprofen 300mg SR\r\nCapsule.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">lbuprofen is a non-steroidal\r\nanti-inflammatory agent with analgesic\r\nand antipyretic properties. Bufen-SR is\r\nindicated for the treatment of rheumatoid\r\narthritis, osteoarthritis, ankylosing\r\nspondylitis. It is also indicated in acute\r\nperiarticular disorders such as bursitis,\r\nFrozen shoulder (capsulitis), tendinitis,\r\ntenosynovitis and for the relief of mild to\r\nmoderate pain in sprains, strains, low\r\nback pain, dysmenorrhoea and dental\r\nand post operative pain. Bufen-SR is\r\nalso indicated for the relief of migraine.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Adults &\r\nchildren over 12 years : Usual starting\r\ndose is one capsule 300mg twice daily,\r\ntaken at night & morning. This may be\r\nincreased to three capsules (900mg)\r\ndaily until the acute pain is controlled.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Pregnancy Category C. Based on animal\r\nstudies and clinical experience, there is\r\nno evidence to suggest associated foetal\r\nabnormalities. However, as with other\r\nNSAIDs, Bufen-SR spansule capsules\r\nshould be avoided during pregnancy and\r\nlactation unless essential, Traces of\r\nlbuprofen have been detected in breast\r\nmilk, but no adverse effects have been\r\nreported.</span></p><p><strong>Packing : </strong>: Bufen-SR : 6 x 5''s capsules</p>', 'uploads/images/bufen_SR.jpg', 1, '2017-11-28 00:42:36', NULL, NULL, '', 'Y', 4, 'uploads/IMG/bufen-sr.jpg'),
(820, 'Canasa', 87, '<p><strong></strong><strong>Composition : </strong>Each Metered dose (Puff) contains Beclometasone Dipropionate 100 mcg.</p><p><strong>Indication : </strong>Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. </p><p><strong>Dosage and administration : </strong>Becovent inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled Becovent appropriate to the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to individual response. Management of chronic asthma (Adults & Children over 12 years): 100-400 mcg twice daily. Maximum 1000 mcg twice daily. Children (5-12 years): 100-200 mcg twice daily. the dose may be adjusted as necessary.</p><p><strong>Use in pregnancy and lactation : </strong>Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.</p><p><strong>Packing : </strong>Becovent HFA Inhaler : Each box contains one inhaler of 200 Puffs</p>', 'uploads/images/canasa.jpg', 1, '2017-11-06 03:39:41', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/04.jpg'),
(821, 'Depomed ', 89, '<p><strong></strong><strong>Composition : <em></em></strong><span class="redactor-invisible-space">Methylprednisolone Acetate 40mg/ml &\r\n80mg/2ml Injection</span></p><p><strong>Indication :</strong>Depomed is indicated in the treatment of asthma,\r\natopic dermatitis, contact dermatitis, bullous dermatitis\r\nherpetiformis, mycosis fungoides, pemphigus, severe erythema\r\nmultiforme, primary or secondary adrenocortical insufficiency,\r\nhypercalcemia associated with cancer, nonsuppurative thyroiditis,\r\nulcerative colitis, hematologic disorders, palliative management\r\nof leukemias and lymphomas, sympathetic ophthalmia, keratitis,\r\nallergic conjunctivitis, Juvenile rheumatoid arthritis, ankylosing\r\nspondylitis, symptomatic sarcoidosis, aspiration pneumonitis. </p><p><strong>Dosage and administration :</strong></p><p><span class="redactor-invisible-space">A. Administration For Local\r\nEffect: </span></p><p><span class="redactor-invisible-space">1. Rheumatoid and Osteoarthritis: The dose for intraarticular\r\nadministration depends upon the size of the joint and\r\nvaries with the severity of the condition in the individual patient.\r\nThe doses in the following table are given as a general guide:</span></p><p><span class="redactor-invisible-space">\r\n2. Miscellaneous (Ganglion, Tendinitis, Epicondylitis):\r\nThe dose in the treatment of the various conditions of the\r\ntendinous or bursal structures varies with the condition\r\nbeing treated and ranges from 4 to 30mg. In recurrent or\r\nchronic conditions, repeated injections may be necessary.</span></p><p><span class="redactor-invisible-space">\r\n3. Dermatological Conditions: 20 to 60mg of the\r\nsuspension is injected into the lesion. It may be necessary\r\nto distribute doses ranging from 20 to 40mg by repeated\r\nlocal injections in the case of large lesions. One to four\r\ninjections are usually employed, the intervals between\r\ninjections varying with the type of lesion being treated and\r\nthe duration of improvement produced by the initial\r\ninjection. B. Administration For Systemic Effect: In\r\npatients with the adrenogenital syndrome, a single\r\nintramuscular injection of 40mg every two weeks may be\r\nadequate. For maintenance of patients with rheumatoid\r\narthritis, the weekly intramuscular dose will vary from 40 to\r\n120mg. The usual dosage for patients with dermatologic\r\nlesions benefited by systemic corticoid therapy is 40 to\r\n120mg of methylprednisolone acetate administered\r\nintramuscularly at weekly intervals for one to four weeks.\r\nIn acute severe dermatitis due to poison ivy, relief may\r\nresult within 8 to 12 hours following intramuscular\r\nadministration of a single dose of 80 to 120mg. In chronic\r\ncontact dermatitis, repeated injections at 5 to 10 day\r\nintervals may be necessary. In seborrheic dermatitis, a\r\nweekly dose of 80mg may be adequate to control the\r\ncondition. Following intramuscular administration of 80 to\r\n120mg to asthmatic patients, relief may result within 6 to 48\r\nhours and persist for several days to two weeks. Similarly in\r\npatients with allergic rhinitis (hay fever), an intramuscular dose of\r\n80 to 120mg may be followed by relief of coryzal symptoms\r\nwithin six hours persisting for several days to three weeks.\r\nMultiple Sclerosis: In treatment of acute exacerbations of\r\nmultiple sclerosis, daily doses of 160mg of methylprednisolone\r\nfor a week followed by 64mg every other day for 1 month have\r\nbeen shown to be effective (4mg of methylprednisolone is\r\nequivalent to 5mg of prednisolone). Or, as directed by the\r\nregistered physician.</span></p><p><strong>Use in pregnancy and lactation : </strong></p><p><strong>Packing : </strong></p><p>Depomed-40 Injection : 1 x 3''s vial.</p><p><span class="redactor-invisible-space">\r\nDepomed-80 Injection : 1 x 3''s vial.</span></p>', 'uploads/images/depomed _40.jpg', 1, '2017-11-29 04:21:49', NULL, NULL, '', 'Y', 4, 'uploads/IMG/Depomed-Injection.jpg'),
(823, 'Diproxen Gel', 95, '<p><strong></strong><strong>Composition : </strong>: Naproxen Sodium 10%.</p><p><strong>Indication : </strong><span class="redactor-invisible-space">This gel is indicated for\r\ntreatment of rheumatoid arthritis,\r\nosteoarthritis, ankylosing spondylitis,\r\ntendonitis, bursitis, acute gout, and the\r\nmanagement of mild to moderate pain\r\nand primary dysmenorrhoea.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Diproxen\r\nGel is to be applied 2-6 times a day as\r\nrequired and is not recommended for\r\nuse in children. Or, as directed by the\r\nregistered physician</span></p><p><br></p><p><strong>Packing :</strong>Diproxen Gel : 15gm in a\r\ntube.</p>', 'uploads/images/diproxen_250.jpg', 1, '2017-12-03 00:10:00', NULL, NULL, '', 'Y', 4, 'uploads/IMG/diproxen-gel.jpg'),
(824, 'Fenaton ', 85, '<p><strong></strong><strong>Composition : </strong>Mefenamic Acid 500mg.</p><p><strong>Indication :</strong>Mefenamic acid is indicated\r\nfor the symptomatic relief of rheumatoid\r\narthritis, osteoarthritis and pain including\r\nmuscular, traumatic and dental pain,\r\nheadaches of most aetiology, postoperative\r\nand post-partum pain, pyrexia in\r\nchildren and for primary dysmenorrhoea.Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. </p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Administration\r\nis by the oral route, preferably with food.\r\nFor relief of acute pain in adults and\r\nadolescents &gt;_14 years of age, the\r\nrecommended dose is 500mg as an initial\r\ndose followed by 250mg every 6 hours as\r\nneeded, usually not to exceed one week.\r\nFor the treatment of primary dysmenorrhea,\r\nthe recommended dose is 500mg as an\r\ninitial dose followed by 250mg every 6\r\nhours, starting with the onset of bleeding\r\nand associated symptoms or as directed by\r\nthe registered physician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Pregnancy Category C. Fenaton should\r\nbe used during pregnancy only if the\r\npotential benefit justifies the potential risk\r\nto the fetus. Because of the potential for\r\nserious adverse reactions in nursing\r\ninfants from Fenaton, a decission should\r\nbe made whether to discontinue the drug,\r\ntaking into account the importance of the\r\ndrug to the mother.</span></p><p><strong>Packing : </strong>Fenaton : 6 x 10''s tablets.</p>', 'uploads/images/fenaton.jpg', 1, '2017-11-29 03:10:25', NULL, NULL, '', 'Y', 4, 'uploads/IMG/fenaton.jpg'),
(825, 'Fevedol', 106, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Paracetamol\r\n(Acetaminophen) 325mg + Tramadol\r\nHydrochloride; (325mg + 37.5mg) Tablet.</span></p><p><strong>Indication :</strong>This medicine is indicated\r\nfor the short-term treatment (i.e. three\r\ndays or less) of mild to moderate acute\r\npain.Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. </p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">: It should\r\nbe used in adults and children over 12\r\nyears of age. The recommended dose\r\nshould not be exceeded. Acute pain: 1\r\nor 2 tablets every 4 to 6 hours as needed\r\nfor pain relief up to a maximum of 8\r\ntablets per day. Or, as directed by the\r\nregistered physician.</span></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Fevedol 3 x 10''s tablets in\r\nblister pack</span></p>', 'uploads/images/fevedol.jpg', 1, '2017-11-29 03:08:18', NULL, NULL, '', 'Y', 4, 'uploads/IMG/fevedol.jpg'),
(826, 'Kingdol', 144, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Tramadol Hydrochloride\r\n50mg Capsule.</span></p><p><strong>Indication :</strong>It is indicated for the\r\ntreatment of moderate to severe pain. </p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space"><strong>Adult &\r\nchildren over 12 years :</strong> For acute pain\r\n: an initial dose of 100 mg is usually\r\nnecessary. This can be followed by\r\ndoses of 50 mg or 100 mg not more\r\nfrequently than 4 hourly and duration of\r\ntherapy should be matched to clinical\r\nneed. The total daily dosage by mouth\r\nshould not exceed 400 mg. For chronic\r\npain : an initial dose of 50mg is\r\nrecommended and then subsequent\r\ndoses are maintained according to pain\r\nseverity. Or, as directed by the registered\r\nphysicians.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">There are no adequate and wellcontrolled\r\nstudies in pregnant women.\r\nTramadol should be used during\r\npregnancy only if the potential benefit\r\njustifies the potential risk to the fetus.\r\nTramadol has been detected in human\r\nbreast milk. A decision should be made\r\nwhether to discontinue nursing or to\r\ndiscontinue the drug, taking into account\r\nthe importance of the drug to the mother.</span></p><p><strong>Packing :</strong>Kingdol 3 x 10''s capsules in\r\nblister pack.</p>', 'uploads/images/kingdol.jpg', 1, '2017-11-27 23:50:49', NULL, NULL, '', 'Y', 4, 'uploads/IMG/16.jpg'),
(828, 'Napsec', 96, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Naproxen + Esomeprazole;\r\n(375mg+20mg) & (500mg+20mg) Tablet.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">This is indicated for the relief of\r\nsigns and symptoms of osteoarthritis,\r\nrheumatoid arthritis and ankylosing spondylitis,\r\ndysmenorrhoea and to decrease the risk of\r\ndeveloping gastric ulcers in patients at risk of\r\ndeveloping NSAID-associated gastric ulcers.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Rheumatoid\r\nArthritis, Osteoarthritis and Ankylosing\r\nSpondylitis : The dosage is one tablet twice\r\ndaily of 375mg naproxen and 20mg of\r\nesomeprazole or 500mg naproxen and 20mg\r\nof esomeprazole The tablets are to be\r\nswallowed whole with liquid. This drug is to be\r\ntaken at least 30 minutes before meals.\r\nGeriatric Patients : Studies indicate that\r\nalthough total plasma concentration of\r\nnaproxen is unchanged, the unbound plasma\r\nfraction of naproxen is increased in the elderly.\r\nUse caution when high doses are required and\r\nsome adjustment of dosage may be required\r\nelderly patients. Patients with Moderate to\r\nSevere Renal Impairment : Naproxencontaining\r\nproducts are not recommended for\r\nuse in patients with moderate to severe or\r\nsevere renal impairment (creatinine clearance\r\n&lt; 30 mL/min) Hepatic Insufficiency : Monitor\r\npatients with mild to moderate hepatic\r\nimpairment closely and consider a possible\r\ndose reduction based on the naproxen\r\ncomponent of this drug. It should be avoided in\r\npatients with severe hepatic impairment.\r\nPaediatric Patients : The safety and efficacy\r\nof this drug in children younger than 18 years\r\nhas not been established. Or, as directed by\r\nthe registered physician.</span></p><p><br></p><p><strong>Packing : </strong></p><p>Napsec-375 : 3x10''s tablets.</p><p><span class="redactor-invisible-space">\r\nNapsec-500 : 3x10''s tablets.</span></p>', 'uploads/images/napsec375.jpg', 1, '2017-11-28 03:46:27', NULL, NULL, '', 'Y', 4, 'uploads/IMG/napsec-375.jpg'),
(829, 'Nofenac ', 5, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Aceclofenac 100mg\r\nTablet.</span></p><p><strong>Indication :</strong></p><p><strong> </strong><span class="redactor-invisible-space">Nofenac is used for the\r\nrelief of pain and inflammation in the\r\nfollowing conditions:</span></p><p><span class="redactor-invisible-space">\r\nF Acute and chronic rheumatoid arthritis</span></p><p><span class="redactor-invisible-space">\r\nF Osteoarthritis\r\nF Ankylosing spondylitis </span></p><p><span class="redactor-invisible-space">F Pain and inflammation in orthopaedic,\r\ngynecologic, dental and other minor\r\nsurgery</span></p><p><span class="redactor-invisible-space">\r\nF Post operative pain </span></p><p><span class="redactor-invisible-space">F Low back pain and other acute\r\nmusculoskeletal disorder </span></p><p>F Primary dysmenorrhea</p><p><span class="redactor-invisible-space">\r\nF Severe traumatic injuries</span></p><p><span class="redactor-invisible-space">\r\nF Severe migraine attacks </span></p><p>F Renal and biliary colic</p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Adults : The\r\nrecommended dose is 100mg, twice\r\ndaily. Children : There are no clinical\r\ndata on the use of Aceclofenac in\r\nchildren. Elderly : Generally no dose\r\nadjustment is necessary.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">There are no well controlled studies the\r\nsafe use of drug in pregnant woman.\r\nThis drug should not be used during\r\npregnancy unless the benefits to the\r\nmother justify the potential risk to the\r\nfetus.</span></p><p><strong>Packing : </strong>Nofenac : 5 x 10''s tablets .</p>', 'uploads/images/nofenac.jpg', 1, '2017-11-28 03:48:24', NULL, NULL, '', 'Y', 4, 'uploads/IMG/nofenac.jpg'),
(830, 'Nopain', 47, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Diclofenac Potassium\r\n25mg & 50mg Tablet</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">Pain and inflammation\r\ndue to sprains, dental or orthopaedic\r\nsurgery and gynocology e.g. primary\r\ndysmenorrhoea or adnexitis.\r\nPainful syndromes of the vertebral\r\ncolumn, non-articular rheumatism and as\r\nan adjuvant in severe painful\r\ninflammatory infections of the throat\r\nnose or earns e.g. pharyngotonsillitis,\r\notitis etc.</span></p><p><strong>Dosage and administration :<em> </em></strong><span class="redactor-invisible-space"><em>Adults :\r\n</em>Generally for adults 100- 150mg. daily in\r\n2-3 divided doses.\r\nIn milder cases, as well as for children\r\nover 14 years 75-100mg. daily in 2-3\r\ndivided doses.\r\nIn Primary dysmenorrhoea the daily\r\ndosage which should be individually\r\nadapted is generally 50-150mg in 2-3\r\ndivided doses. This can be raised in the\r\ncourse of several conditions and the\r\ntablet should be taken preferably before\r\nmeal or as directed by the registered\r\nphysician.</span></p><p><strong>Use in pregnancy and lactation : </strong>Pregnancy Category C.</p><p><strong>Packing : </strong></p><p>Nopain-25 : 10 x 10''s tablets. </p><p>Nopain-50 : 5 x 10''s tablets</p>', 'uploads/images/nopain25.jpg', 1, '2017-11-28 03:50:23', NULL, NULL, '', 'Y', 4, 'uploads/IMG/nopain-50.jpg'),
(831, 'Nopain Extra', 49, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Diclofenac Sodium + Misoprostol;\r\n(50mg+0.2mg) & (75mg+0.2mg) Tablet.\r\n</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">It is indicated for treatment of the\r\nsigns and symptoms of osteoarthritis or rheumatoid\r\narthritis in patients at high risk of developing\r\nNSAID-induced gastric and duodenal ulcers and\r\ntheir complications.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Osteoarthritis: The\r\nrecommended dosage for maximal GI mucosal\r\nprotection is Nopain Extra 50 tid. For patients who\r\nexperience intolerance, Nopain Extra 75 bid or\r\nNopain Extra 50 bid can be used. Rheumatoid\r\nArthritis: The recommended dosage is Nopain Extra\r\n50 tid or qid. For patients who experience\r\nintolerance, Nopain Extra 75 bid or Nopain Extra 50\r\nbid can be used. Special Dosing Considerations:\r\nNopain Extra contains misoprostol, which provides\r\nprotection against gastric and duodenal ulcers. For\r\ngastric ulcer prevention, the 0.2mg qid and tid\r\nregimens are therapeutically equivalent, but more\r\nprotective than the bid regimen. Or, as directed by\r\nthe registered physician.</span></p><p><strong>Use in pregnancy and lactation : <em></em></strong><span class="redactor-invisible-space">In late\r\npregnancy, as with other NSAIDs, this drug should\r\nbe avoided because it may cause premature\r\nclosure of the ductus arteriosus.</span></p><p><strong>Packing : </strong></p><p>Nopain Extra 50 : 2x10''s tablets. </p><p>Nopain Extra 75 : 3x10''s tablets.</p>', 'uploads/images/nopainextra75.jpg', 1, '2017-11-28 03:57:34', NULL, NULL, '', 'Y', 4, 'uploads/IMG/nopain-extra-50.jpg'),
(832, 'Pair', 72, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Ketorolac tromethamine\r\n10mg Tablet & 30mg/ml (IV/IM) injection.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">Pair Tablet and Injection are\r\nindicated for the short-term management of\r\nmoderate to severe acute post-operative\r\npain.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Pair Tablet :\r\nAdults : 10mg every 4 to 6 hours as required.\r\nDoses exceeding 40mg per day are not\r\nrecommended. Tablet are recommended for\r\nshort term use only (up to 7 days) and are not\r\nrecommended for chronic use</span>.</p><p><strong>Use in pregnancy and lactation : </strong>Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.</p><p><strong>Packing : </strong><span class="redactor-invisible-space"><strong>Pair Tablet : </strong>3x10''s tablets.\r\nPair-30 (IV/IM) Injection : 1x1''s ampoule.</span></p>', 'uploads/images/pair-30.jpg', 1, '2017-11-28 00:16:08', NULL, NULL, '', 'Y', 4, 'uploads/IMG/pair.jpg'),
(833, 'Sudac', 133, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Sulindac 100 mg & 200\r\nmg Tablet.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">Sulindac is indicated for the\r\nsymptomatic treatment of rheumatoid\r\narthritis, osteoarthritis, ankylosing\r\nspondylitis, periarticular inflammatory\r\ndisorders, acute painful shoulder, acute\r\ngouty arthritis, diabetic neuropathy &\r\ndiabetic retinopathy.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Sulindac\r\nshould be administered orally twice a day\r\nwith food. The maximum dosage is 400\r\nmg per day. Dosages above 400 mg per\r\nday are not recommended. In\r\nosteoarthritis, rheumatoid arthritis &\r\nankylosing spondylitis, the recommended\r\nstarting dosage is 150 mg. In acute\r\npainful shoulder & acute gouty arthritis\r\nthe recommended dosage is 200 mg\r\ntwice a day. The dosage may be lowered\r\nor raised depending on the response.\r\nAfter a satisfactory response has been\r\nachieved, the dosage may be reduced\r\naccording to the response. Or, as\r\ndirected by the registered physicians.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">There\r\nare no adequate and well-controlled\r\nstudies in pregnant women. Sulindac\r\nshould be used during pregnancy only if\r\nthe potential benefit justifies the potential\r\nrisk to the fetus. It is not known whether\r\nthis drug is excreted in human milk.</span></p><p><strong>Packing :</strong></p><p> <span class="redactor-invisible-space">Sudac-100: 5X10''s tablets in\r\nblister pack. </span></p><p><span class="redactor-invisible-space">Sudac-200: 2X10''s tablets in blister\r\npack.</span></p>', 'uploads/images/sudac_100.jpg', 1, '2017-11-28 00:30:10', NULL, NULL, '', 'Y', 4, 'uploads/IMG/sudac-100.jpg'),
(834, 'Sulfacol', 132, '<p><strong></strong><strong>Composition : </strong>Sulfasalazine 500mg Tablet.</p><p><strong>Indication :</strong><strong> </strong><span class="redactor-invisible-space"><strong>Rheumatoid arthritis &\r\nJuvenile arthritis : </strong>Sulfasalazine is\r\nindicated for Rheumatic arthritis and Juvenile\r\narthritis which has failed to responded to nonsteroidal\r\nanti-inflammatory drugs (NSAIDs).</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">The dosage of\r\nSulfasalazine (Sulfacol) tablets should be\r\nindividually adjusted according to the\r\npatient''s tolerance and response to the\r\ntreatment and taken in evenly divided doses\r\npreferably after meals.</span></p><p><br></p><p><strong>Packing : </strong><span class="redactor-invisible-space">3x10''s tablets in blister\r\npack.</span></p>', 'uploads/images/sulfacol.jpg', 1, '2017-11-27 05:54:58', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/sulfacol.jpg'),
(836, 'COSEC ', 100, '<strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Omeprazole 20mg, 40mg\r\nCapsule & 40mg injection.</span><p><strong>Indication : </strong></p><p><span class="redactor-invisible-space">J	Healing of erosive reflux oesophagitis.\r\nJ	Zollinger - Ellison syndrome.\r\nJ	For the treatment of gastric ulcers.\r\nJ	For the treatment of duodenal ulcers.</span></p><p><br></p><p><strong>Dosage and administration :</strong></p><p><strong> </strong><span class="redactor-invisible-space">Erosive Reflux\r\nOesophagitis : The recommended dosage\r\nis one 20mg Cosec capsule once daily\r\nbefore meal, given for 4 weeks. For those\r\npatients not fully healed after the initial\r\ncourse, healing usually occurs during a\r\nfurther 4 weeks treatment. </span></p><p><span class="redactor-invisible-space">Patients With Reflux Oesophagitis\r\nRefractory to Other Therapy :\r\nThe recommended dosage is 40mg Cosec\r\nonce daily before meal. Healing usually\r\noccurs within 8 weeks.</span></p><p><span class="redactor-invisible-space">\r\nDuodenal Ulcer : The usual dose is one\r\n20mg Cosec capsule once daily, before\r\nmeal for 4 weeks. In severe cases the dose\r\nmay be increased to 40mg Cosec capsule\r\nonce daily before meal.\r\nGastric Ulcer : The usual dose is one 20mg\r\nCosec capsule once daily before meal for 8\r\nweeks. In severe cases, the dose may be\r\nincreased to 40mg Cosec capsule once\r\ndaily. Long-term maintenance treatment with\r\nCosec capsule is not recommended.</span></p><p><span class="redactor-invisible-space">\r\nZollinger-Ellison Syndrome : The\r\nrecommended initial dosage is 60mg (40mg\r\n+ 20mg) once daily before meal. The\r\ndosage should be adjusted individually and\r\ntreatment continued as long as clinically\r\nindicated. More than 90% of patients with\r\nsevere disease and inadequate response to\r\nother therapies have been effectively\r\ncontrolled on doses of 20mg - 120mg daily.\r\nWith doses above 80mg daily, the dose\r\nshould be divided and given twice daily.\r\nElderly : Dose adjustment is not required in\r\nthe elderly. </span></p><p><span class="redactor-invisible-space">Children : There is no experience of the use\r\nof Cosec capsule in children.</span></p><p><br></p><p><span class="redactor-invisible-space">\r\nImpaired Renal or Hepatic Function :\r\nDose adjustment is not required in patients\r\nwith impaired renal or hepatic function.\r\nPatients with severe liver disease should not\r\nrequire more than one 20mg Cosec daily or\r\nas directed by a registered physician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Omeprazole has been assigned to\r\npregnancy category C by the FDA.</span></p><p><strong>Packing :</strong></p><p><strong></strong>Cosec 20mg Capsule : 6 x 10''s\r\ncapsules in blister pack. </p><p>Cosec 40mg Capsule : 6 x 7''s capsules in\r\nblister pack. </p><p>Cosec 40mg Injection : Combipack.</p>', 'uploads/images/Cosec20.jpg', 1, '2017-11-29 05:05:43', NULL, NULL, '', 'Y', 4, 'uploads/IMG/cosec-40.jpg'),
(844, 'D-Lac', 75, '<p><strong></strong><strong>Composition : </strong>Lactulose 3.35g/5ml Oral Solution.</p><p><strong>Indication : </strong><span class="redactor-invisible-space">DLAC is indicated for the\r\ntreatment of constipation and hepatic\r\nencephalopathy.</span></p><p><strong>Dosage and administration : </strong></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Lactulose has been assigned to\r\npregnancy category B by the FDA.</span></p><p><strong>Packing : </strong><span class="redactor-invisible-space">50ml, 100ml, 200ml in each\r\nbottle.</span></p>', 'uploads/images/d-lac_50.jpg', 1, '2017-11-29 04:18:30', NULL, NULL, '', 'Y', 4, 'uploads/IMG/D-lac.jpg'),
(845, 'ONDASON', 101, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Ondansetron 8mg Tablet &\r\n4mg/5ml Syrup.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">It is used in the management of\r\nnausea and vomiting induced by cytotoxic\r\nchemotherapy and radiotherapy. It is also\r\nused for the prevention and treatment of\r\npostoperative nausea and vomiting.</span></p><p><strong>Dosage and administration : </strong></p><p><span class="redactor-invisible-space">1) Prevention\r\nof Nausea and Vomiting Associated\r\nChemotherapy : </span></p><p><span class="redactor-invisible-space">Adults : The recommended\r\nadult oral dosage for highly emetogenic\r\ncancer chemotherapy is 24mg given as three\r\n8mg tablets administered 30 minutes before\r\nthe start of emetogenic chemotherapy. For\r\nmoderate emetogenic cancer chemotherapy\r\nthe recommended adult oral dosage is 8mg\r\n(one tablet) or 10ml Syrup (8mg) should be\r\nadministered 30 minutes before the start of\r\nemetogenic chemotherapy, with a subsequent\r\ndose 8 hours after the first dose. one 8mg\r\ntablet or 10ml syrup (8mg) should be\r\nadministered twice a day (every 12 hours) for\r\n1 to 2 days after completion of chemotherapy.\r\nPediatric : For pediatric patients 4 to 11 years\r\nof age, the dosage is 4mg tablet or 5ml Syrup\r\n(4mg). The first dose should be administered\r\n30 minutes before the start of emetogenic\r\nchemotherapy, with subsequent doses 4 and\r\n8 hours after the first dose. one 4mg tablet or\r\n5ml syrup (4mg) should be administered 3\r\ntimes a day (every 8 hours) for 1 to 2 days\r\nafter completion of chemotherapy.</span></p><p><span class="redactor-invisible-space"> 2)\r\nPrevention of Nausea and Vomiting\r\nAssociated With Radiotherapy: </span></p><p><span class="redactor-invisible-space">Adults : For\r\ntotal body irradiation : One tablet (8mg) or\r\n10ml (8mg) syrup should be administered 1 to\r\n2 hours before each fraction of radiotherapy\r\nadministered each day. For single high-dose\r\nfraction radiotherapy to the abdomen: One\r\ntablet (8mg) or 10ml (8mg) syrup should be\r\nadministered 1 to 2 hours before radiotherapy,\r\nwith subsequent doses every 8 hours after the\r\nfirst dose for 1 to 2 days after completion of\r\nradiotherapy. For daily fractionated\r\nradiotherapy to the abdomen : One tablet\r\n(8mg) or 10ml (8mg) syrup should be\r\nadministered 1 to 2 hours before radiotherapy,\r\nwith subsequent doses every 8 hours after the\r\nfirst dose for each day radiotherapy is given.</span></p><p><span class="redactor-invisible-space">\r\n3) Postoperative nausea and vomiting :</span></p><p><span class="redactor-invisible-space"> Adults\r\n: The recommended dosage is 16mg given as\r\ntwo tablets (8mg) or 20ml syrup (16mg) 1 hour\r\nbefore induction of anesthesia. Or, as directed\r\nby the registered physician.</span></p><p><br></p><p><strong>Packing :</strong>Ondason-8 : 3 x 10''s tablets in blister pack.\r\nOndason syrup : 50ml Ondason syrup.</p>', 'uploads/images/ONDASON.jpg', 1, '2017-11-28 04:28:10', NULL, NULL, '', 'Y', 4, 'uploads/IMG/ondason-syrup.jpg'),
(847, 'Paridon', 51, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Domperidone 10mg\r\nTablet & 5mg/5ml Suspension.</span></p><p><strong>Indication : <em></em></strong><span class="redactor-invisible-space">Paridon is indicated for the\r\ntreatment of\r\n1. Functional dyspepsia 2. Stimulation of\r\ngut mobility (a) non-ulcer dyspepsia (b)\r\nesophageal reflux, reflux esophagitis and\r\ngastritis 3. Acute treatment of nausea\r\nand vomiting, in adults. 4. For up to 12\r\nweeks treatment of nausea and vomiting\r\ncaused by L-dopa and bromocriptine.</span></p><p><strong>Dosage and administration :</strong>The\r\nrecommended oral dose of Paridon\r\nSuspension for :\r\nAdults : 10 - 20ml every 4-8 hours daily.\r\nChildren : 0.2 - 0.4mg/kg every 4 - 8\r\nhours daily.\r\nFor the treatment of nausea and\r\nvomiting - Adults (including the elderly) :\r\n10-20 mg orally at 4-8 hourly intervals.\r\nOr, as directed by the physician.\r\nFor the treatment of symptoms of\r\nfunctional dyspepsia & others : Adults\r\n(including the elderly): Tablets up to 10-\r\n20mg orally 3 times daily before meals\r\nand 10-20mg at night depending on\r\nclinical response. A course of treatment\r\nshould not exceed 12 weeks. Or, as\r\ndirected by the physician.Becovent inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled Becovent appropriate to the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to individual response. Management of chronic asthma (Adults & Children over 12 years): 100-400 mcg twice daily. Maximum 1000 mcg twice daily. Children (5-12 years): 100-200 mcg twice daily. the dose may be adjusted as necessary.</p><p><strong>Use in pregnancy and lactation : </strong>Pregnancy Category C by FDA.</p><p><strong>Packing : </strong><span class="redactor-invisible-space">Paridon : 7x14''s tablets in\r\nblister pack.\r\nParidon suspension : 100ml bottle.</span></p>', 'uploads/images/Paridont.jpg', 1, '2017-11-28 04:42:06', NULL, NULL, '', 'Y', 4, 'uploads/IMG/paridon.jpg'),
(848, 'Nomosic ', 84, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Meclizine hydrochloride\r\n50mg Tablet.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">This tablet is indicated for\r\nthe management of nausea and\r\nvomiting, and dizziness associated with\r\nmotion sickness, vertigo associated with\r\ndiseases affecting the vestibular system.\r\n</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">For the\r\nprevention and treatment of nausea,\r\nvomiting and vertigo associated with\r\nmotion sickness, the usual oral dosage\r\nof meclizine hydrochloride in adults and\r\nchildren 12 years of age or older is 25-\r\n50mg once daily. Vertigo : for the control\r\nof vertigo associated with diseases\r\naffecting the vestibular system, the\r\nrecommended dose is 25 to 100mg daily,\r\nin divided doses, depending upon clinical\r\nresponse. Motion Sickness : The initial\r\ndose of 25 to 50mg should be taken one\r\nhour prior to embarkation for protection\r\nagainst motion sickness. Thereafter, the\r\ndose may be repeated every 24 hours\r\nfor the duration of the journey.</span></p><p><strong>Use in pregnancy and lactation : </strong>Pregnancy Category B by FDA.</p><p><strong>Packing : </strong></p><p><span class="redactor-invisible-space">Nomosic Tablet : 5x10’s\r\ntablets in blister pack</span></p>', 'uploads/images/Nomosic.jpg', 1, '2017-11-28 04:02:27', NULL, NULL, '', 'Y', 4, 'uploads/IMG/nomosic.jpg'),
(850, 'D-FEN', 110, '<p><strong>Composition :</strong>Pizotifen Malate 0.5mg.\r\n& 1.5mg Tablet.Each Metered dose (Puff) contains Beclometasone Dipropionate 100 mcg.</p><p><strong>Indication : </strong><span class="redactor-invisible-space">Pizotifen (D-fen) is indicated\r\nfor the prophylactic treatment of vascular\r\nheadaches of migraine type such as\r\nclassical migraine, common migraine and\r\ncluster headache.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">The\r\nrecommended dose is as followings : Adult:\r\nThe initial dose is 1.5mg daily; this may be\r\ntaken at bedtime as a single dose or in\r\nthree divided doses. Dosage can be\r\nadjusted according to the individual\r\npatient''s requirements up to a maximum of\r\n4.5mg daily. Up to 3mg may be given as a\r\nsingle daily dose.\r\nChildren : Up to 1.5mg daily, usually as a\r\ndivided dose. Use of 1.5mg at a time is not\r\nrecommended, but up to 1mg can be given\r\nas a single daily dose at night. Children\r\nbelow two years of age should not be given\r\npizotifen (D-fen). Or, as directed by the\r\nregistered physician.\r\n</span></p><p><br></p><p><strong>Packing :</strong></p><p><strong> </strong> D-fen 0.5 : 5x10’s tablets in blister pack. </p><p>D-fen 1.5 : 5x10’s tablets in blister pack.</p>', 'uploads/images/D-FEN1_5.jpg', 1, '2017-11-29 04:17:12', NULL, NULL, '', 'Y', 4, 'uploads/IMG/d-fen05.jpg'),
(851, 'Miotrol', 149, '<p><strong></strong><strong>Composition : </strong>Zolmitriptan 2.5mg Tablet.</p><p><strong>Indication : </strong><span class="redactor-invisible-space">Zolmitriptan is indicated for\r\nthe acute treatment of migraine with or\r\nwithout aura in adult</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">The\r\nrecommended dose of Zolmitriptan to\r\ntreat a migraine attack is 2.5mg. If\r\nsymptoms persist or return within 24\r\nhours, a second dose has been shown to\r\nbe effective. If a second dose is required,\r\nit should not be taken within 2 hours of\r\nthe initial dose. If a patient does not\r\nachieve satisfactory relief with 2.5mg\r\ndoses, subsequent attacks can be\r\ntreated with 5mg doses of Zolmitriptan.\r\nIn the event of recurrent attacks, it is\r\nrecommended that the total intake of\r\nZolmitriptan in a 24 hour period should\r\nnot exceed 15mg. Or, as directed by the\r\nregistered physician.</span></p><p><br></p><p><strong>Packing :</strong><em> </em><span class="redactor-invisible-space"><em>Miotrol : </em>5 x 10''s tablets in\r\nblister pack.</span></p>', 'uploads/images/Miotrol.jpg', 1, '2017-11-28 03:16:13', NULL, NULL, '', 'Y', 4, 'uploads/IMG/miotrol.jpg');
INSERT INTO `drg_medicine_info` (`MEDICINE_ID`, `MEDICINE_NAME`, `GN_GRP_ID`, `MEDICINE_DESC`, `INSERT_FILE`, `CRE_BY`, `CRE_DT`, `UPD_BY`, `UPD_DT`, `IS_LATEST`, `ACTIVE_STATUS`, `CAT_ID`, `PRODUCT_FET_PHOTO`) VALUES
(852, 'Migon', 64, '<p><strong></strong><strong>Composition : </strong>Each Metered dose (Puff) contains Beclometasone Dipropionate 100 mcg.</p><p><strong>Indication : </strong>Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. </p><p><strong>Dosage and administration : </strong>Becovent inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled Becovent appropriate to the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to individual response. Management of chronic asthma (Adults & Children over 12 years): 100-400 mcg twice daily. Maximum 1000 mcg twice daily. Children (5-12 years): 100-200 mcg twice daily. the dose may be adjusted as necessary.</p><p><strong>Use in pregnancy and lactation : </strong>Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.</p><p><strong>Packing : </strong>Becovent HFA Inhaler : Each box contains one inhaler of 200 Puffs</p>', 'uploads/images/Miotrol.jpg', 1, '2017-11-07 00:20:30', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/20.jpg'),
(853, 'Meverine', 83, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Mebeverine HCI 135mg\r\nTablet & 200mg SR Capsule</span></p><p><strong>Indication :</strong></p><p><strong> </strong><span class="redactor-invisible-space">Meverine is indicated for\r\nthe symptomatic treatment of irritable\r\nbowel syndromme and other conditions\r\nusually included in this grouping such as:\r\nchronic irritable colon, spastic\r\nconstipation, mucous colitis, spastic\r\ncolitis. Meverine is also effective in\r\ncolicky abdominal pain and cramps,\r\npersistent, non-specific diarrhoea (with\r\nor without alternating constipation) and\r\nflatulence.\r\nFor the symptomatic treatment of gastrointestinal\r\nspasm secondary to organic\r\ndiseases.<em><strong>\r\n</strong>Meverine-SR :</em> Mebeverine Hydrochloride\r\nis indicated: For the symptomatic\r\ntreatment of irritable bowel syndrome\r\n(IBS), other conditions include: Chronic\r\nirritable colon, Spastic constipation,\r\nMucous Colitis, Colicky abdominal pain,\r\nPersistent non-specific diarrhoea.</span></p><p><strong>Dosage and administration :</strong>Adults & Children over 10\r\nyears, 1 tablet 3 times daily, preferably\r\n20 minutes before meals or as directed\r\nby a registered physician.\r\n<em>Meverine-SR :</em> Adults, elderly : 1 Capsule\r\ntwice daily, preferably 20 minutes before\r\nmeals. Or, as directed by the registered\r\nphysician.</p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">No\r\nteratogenicity has been shown in animal\r\nexperiments. However, the usual\r\nprecautions concerning the administration\r\nof any drug during pregnancy should be\r\nexercised. Mebeverine dose not excrete in\r\nthe breast milk after administering at\r\ntherapeutic dose.</span></p><p><strong>Packing : </strong></p><p><span class="redactor-invisible-space">Meverine : 5 x 10''s tablets in\r\nblister pack.</span></p><p><span class="redactor-invisible-space">\r\nMeverine SR : 3x10''s Capsules in blister\r\npack.</span></p>', 'uploads/images/mebev200.jpg', 1, '2017-11-28 03:24:55', NULL, NULL, '', 'Y', 4, 'uploads/IMG/meverine-sr.jpg'),
(854, 'Visonium', 139, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Tiemonium Methylsulfate\r\n50mg Tablet & 5mg/2ml Injection.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">: It is indicated for treatment\r\nof gastroenteritis, diarrhoea, dyscentery,\r\nbiliary, colic, enterocolitis, cholecystitis,\r\ncolonopathies, mild cystitis. Visonium is\r\nthe drug of choice for the treatment of\r\nspasmodic dysmenorrhoea.</span></p><p><strong>Dosage and administration :</strong>Visonium\r\nTablet : In adults, the usual dosage is 2\r\nto 6 tablets is given in a dose of 100 to\r\n300mg daily in divided doses by mouth.\r\nVisonium Injection (IM/IV) : The usual\r\ndosage is 5mg (1 ampoule) three times\r\ndaily by intramuscular or slow\r\nintravenous injection. Or, as directed by\r\nthe registered physician.</p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">The\r\ndrug should be used with caution during\r\npregnancy and lactation.</span></p><p><strong>Packing :</strong><em><strong></strong></em></p><p><strong><em>Visonium Tablet :</em> </strong>5x10''s\r\ntablets in blister pack.<strong><em>\r\nVisonium Injection (IM/IV) :</em> </strong>1x5''s\r\nampoules (2ml) in a blister pack.</p>', 'uploads/images/visoninj.jpg', 1, '2017-11-27 04:15:55', NULL, NULL, '', 'Y', 4, 'uploads/IMG/visonium.jpg'),
(858, 'Bacmax', 15, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Baclofen 5mg & 10mg\r\nTablet.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">Baclofen is useful for the\r\nalleviation of signs and symptoms of\r\nspasticity resulting from multiple\r\nsclerosis, particularly for the relief of\r\nflexor spasms and concomitant pain,\r\nclonus and muscular rigidity.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">The\r\ndetermination of optimal dosage requires\r\nindividual titration. Start therapy at a low\r\ndosage and increase gradually until\r\noptimum effect is achieved (usually\r\nbetween 40-80mg daily). The following\r\ndosage titration schedule is suggested :</span></p><p><span class="redactor-invisible-space">\r\n5mg t.i.d. for </span>3 days</p><p>\r\n10mg t.i.d. for 3 days</p><p>\r\n15mg t.i.d. for 3 days </p><p>20mg t.i.d. for 3 days </p><p>Thereafter additional increases may be\r\nnecessary but the total daily dose should\r\nnot exceed a maximum of 80mg daily\r\n(20mg q.i.d.). Or, as directed by the\r\nregistered physician.</p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Pregnancy Category-C. There are no\r\nadequate and well-controlled studies in\r\npregnant women. Baclofen should be\r\nused during pregnancy only if the\r\npotential benefit justifies the potential risk\r\nto the fetus. It is not known whether this\r\ndrug is excreted in human milk. Because\r\nmany drugs are excreted in human milk,\r\ncaution should be exercised when\r\nbaclofen is administered to a nursing\r\nwoman.</span></p><p><strong>Packing : </strong></p><p><span class="redactor-invisible-space">Bacmax-5 : 4x14''s tablets\r\nin blister pack.</span></p><p><span class="redactor-invisible-space">\r\nBacmax-10 : 2x14''s tablets in blister\r\npack.</span></p>', 'uploads/images/bacmax10.jpg', 1, '2017-11-29 05:26:36', NULL, NULL, '', 'Y', 4, 'uploads/IMG/bacmax-5.jpg'),
(859, 'Lexaton', 143, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Tolperisone\r\nHydrochloride 50mg Tablet.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">1. Treatment of increased\r\ntone of skeletal muscles due to organic\r\nneurological disorders (injury of the\r\npyramidal tract, multiple sclerosis,\r\nmyelopathy, encephalomyelitis).\r\n2. Treatment of muscular spasm,\r\nmuscular contracture, rigidity, spinal\r\nautomatism.\r\n3. In the treatment of vascular diseases\r\n(Obliterative arteriosclerosis, diabetic\r\nangiopathy, obliterative thromboangitis,\r\nRaynaud''s disease, diffuse scleroderma).\r\n4. In individual cases, post-thrombotic\r\nvenous and lymphatic circulation\r\ndisorders and crural ulcer.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">The\r\nrecommended dose is as followings :\r\nAdult : 50-150mg three times daily\r\naccording to the individual requirement\r\nand tolerance of the patient.\r\nChildren (from 3 months to 6 years) :\r\n5mg/kg/day in three divided doses.\r\nChildren (from 6 to 14 years) : 2-\r\n4mg/kg/day in three divided doses. Or, as\r\ndirected by the registered physician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Lexaton should be used in pregnancy\r\naccording to physician''s advice. It should\r\nnot be used during breast feeding.</span></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Lexaton : 4x14''s tablets in\r\nblister pack.</span></p>', 'uploads/images/lexaton.jpg', 1, '2017-11-28 02:57:27', NULL, NULL, '', 'Y', 4, 'uploads/IMG/lexaton.jpg'),
(860, 'Trolen-25', 42, '<p><strong></strong><strong>Composition : </strong>Dantrolene Sodium USP 25 mg.</p><p><strong>Indication : </strong><span class="redactor-invisible-space">In Chronic Spasticity :\r\nDantrolene Sodium is indicated in controlling the\r\nmanifestations of clinical spasticity resulting\r\nfrom upper motor neuron disorders such as\r\nspinal cord injury, stroke, cerebral palsy or\r\nmultiple sclerosis. It is of particular benefit to the\r\npatient whose functional rehabilitation has been\r\nretarded by the sequelae of spasticity</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">For use in\r\nChronic Spasticity : Adults Patients : The\r\nfollowing gradual titration schedule is\r\nsuggested. Some patients will not respond until\r\nhigher daily dosage is achieved. Each dosage\r\nlevel should be maintained for seven days to\r\ndetermine the patient''s response. If no further\r\nbenefit is observed at the next higher dose,\r\ndosage should be decreased to the previous\r\nlower dose. 25 mg once daily for seven days,\r\nthen 25 mg 3 times for seven days, 50 mg 3\r\ntimes for seven days, 100 mg 3 times. For</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Pregnancy\r\nCategory C. Dantrolene should be used during\r\npregnancy only if the potential benefit justifies\r\nthe potential risk to the fetus. Dantrolene should\r\nnot be used in nursing mothers.</span></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Trolen-25 : 2 x 10''s capsules in\r\nblister pack.</span></p>', 'uploads/images/trolen.jpg', 1, '2017-12-04 03:44:53', NULL, NULL, '', 'Y', 4, 'uploads/IMG/38.jpg'),
(866, 'EYETEAR', 111, '<p>Composition : Each Metered dose (Puff) contains Beclometasone Dipropionate 100 mcg.</p><p><br></p><p>Indication : Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. </p><p><br></p><p>Dosage and administration : Becovent inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled Becovent appropriate to the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to individual response. Management of chronic asthma (Adults & Children over 12 years): 100-400 mcg twice daily. Maximum 1000 mcg twice daily. Children (5-12 years): 100-200 mcg twice daily. the dose may be adjusted as necessary.</p><p><br></p><p>Use in pregnancy and lactation : Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.</p><p><br></p><p>Packing : Becovent HFA Inhaler : Each box contains one inhaler of 200 Puffs</p>', 'uploads/images/EYETEAR.jpg', 1, '2017-11-07 01:22:32', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/.jpg'),
(869, '	FENAT', 73, '<p><strong></strong><strong>Composition : </strong>Each Metered dose (Puff) contains Beclometasone Dipropionate 100 mcg.</p><p><strong>Indication : </strong>Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. </p><p><strong>Dosage and administration : </strong>Becovent inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled Becovent appropriate to the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to individual response. Management of chronic asthma (Adults & Children over 12 years): 100-400 mcg twice daily. Maximum 1000 mcg twice daily. Children (5-12 years): 100-200 mcg twice daily. the dose may be adjusted as necessary.</p><p><strong>Use in pregnancy and lactation : </strong>Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.</p><p><strong>Packing : </strong>Becovent HFA Inhaler : Each box contains one inhaler of 200 Puffs</p>', 'uploads/images/FENATE.jpg', 1, '2017-11-07 01:32:56', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/fenat.jpg'),
(870, '	F-Lon', 65, '<p><strong></strong><strong>Composition : </strong>Each Metered dose (Puff) contains Beclometasone Dipropionate 100 mcg.</p><p><strong>Indication : </strong>Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. </p><p><strong>Dosage and administration : </strong>Becovent inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled Becovent appropriate to the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to individual response. Management of chronic asthma (Adults & Children over 12 years): 100-400 mcg twice daily. Maximum 1000 mcg twice daily. Children (5-12 years): 100-200 mcg twice daily. the dose may be adjusted as necessary.</p><p><strong>Use in pregnancy and lactation : </strong>Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.</p><p><strong>Packing : </strong>Becovent HFA Inhaler : Each box contains one inhaler of 200 Puffs</p>', 'uploads/images/F-Lon.jpg', 1, '2017-11-07 01:34:57', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/F-Lon.jpg'),
(871, 'FLOXALONE', 93, '<p><strong>Composition : </strong><span class="redactor-invisible-space">Moxifloxacin 5mg/ml as Moxifloxacin Hydrochloride.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">Floxalone eye drop is indicated for the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms:</span></p><p><span class="redactor-invisible-space">Aerobic Gram-positive microorganisms: Corynebacterium species, Micrococcus luteus, Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus haemolyticus, Staphylococcus hominis, Staphylococcus warneri, Streptococcus pneumoniae, Streptococcus viridans group.</span></p><p><span class="redactor-invisible-space">Aerobic Gram-negative microorganisms: Acinetobacter lwoffii, Haemophilus influenzae, Haemophilus parainfluenzae. Other microorganisms: Chlamydia trachomatis.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">The recommended dose is one drop in the affected eye every 8 hours (3 times) daily for 7 days. Or, as directed by the registered physician.</span></p><p><strong>Packing : </strong>5ml in plastic dropper bottle.</p>', 'uploads/images/FLOXALONE.jpg', 1, '2017-11-29 03:05:27', NULL, NULL, '', 'Y', 4, 'uploads/IMG/floxalone-400.jpg'),
(872, 'LEVOFLOX', 80, '<p><strong>Composition : </strong>Levofloxacin 500mg & 750mg Tablet.</p><p><strong>Indication :</strong>Levofloxacin is indicated for the treatment of mild, moderate, and severe infections caused by susceptible strains of the designated micro-organisms in the condition listed below: l Acute maxillary sinusitis due to Streptococcus pneumoniae, Haemophilus influenzae, or Moraxella catarrhalis. l Acute bacterial exacerbation of chronic bronchitis due to Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae, or Moraxella catarrhalis. l Community-acquired pneumonia due to Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae, Klebsiella pneumoniae, Moraxella catarrhalis, Chlamydia pneumoniae, Legionella pneumophila, or Mycoplasma pneumoniae. l Uncomplicated & complicated urinary tract infections due to Escherichia coli, Klebsiella pneumoniae, or Staphylococcus saprophyticus. l Acute pyelonephritis caused by Escherichia coli. l Uncomplicated & complicated skin and soft tissue infections including abscesses, cellulitis, furuncles, impetigo, pyoderma, wound infections, due to Staphylococcus aureus, Streptococcus pyogenes, Proteus mirabilis or Enterococcus faecalis. l Enteric infections caused by Enterobacter sp., Escherichia coli, Campylobacter sp., Vibrio cholerae, Shigella sp., Salmonella sp.</p><p><strong>Dosage and administration : </strong>: l Acute sinusitis: 500mg once daily for 10-14 days or 750mg once daily for 5 days. l Exacerbation of chronic bronchitis: 500mg once daily for 7 days, or 750mg once daily for 3 days (Uncomplicated), 750mg once daily for 5 days (Complicated). l Community-acquired pneumonia: 500mg once daily for 7-14 days, or 750mg once daily for 5 days. l Uncomplicated urinary-tract infections: 250mg once daily for 3 days. l Complicated urinary-tract infections and acute pyelonephritis: 250mg once daily for 7-10 days. l Uncomplicated skin and soft-tissue infections: 500mg once daily for 7-10 days. l Complicated skin and soft-tissue infections: 750mg once daily for 7-14 days. l Enteric fever: 500mg once daily for 7-14 days. l Diarrhea, cholera, shigellosis & enteritis: Mild to moderate case: 500mg (single dose), Moderate to sever case: 500mg once daily for 3 days. Or, as directed by the registered physician.</p><p><strong>Use in pregnancy and lactation :</strong>: Levofloxacin has been assigned to pregnancy category C by the FDA. It can be presumed that Levofloxacin will be excreted in human milk. Because of the potential for serious adverse reaction from Levofloxacin in nursing infants, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.</p><p><strong>Packing : </strong>Levoflox-500 : 2 x 10''s tablets in blister pack. Levoflox-750 : 2 x 5''s tablets in blister pack.</p>', 'uploads/images/LEVOFLOX.jpg', 1, '2017-11-27 23:54:28', NULL, NULL, '', 'Y', 4, 'uploads/IMG/levoflox.jpg'),
(874, 'NOPAIN ', 48, '<p><strong>Composition : </strong><span class="redactor-invisible-space">Diclofenac sodium\r\n1.00mg/ml.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">Postoperative inflammation\r\nafter cataract surgery and other surgical\r\nprocedures. Preoperative and\r\npostoperative prevention of cystoid\r\nmacular oedema associated with lens\r\nextraction and intraocular lens\r\nimplantation. Non-infectious\r\ninflammatory conditions affecting the\r\nanterior region of the eye (e.g. chronic\r\nnon-infectious conjunctivitis). Posttraumatic\r\ninflammation in penetrating\r\nwounds (as an adjuvant to local antiinfective\r\ntherapy).</span></p><p><strong>Dosage and administration :<em> </em></strong>Preoperative : up to 5x1 drop over the 3\r\nhours preceding surgery. Postoperative :\r\n3x1 drop immediately after surgery,\r\nthereafter 3-5x1 drop daily for as long as\r\nrequired.</p><p><br></p><p><strong>Packing : </strong></p><p>5ml in plastic dropper bottle.<br></p>', 'uploads/images/NOPAIN.jpg', 1, '2017-11-28 03:53:17', NULL, NULL, '', 'Y', 4, 'uploads/IMG/nopain-50.jpg'),
(875, 'NEO-DP ', 45, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">(Dexamethasone 1mg+\r\nNeomycin Sulfate 3,500 IU+ Polymyxin\r\nB Sulfate 6,000 IU)/ml.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">Neo-DP is indicated for\r\nthe short term treatment of steroid\r\nresponsive conditions of the eye when\r\nprophylactic antibiotic treatment is also\r\nrequired, after excluding the presence of\r\nfungal and viral disease.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Apply one or\r\ntwo drops to each affected eye up to six\r\ntimes daily or more frequently if required.\r\nSevere infections may require one or two\r\ndrops every 15-20 minutes initially,\r\nreducing the frequency of instillation\r\ngradually as the infection is controlled.\r\nOr as directed by registered physician.</span></p><p><br></p><p><strong>Packing : </strong>5ml in plastic dropper bottle.</p>', 'uploads/images/NEO-DP.jpg', 1, '2017-11-28 03:59:16', NULL, NULL, '', 'Y', 4, 'uploads/IMG/Neo-DP-Sterile-Ophthalmic-Suspension.jpg'),
(876, 'OPTHACOL', 31, '<p><strong></strong><strong>Composition : </strong>Chloramphenicol 5.00mg/ml</p><p><strong>Indication : </strong><span class="redactor-invisible-space">Eye : Chloramphenicol is a\r\nbroad spectrum bacteriostatic antibiotic.\r\nIt is active against a wide variety of\r\ngram-negative & gram-positive\r\norganisms as well as rickettsiae and\r\nspiro-chaetes. It is indicated for use as\r\ntopical antibacterial in the treatment of\r\nsuperficial ocular infections caused by\r\nsensitive organisms.\r\nEar : External ear canal infections.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Eye : For\r\nadults (including the elderly):\r\nOne to two drops applied to each\r\naffected eye upto six times daily or more\r\nfrequently if required. (Severe infections\r\nmay require one to two drops every\r\nfifteen to twenty minutes initially,\r\nreducing the frequency of instillation\r\ngradually as the infection is controlled).\r\nEar : 2-3 drops into the ear canal three\r\nto four times a day or as directed by the\r\nphysician.</span></p><p><br></p><p><strong>Packing :</strong>10ml in plastic dropper bottle.Becovent HFA Inhaler : Each box contains one inhaler of 200 Puffs</p>', 'uploads/images/OPTHACOL.jpg', 1, '2017-11-28 04:26:22', NULL, NULL, '', 'Y', 4, 'uploads/IMG/Opthacol-Sterile-Eye-&-Ear-Drops.jpg'),
(877, 'OPTHAFLOX', 81, '<p><strong></strong><strong>Composition :</strong>Lomefloxacin 3mg/ml.</p><p><strong>Indication : </strong><span class="redactor-invisible-space">Bacterial infections including\r\nconjunctivitis, blepharitis, blepharoconjunctivitis,\r\nlomefloxacin susceptible\r\norganisms and staphylococcus aureusinduced\r\ncorneal ulcers.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Adults\r\nand children (above 1 year of age) :\r\nInsert 1 drop into the lower conjunctival\r\nsac 2-3 times daily. At the beginning of\r\nthe treatment, applications should be\r\nmore frequent, apply 1 drop every hour\r\nduring 6-10 hour. Duration of the\r\ntreatment: 7 to 9 days. Or as directed by\r\nthe physician</span></p><p><strong>Use in pregnancy and lactation : </strong>Pregnancy Category C by FDA.</p><p><strong>Packing : </strong>5ml in plastic dropper bottle.</p>', 'uploads/images/OPTHAFLOX.jpg', 1, '2017-11-28 04:24:55', NULL, NULL, '', 'Y', 4, 'uploads/IMG/Opthaflox-Sterile-Eye--Drops.jpg'),
(879, 'STENICOL', 32, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Chloramphenicol +\r\nDexamethasone phosphate (5mg+1mg)/ml.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">For steroid-responsive\r\ninflammatory ocular condition for which a\r\ncorticosteroid is indicated and where\r\nbacterial infection or a risk of bacterial\r\nocular infection exists. For inflammatory\r\nconditions of the palpebral and bulbar\r\nconjunctiva, cornea and anterior segment\r\nof the globe. For chronic anterior uveitis\r\nand corneal injury from chemical,\r\nradiation or thermal burns, or penetration\r\nof foreign bodies</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">1 or 2\r\ndrops is instilled into the affected eyes\r\nevery 3 or 4 hours, or more frequently if\r\nadvised by the prescribing physician.\r\nAdministration should be continued day\r\nand night for the first 48 hours, after\r\nwhich the interval between applications\r\nshould be increased. Treatment should be\r\ncontinued for at last 48 hours, after the\r\neye appears normal. Or as directed by\r\nthe physician.</span></p><p><br></p><p><strong>Packing : </strong>5ml in plastic dropper bottle.</p>', 'uploads/images/STENICOL.jpg', 1, '2017-11-28 05:24:03', NULL, NULL, '', 'Y', 4, 'uploads/IMG/STENICOL.jpg'),
(880, 'TEXA ', 140, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Tobramycin +\r\nDexamethasone (3mg+1mg)/ml</span></p><p><strong>Indication :</strong>Texa is indicated for\r\nsteroid-responsive inflammatory ocular\r\nconditions for which a corticosteroid is\r\nindicated and where superficial bacterial\r\nocular infection or a risk of bacterial\r\ninfection exists. </p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">One or\r\ntwo drops instilled into the conjunctival\r\nsac(s) every four to six hours. During the\r\ninitial 24 to 48 hours, the dosage may be\r\nincreased to one or two drops every two\r\n(2) hours. Frequency should be\r\ndecreased gradually as warranted by\r\nimprovement in clinical signs. Or, as\r\ndirected by the registered physician.</span></p><p><br></p><p><strong>Packing :</strong>5ml in plastic dropper bottle</p>', 'uploads/images/TEXA.jpg', 1, '2017-11-27 04:35:19', NULL, NULL, '', 'Y', 4, 'uploads/IMG/Texa.jpg'),
(881, 'SYNTAR', 46, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Dextran 70 +\r\nHypromellose (1mg+3mg)/ml.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">This eye lubricant is\r\nformulated for relief of various ocular\r\nirritation syndromes (dry and irritated\r\neyes) and for use as a protectant against\r\nfurther irritation. It may also be used to\r\ntreat drying, inflammation of cornea and\r\nconjunctiva of eyes.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Instill 1-2\r\ndrops in the affected eye (s) as needed,\r\nor as directed by the registered\r\nphysician.</span></p><p><br></p><p><strong>Packing : </strong>10ml in plastic dropper bottle</p>', 'uploads/images/SYNTAR.jpg', 1, '2017-11-28 05:22:45', NULL, NULL, '', 'Y', 4, 'uploads/IMG/SYNTAR.jpg'),
(882, 'CARNITEN', 77, '<p><strong>Composition :</strong>Levocarnitine 330mg\r\nTablet.Each Metered dose (Puff) contains Beclometasone Dipropionate 100 mcg.</p><p><strong>Indication : </strong><span class="redactor-invisible-space">Levocarnitine\r\nsupplementation may benefit individuals\r\nwith the following conditions : </span></p><p>1. Congestive Heart Failure (CHF) </p><p><span class="redactor-invisible-space">2.\r\nHypercholesterolemia </span></p><p><span class="redactor-invisible-space">3. Intermittent\r\nclaudication </span></p><p>4. Athletic performance </p><p><span class="redactor-invisible-space">5.\r\nWeight loss</span></p><p><span class="redactor-invisible-space"> 6. Chronic Obstructive\r\nPulmonary Disease (COPD) </span></p><p><span class="redactor-invisible-space">7.\r\nAlzheimer''s disease </span></p><p>8. Mild depression</p><p><span class="redactor-invisible-space">\r\n9. Hyperthyroidism</span></p><p><span class="redactor-invisible-space"> 10. Peyronie''s\r\ndisease & </span></p><p>11. Male infertility.</p><p><strong>Dosage and administration :</strong>Adults :\r\nThe recommended dosage for adult is\r\n990mg (3 tablets) two or three times a\r\nday depending on clinical response.\r\nInfants and children : The recommended\r\noral dosage for infants and children is\r\nbetween 50 -100mg/kg/day in divided\r\ndoses, with a maximum of 3g/day.\r\nDosage should begin at 50mg/kg/day.\r\nThe exact dosage will depend on clinical\r\nresponse. Or, as directed by the\r\nregistered physician.</p><p><br></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Carniten : 7 x 7''s tablets in\r\nblister pack.</span></p>', 'uploads/images/CARNITEN.jpg', 1, '2017-11-29 05:03:39', NULL, NULL, '', 'Y', 4, 'uploads/IMG/carniten.jpg'),
(883, 'COZYME', 41, '<p><strong></strong><strong>Composition : </strong>Each Metered dose (Puff) contains Beclometasone Dipropionate 100 mcg.</p><p><strong>Indication : </strong>Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. </p><p><strong>Dosage and administration : </strong>Becovent inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled Becovent appropriate to the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to individual response. Management of chronic asthma (Adults & Children over 12 years): 100-400 mcg twice daily. Maximum 1000 mcg twice daily. Children (5-12 years): 100-200 mcg twice daily. the dose may be adjusted as necessary.</p><p><strong>Use in pregnancy and lactation : </strong>Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.</p><p><strong>Packing : </strong>Becovent HFA Inhaler : Each box contains one inhaler of 200 Puffs</p>', 'uploads/images/COZYME6.jpg', 1, '2017-11-07 02:36:50', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/cozyme60.jpg'),
(884, 'ALBASINE', 8, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Almitrine Bismesylate +\r\nRaubasine; (30mg+10mg) Tablet.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">This tablet is indicated for\r\nreduction of neurological damage &\r\naccelerates recovery after cerebral\r\nstroke, Minor age related neurological\r\ndisorders, some visual disorders related\r\nto the circulation, some disorders of the\r\ninner ear related to the circulation\r\n(hearing loss, dizziness, buzzing sounds\r\nin the ear).</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">1 tablet\r\nonce or twice daily (taken separately,\r\nseveral hours apart), without exceeding\r\n2 tablets per day. Or, as directed by the\r\nregistered physicians.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">It is\r\nnot recommended in pregnancy. It\r\nshould be used with caution only when\r\nthe expected benefit to the mother is\r\ngreater than the possible risk to the\r\nfetas.</span></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Albasine : 2x14''s tablets in\r\nalu alu blister pack.</span></p>', 'uploads/images/ALBASINE.jpg', 1, '2017-11-26 06:23:33', NULL, NULL, '', 'Y', 4, 'uploads/IMG/43.jpg'),
(886, 'Ardium', 50, '<p><strong></strong><strong>Composition : </strong>Each Metered dose (Puff) contains Beclometasone Dipropionate 100 mcg.</p><p><strong>Indication : </strong>Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. </p><p><strong>Dosage and administration : </strong>Becovent inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled Becovent appropriate to the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to individual response. Management of chronic asthma (Adults & Children over 12 years): 100-400 mcg twice daily. Maximum 1000 mcg twice daily. Children (5-12 years): 100-200 mcg twice daily. the dose may be adjusted as necessary.</p><p><strong>Use in pregnancy and lactation : </strong>Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.</p><p><strong>Packing : </strong>Becovent HFA Inhaler : Each box contains one inhaler of 200 Puffs</p>', 'uploads/images/ALBASINE.jpg', 1, '2017-11-07 02:43:12', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/02.jpg'),
(888, 'Combomax', 135, '<p><strong></strong><strong>Composition : </strong>Each Metered dose (Puff) contains Beclometasone Dipropionate 100 mcg.</p><p><strong>Indication : </strong>Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. </p><p><strong>Dosage and administration : </strong>Becovent inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled Becovent appropriate to the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to individual response. Management of chronic asthma (Adults & Children over 12 years): 100-400 mcg twice daily. Maximum 1000 mcg twice daily. Children (5-12 years): 100-200 mcg twice daily. the dose may be adjusted as necessary.</p><p><strong>Use in pregnancy and lactation : </strong>Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.</p><p><strong>Packing : </strong>Becovent HFA Inhaler : Each box contains one inhaler of 200 Puffs</p>', 'uploads/images/Combomax.jpg', 1, '2017-11-07 03:01:17', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/combomax.jpg'),
(889, 'Dutamax', 55, '<p><strong>Composition : </strong><span class="redactor-invisible-space">Dutasteride 0.5mg\r\nCapsule.</span></p><p><strong><br></strong></p><p><strong>Indication : </strong>It is indicated for the\r\ntreatment of symptomatic benign\r\nprostatic hyperplasia (BPH) in men with\r\nan enlarged prostate to; 1. Improve\r\nsymptoms, 2. Reduce the risk of acute\r\nurinary retention, 3. Reduce the risk of\r\nthe need for BPH-related surgery.<strong></strong></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">The\r\nrecommended dose of Dutasteride is\r\none capsule (0.5mg) taken orally once a\r\nday. Dutasteride may be administered\r\nwith or without food. No dosage\r\nadjustment is necessary for subjects with\r\nrenal impairment or for the elderly\r\npatients. Or, as directed by the\r\nregistered physician.</span></p><p><strong><br></strong></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Dutamax : 3 x 7’s soft\r\ncapsules in blister pack.</span></p>', 'uploads/images/Dutamax.jpg', 1, '2017-11-29 04:15:57', NULL, NULL, '', 'Y', 4, 'uploads/IMG/dutamax.jpg'),
(890, 'Prostam', 134, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Tamsulosin hydrochloride\r\n0.4mg Capsule.</span></p><p><strong>Indication :</strong>It is indicated for the\r\ntreatment of symptomatic benign\r\nprostatic hyperplasia (BPH). </p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space"> 1 (one)\r\nProstam capsules once daily is\r\nrecommended as the dose for the\r\ntreatment of the signs and symptoms of\r\nBPH. It should be administered\r\napproximately one-half hour following the\r\nsame meal each day. For those patients\r\nwho fail to respond to the 0.4mg dose\r\nafter two to four weeks of dosing, the\r\ndose of the capsule can be increased to\r\n0.8mg once daily if the capsules\r\nadministration is discontinued or\r\ninterrupted for several days at either the\r\n0.4mg or 0.8mg dose, therapy should be\r\nstarted again with the 0.4mg once daily\r\ndose. Or, as directed by the physician.</span></p><p><br></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Prostam : 3 x 10''s capsules\r\nin blister</span></p>', 'uploads/images/Prostam.jpg', 1, '2017-11-28 00:01:16', NULL, NULL, '', 'Y', 4, 'uploads/IMG/prostam.jpg'),
(891, 'Palnox', 104, '<p><strong></strong><strong><em></em>Composition : </strong><span class="redactor-invisible-space">Palonosetron 0.5mg\r\nTablet & .025mg IV Injection.</span></p><p><strong>Indication <em>: </em></strong><span class="redactor-invisible-space"><em>Moderately emetogenic\r\ncancer chemotherapy : </em>prevention of\r\nacute and delayed nausea and vomiting\r\nassociated with initial and repeat\r\ncourses.</span></p><p><strong>Dosage and administration :<em> </em></strong><span class="redactor-invisible-space"><em></em><span class="redactor-invisible-space"><em>Chemotherapy-Induced Nausea and\r\nVomiting (Dosage for Adults) Tablet :</em>\r\n0.5 mg tablet approximately 1 hour\r\nbefore the start of chemotherapy.\r\nInjection : A single 0.25mg I.V dose\r\nadministered over 30 seconds. Dosing\r\nshould occur 30 minutes before the start\r\nof chemotherapy.</span></span></p><p><strong>Use in pregnancy and lactation :</strong>Pregnancy : Pregnancy category B.\r\nThere are no adequate and wellcontrolled\r\nstudies in pregnant women.\r\nTherefore, Palonosetron should be used\r\nduring pregnancy only if clearly needed.</p><p><strong>Packing : </strong><span class="redactor-invisible-space"> Palnox 0.5 tablet : 2 x 14''s\r\ntablets in blister pack.\r\nPalnox 0.25 Injection (IV) : 1 x 3''s\r\nAmpoules (5ml) in a blister pack.</span></p>', 'uploads/images/Palnoxi.jpg', 1, '2017-11-28 00:05:40', NULL, NULL, '', 'Y', 4, 'uploads/IMG/27.jpg'),
(892, 'CIPROZID ', 33, '<p><strong>Composition : </strong>Ciprofloxacin 3 mg/ml.</p><p><strong>Indication : </strong><span class="redactor-invisible-space">Eye : Ciprofloxacin is indicated for the treatment of corneal ulcers and superficial infections of the eye and adnexa caused by suceptible strains of bacteria. Ear : Otitis Externa</span></p><p><strong>Dosage and administration :</strong></p><p><strong></strong><span class="redactor-invisible-space">Eye : Adults : Superficial ocular infection: The usual dose is one or two drops in the affected eye (s) four times a day. In severe infections, the dosage for the first two days may be one or two drops every two hours during waling hours.</span></p><p><span class="redactor-invisible-space">Bacterial corneal ulcer : Two drops into the affected eye every 15 minutes for the six hours and then two drops into affected eye every 30 minutes for the remainder of the first day. On the second day, instill two drops in the affected eye hourly. On the third to the fourteenth day, place two drops is the affected eye every four hours. Treatment may be continued after 14 days if corneal reepithelialization has not occured.</span></p><p><span class="redactor-invisible-space">Children : The safety & efficacy of Ciprofloxacin in children under the age of 11 years has not been established.</span></p><p>Ear : One or two drops is instilled into the infected ear every four hours. Or, as directed by the registered physician.</p><p><strong>Packing : </strong><span class="redactor-invisible-space" style="background-color: initial;">10 ml in plastic dropper bottle.</span></p>', 'uploads/images/CIPROZI.jpg', 1, '2017-11-29 04:59:30', NULL, NULL, '', 'Y', 4, 'uploads/IMG/ciprozid.jpg'),
(893, 'Avro ', 145, '<p><strong></strong><strong>Composition : </strong>Travoprost 0.04mg/ml</p><p><strong>Indication : </strong><span class="redactor-invisible-space">It is indicated for the\r\nreduction of elevated intraocular\r\npressure in patients with open-angle\r\nglaucoma.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Adults :\r\nOne drop in the affected eye once daily\r\nin the evening. The dosage of travoprost\r\nshould not exceed once daily since it has\r\nbeen shown that more frequent\r\nadministration may decrease the normal\r\nintraocular pressure. Paediatric patients:\r\nThe efficacy and safety of travoprost eye\r\ndrops patients below the age of 18 years\r\nhave not been established. Or as\r\ndirected by the registered physician.</span></p><p><strong>Use in pregnancy and lactation : </strong>Pregnancy category C by FDA.</p><p><strong>Packing : </strong>3ml in plastic dropper bottle.</p>', 'uploads/images/CELUDEX.jpg', 1, '2017-11-26 06:25:42', NULL, NULL, '', 'Y', 4, 'uploads/IMG/av-5.jpg'),
(894, 'CIPROZID-DX   ', 35, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Ciprofloxacin +\r\nDexamethasone (3mg+1mg)/ml.</span></p><p><strong>Indication :</strong>Eye : Ciprozid-DX drop is\r\nindicated for the treatment of\r\ninflammatory ocular conditions for which\r\na corticosteroid is indicated and where\r\nbacterial infection or risk of bacterial\r\ninfection exists. The combination can\r\nalso be used for postoperative\r\ninflammation and any other ocular\r\ninflammation associated with infection.\r\nEar : Ciprozid-DX is also indicated for\r\nthe treatment of ear infections\r\naccompanied by inflammation such as\r\notitis externa, acute and chronic otitis\r\nmedia etc. The combination may also be\r\nused postoperatively in the ear. </p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Eye :\r\nOne or two drops to be instilled into\r\nconjunctival sac (s) every four to six\r\nhours. During the initial 24 to 48 hours,\r\nthe dosage may be increased to one to\r\ntwo drops every two hours.\r\nEar : Instill 2-4 drops 3-4 times daily.\r\nOr as directed by the registered\r\nphysician</span></p><p><br></p><p><strong>Packing : </strong>5 ml in plastic dropper bottle.</p>', 'uploads/images/CIPROZID-DX.jpg', 1, '2017-11-29 04:57:24', NULL, NULL, '', 'Y', 4, 'uploads/IMG/ciprozid-ds.jpg'),
(895, 'CIPROCORT', 36, '<p><strong></strong><strong>Composition :</strong>Ciprofloxacin+\r\nHydrocortisone Acetate (3mg+10mg)/ml.</p><p><strong>Indication :</strong>Ciprocort otic suspension is\r\nindicated for the treatment of acute otitis\r\nexterna in adult and paediatric patients\r\ndue to susceptible strains of\r\npseudomonas aeruginosa,\r\nstaphylococcus aureus and proteus\r\nmirabilis. </p><p><strong>Dosage and administration :</strong>: Adults and\r\nchildren (one year and older) : After\r\ncleansing 2-4 drops instilled thrice to four\r\ntimes a day and at night. Or as directed\r\nby the physician.</p><p><strong>Packing : </strong>10ml in plastic dropper bottle</p>', 'uploads/images/CIPROCORT.jpg', 1, '2017-11-29 04:55:58', NULL, NULL, '', 'Y', 4, 'uploads/IMG/ciprocort.jpg'),
(896, 'CELUDEX', 44, '<p><strong></strong><strong>Composition : </strong>Dexamethasone 1.0 mg / ml.</p><p><strong>Indication :<em> </em></strong><span class="redactor-invisible-space"><em>Eye : </em>Non-infectious forms\r\nof conjunctivitis, keratitis and blepharitis,\r\nespecially of allergic origin. Inflammation\r\nof the anterior uvea (iritis, iridocyclitis),\r\nscleritis, episcleritis, orbital myositis and\r\nsympathetic ophthalmia.\r\nEar : Redness, itching and swelling\r\ncaused by certain ear problems.</span></p><p><strong>Dosage and administration :</strong>Eye :\r\nAdminister 1 drop 3-5 times daily into the\r\nconjunctival sac.\r\nAcute cases : up to 1 drop hourly.\r\nEar : 3 or 4 drops in the ear two or three\r\ntimes a day.\r\nOr, as directed by the registered\r\nphysician.</p><p><br></p><p><strong>Packing : </strong>5 ml in plastic dropper bottle.</p>', 'uploads/images/CELUDEX.jpg', 1, '2017-11-29 04:54:43', NULL, NULL, '', 'Y', 4, 'uploads/IMG/Celudex--Eye-&-Ear-Drops.jpg'),
(902, 'Tocit', 141, '<p><strong></strong><strong>Composition : </strong>Each Metered dose (Puff) contains Beclometasone Dipropionate 100 mcg.</p><p><strong>Indication : </strong>Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. </p><p><strong>Dosage and administration : </strong>Becovent inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled Becovent appropriate to the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to individual response. Management of chronic asthma (Adults & Children over 12 years): 100-400 mcg twice daily. Maximum 1000 mcg twice daily. Children (5-12 years): 100-200 mcg twice daily. the dose may be adjusted as necessary.</p><p><strong>Use in pregnancy and lactation : </strong>Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.</p><p><strong>Packing : </strong>Becovent HFA Inhaler : Each box contains one inhaler of 200 Puffs</p>', 'uploads/images/ALBASINE.jpg', 1, '2017-11-07 04:15:01', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/tocit.jpg'),
(904, 'Block-T', 142, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Tranexamic acid 500 mg Tablet\r\n& 500mg/5ml IV/IM Injection.</span></p><span></span><p><strong>Indication : </strong><span class="redactor-invisible-space">Block-T is indicated to prevent\r\nbleeding or to treat bleeding associated with\r\nexcessive fibrinolysis. Local fibrinolysis may\r\noccurs in the following conditions: Prostatectomy\r\nand bladder surgery, epistaxis, menorrhagia,\r\nTraumatic Hyphaema, conisation of the cervix,\r\nmanagement of dental extraction in patients with\r\nhemophilic & Hereditary angioneurotic oedema.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Tablet : The\r\nrecommended standard dosage is 2-3 tablets of\r\n500 mg (15-25 mg/kg). For the indications listed\r\nbelow the following doses are recommended.</span></p><p><strong>Use in pregnancy and lactation :</strong>Pregnancy\r\ncategory "B". There are no adequate and wellcontrolled\r\nstudies in pregnant women.\r\nTranexamic acid passes into breast milk to a\r\nconcentration of approximately one hundredth of\r\nthe concentration in the maternal blood. So\r\ncaution should be exercised when this product\r\nis administered to a nursing woman.</p><p><strong>Packing :</strong></p><p><span class="redactor-invisible-space">Block-T 500 Tablet : 2 x 10''s tablets\r\nin blister pack. </span></p><p><span class="redactor-invisible-space">Block-T IV/IM Injection : 1 x 3''s Ampoules\r\n(5ml) in a blister pack.</span></p>', 'uploads/images/Blt-500.jpg', 1, '2017-11-29 05:24:50', NULL, NULL, '', 'Y', 4, 'uploads/IMG/03.jpg');
INSERT INTO `drg_medicine_info` (`MEDICINE_ID`, `MEDICINE_NAME`, `GN_GRP_ID`, `MEDICINE_DESC`, `INSERT_FILE`, `CRE_BY`, `CRE_DT`, `UPD_BY`, `UPD_DT`, `IS_LATEST`, `ACTIVE_STATUS`, `CAT_ID`, `PRODUCT_FET_PHOTO`) VALUES
(905, 'Ejalong', 150, '<p><strong></strong><strong>Composition :</strong>Dapoxetine 30mg &\r\n60mg Tablet.</p><p><strong>Indication : </strong><span class="redactor-invisible-space">It is indicated for the\r\ntreatment of premature ejaculation (PE)\r\nin adult men aged 18 to 64 years of age.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Adult\r\nmen (aged 18 to 64 years):The\r\nrecommended starting dose for all\r\npatients is 30 mg, taken as needed\r\napproximately 1 to 3 hours prior to\r\nsexual activity. If the individual response\r\nto 30 mg is insufficient and the patient\r\nhas not experienced moderate or\r\nsevere adverse reactions, the dose may\r\nbe increased to a maximum\r\nrecommended dose of 60 mg taken as\r\nneeded approximately 1 to 3 hours prior\r\nto sexual activity. Or,as directed by the\r\nregistered physician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">This\r\ntablet is not indicated for women.</span></p><p><strong>Packing :</strong></p><p><strong> </strong><span class="redactor-invisible-space">Ejalong 30 : 1 x 6''s tablets in\r\nblister pack. </span></p><p>Ejalong 60 : 1 x 6''s tablets in blister pack.</p>', 'uploads/images/Eja-60.jpg', 1, '2017-11-29 03:35:10', NULL, NULL, '', 'Y', 4, 'uploads/IMG/ejalon-30.jpg'),
(906, 'Glucotin Plus', 151, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space"> : Glucosamine + Chondroitin\r\nSulfate Sodium; (250mg + 200mg) Tablet.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">This tablet is indicated in\r\nthe treatment of rheumatoid arthritis,\r\nOsteoarthritis of hand, spine and other\r\nlocation, large weight bearing joints,\r\nsuch as the knee and hips, inflammatory\r\nbowel disease (Crohns disease,\r\nulcerative colitis). It is also beneficial in\r\nsport injuries, vascular migraine\r\nheadache etc.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">1 to 2\r\ntablets 3 times daily or as directed by the\r\nphysician. Obese individuals may need\r\nhigher doses, based on body weight. Or\r\nas directed by the registered physician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Women who are pregnant or who could\r\nbecome pregnant should not supplement\r\nwith Glucosamine and Chondroitin. No\r\nstudies have evaluated the use of\r\nGlucosamine and Chondroitin during\r\npregnancy or lactation. It should be\r\ntaken with caution and medical advice\r\nduring pregnancy and lactation.</span></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Glucotin-Plus : 3x10''s tablets\r\nin blister pack.</span></p>', 'uploads/images/Glut.jpg', 1, '2017-11-28 02:40:28', NULL, NULL, '', 'Y', 4, 'uploads/IMG/glucotin-plus.jpg'),
(907, 'Glucotin Max', 152, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Glucosamine + Chondroitin\r\nSulfate Sodium; (250mg + 200mg) Tablet.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">This tablet is indicated in\r\nthe treatment of rheumatoid arthritis,\r\nOsteoarthritis of hand, spine and other\r\nlocation, large weight bearing joints,\r\nsuch as the knee and hips, inflammatory\r\nbowel disease (Crohns disease,\r\nulcerative colitis). It is also beneficial in\r\nsport injuries, vascular migraine\r\nheadache etc.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">1 to 2\r\ntablets 3 times daily or as directed by the\r\nphysician. Obese individuals may need\r\nhigher doses, based on body weight. Or\r\nas directed by the registered physician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Women who are pregnant or who could\r\nbecome pregnant should not supplement\r\nwith Glucosamine and Chondroitin. No\r\nstudies have evaluated the use of\r\nGlucosamine and Chondroitin during\r\npregnancy or lactation. It should be\r\ntaken with caution and medical advice\r\nduring pregnancy and lactation.</span></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Glucotin-Plus : 3x10''s tablets\r\nin blister pack.</span></p>', 'uploads/images/glmax.jpg', 1, '2017-11-28 05:31:34', NULL, NULL, '', 'Y', 4, 'uploads/IMG/glucotin-max.jpg'),
(908, 'OMG-3', 153, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Omega-3-Acid Ethyl\r\nEsters 1gm (A combination of\r\nEicosapentaenoic Acid &\r\nDocosahexaenoic Acid ) Capsule.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">OMG-3 is indicated as an\r\nadjunct to diet to reduce very high\r\n(500mg/dL) triglyceride (TG) level in\r\nadult patients.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">In\r\nHypertriglyceridaemia, it can be taken as\r\nsingle dose 4 capsules (4gm) or 2\r\ncapsules (2gm) twice daily with food.\r\nPatients should be placed on an\r\nappropriate lipid lowering diet before\r\nreceiving OMG-3 and should continue\r\nthis diet during treatment. Or, as directed\r\nby the registered physician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">There are no adequate and wellcontrolled\r\nstudies in pregnant women.</span></p><p><strong>Packing :</strong>OMG-3 : 6 x 5''s soft capsules\r\nin blister pack.</p>', 'uploads/images/Omg.jpg', 1, '2017-11-28 04:23:26', NULL, NULL, '', 'Y', 4, 'uploads/IMG/OMG-3.jpg'),
(909, 'Pancil', 154, '<p><strong></strong><strong>Composition : </strong>Each Metered dose (Puff) contains Beclometasone Dipropionate 100 mcg.</p><p><strong>Indication : </strong>Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. </p><p><strong>Dosage and administration : </strong>Becovent inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled Becovent appropriate to the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to individual response. Management of chronic asthma (Adults & Children over 12 years): 100-400 mcg twice daily. Maximum 1000 mcg twice daily. Children (5-12 years): 100-200 mcg twice daily. the dose may be adjusted as necessary.</p><p><strong>Use in pregnancy and lactation : </strong>Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.</p><p><strong>Packing : </strong>Becovent HFA Inhaler : Each box contains one inhaler of 200 Puffs</p>', 'uploads/images/pancil.jpg', 1, '2017-11-07 04:49:05', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/28.jpg'),
(910, 'Ursolic-300', 155, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Ursodeoxycholic Acid\r\n150mg, 300mg Tablet & 250mg/5ml\r\nSuspension.</span></p><p><strong>Indication :</strong>: This drug is indicated for\r\nthe dissolution of small to medium sized\r\nradiolucent, cholesterol rich gall-stones\r\nin functioning gall bladders. This drug is\r\nalso indicated for the treatment of\r\nprimary biliary cirrhosis. </p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Adults and\r\nElderly : Dissolution of gallstones : 8-\r\n12mg/kg body weight daily as a single\r\ndose at bedtime or in two divided doses,\r\nfor up to 2 years; treatment is continued\r\nfor 3-4 months after stones dissolve. The\r\nfollowing dosage regimen is\r\nrecommended for suspension :\r\n	Body weight (kg)S	poonfuls (5ml)	mg/kg/day\r\n		(in 2-4 divided doses)\r\n	50-62	2	8.1-10.0\r\n	63-85	3	8.8-11.9\r\n	86-120	4	8.3-11.6\r\nPrevention of gallstone formation: 300mg\r\ntwice daily. Primary biliary cirrhosis: 10-\r\n15mg/kg body weight daily as a single dose\r\nor in 2-4 divided doses. The following dosage\r\nregimen is recommended for suspension :\r\n	Body weight (kg)S	poonfuls (5ml)	mg/kg/day\r\n		(in 2-4 divided doses)\r\n	50-62	2-4	10.0-16.1\r\n	63-85	3-5	11.9-14.7\r\n	86-120	4-7	11.6-14.6\r\nChildren : Not recommended. Or, as directed\r\nby the registered physician.</span></p><p><strong>Use in pregnancy and lactation :  </strong>Pregnancy Category B by FDA</p><p><strong>Packing : </strong><span class="redactor-invisible-space">Ursolic 150 : 2x10''s tablets in blister\r\npack.\r\nUrsolic 300 : 1x10''s tablets in blister\r\npack.\r\nUrsolic Suspension : 50ml oral\r\nsuspension.</span></p>', 'uploads/images/Urso-300.jpg', 1, '2017-11-27 04:20:31', NULL, NULL, '', 'Y', 4, 'uploads/IMG/ursolic-150.jpg'),
(911, 'Feripon ', 156, '<p><strong></strong><strong>Composition : </strong>Each Metered dose (Puff) contains Beclometasone Dipropionate 100 mcg.</p><p><strong>Indication : </strong>Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. </p><p><strong>Dosage and administration : </strong>Becovent inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled Becovent appropriate to the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to individual response. Management of chronic asthma (Adults & Children over 12 years): 100-400 mcg twice daily. Maximum 1000 mcg twice daily. Children (5-12 years): 100-200 mcg twice daily. the dose may be adjusted as necessary.</p><p><strong>Use in pregnancy and lactation : </strong>Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.</p><p><strong>Packing : </strong>Becovent HFA Inhaler : Each box contains one inhaler of 200 Puffs</p>', 'uploads/images/feri.jpg', 1, '2017-11-07 04:54:43', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/feripon.jpg'),
(912, 'Purinol-100 ', 157, '<p><strong></strong><strong>Composition : </strong>Allopurinol 100mg Tablet.</p><p><strong>Indication : </strong><span class="redactor-invisible-space">Allopurinol is indicated in 1.\r\nThe management of patients with signs\r\nand symptoms of primary or secondary\r\ngout (acute attacks, tophi, joint\r\ndestruction, uric acid). 2. The\r\nmanagement of patients with leukemia,\r\nlymphoma and malignancies who\r\nreceive cancer therapy</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">The\r\naverage is 200 to 300 mg per day for\r\npatients with mild gout and 400 to 600\r\nmg per day for those with moderately\r\nsevere tophaceous gout. The\r\nappropriate dosage may be administered\r\nin divided doses or as a single equivalent\r\ndose with the 300 mg tablet. The minimal\r\neffective dosage is 100 to 200 mg daily\r\nand the maximal recommended dosage\r\nis 800 mg daily. Or, as directed by the\r\nRegistered Physician.</span></p><p><br></p><p><strong>Packing :</strong>Purinol : 5x10''s tablets in\r\nblister pack.Becovent HFA Inhaler : Each box contains one inhaler of 200 Puffs</p>', 'uploads/images/pu_300.jpg', 1, '2017-11-28 00:18:07', NULL, NULL, '', 'Y', 4, 'uploads/IMG/purinol-300.jpg'),
(914, 'Oramet  ', 158, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Metformin Hydrochloride\r\n500mg & 850mg Tablet.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">Oramet is an oral\r\nantihyperglycemic drug used in the\r\nmanagement of non-insulin dependent\r\ndiabetes mellitus (NIDDM) & Polycystic\r\novarian syndrome.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">The usual\r\nstarting dose is one tablet 2 or 3 times\r\ndaily given during or after meals. The\r\nmaximum recommended dose of\r\nmetformin is 3gm daily.\r\nOr as directed by the registered\r\nphysician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Metformin has been assigned to\r\npregnancy category B by the FDA.</span></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Oramet-500 : 5 x 10''s tablets\r\nin blister pack.\r\nOramet-850 : 5 x 10''s tablets in blister\r\npack.</span></p>', 'uploads/images/oramet850.jpg', 1, '2017-11-28 00:10:34', NULL, NULL, '', 'Y', 4, 'uploads/IMG/oramet.jpg'),
(915, 'Oramet-SR ', 159, '<p><strong>Composition : </strong><span class="redactor-invisible-space">Metformin Hydrochloride 500mg & 850mg Tablet.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">Oramet is an oral antihyperglycemic drug used in the management of non-insulin dependent diabetes mellitus (NIDDM) & Polycystic ovarian syndrome.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">The usual starting dose is one tablet 2 or 3 times daily given during or after meals. The maximum recommended dose of metformin is 3gm daily. Or as directed by the registered physician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Metformin has been assigned to pregnancy category B by the FDA.</span></p><p><strong>Packing : </strong><span class="redactor-invisible-space" style="background-color: initial;">Oramet-500 : 5 x 10''s tablets in blister pack. Oramet-850 : 5 x 10''s tablets in blister pack.</span></p>', 'uploads/images/Oramet-S5.jpg', 1, '2017-11-28 00:11:06', NULL, NULL, '', 'Y', 4, 'uploads/IMG/oramet-sr-500.jpg'),
(916, 'Dialiptin', 160, '<p><strong></strong><strong>Composition : </strong>Vildagliptin 50mg Tablet</p><p><strong>Indication :</strong>Vildagliptin is indicated for\r\nthe treatment of type 2 diabetes mellitus\r\n(in combination with metformin or with a\r\nsulphonylurea or with a\r\nthiazolidinedione). </p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Adult over\r\n18 years: Vildagliptin administered in\r\ncombination with metformin or a\r\nthiazolidinedione, 50mg twice daily; in\r\ncombination with a sulphonylurea, 50mg\r\ndaily in the morning. Or as directed by\r\nthe registered physician.</span></p><p><strong>Use in pregnancy and lactation :</strong>Vildagliptin has been assigned to\r\npregnancy category B by the FDA.</p><p><strong>Packing :</strong>Dialiptin: 2x14''s tablets in\r\nblister pack.</p>', 'uploads/images/Dialiptin.jpg', 1, '2017-11-29 04:14:25', NULL, NULL, '', 'Y', 4, 'uploads/IMG/dialiptin.jpg'),
(917, 'Dialiptin-M ', 161, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">: Metformin Hydrochloride\r\n+Vildagliptin (500mg+50mg) &\r\n(850mg+50mg) Tablet.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">It is indicated in the\r\ntreatment of type 2 diabetes mellitus\r\npatients who are unable to achieve\r\nsufficient glycaemic control at their\r\nmaximally tolerated dose of oral\r\nmetformin alone or who are already\r\ntreated with the combination of\r\nvildagliptin and metformin as separate\r\ntablets.</span></p><p><strong>Dosage and administration : </strong></p><p><span class="redactor-invisible-space">DialiptinM\r\n500: Max. vildagliptin daily dose:\r\n100mg. Inadequately controlled on\r\nvildagliptin: Initially 50mg/500mg bid.\r\nInadequately controlled on metformin\r\nHCl: one tablet bid. Switching from\r\ncombination therapy of vildagliptin plus\r\nmetformin HCl, as separate tab based\r\nfrom the dose of vildagliptin or metformin\r\nalready being taken. Dialiptin-M 850:\r\nAdult over 18 years: one tablet twice\r\ndaily (based on patient''s current\r\nmetformin dose). Or, as directed by the\r\nregistered physician.</span></p><p><strong>Use in pregnancy and lactation : </strong>Dialiptin-M has been assigned to\r\npregnancy category B by the FDA.ration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.</p><p><strong>Packing : </strong></p><p><span class="redactor-invisible-space">Dialiptin-M 500: 2x7''s tablets\r\nin blister pack.</span></p><p><span class="redactor-invisible-space">Dialiptin-M 850: 2x7''s tablets in blister\r\npack.</span></p>', 'uploads/images/Dialipt-M5.jpg', 1, '2017-11-29 04:10:29', NULL, NULL, '', 'Y', 4, 'uploads/IMG/Dialiptin-M-500-Tablet.jpg'),
(918, 'Linarol', 162, '<p><strong></strong><strong>Composition : </strong>Linagliptin 5 mg Tablet.</p><p><strong>Indication : </strong><span class="redactor-invisible-space">Indicated for adults with\r\ndiabetes mellitus type II along with diet\r\nand exercise to lower blood sugar, may\r\nbe used as monotherapy or in\r\ncombination with other common\r\nantidiabetic medications including\r\nmetformin, sulfonylurea, pioglitazone, or\r\ninsulin.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Linagliptin\r\n5 mg once daily. If added to metformin,\r\nthe dose of metformin should be\r\nmaintained concomitantly, when used in\r\ncombination with sulfonylurea, a lower\r\ndose of sulfonylurea may be considered\r\nto reduce the risk of hypoglycemia.\r\nPatients with renal impairment no need\r\nto dose adjustment required. Linagliptin\r\ncan be taken with or without a meal at\r\nany time of the day. Or, as directed by\r\nthe registered physician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Linagliptin has been assigned to\r\npregnancy category B by the FDA.</span></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Linarol : 2 x 14''s tablets in\r\nblister pack.</span></p>', 'uploads/images/Linarol.jpg', 1, '2017-11-27 23:56:00', NULL, NULL, '', 'Y', 4, 'uploads/IMG/linarol.jpg'),
(919, 'Linarol-M ', 170, '<p><strong>Composition : </strong><span class="redactor-invisible-space">Sulindac 100 mg & 200 mg Tablet.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">Sulindac is indicated for the symptomatic treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, periarticular inflammatory disorders, acute painful shoulder, acute gouty arthritis, diabetic neuropathy & diabetic retinopathy.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Sulindac should be administered orally twice a day with food. The maximum dosage is 400 mg per day. Dosages above 400 mg per day are not recommended. In osteoarthritis, rheumatoid arthritis & ankylosing spondylitis, the recommended starting dosage is 150 mg. In acute painful shoulder & acute gouty arthritis the recommended dosage is 200 mg twice a day. The dosage may be lowered or raised depending on the response. After a satisfactory response has been achieved, the dosage may be reduced according to the response. Or, as directed by the registered physicians.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">There are no adequate and well-controlled studies in pregnant women. Sulindac should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. It is not known whether this drug is excreted in human milk.</span></p><p><strong>Packing :</strong></p><p><span class="redactor-invisible-space">Sudac-100: 5X10''s tablets in blister pack.</span></p><p>Sudac-200: 2X10''s tablets in blister pack.</p>', 'uploads/images/Linarol-M8.jpg', 1, '2017-11-28 02:58:21', NULL, NULL, '', 'Y', 4, 'uploads/IMG/19.jpg'),
(920, 'Sixtin', 163, '<p><strong></strong><strong>Composition : </strong>Each Metered dose (Puff) contains Beclometasone Dipropionate 100 mcg.</p><p><strong>Indication : </strong>Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. </p><p><strong>Dosage and administration : </strong>Becovent inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled Becovent appropriate to the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to individual response. Management of chronic asthma (Adults & Children over 12 years): 100-400 mcg twice daily. Maximum 1000 mcg twice daily. Children (5-12 years): 100-200 mcg twice daily. the dose may be adjusted as necessary.</p><p><strong>Use in pregnancy and lactation : </strong>Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.</p><p><strong>Packing : </strong>Becovent HFA Inhaler : Each box contains one inhaler of 200 Puffs</p>', 'uploads/images/Sixtin-5.jpg', 1, '2017-11-08 02:18:31', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/34.jpg'),
(924, 'Sliptin', 171, '<p><strong>Composition : </strong><span class="redactor-invisible-space">Sitagliptin 25mg, 50mg & 100mg Tablet</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">Sitagliptin is indicated for the treatment of patients suffering from type-II diabetes mellitus. It is also used in combination with metformin or other glycemic control drugs.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">The recommended dose of Sitagliptin is 100mg once daily. Sitagliptin can be taken with or without food. For patients with mild renal insufficiency (creatinine clearance crcl &gt;- 50ml/min), no dosage adjustment is required. For patients with moderate renal insufficiency (crcl &gt;- 30 to &lt;50 ml/min), the dose of Sitagliptin is 50mg once daily. For patients with severe renal insufficency (CrCl&lt;30 ml/min) or with end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis, the dose of Sitagliptin is 25mg once daily. Or, as directed by the registered physicians.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Sitagliptin has been assigned to pregnancy category B by the FDA</span></p><p><strong>Packing : </strong><span class="redactor-invisible-space" style="background-color: initial;">Sliptin 25 : 2x 14''s tablets in blister pack. Sliptin 50 : 2x 14''s tablets in blister pack. Sliptin 100 : 1x 14''s tablets in blister pack.</span></p>', 'uploads/images/Sliptin-100.jpg', 1, '2017-11-27 05:44:27', NULL, NULL, '', 'Y', 4, 'uploads/IMG/Sliptin-M-500-ER-Tablet.jpg'),
(925, 'Dimerol', 166, '<p><strong></strong><strong>Composition : </strong>Gliclazide 80mg Tablet.</p><p><strong>Indication : </strong><span class="redactor-invisible-space">For the treatment of\r\nmaturity onset diabetes in patients who\r\ncannot be controlled on diet alone.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">The usual\r\ninitial dose by mouth in the treatment of\r\nnon-insulin-dependent diabetes mellitus,\r\nis initially 40mg (1/2 tablet) to 80mg (1\r\ntablet) daily, adjusted according to\r\nresponse up to 160mg (2 tablets) as a\r\nsingle dose, with breakfast. If necessary\r\nup to 320mg can be given daily. It is\r\nsuggested that doses of more than\r\n160mg should be given in 2 divided\r\ndoses or as directed by a registered\r\nphysician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Dimerol has been assigned to\r\npregnancy category C by the FDA.</span></p><p><strong>Packing :</strong>Dimerol : 4 x 14''s tablets per\r\nbox</p>', 'uploads/images/Dimerol.jpg', 1, '2017-11-29 04:11:47', NULL, NULL, '', 'Y', 4, 'uploads/IMG/dimerol.jpg'),
(926, 'Dimerol-MR', 166, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Gliclazide 30mg &\r\nGliclazide 60 mg Tablet.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">This medication is\r\nrecommended in adults for non-insulindependent\r\ndiabetes (type-II), in\r\nassociation with dietary measures and\r\nwith physical exercise, when these\r\nmeasures alone are not sufficient to\r\nobtain normal blood glucose levels.\r\n</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">The usual\r\ndaily dose is 1 to 4 tablets /day as a\r\nsingle dose or as directed by the\r\nphysician. It is recommended that the\r\ndrug should be taken at breakfast time.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Dimerol-MR has been assigned to\r\npregnancy category C by the FDA.</span></p><p><strong>Packing :</strong></p><p><strong></strong>Dimerol-MR-30 : 4 x 14''s\r\ntablets in blister pack.</p><p>\r\nDimerol-MR-60 : 2 x 10''s tablets in\r\nblister pack.</p>', 'uploads/images/Dimerol.jpg', 1, '2017-11-29 04:13:08', NULL, NULL, '', 'Y', 4, 'uploads/IMG/dimerolmr-30.jpg'),
(927, 'Limpet', 167, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Glimepiride 1mg, 2mg, 3mg &\r\n4mg Tablet.</span></p><p><strong>Indication :</strong>Limpet is indicated as an\r\nadjunct to diet and exercise to lower the\r\nblood glucose in patients with non-insulin\r\ndependent (Type-II) diabetes mellitus\r\n(NIDDM) whose hyperglycaemia cannot be\r\ncontrolled by diet and exercise alone. Limpet\r\nmay be used concomitantly with metformin\r\nwhen diet, exercise, and Limpet or metformin\r\nalone do not result in adequate glycemic\r\ncontrol. Limpet is also indicated for use in\r\ncombination with insulin to lower blood\r\nglucose in patients whose hyperglycaemia\r\ncan not be controlled by diet and exercise in\r\nconjunction with an oral hypoglycaemic\r\nagent.Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. </p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">The usual\r\nstarting dose of Limpet as initial therapy is 1-\r\n2mg once daily, administered with breakfast\r\nor the first main meal. The usual maintenance\r\ndose is 1-4mg once daily. The maximum\r\nrecommended dose is 8mg once daily. or, as\r\ndirected by the registered physicians.</span></p><p><strong>Use in pregnancy and lactation :  </strong><span class="redactor-invisible-space">Limpet\r\nhas been assigned to pregnancy category C by\r\nthe FDA.</span></p><p><strong>Packing : </strong></p><p>Limpet-1 : 4 x 14''s tablets in blister pack</p><p>Limpet-2 : 4 x 14''s tablets in blister pack. </p><p>Limpet-3 : 2 x 14''s tablets in blister pack. </p><p>Limpet-4 : 2 x 14''s tablets in blister pack.</p>', 'uploads/images/Limpet-4.jpg', 1, '2017-11-28 03:00:50', NULL, NULL, '', 'Y', 4, 'uploads/IMG/limpet-4.jpg'),
(928, 'Daparol', 168, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Dapagliflozin 5 mg\r\nTablet.</span></p><p><strong>Indication :</strong>Dapagliflozin is indicated\r\nas an adjunct to diet and exercise to\r\nimprove glycemic control in adults with\r\ntype 2 diabetes mellitus .Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. </p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">The\r\nrecommended starting dose is 5 mg\r\nonce daily, taken in the morning, with or\r\nwithout food. It may increase to 10 mg\r\norally once a day in patients tolerating\r\ntherapy with 5 mg and requiring\r\nadditional glycemic control. Or, as\r\ndirected by the registered physicians.</span></p><p><br></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Daparol : 1 x 14''s tablets in\r\nblister pack.</span></p>', 'uploads/images/Daparol.jpg', 1, '2017-12-04 02:40:20', NULL, NULL, '', 'Y', 4, 'uploads/IMG/Daparol-Tablet.jpg'),
(929, ' Canarol-100', 169, '<p><strong></strong><strong>Composition : </strong>Each Metered dose (Puff) contains Beclometasone Dipropionate 100 mcg.</p><p><strong>Indication : </strong>Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. </p><p><strong>Dosage and administration : </strong>Becovent inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled Becovent appropriate to the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to individual response. Management of chronic asthma (Adults & Children over 12 years): 100-400 mcg twice daily. Maximum 1000 mcg twice daily. Children (5-12 years): 100-200 mcg twice daily. the dose may be adjusted as necessary.</p><p><strong>Use in pregnancy and lactation : </strong>Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.</p><p><strong>Packing : </strong>Becovent HFA Inhaler : Each box contains one inhaler of 200 Puffs</p>', 'uploads/images/Canarol-100.jpg', 1, '2017-11-08 03:22:56', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/Canarol-100.jpg'),
(930, 'Astaking', 262, '<p><strong></strong><strong>Composition : </strong>Astaxanthin 2mg &\r\n4mg Capsule.</p><p><strong>Indication : </strong>Astaxanthin is indicated\r\nas strong antioxidant. Also indicated\r\ninl\r\nInternal beauty & skin improvement l\r\nArthritis l Cardiovascular health l\r\nBrain and central nervous system\r\nhealth l Silent inflammation (Creactive\r\nprotein) l Eye health l For\r\nimprovement of strength, endurance\r\n& immune systemBecovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids.</p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">1-2\r\ncapsules daily. Or, as directed by the\r\nregistered physician.</span></p><p><strong>Packing :</strong></p><p><strong> </strong><span class="redactor-invisible-space">ASTA KING-2 : 2x10''s soft\r\ngelatin capsules in blister pack. </span></p><p><span class="redactor-invisible-space">ASTA KING-4 : 1x10''s soft gelatin\r\ncapsules in blister pack.</span><span class="redactor-invisible-space"></span></p>', 'uploads/images/asta_4.jpg', 1, '2017-11-30 04:16:51', NULL, NULL, '', 'Y', 4, 'uploads/IMG/51.jpg'),
(932, 'Caldil', 263, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Calcium Carbonate\r\nequivalent to 500mg Calcium Tablet</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">Calcium cation are used for\r\nthe treatment or prevention of calcium\r\ndepletion in patients in whom dietary\r\nmeasures are inadequate. Calcium therapy\r\nused for the treatment of osteoporosis in\r\nelderly, tooth formation, osteomalacia,\r\nchronic hypoparathyroidism, rickets, latent\r\ntetany, hypocalcemia and as supplemental\r\ntherapy for pregnancy and lactation, pre\r\nand post menopausal woman, children and\r\nadolescents (specially girls). Calcium\r\ndeficiency include achlorhydria, chronic\r\ndiarrhea, vitamin D deficiency, steatorrhea,\r\nsprue, pancreatitis, renal failure, alkalosis\r\nand hyperphosphatemia.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">One tablet\r\ndaily or as directed by the physician. The\r\ntablets must be swallowed. Calcium\r\ncarbonate should be given with meals.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Calcium containing drugs have been\r\nwidely used in pregnancy by way to oral\r\ncalcium supplementation or antacid\r\ntherapy. Calcium carbonate can be used in\r\nlactating woman too.</span></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Caldil : 6 x 10''s tablets in\r\nblister pack</span></p>', 'uploads/images/caldil.jpg', 1, '2017-11-29 04:49:16', NULL, NULL, '', 'Y', 4, 'uploads/IMG/caldil.jpg'),
(933, 'Caldil Plus', 264, '<p><strong>Composition : </strong><span class="redactor-invisible-space">Calcium Carbonate\r\n1250mg (Eq. to. Elemental Calcium\r\n500mg) & Cholecalciferol 200 I.U\r\n(Vitamin D3) Tablet.</span><span class="redactor-invisible-space"></span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">Calcium and Vitamin D is\r\nprescribed for treatment of osteoporosis,\r\nosteomalacia, rickets, tetany, and\r\nparathyroid disease. Calcium\r\nsupplements are often used to ensure\r\nadequatey intake in conditions such as\r\npregnancy, nursing, kidney disease, and\r\npancreatitis or during therapy with antiseizure\r\nmedications.</span><span class="redactor-invisible-space"></span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Two tablets\r\ndaily or one tablet twice daily. It is best\r\ntaken with or just after a meal to improve\r\nabsorption. Each dose should be taken\r\nwith a full glass of water. Or, as directed\r\nby the registered physician.</span><span class="redactor-invisible-space"></span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Caldil-Plus should be used as directed\r\nby registered physician during pregnancy\r\nor while breast feeding</span><span class="redactor-invisible-space"></span></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Caldil-Plus : 6 x 10''s tablets\r\nin blister pack.</span><span class="redactor-invisible-space" style="background-color: initial;"></span></p>', 'uploads/images/Caldil_p.jpg', 1, '2017-11-29 04:52:55', NULL, NULL, '', 'Y', 4, 'uploads/IMG/caldil-plus.jpg'),
(934, 'Calcirol', 266, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Cholecalciferol (Vitamin\r\nD3) 2,00000 I.U/ml (Ampoul).</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">It is indicated in the\r\nprevention and treatment of Vitamin D\r\ndeficiencies. These are osteoporosis,\r\nosteomalacia, hypocalcaemia, tetany\r\nand rickets.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">By oral or\r\nintramuscular injection. Prevention:\r\nInfants receiving Vitamin D enriched\r\nmilk: 1/2 ampoule (0.5ml) i.e. 1,00000\r\nI.U. every 6 months. Nursed infants or\r\ninfants not receiving Vitamin D enriched\r\nmilk or young children up to 5 years of\r\nage: 1 ampoule (1ml) i.e. 2,00000 I.U.\r\nevery 6 months.\r\nAdolescents : 1 ampoule (1ml) i.e.\r\n2,00000 I.U. every 6 months during\r\nwinter.\r\nPregnancy : 1/2 ampoule (0.5ml) i.e.\r\n1,00000 I.U. from the 6th or 7th month of\r\npregnancy.\r\nElderly : 1/2 ampoule (0.5ml) i.e.\r\n1,00000 I.U. every 3 months. Digestive\r\ndisorders, concomitant treatment with\r\nantiepileptics & other particular condition\r\nnot described above; 1/2 ampoule\r\n(0.5ml) i.e. 1,00000 I.U. or 1 ampoule\r\n(1ml) i.e. 2,00000 I.U. every 3 or 6\r\nmonths. Vitamin D deficiency : 1\r\nampoule (1ml) i.e. 2,00000 I.U. which\r\ncan be repeated 1 to 6 months later. Or,\r\nas directed by the registered physician.</span></p><p><br></p><p><strong>Packing : </strong>Calcirol Inj. : 1 x 1 ampoule.</p>', 'uploads/images/Calci.jpg', 1, '2017-11-29 04:51:23', NULL, NULL, '', 'Y', 4, 'uploads/IMG/Calci.jpg'),
(935, 'Caldil-OT', 288, '<p><strong>Composition : <em></em></strong><span class="redactor-invisible-space"><span class="redactor-invisible-space">Each film coated tablet\r\ncontains Calcium Orotate Dihydrate\r\neq.to Calcium Orotate 400mg.</span></span><span class="redactor-invisible-space"></span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">This medication is used-1.\r\nTo prevent or treat low blood calcium\r\nlevels. 2. To fulfill the calcium deficiency\r\nin conditions like, Osteomalacia, Drug\r\ninduced osteoporosis (phenytoin,\r\nphenobarbital or prednisone), Rickets,\r\nLatent tetany, Pregnancy and lactation,\r\nPostmenopausal osteoporosis,\r\npremenstrual syndrome (PMS), senile\r\nosteoporosis, Hypoparathyroidism,\r\njuvenile osteoporosis, Hip joint plastic\r\nsurgery. 3. It is also used number of\r\ninflammatory diseases like, Arthritis,\r\nMultiple sclerosis, Spondylitis. 4. It is\r\nalso beneficial in reducing the effects of\r\nmood swings. 5. Proved to be quite\r\neffective in cognitive enhancement. 6.\r\nProtects the heart by enhancing the\r\nefficiency of cardiac muscles.</span><span class="redactor-invisible-space"></span></p><p><strong>Dosage and administration :</strong><span class="redactor-invisible-space">As an\r\naddition to the daily diet, 2-3 tablets are\r\nusually recommended with meal Or, as\r\ndirected by the registered physician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Women who are pregnant and breastfeeding\r\nneed more calcium. Pregnancy\r\nrelated high blood pressure is a common\r\nand serious risk for women and their\r\nbabies and taking supplemental forms of\r\ncalcium orotate can help reduce this risk.</span><span class="redactor-invisible-space"></span></p><p><strong>Packing :</strong><span class="redactor-invisible-space" style="background-color: initial;">Caldil-OT : 3x10''s tablets in\r\nblister pack.</span></p>', 'uploads/images/caldilo.jpg', 1, '2017-11-30 05:01:35', NULL, NULL, '', 'Y', 4, 'uploads/IMG/caldil-ot.jpg'),
(936, 'D-Cap', 266, '<p><strong>Composition : <em></em></strong><span class="redactor-invisible-space"> Colecalciferol (Vitamin\r\nD3) 800 IU (Eq. to 0.02 mg).</span></p><p><strong>Indication :</strong>It is indicated for the\r\ntreatment and prevention of vitamin D3\r\ndeficiencies. As an adjunct to specific\r\ntherapy for osteoporosis in patients with\r\nvitamin D3 deficiency or at risk of vitamin\r\nD3 insufficiency. It is also indicated for\r\nsupporting bone health, immune\r\nwellness, cardiovascular function and\r\ncellular metabolism. It is also essential to\r\nprevent pre-eclampsia during pregnancyBecovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. </p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Adult : One\r\ncapsule daily with meal. The daily dose\r\nshall not exceed 4000 IU (5 capsules per\r\nday).</span></p><p><strong>Use in pregnancy and lactation : </strong>Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.</p><p><strong>Packing : </strong><span class="redactor-invisible-space">5x10''s soft capsules in blister\r\npack.</span></p>', 'uploads/images/D_cap.jpg', 1, '2017-12-04 02:43:50', NULL, NULL, '', 'Y', 4, 'uploads/IMG/07.jpg'),
(937, 'Dicaltrol', 269, '<p><strong>Composition : </strong>Calcitriol 0.25mcg Soft Capsule.</p><p><strong>Indication : </strong></p><p><span class="redactor-invisible-space">Predialysis patients : Dicaltrol is\r\nindicated in the management of secondary\r\nhyperparathyroidism and resultant metabolic bone\r\ndisease in patients with moderate to severe chronic\r\nrenal failure not yet on dialysis. </span></p><p><span class="redactor-invisible-space">Dialysis patients : Dicaltrol is indicated in the\r\nmanagement of hypocalcaemia and the resultant\r\nmetabolic bone disease in patients undergoing\r\nchronic renal dialysis. </span></p><p><span class="redactor-invisible-space">Hypoparathyroidism patients : Dicaltrol is also\r\nindicated in the management of hypocalcaemia and\r\nits clinical manifestations in patients with post surgical\r\nhypoparathyroidism, idiopathic hypoparathyroidism\r\nand pseudohypoparathyroidism. </span></p><p><span class="redactor-invisible-space">Osteoporosis : Dicaltrol is also indicated for the\r\ntreatment of established postmenopausal\r\nosteoporosis and senile osteoporosis.</span></p><p><strong>Dosage and administration :</strong></p><p><strong> </strong><span class="redactor-invisible-space">Predialysis Patients :\r\nThe recommended initial dosage of Dicaltrol is 0.25\r\nmcg/day in adults and pediatric patients 3 years of\r\nage and older. This dosage may be increased if\r\nnecessary to 0.5 mcg/day. </span></p><p><span class="redactor-invisible-space">Dialysis Patients : The recommended initial dose of\r\nDicaltrol is 0.25 mcg/day. If a satisfactory response in\r\nthe biochemical parameters and clinical\r\nmanifestations of the disease state is not observed,\r\ndosage may be increased by 0.25 mcg/day at 4 to 8-\r\nweek intervals.</span></p><p><span class="redactor-invisible-space">\r\nHypoparathyroidism : The recommended initial\r\ndosage of Dicaltrol is 0.25 mcg/day given in the\r\nmorning. If a satisfactory response in the biochemical\r\nparameters and clinical manifestations of the disease\r\nis not observed, the dose may be increased at 2 to 4\r\nweek intervals. if hypercalcaemia is noted, Dicaltrol\r\nshould be immediately discontinued until\r\nnormocalceamia ensues. Careful consideration\r\nshould also be given to lowering the dietary calcium\r\nintake. Most adult patients and pediatric patients age\r\n6 years and older have responded to dosages in the\r\nrange of 0.5 mcg to 2 mcg daily. Pediatric patients in\r\nthe 1 to 5 year age group with hypoparathyroidism\r\nhave usually been given 0.25mcg to 0.75mcg daily.\r\nThe number of treated patients with\r\npseudohypoparathyroidism less than 6 years of age is\r\ntoo small to make dosage recommendations. </span></p><p><span class="redactor-invisible-space">Postmenopausal Osteoporosis : The\r\nrecommended dose for Dicaltrol is 0.25 mcg twice\r\ndaily. Serum calcium and creatinine levels should be\r\ndetermined at 4 weeks, 3 and 6 months and at 6\r\nmonthly intervals there after.</span></p><p><strong>Use in pregnancy and lactation : <em></em></strong><span class="redactor-invisible-space">Dicaltrol should\r\nbe given only when the potential benefit has been\r\nweighed against the possible hazard to the fetus.\r\nMothers should not breast-feed while taking Dicaltrol.</span><span class="redactor-invisible-space"></span></p><p><strong>Packing :</strong>Dicaltrol : 5 x 10''s capsule.</p>', 'uploads/images/Dical.jpg', 1, '2017-11-29 04:08:35', NULL, NULL, '', 'Y', 4, 'uploads/IMG/dicaltrol.jpg'),
(938, 'Dicaltrol Plus', 270, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Calcium Citrate 1200mg\r\neq. to elemental Calcium 252mg and\r\nCalcitriol 0.25mcg Tablet.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">This combination is used\r\nto prevent or treat low blood calcium\r\nlevels in people who do not get enough\r\ncalcium from their diets. It may be used\r\nto treat conditions caused by low calcium\r\nlevels such as bone loss (osteoporosis),\r\nweak bones (osteomalacia, rickets),\r\ndecreased activity of the parathyroid\r\ngland (hypoparathyroidism) and a certain\r\nmuscle disease (latent tetany). It may\r\nalso be used in certain patients to make\r\nsure they are getting enough calcium\r\n(e.g. postmenopausal).</span></p><p><strong>Dosage and administration :</strong>1-4\r\ntablets daily with or without food\r\ndepending on clinical situation. Or, as\r\ndirected by the registered physician.</p><p><strong>Use in pregnancy and lactation : <em></em></strong><span class="redactor-invisible-space"><span class="redactor-invisible-space">Pregnancy catagory C. Dicaltrol Plus\r\nshould be used as directed by the\r\nregistered physician during pregnancy\r\nand lactation.</span></span></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Dicaltrol Plus : 6x5''s tablets\r\nin blister pack.</span></p>', 'uploads/images/Dical.jpg', 1, '2017-11-29 04:06:00', NULL, NULL, '', 'Y', 4, 'uploads/IMG/dicaltrol-plus.jpg'),
(940, 'E-Cap', 272, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">: Vitamin-E 200 I.U & 400\r\nI.U. Capsule.</span></p><p><strong>Indication : </strong>.Vitamin E is used for the\r\ntreatment & prevention of Vitamin E\r\ndeficiency. There is a possible need for\r\nsupplimentation of Vitamin-E in the diet\r\nof pregnant & lactating women and for\r\nnew born infants where anemia can arise\r\nas a result of insufficiency of Vitamin-E.\r\nVitamin-E has been tried in the treatment\r\nof various disorders including angina\r\npectoris, hypercholesterolaemia,\r\nintermittent claudication, fibrocystic\r\nbreast disease, cancer, nocturnal leg\r\ncramps, osteoarthritis etc. Vitamin-E has\r\nalso been claimed to enhance athletic\r\nperformance. </p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">1-2\r\ncapsules daily or as directed by the\r\nphysician.</span></p><p><br></p><p><strong>Packing : </strong><span class="redactor-invisible-space">E-Cap 200 : 6 x 10''s capsules in blister\r\npack.\r\nE-Cap 400 : 5 x 10''s capsules in blister\r\npack.</span></p>', 'uploads/images/E_4.jpg', 1, '2017-11-29 03:33:15', NULL, NULL, '', 'Y', 4, 'uploads/IMG/E-cap.jpg'),
(941, 'E-Cap Plus', 273, '<p><strong>Composition : </strong><span class="redactor-invisible-space">: Vitamin-E 200 I.U & 400 I.U. Capsule.</span></p><p><strong>Indication : </strong>.Vitamin E is used for the treatment & prevention of Vitamin E deficiency. There is a possible need for supplimentation of Vitamin-E in the diet of pregnant & lactating women and for new born infants where anemia can arise as a result of insufficiency of Vitamin-E. Vitamin-E has been tried in the treatment of various disorders including angina pectoris, hypercholesterolaemia, intermittent claudication, fibrocystic breast disease, cancer, nocturnal leg cramps, osteoarthritis etc. Vitamin-E has also been claimed to enhance athletic performance.</p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">1-2 capsules daily or as directed by the physician.</span></p><p><br></p><p><strong>Packing : </strong><span class="redactor-invisible-space" style="background-color: initial;">E-Cap 200 : 6 x 10''s capsules in blister pack. E-Cap 400 : 5 x 10''s capsules in blister pack.</span></p>', 'uploads/images/E_pl.jpg', 1, '2017-11-29 03:33:41', NULL, NULL, '', 'Y', 4, 'uploads/IMG/e-cap_plus.jpg');
INSERT INTO `drg_medicine_info` (`MEDICINE_ID`, `MEDICINE_NAME`, `GN_GRP_ID`, `MEDICINE_DESC`, `INSERT_FILE`, `CRE_BY`, `CRE_DT`, `UPD_BY`, `UPD_DT`, `IS_LATEST`, `ACTIVE_STATUS`, `CAT_ID`, `PRODUCT_FET_PHOTO`) VALUES
(943, 'Mecolin ', 275, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Mecobalamin 0.5mg\r\nTablet.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">Mecobalamin is indicated\r\nfor following diseases. </span></p><p><span class="redactor-invisible-space">u	Diabetic neuropathy\r\nu	Peripheral neuropathies\r\nu	Diabetic retinopathy\r\nu	Drug induced neuropathy\r\nu	Entrapment neuropathy\r\nu	Intercostal neuralgia\r\nu	Lumbago\r\nu	Vertebral syndrome\r\nu	Nerve compression syndrome\r\nu	Multiple sclerosis\r\nu	Amyotrophic lateral sclerosis\r\nu	Parkinson''s disease\r\nu	Alzheimer''s disease</span></p><p><br></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Adults : One\r\n0.5mg tablet three times daily. Or as\r\ndirected by the physician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Not\r\nrecommended during pregnancy &\r\nlactation. Not recommended for children.</span></p><p><strong>Packing : </strong>Mecolin : 5x10''s tablets in\r\nblister pack.contains one inhaler of 200 Puffs</p>', 'uploads/images/asta_2.jpg', 1, '2017-11-28 03:28:20', NULL, NULL, '', 'Y', 4, 'uploads/IMG/mecolin.jpg'),
(944, 'Paricap', 276, '<p><strong></strong><strong>Composition : </strong>Each Metered dose (Puff) contains Beclometasone Dipropionate 100 mcg.</p><p><strong>Indication : </strong>Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. </p><p><strong>Dosage and administration : </strong>Becovent inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled Becovent appropriate to the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to individual response. Management of chronic asthma (Adults & Children over 12 years): 100-400 mcg twice daily. Maximum 1000 mcg twice daily. Children (5-12 years): 100-200 mcg twice daily. the dose may be adjusted as necessary.</p><p><strong>Use in pregnancy and lactation : </strong>Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.</p><p><strong>Packing : </strong>Becovent HFA Inhaler : Each box contains one inhaler of 200 Puffs</p>', 'uploads/images/Pari.jpg', 1, '2017-11-08 05:00:18', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/29.jpg'),
(945, 'Ratinol-Forte ', 277, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Vitamin A 50,000 I.U. &\r\n2,00,000 I.U. Soft Capsule.\r\n</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">Illness due to vitamin A\r\ndeficiency in ophthalmology such as\r\nnight blindness, xerophthalmia and\r\ndermatological such as changes in skin,\r\nhair and nails. Concomitant therapy of\r\nmucosa illnesses such as sinusitis,\r\nbronchitis, in acne vulgaris, ichthyosis,\r\nDarier''s disease, psoriasis etc.\r\nTo meet vitmin A demand in growth,\r\nresistance to infections and night\r\nblindness. Ratinol Forte is also indicated\r\nto meet vitamin A deficiency after\r\ndiarrhoea and prophylaxis of measles</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">For Adults : 50,000 I.U -\r\n1,00,000 I.U daily up to 2,00,000 I.U if\r\nnecessary</span></p><p><br></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Ratinol Forte-50,000 : 6 x 10''s soft\r\ncapsules blister pack.\r\nRatinol Forte-2 lac : 5 x 10''s soft\r\ncapsules blister pack.</span></p>', 'uploads/images/rati.jpg', 1, '2017-11-28 05:05:28', NULL, NULL, '', 'Y', 4, 'uploads/IMG/ratinol-forte.jpg'),
(946, 'Seacal', 278, '<p><strong></strong><strong>Composition : </strong>Each Metered dose (Puff) contains Beclometasone Dipropionate 100 mcg.</p><p><strong>Indication : </strong>Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. </p><p><strong>Dosage and administration : </strong>Becovent inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled Becovent appropriate to the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to individual response. Management of chronic asthma (Adults & Children over 12 years): 100-400 mcg twice daily. Maximum 1000 mcg twice daily. Children (5-12 years): 100-200 mcg twice daily. the dose may be adjusted as necessary.</p><p><strong>Use in pregnancy and lactation : </strong>Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.</p><p><strong>Packing :</strong> Becovent HFA Inhaler : Each box contains one inhaler of 200 Puffs</p>', 'uploads/images/sed.jpg', 1, '2017-11-08 05:05:39', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/32.jpg'),
(947, 'Supravit', 279, '<p><em><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Each Supravit soft\r\ncapsule contains :</span></em></p><p><em><br></em></p><p style="text-align: center;"><span class="redactor-invisible-space"><em>Vitamin	A		5000	IU\r\nVitamin	D3		400	IU\r\nVitamin	C		75	mg\r\nVitamin	B1		1.50	mg\r\nVitamin	B2		10	mg\r\nVitamin	B6		1	mg\r\nVitamin	B3		13	mg\r\nVitamin	B5		5	mg\r\nVitamin	E		5	IU\r\nVitamin	B12		2	mcg<br></em></span></p><p><em><strong>Indication :</strong>: Supravit is indicated for the\r\ntreatment and prevention of vitamin\r\ndeficiencies. </em></p><p><em><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Orally\r\none capsule daily for adults and children\r\nover 5 years of age or as directed by the\r\nphysician.</span></em></p><p><em><br></em></p><p><strong><em>Packing : </em></strong><span class="redactor-invisible-space"><em>Supravit : 6 x 10''s capsules\r\nin blister pack.</em></span></p>', 'uploads/images/Supvit.jpg', 1, '2017-11-27 05:39:44', NULL, NULL, '', 'Y', 4, 'uploads/IMG/36.jpg'),
(949, 'Supracod', 281, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Each 5ml Syrup contains\r\nVitamin A 2000 IU, Vitamin D 200 IU,\r\nVitamin B1 (as Thiamine Hydrochloride)\r\n0.7mg, Vitamin B2 (as Riboflavin 5''\r\nPhosphate Sodium) 0.85mg, Vitamin B6\r\n(as Pyridoxin Hydrochloride) 0.35mg,\r\nVitamin E 1.5mg, Nicotinamide 9.00mg,\r\nVitamin C (as Ascorbic Acid) 17.5mg and\r\nCod Liver Oil 100mg.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">This multivitamin is\r\nindicated for the treatment and\r\nprevention of multivitamin deficiencies\r\nassociated with restricted diets and\r\nimproper food intake. It is also mediated\r\nin children with increased requirements\r\nfor vitamins due to acute and chronic\r\ndisease, vitamin lacking symptom for\r\ngrowing child, lack of appetite child,\r\nincluding patient under rehabilitating\r\nperiod.</span></p><p><strong>Dosage and administration : </strong></p><p><span class="redactor-invisible-space">Infant (1-12 months)	: 1\r\n/2	teaspoonful (2.5ml) / day.\r\nChild (1-4 years)	: 1	teaspoonful (5ml) / day.\r\nChild (Above 4 years)	: 11\r\n/2	teaspoonful (7.5ml) / day<br></span></p><p><br></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Supracod : 100ml\r\nmultivitamin syrup with Cod Liver Oil and\r\na measuring Cup.</span></p>', 'uploads/images/Supracod.jpg', 1, '2017-11-28 05:20:49', NULL, NULL, '', 'Y', 4, 'uploads/IMG/supracod.jpg'),
(950, 'Supra-B', 282, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Thiamine Hydrochloride\r\n(Vitamin B1) 100mg, Pyridoxine\r\nHydrochloride (Vitamin B6) 200mg and\r\nCyanocobalamin (Vitamin B12) 200mcg\r\nTablet.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">Chronic pains like sciatica,\r\nlumbago, trigeminal neuralgia, facial\r\nparalysis, optic neuritis as well as\r\nneuropathy & cardiac complications.\r\nBesides these, deficiency exits of these\r\nrelevant Vitamins.</span></p><p><strong>Dosage and administration :</strong></p><p><strong></strong>Supra-B\r\nTablet : 1-2 tablets three times a day.\r\nOr, as directed by the registered\r\nphysician.Becovent inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled Becovent appropriate to the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to individual response. Management of chronic asthma (Adults & Children over 12 years): 100-400 mcg twice daily. Maximum 1000 mcg twice daily. Children (5-12 years): 100-200 mcg twice daily. the dose may be adjusted as necessary.</p><p><br></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Supra-B : 5 x 10''s tablet''s in blister\r\npack.</span></p>', 'uploads/images/suprag.jpg', 1, '2017-11-28 05:17:24', NULL, NULL, '', 'Y', 4, 'uploads/IMG/Supra-B-Tablet.jpg'),
(955, 'Tannox-Plus', 286, '<p style="text-align: justify;"><strong></strong><strong>Composition :  </strong><span class="redactor-invisible-space">Each soft capsule\r\ncontains:\r\nBeta Carotene\r\n(Eq. to Vitamin A 2000 IU)	BP	\r\n6mg\r\nAscorbic Acid (Vitamin C)	BP	200mg\r\nVitamin E	BP	50mg\r\nVitamin K	BP	75mcg\r\nZinc	BP	15mg\r\nSelenium	USP	70mcg\r\nCopper	BP	1mg\r\nManganese	BP	3mg</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">It is used as the treatment\r\nof develop immune system, prevents\r\nosteoporosis, arteriosclerosis, protects\r\nhuman skin from UV-induced damage,\r\nprevents the well known deficiency\r\ndiseases such as scurvy, beriberi,\r\npellagra and others, prevents certain\r\ntypes of cancer by blocking the formation\r\nof cancer causing substances in the\r\nbody. It has a role in retinal metabolism\r\nand may be beneficial in macular\r\ndegeneration. It is also capable of\r\ncombating cardiovascular and\r\nimmunological disorders.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">once capsule daily. Or as directed\r\nby the registered physician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Recommended by the consultation with\r\nthe registered physician.</span></p><p><strong>Packing : </strong><span class="redactor-invisible-space">5 x 10''s soft\r\ncapsules in blister pack.</span></p>', 'uploads/images/tannoxp.jpg', 1, '2017-11-27 04:37:54', NULL, NULL, '', 'Y', 4, 'uploads/IMG/tannox-plus.jpg'),
(956, 'Ziton', 287, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Zinc Sulfate\r\nMonohydrate Eq. to 10mg of elemental\r\nZinc/5ml Syrup.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">It is indicated for the\r\nfollowing conditions-growth retardation,\r\nRTI, alopecia, dermatitis, diarrhoea,\r\nimmunological dysfunction,\r\npsychological disturbances, gonadal\r\natrophy, impaired spermatogenesis,\r\ncongenital malformation.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Children\r\nunder 10kg : 22.5mg (2\r\n1\r\n-\r\n4 spoonful) Ziton\r\nsyrup daily in divided doses. Children\r\nover 10kg to 30kg : 22.5mg (2\r\n1\r\n-\r\n4 spoonful)\r\n1 to 3 times daily. Adult & children over\r\n30kg : 45mg (4\r\n1\r\n-\r\n2 spoonful) 1 to 3 times\r\ndaily after food.\r\nOr, as directed by the registered\r\nphysician.</span></p><p><br></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Ziton :100ml in amber glass\r\nbottle.</span></p>', 'uploads/images/Ziton.jpg', 1, '2017-11-27 04:12:45', NULL, NULL, '', 'Y', 4, 'uploads/IMG/Ziton.jpg'),
(958, 'Acepril', 172, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Lisinopril 5mg & 10mg\r\nTablet.</span></p><p><strong>Indication :</strong>Acepril is indicated for all\r\ngrades of essential hypertension and\r\nrenovascular hypertension. Acepril can\r\nbe used alone or with other anti\r\nhypertensive agents.Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. </p><p><strong>Dosage and administration : </strong>Treatment\r\nshould be started with 2.5mg once daily.\r\nIn patients with uncomplicated essential\r\nhypertension, not on diuretic therapy, the\r\nrecommended initial dose is 10mg once\r\ndaily. Dosage should be adjusted\r\naccording to blood pressure response.\r\nThe usual dosage range is 10-20mg\r\nonce daily. Maximum dose is 40mg per\r\nday as a single dose or as directed by\r\nthe physician.</p><p><br></p><p><strong>Packing :</strong></p><p><strong></strong>Acepril 10mg : 2 x 14''s blister\r\npack. </p><p>Acepril 5mg : 4 x 14''s blister pack. </p>', 'uploads/images/Acepril10.jpg', 1, '2017-11-30 04:17:55', NULL, NULL, '', 'Y', 4, 'uploads/IMG/39.jpg'),
(959, 'Acetor', 173, '<p><strong></strong><strong>Composition : </strong>Captopril 25mg Tablet.</p><p><strong>Indication : </strong><span class="redactor-invisible-space">Mild-to-moderate hyprtension\r\n: As an adjunct to thiazide therapy in patients\r\nwho have not responded effectively to\r\nthiazide treatment alone.\r\nSevere hypertension : Where standard\r\ntherapy has failed.\r\nCongestive heart failure : Acetor is\r\nindicated for the treatment of congestive\r\nheart failure. The drug should be used\r\ntogether with diuretics and where\r\nappropriate, digitalis.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Adults : Mild-tomoderate\r\nhypertension: The initial dose is\r\n12.5mg twice daily. The usual maintenance\r\ndose is 25mg twice daily which can be\r\nincreased incrementally, at two to four week\r\nintervals, until a satisfactory response is\r\nachieved, to a maximum of 50mg twice daily.\r\nSevere hypertension : In severe\r\nhypertension the starting dose is 12.5mg b.d.\r\nThe dosage may be increased incrementally\r\nto a maximum of 50mg t.d.s.\r\nHeart failure : A starting dose of 6.25mg or\r\n12.5mg may minimise a transient\r\nhypotensive effect. The usual maintenance\r\ndose is 25mg three times a day. The usual\r\nmaximum dose is 150mg daily.\r\nAcetor must be taken 1 hour before meals to\r\nensure maximum absorption.</span></p><p><br></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Acetor : 10 x 10 tablets in blister\r\npack.</span></p>', 'uploads/images/Acetor.jpg', 1, '2017-11-26 06:31:30', NULL, NULL, '', 'Y', 4, 'uploads/IMG/41.jpg'),
(960, 'Ramicard', 174, '<p><strong>Composition : </strong><span class="redactor-invisible-space">Ramipril 1.25mg, 2.5mg & 5mg Tablet.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">Ramicard is indicated in the treatment of : (1)	Mild to severe hypertension, where it may be used alone or in combination with thiazide diuretics. (2)	Congestive heart failure. (3)	To reduce the risk of stroke, myocardial infarction and death from cardiovascular events in patients with a history of cardiovascular disease. (4)	Proteinuric non-diabetic nephropathy.</span></p><p><strong>Dosage and administration :</strong></p><p><strong></strong><span class="redactor-invisible-space">Dosage of Ramicard must be adjusted according to the patient tolerance and response. Hypertension: For the management of hypertension in adults not receiving a diuretic, the usual initial dose of Ramicard is 1.25 - 2.5 mg once daily. Dosage generally is adjusted no more rapidly than at 2-week intervals. The usual maintenance dosage in adults is 2.5 - 20 mg daily given as a single dose or in 2 divided doses daily. If BP is not controlled with Ramicard alone, a diretic may be added. Congestive heart failure after myocardial infarction: In this case, Ramicard therapy may be initiated as early as 2 days after myocardial infarction. An initial dose of 2.5 mg twice daily is recommended, but if hypotension occurs, dose should be reduced to 1.25 mg twice daily. Therapy is then titrated to a target daily dose of 5 mg twice daily. Prevention of major cardiovascular events: In this case, the recommended dose is 2.5 mg once daily for the first week of therapy and 5 mg once daily for the following 3 weeks; dosage then may be increased, as tolerated, to a maintenance dosage of 10 mg once daily. Dosage in renal impariment: For the patients with hypertension and renal impairment, the recommended initial dose is 1.25 mg Ramicard once daily. Subsequent dosage should be titrated according to individual tolerance and BP response, up to a maximum of 5 mg daily. For the patients with heart failure and renal impairment, the recommended dose is 1.25 mg once daily. The dose may be increased to 1.25 mg twice daily and up to a maximum dose of 2.5 mg twice daily depending upon clinical response and tolerability. Or as directed by registered physician.</span></p><p><br></p><p><strong>Packing : </strong><span class="redactor-invisible-space" style="background-color: initial;">Ramicard-1.25mg tablet : 4 x 14''s tablets in blister pack. Ramicard-2.5mg tablet : 4 x 14''s tablets in blister pack. Ramicard-5mg tablet : 4 x 14''s tablets in blister pack.</span></p>', 'uploads/images/Ramicard-5.JPG', 1, '2017-11-28 05:03:49', NULL, NULL, '', 'Y', 4, 'uploads/IMG/ramicard-1.25.JPG'),
(961, 'Ramicard Plus', 175, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Ramipril 1.25mg, 2.5mg & 5mg\r\nTablet.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">Ramicard is indicated in the treatment\r\nof : (1)	Mild to severe hypertension, where it may be\r\nused alone or in combination with thiazide diuretics.\r\n(2)	Congestive heart failure. (3)	To reduce the risk of\r\nstroke, myocardial infarction and death from\r\ncardiovascular events in patients with a history of\r\ncardiovascular disease. (4)	Proteinuric non-diabetic\r\nnephropathy.</span></p><p><strong>Dosage and administration : </strong></p><p><strong></strong><span class="redactor-invisible-space">Dosage of Ramicard\r\nmust be adjusted according to the patient tolerance\r\nand response. Hypertension: For the management\r\nof hypertension in adults not receiving a diuretic, the\r\nusual initial dose of Ramicard is 1.25 - 2.5 mg once\r\ndaily. Dosage generally is adjusted no more rapidly\r\nthan at 2-week intervals. The usual maintenance\r\ndosage in adults is 2.5 - 20 mg daily given as a single\r\ndose or in 2 divided doses daily. If BP is not\r\ncontrolled with Ramicard alone, a diretic may be\r\nadded. Congestive heart failure after myocardial\r\ninfarction: In this case, Ramicard therapy may be\r\ninitiated as early as 2 days after myocardial\r\ninfarction. An initial dose of 2.5 mg twice daily is\r\nrecommended, but if hypotension occurs, dose\r\nshould be reduced to 1.25 mg twice daily. Therapy is\r\nthen titrated to a target daily dose of 5 mg twice daily.\r\nPrevention of major cardiovascular events: In this\r\ncase, the recommended dose is 2.5 mg once daily\r\nfor the first week of therapy and 5 mg once daily for\r\nthe following 3 weeks; dosage then may be\r\nincreased, as tolerated, to a maintenance dosage of\r\n10 mg once daily. Dosage in renal impariment: For\r\nthe patients with hypertension and renal impairment,\r\nthe recommended initial dose is 1.25 mg Ramicard\r\nonce daily. Subsequent dosage should be titrated\r\naccording to individual tolerance and BP response,\r\nup to a maximum of 5 mg daily. For the patients with\r\nheart failure and renal impairment, the recommended\r\ndose is 1.25 mg once daily. The dose may be\r\nincreased to 1.25 mg twice daily and up to a\r\nmaximum dose of 2.5 mg twice daily depending upon\r\nclinical response and tolerability. Or as directed by\r\nregistered physician.</span></p><p><br></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Ramicard-1.25mg tablet : 4 x 14''s tablets\r\nin blister pack.\r\nRamicard-2.5mg tablet : 4 x 14''s tablets in blister\r\npack.\r\nRamicard-5mg tablet : 4 x 14''s tablets in blister\r\npack.</span></p>', 'uploads/images/Ramicpl5.jpg', 1, '2017-11-28 05:03:13', NULL, NULL, '', 'Y', 4, 'uploads/IMG/ramicard-2.5plus.jpg'),
(962, 'Cardival', 176, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Valsartan USP 80mg\r\nTablet.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">Hypertension : Cardival\r\n(valsartan) is indicated for the treatment\r\nof hypertension. It may be used alone or\r\nin combination with other\r\nantihypertensive agents.\r\nHeart Failure : Cardival (valsartan) is\r\nindicated for the treatment of heart\r\nfailure (NYHA class II-IV) in patients who\r\nare intolerant of angiotensin converting\r\nenzyme inhibitors.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Usually\r\n80mg once daily if necessary increased\r\nafter at least 4 weeks to 160mg daily\r\n(elderly over 75years, mild to moderate\r\nhepatic impairment, moderate to severe\r\nrenal impairment, intravascular volume\r\ndepletion initially 40mg once daily). On\r\nas directed by a registered physician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">The\r\nuse of valsartan is not advised at the\r\ntime of pregnancy. Decision should be\r\nmade whether to discontinue nursing or\r\ndiscontinue the drug, taking into account\r\nthe importance of the drug to the mother.</span></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Cardival : 3x10''s tablets in\r\nblister pack.</span></p>', 'uploads/images/Cardival.jpg', 1, '2017-11-29 04:47:51', NULL, NULL, '', 'Y', 4, 'uploads/IMG/cardival.jpg'),
(963, 'Cardival Plus', 177, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Valsartan +\r\nHydrochlorothiazide ; (80mg+12.5mg) &\r\n(160mg+12.5mg) Tablet.</span></p><p><strong>Indication :</strong>It is indicated for the\r\ntreatment of hypertension & myocardial\r\ninfraction with left ventricular failure.Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. </p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">A patient\r\nwhose blood pressure is not adequately\r\ncontrolled with valsartan monotherapy\r\nmay add hydrochlorothiazide by\r\nswitching to Cardival Plus (Valsartan\r\n80mg/hydrochlorothiazide 12.5mg or\r\nValsartan 160mg/hydrochlorothiazide\r\n12.5mg) once daily. The clinical\r\nresponse to Cardival Plus should be\r\nsubsequently evaluated and if blood\r\npressure remains uncontrolled after 3-4\r\nweeks of therapy, the dose may be\r\ntitrated up to valsartan\r\n160mg/hydrochlorothiazide 25mg. Or, as\r\ndirected by the registered physician.</span></p><p><br></p><p><strong>Packing :</strong></p><p><strong> </strong><span class="redactor-invisible-space">Cardival Plus 80 : 2 x 10''s tablets in\r\nblister pack. </span></p><p><span class="redactor-invisible-space">Cardival Plus 160 : 1 x 10''s tablets in\r\nblister pack.</span></p>', 'uploads/images/Cardival.jpg', 1, '2017-11-29 04:46:30', NULL, NULL, '', 'Y', 4, 'uploads/IMG/cardival-plus_80.jpg'),
(964, 'Losardil', 178, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Losartan Potassium 25mg,\r\n50mg & 100mg Tablet &\r\nLosartan Potassium+Hydrochlorothiazide,\r\n(25+12.5mg), (50+12.5mg), (100+12.5mg),\r\n(100+25mg) Tablet</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">This tablet is indicated for the\r\ntreatment of hypertension. It may be used\r\nalone or in combination with other\r\nantihypertensive agents. This fixed dose\r\ncombination is not indicated for initial therapy.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">The usual\r\nstarting dose of Losartan is 50mg once daily,\r\nwith 25mg used in patients with possible\r\ndepletion of intravascular volume and\r\npatients with a history of hepatic impairment.\r\nLosartan can be administered once or twice\r\ndaily at total daily doses of 25 to 100 mg. If\r\nthe antihypertensive effect measured at\r\nthrough using once a day dosing is\r\ninadequate, a twice a day regimen at the\r\nsame total daily dose or an increase in dose\r\nmay give a more satisfactory response.\r\nHydrochlorothiazide is effective in doses of\r\n12.5 to 50mg once daily and can be given at\r\ndoses of 12.5 to 25mg as this medicine.Or,\r\nas directed by the registered physician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">This\r\nmedicine is not generally recommended\r\nduring pregnancy, except under exceptional\r\ncircumstances. This medicine passes into\r\nbreast milk. Consequently, breast-feeding is\r\nnot recommended.</span></p><p><strong>Packing : </strong></p><p><span class="redactor-invisible-space">Losardil-25 : 4x14''s tablets in\r\nblister pack.</span></p><p><span class="redactor-invisible-space">\r\nLosardil-50 : 2x14''s tablets in blister pack.</span></p><p><span class="redactor-invisible-space">\r\nLosardil-100 : 2x14''s tablets in blister pack. </span></p><p><span class="redactor-invisible-space">Losardil 25/12.5: 4x14''s tablets in blister\r\npack.</span></p><p><span class="redactor-invisible-space">\r\nLosardil 50/12.5: 4x14''s tablets in blister\r\npack. </span></p><p><span class="redactor-invisible-space">Losardil 100/12.5 : 2x14''s tablets in blister\r\npack.</span></p><p><span class="redactor-invisible-space">\r\nLosardil 100/25 : 2x10''s tablets in blister\r\npack.</span></p><p><br></p>', 'uploads/images/Losardil100.Jpg', 1, '2017-11-28 03:07:43', NULL, NULL, '', 'Y', 4, 'uploads/IMG/losardil.Jpg'),
(965, 'Losardil ', 179, '<p><strong>Composition : </strong><span class="redactor-invisible-space">Losartan Potassium 25mg, 50mg & 100mg Tablet & Losartan Potassium+Hydrochlorothiazide, (25+12.5mg), (50+12.5mg), (100+12.5mg), (100+25mg) Tablet</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">This tablet is indicated for the treatment of hypertension. It may be used alone or in combination with other antihypertensive agents. This fixed dose combination is not indicated for initial therapy.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">The usual starting dose of Losartan is 50mg once daily, with 25mg used in patients with possible depletion of intravascular volume and patients with a history of hepatic impairment. Losartan can be administered once or twice daily at total daily doses of 25 to 100 mg. If the antihypertensive effect measured at through using once a day dosing is inadequate, a twice a day regimen at the same total daily dose or an increase in dose may give a more satisfactory response. Hydrochlorothiazide is effective in doses of 12.5 to 50mg once daily and can be given at doses of 12.5 to 25mg as this medicine.Or, as directed by the registered physician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">This medicine is not generally recommended during pregnancy, except under exceptional circumstances. This medicine passes into breast milk. Consequently, breast-feeding is not recommended.</span></p><p><strong>Packing :</strong></p><p><span class="redactor-invisible-space">Losardil-25 : 4x14''s tablets in blister pack.</span></p><p><span class="redactor-invisible-space">Losardil-50 : 2x14''s tablets in blister pack.</span></p><p><span class="redactor-invisible-space">Losardil-100 : 2x14''s tablets in blister pack.</span></p><p><span class="redactor-invisible-space">Losardil 25/12.5: 4x14''s tablets in blister pack.</span></p><p><span class="redactor-invisible-space">Losardil 50/12.5: 4x14''s tablets in blister pack.</span></p><p><span class="redactor-invisible-space">Losardil 100/12.5 : 2x14''s tablets in blister pack.</span></p><p><span class="redactor-invisible-space">Losardil 100/25 : 2x10''s tablets in blister pack.</span></p>', 'uploads/images/Losardil100_25.jpg', 1, '2017-11-28 03:10:40', NULL, NULL, '', 'Y', 4, 'uploads/IMG/losardil5012.5.jpg'),
(966, 'Olmetic', 180, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Olmesartan Medoxomil\r\n20mg Tablet.\r\n</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">Olmesartan Medoxomil is\r\nindicated for the treatment of hypertension. It\r\nmay be used alone or in combination with\r\nother antihypertensive agents.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Olmetic :\r\nAdults: Dosage must be individualized. The\r\nusual recommended starting dose of\r\nOlmesartan Medoxomil is 10 to 20mg once\r\ndaily when used as monotherapy. For\r\npatients requiring further reduction in blood\r\npressure after 2 weeks of therapy, the dose of\r\nOlmesartan Medoxomil may be increased to\r\n20 to 40 mg. Maximum recommended daily\r\ndose is 40mg. Elderly and renal\r\nimpairment: The maximum dose in elderly\r\nand patients with mild to moderate renal\r\nimpairment is 20mg daily. Children and\r\nadolescents: The safety and efficacy have\r\nnot been established in children and\r\nadolescents up to 18 years of age. Patients\r\nwith Hepatic Impairment : No dosage\r\nadjustment is necessary with hepatic\r\nimpairment. Or as directed by the registered\r\nphysicians.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Pregnancy Categories C (first trimester) and\r\nD (second and third trimesters). It is not\r\nknown whether Olmesartan Medoxomil is\r\nexcreted in human milk. Mothers must not\r\nbreast-feed if they are taking Olmesartan\r\nMedoxomil. Drugs that act directly on the\r\nrenin-angiotensin system can cause fetal and\r\nneonatal morbidity and death when\r\nadministered to pregnant women. When\r\npregnancy is detected, this drug should be\r\ndiscontinued as soon as possible.</span></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Olmetic : 3 x 10''s tablets in blister\r\npack.</span></p>', 'uploads/images/Olmetic.jpg', 1, '2017-11-28 00:24:29', NULL, NULL, '', 'Y', 4, 'uploads/IMG/olmetic.jpg'),
(967, 'Olmetic Plus', 181, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Olmesartan Medoxomil +\r\nHydrochlorothiazide; (20mg+12.5mg) Tablet.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">Olmesartan Medoxomil is indicated\r\nfor the treatment of hypertension. It may be used\r\nalone or in combination with other\r\nantihypertensive agents.</span></p><p><strong>Dosage and administration</strong> <strong>: </strong></p><p><span class="redactor-invisible-space"><strong>Olmetic Plus : </strong>A\r\npatient whose blood pressure is inadequately\r\ncontrolled by olmesartan or hydrochlorothiazide\r\nalone may be switched to one tablet (olmesaran\r\nmedoxomil 20mg-hydrochlorothiazide 12.5mg)\r\nonce daily.<strong> </strong></span></p><p><span class="redactor-invisible-space"><strong>Patients with Renal Impairment : </strong>The\r\nusual regimens of therapy with olmesartanhydrochlorothiazide\r\nmay be followed provided the\r\npatient''s creatinine clearance is &gt;30 mL/min. In\r\npatients with more severe renal impairment, loop\r\ndiuretics are preferred to thiazides, so\r\nolmesartan-hydrochlorothiazide is not\r\nrecommended. Patients with Hepatic\r\nImpairment : No dosage adjustment is necessary\r\nwith hepatic impairment. Or as directed by the\r\nregistered physicians.</span></p><p><strong><br></strong></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Pregnancy\r\nCategories C (first trimester) and D (second and\r\nthird trimesters). It is not known whether\r\nOlmesartan Medoxomil is excreted in human milk.\r\nMothers must not breast-feed if they are taking\r\nOlmesartan Medoxomil. Drugs that act directly on\r\nthe renin-angiotensin system can cause fetal and\r\nneonatal morbidity and death when administered\r\nto pregnant women. When pregnancy is detected,\r\nthis drug should be discontinued as soon as\r\npossible. Thiazides appear in human milk.\r\nBecause of the potential for adverse effects on\r\nthe nursing infant, a decision should be made\r\nwhether to discontinue nursing or discontinue the\r\ndrug, taking into account the importance of the\r\ndrug to the mother.</span></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Olmetic Plus : 3 x 10''s tablets in\r\nblister pack.</span></p>', 'uploads/images/OlmeticPlus.jpg', 1, '2017-11-28 00:14:40', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/olmetic-plus.jpg'),
(968, 'Tanzil', 182, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Azilsartan equivalent to\r\nAzilsartan Medoxomil 40mg.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">Azilsartan Medoxomil is\r\nindicated for the treatment of hypertension\r\nto lower blood pressure. Lowering blood\r\npressure reduces the risk of fatal and\r\nnonfatal cardiovascular events, primarily\r\nstroke and myocardial infarction. Azilsartan\r\nmedoxomil may be used either alone or in\r\ncombination with other antihypertensive\r\nagents.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">The\r\nrecommended starting dose in adults is\r\n40mg (1 tablet) taken orally once daily.\r\nThe dose may be increased to a maximum\r\nof 80 mg once daily, if required. Consider a\r\nstarting dose of 40mg for patients who are\r\ntreated with high doses of diuretics.\r\nAzilsartan may be taken with or without\r\nfood. Or, as directed by the registered\r\nphysician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Pregnancy Category D. The risk to the\r\nfetus reduces renal function & death\r\nincreases if Azilsartan Medoxomil is\r\nadministered during the second or third\r\ntrimesters of pregnancy. It is not known\r\nwhether Azilsartan Medoxomil is excreted\r\nin human milk, as many drugs are\r\nexcreted in human milk and because of\r\nthe potential for adverse effects on the\r\nnursing infant, a decision should be made\r\nwhether to discontinue nursing or\r\ndiscontinue the drug, taking into account\r\nthe importance of the drug to the mother</span></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Tanzil Tablet : 1 x 14''s tablets\r\nin Alu-Alu blister pack.</span></p>', 'uploads/images/Tanzil.jpg', 1, '2017-12-04 03:47:12', NULL, NULL, '', 'Y', 4, 'uploads/IMG/37.jpg'),
(969, 'Trimet', 183, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Trimetazidine\r\nDihydrochloride 20mg & Modified release\r\n35mg Tablet.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">This tablet is indicated for\r\nthe treatment of Ischaemic heart disease\r\n(angina pectoris, sequelae of infarction),\r\nadjuvant symptomatic treatment of vertigo\r\nand tinnitus, adjuvant treatment of the\r\ndecline visual acuity and visual field\r\ndisturbances, presumably of vascular\r\norigin.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Trimet\r\nOne tablet (20mg) thrice daily after meals.\r\nTrimet-MR one tablet twice daily at\r\nmealtimes in the morning and evening. Or\r\nas directed by the registered physician.</span></p><p><strong>Use in pregnancy and lactation :</strong>: No drug interactions\r\nhave so far been reported. In particular,\r\nno interactions of Trimetazidine with betablockers,\r\ncalcium antagonists, nitrates,\r\nheparin, hypolipidemic agents or digitalis\r\nhave been reported.</p><p><strong>Packing :</strong>: Trimet : 5x10’s tablets in\r\nblister pack.\r\nTrimet-MR : 2x14’s tablets in blister pack.</p>', 'uploads/images/Trimet.jpg', 1, '2017-11-27 04:39:38', NULL, NULL, '', 'Y', 4, 'uploads/IMG/trimet.jpg'),
(970, 'Trimet-MR', 183, '<p style="margin-bottom: 10px; color: rgb(68, 68, 68); font-family: Roboto, &quot;Helvetica Neue&quot;, Helvetica, Arial, sans-serif; background-color: rgb(255, 255, 255);"><strong>Composition :</strong> Trimetazidine Dihydrochloride 20mg & Modified release 35mg Tablet.<strong></strong></p><p style="margin-bottom: 10px; color: rgb(68, 68, 68); font-family: Roboto, &quot;Helvetica Neue&quot;, Helvetica, Arial, sans-serif; background-color: rgb(255, 255, 255);"><strong>Indication : </strong>This tablet is indicated for the treatment of Ischaemic heart disease (angina pectoris, sequelae of infarction), adjuvant symptomatic treatment of vertigo and tinnitus, adjuvant treatment of the decline visual acuity and visual field disturbances, presumably of vascular origin.</p><p style="margin-bottom: 10px; color: rgb(68, 68, 68); font-family: Roboto, &quot;Helvetica Neue&quot;, Helvetica, Arial, sans-serif; background-color: rgb(255, 255, 255);"><strong>Dosage and administration :</strong> Trimet One tablet (20mg) thrice daily after meals. Trimet-MR one tablet twice daily at mealtimes in the morning and evening. Or as directed by the registered physician.</p><p style="margin-bottom: 10px; color: rgb(68, 68, 68); font-family: Roboto, &quot;Helvetica Neue&quot;, Helvetica, Arial, sans-serif; background-color: rgb(255, 255, 255);"><strong>Use in pregnancy and lactation : </strong>No drug interactions have so far been reported. In particular, no interactions of Trimetazidine with betablockers, calcium antagonists, nitrates, heparin, hypolipidemic agents or digitalis have been reported.</p><p><strong>Packing :</strong><strong> </strong>Trimet : 5x10’s tablets in blister pack. Trimet-MR : 2x14’s tablets in blister pack.</p>', 'uploads/images/Trimet-MR.jpg', 1, '2017-11-27 04:41:38', NULL, NULL, '', 'Y', 4, 'uploads/IMG/trimet-mr.jpg'),
(971, 'Cardinex-40', 184, '<p><strong></strong><strong>Composition : </strong></p><p><strong></strong>Active ingredient :</p><p><span class="redactor-invisible-space"> Enoxaparin\r\nsodium Solvent :</span>Water for injections. </p><p>Each ml of the solution contains : </p><p>10000 anti-Xa IU\r\nequivalent to </p><p>100mg Enoxaparin sodium. </p><p>Cardinex-40 : 4000 anti-Xa IU/0.4ml.</p><p>\r\nCardinex-60 : 6000 anti-Xa IU/0.6ml. </p><p>Cardinex-80 : 8000 anti-Xa IU/0.8ml.</p><p><strong>Indication : </strong><span class="redactor-invisible-space">Cardinex is indicated for o\r\nProphylaxis of venous thromboembolic disease\r\n(prevention of blood clot formation in the veins). o\r\nPrevention of thrombus formation in the\r\nextracorporal circluation during haemodialysis. o\r\nTreatment of unstable angina and non-Q-wave\r\nmyocardial infarction during acute stage. o\r\nTreatment of established deep vein thrombosis\r\nwith or without pulmonary embolism.</span></p><p><strong>Dosage and administration :</strong></p><p><strong></strong>1mg (0.01ml) of enoxaparin corresponds\r\napproximately to 100 anti-Xa I.U. Enoxaparin\r\nshould be injected by deep SUBCUTANEOUS\r\nROUTE in prophylactic and curative treatment and\r\nby INTRAVASCULAR ROUTE during\r\nhaemodialysis. Do not administer by\r\nINTRAMASCULAR ROUTE.\r\nProphylaxis of venous thrombo-embolic\r\ndisease in medical patients. </p><p>The recommended\r\ndose of enoxaparin sodium is 4000 anti-Xa IU\r\n(0.4ml) once daily. </p><p>Treatment of established deep vein thrombosis\r\nwith or without pulmonary embolism: A dose of\r\n1mg/kg should be given subcutaneously every 12\r\nhours. </p><p>The duration of the treatment should not\r\nexceed a preiod of 10 days.\r\nTreatment of unstable angina and non-Q-wave\r\nmyocardial infarction : A dose of 1mg/kg should\r\nbe given subcutaneously every 12 hours.</p><p> The\r\nrecommended treatment should be prescribed for\r\na period of 2 to 8 days, until clinical stabilization of\r\nthe patient.\r\nElderly : No dosage adjustment is necessary in\r\npreventive therapy.\r\nChildren : Enoxaparin is not recommended in\r\nchildren.\r\nOr as directed by the registered physician. </p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Enoxaparin has\r\nbeen assigned to pregnancy category B by the\r\nFDA. There are no controlled data in women\r\npregnancy. It can be used in pregnancy if potential\r\nbenefits outweigh the risk or as directed by the\r\nregistered physician. Enoxaparin is likely to be\r\nexcreted into the breast milk. A decision should be\r\nmade whether to discontinue nursing or to\r\ndiscontinue the drug, taking into account the\r\nbenefit of the drug to the mother.</span></p><p><strong>Packing : </strong></p><p><span class="redactor-invisible-space">Cardinex-40 : 1x1''s prefilled syringe BP (0.4ml) in\r\na blister pack. </span></p><p><span class="redactor-invisible-space">Cardinex-60 : 1x1''s prefilled syringe BP (0.6ml) in\r\na blister pack.</span></p><p><span class="redactor-invisible-space">\r\nCardinex-80 : 1x1''s prefilled syringe BP (0.8ml) in\r\na blister pack.</span></p>', 'uploads/images/Cardinex-40.jpg', 1, '2017-11-29 04:44:20', NULL, NULL, '', 'Y', 4, 'uploads/IMG/Cardinex-40-Pre-filled-syringe.jpg'),
(974, 'Clopid', 187, '<p><strong></strong><strong>Composition : </strong>Clopidogrel 75mg Tablet</p><p><strong>Indication : </strong><span class="redactor-invisible-space">Clopid is indicated for the\r\nreduction of atherosclerotic events\r\n(myocardial infarction, stroke and vascular\r\ndeath) in patients with atherosclerosis\r\ndocumented by recent stroke, recent\r\nmyocardial infarction or established\r\nperipheral arterial disease.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">The\r\nrecommended dose of Clopid is 75mg\r\nonce daily. It can be taken with or without\r\nfood.</span></p><p><strong>Use in pregnancy and lactation : </strong>Pregnancy Category B by FDA.</p><p><strong>Packing : </strong><span class="redactor-invisible-space">Clopid : 2 x 14''s tablets in\r\nblister pack.</span></p>', 'uploads/images/Clopid.jpg', 1, '2017-11-29 04:41:36', NULL, NULL, '', 'Y', 4, 'uploads/IMG/clopid.jpg'),
(975, 'Clopid As', 188, '<p><strong></strong><strong>Composition :</strong>Clopidogrel+Aspirin;\r\n(75mg+75mg) Tablet.</p><p><strong>Indication : </strong><span class="redactor-invisible-space">This tablet is indicated for\r\nthe reduction of atherosclerotic events\r\n(myocardial infarction, stroke and\r\nvascular death) in patients with\r\natherosclerosis documented by recent\r\nstroke, recent myocardial infarction or\r\nestablished peripheral arterial disease.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">The\r\nrecommended dose of this tablet is one\r\ntablet once daily or as directed by the\r\nregistered physician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">There are no adequate and wellcontrolled\r\nstudies of Clopidogrel with\r\nAspirin in pregnant women. However,\r\nClopidogrel with Aspirin should be used\r\nduring pregnancy only if clearly needed.\r\nThis tablet should not be prescribed to\r\nnursing mother unless absolutely\r\nnecessary.</span></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Clopid-As : 3x10''s tablets in\r\nblister pack.</span></p>', 'uploads/images/Clopid_As.jpg', 1, '2017-11-29 04:40:13', NULL, NULL, '', 'Y', 4, 'uploads/IMG/clopid-As.jpg'),
(976, 'Cardiron', 189, '<p><strong></strong><strong>Composition : </strong>Each Metered dose (Puff) contains Beclometasone Dipropionate 100 mcg.</p><p><strong>Indication : </strong>Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. </p><p><strong>Dosage and administration : </strong>Becovent inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled Becovent appropriate to the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to individual response. Management of chronic asthma (Adults & Children over 12 years): 100-400 mcg twice daily. Maximum 1000 mcg twice daily. Children (5-12 years): 100-200 mcg twice daily. the dose may be adjusted as necessary.</p><p><strong>Use in pregnancy and lactation : </strong>Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.</p><p><strong>Packing : </strong>Becovent HFA Inhaler : Each box contains one inhaler of 200 Puffs</p>', 'uploads/images/Cardiron.jpg', 1, '2017-11-08 23:32:42', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/cardiron.jpg'),
(977, 'Camiton', 190, '<p><strong></strong><strong>Composition : </strong>Each Metered dose (Puff) contains Beclometasone Dipropionate 100 mcg.</p><p><strong>Indication : </strong>Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. </p><p><strong>Dosage and administration : </strong>Becovent inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled Becovent appropriate to the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to individual response. Management of chronic asthma (Adults & Children over 12 years): 100-400 mcg twice daily. Maximum 1000 mcg twice daily. Children (5-12 years): 100-200 mcg twice daily. the dose may be adjusted as necessary.</p><p><strong>Use in pregnancy and lactation : </strong>Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.</p><p><strong>Packing : </strong>Becovent HFA Inhaler : Each box contains one inhaler of 200 Puffs</p>', 'uploads/images/Camiton.jpg', 1, '2017-11-08 23:35:08', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/camiton.jpg');
INSERT INTO `drg_medicine_info` (`MEDICINE_ID`, `MEDICINE_NAME`, `GN_GRP_ID`, `MEDICINE_DESC`, `INSERT_FILE`, `CRE_BY`, `CRE_DT`, `UPD_BY`, `UPD_DT`, `IS_LATEST`, `ACTIVE_STATUS`, `CAT_ID`, `PRODUCT_FET_PHOTO`) VALUES
(978, 'D-Dopamine', 191, '<p><strong></strong><strong>Composition :</strong> Each Metered dose (Puff) contains Beclometasone Dipropionate 100 mcg.</p><p><strong>Indication : </strong>Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. </p><p><strong>Dosage and administration : </strong>Becovent inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled Becovent appropriate to the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to individual response. Management of chronic asthma (Adults & Children over 12 years): 100-400 mcg twice daily. Maximum 1000 mcg twice daily. Children (5-12 years): 100-200 mcg twice daily. the dose may be adjusted as necessary.</p><p><strong>Use in pregnancy and lactation : </strong>Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.</p><p><strong>Packing : </strong>Becovent HFA Inhaler : Each box contains one inhaler of 200 Puffs</p>', 'uploads/images/D-Dopamine.jpg', 1, '2017-11-08 23:37:17', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/d-dopa110.jpg'),
(979, 'Diparin', 192, '<p><strong></strong><strong>Composition : </strong>Each Metered dose (Puff) contains Beclometasone Dipropionate 100 mcg.</p><p><strong>Indication : </strong>Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. </p><p><strong>Dosage and administration : </strong>Becovent inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled Becovent appropriate to the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to individual response. Management of chronic asthma (Adults & Children over 12 years): 100-400 mcg twice daily. Maximum 1000 mcg twice daily. Children (5-12 years): 100-200 mcg twice daily. the dose may be adjusted as necessary.</p><p><strong>Use in pregnancy and lactation : </strong>Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.</p><p><strong>Packing : </strong>Becovent HFA Inhaler : Each box contains one inhaler of 200 Puffs</p>', 'uploads/images/Acepril5.jpg', 1, '2017-11-08 23:39:41', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/dipa-syrup.jpg'),
(980, 'Ivaten', 193, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">vabradine 5mg & 7.5mg\r\nTablet.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">Ivabradine is indicated for\r\nsymptomatic treatment of chronic stable\r\nangina pectoris in coronary artery\r\ndisease adults with normal sinus rhythm,\r\nwho has contraindications or intolerance\r\nwith beta-blockers.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">The usual\r\nrecommended starting dose of\r\nIvabradine is 5 mg twice daily after 3-4\r\nweeks of treatment, the dose may be\r\nincreased to 7.5mg twice daily\r\ndepending on therapeutic response. It\r\nmay be adjusted to 2.5mg twice daily as\r\nnecessary. Or, as directed by the\r\nregistered physician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Ivabradine is contra-indicated during\r\npregnancy and lactation.</span></p><p><strong>Packing :<em> </em></strong><span class="redactor-invisible-space"><em>Ivaten-5 :</em> 1x10''s tablets in blister pack<em>.\r\nIvaten-7.5 :</em> 1x10''s tablets in blister pack.</span></p>', 'uploads/images/Acepril5.jpg', 1, '2017-11-27 23:45:58', NULL, NULL, '', 'Y', 4, 'uploads/IMG/ivaten-7.5.jpg'),
(981, 'Prapid', 194, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Prasugrel 5mg & 10mg\r\nTablet.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">Prasugrel is indicated to\r\nreduce the rate of thrombotic\r\ncardiovascular events (including stent\r\nthrombosis) in patients with acute coronary\r\nsyndrome who are to be managed with\r\npercutaneous coronary intervention as\r\nfollows: * Patients with unstable angina or\r\nnon-ST-elevation myocardial infarction. *\r\nPatients with ST-elevation myocardial\r\ninfarction when managed with primary or\r\ndelayed percutaneous coronary\r\nintervention.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space"> Initiate\r\nPrasugrel treatment as a single 60mg oral\r\nloading dose and then continue at 10mg\r\norally once daily. Patients taking Prasugrel\r\nshould also take aspirin (75mg to 325mg)\r\ndaily. Prasugrel may be administered with\r\nor without food. Or, as directed by the\r\nregistered physician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Prasugrel Hydrochloride should be used\r\nduring pregnancy & lactation only if the\r\npotential benefit to the mother justifies the\r\npotential risk to the fetus. Pregnancy\r\nCategory B by FDA.</span></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Prapid-5: 2x10''s tablets in blister pack.\r\nPrapid-10: 1x10''s tablets in blister pack.</span></p>', 'uploads/images/Acepril5.jpg', 1, '2017-11-28 04:37:27', NULL, NULL, '', 'Y', 4, 'uploads/IMG/prapid-5.jpg'),
(982, 'Tigarol', 195, '<p><strong></strong><strong>Composition : </strong>Ticagrelor 90mg Tablet</p><p><strong>Indication : </strong><span class="redactor-invisible-space">Ticagrelor is indicated to\r\nreduce the rate of thrombotic\r\ncardiovascular events in patients with\r\nacute coronary syndrome (ACS)\r\n(unstable angina, non-ST elevation\r\nmyocardial infarction, or ST elevation\r\nmyocardial infarction). It has been shown\r\nto reduce the rate of cardiovascular\r\ndeath, myocardial infarction or stroke\r\ncompared to clopidogrel. In patients\r\ntreated with PCI, it also reduces the rate\r\nof stent thrombosis.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Initiate\r\nTicagrelor treatment with a 180mg (two\r\n90mg tablets) loading dose and continue\r\ntreatment with 90mg twice daily. After the\r\ninitial loading dose of aspirin (usually\r\n325mg) use Ticagrelor with a daily\r\nmaintenance dose of aspirin of 75-\r\n100mg. It can be administered with or\r\nwithout food. A patient who misses a\r\ndose of Ticagrelor should take one 90mg\r\ntablet (their next dose) at its scheduled\r\ntime. Or, as directed by the registered\r\nphysician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Ticagrelor Hydrochloride should be used\r\nduring pregnancy & lactation only if the\r\npotential benefit to the mother justifies\r\nthe potential risk to the fetus.</span></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Tigarol 1x14''s tablets in blister\r\npack.</span></p>', 'uploads/images/Tigarol.jpg', 1, '2017-11-27 04:49:15', NULL, NULL, '', 'Y', 4, 'uploads/IMG/trum3-1.jpg'),
(983, 'Betaloc', 196, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Metoprolol Tartrate 25mg\r\n& 50mg Tablet.</span></p><p><strong>Indication : </strong> </p><p><span class="redactor-invisible-space">Betaloc is indicated for\r\nhypertension, angina, arrhythmia\r\n(including arrhythmias during\r\nanaesthesia), early intervention in acute\r\nmyocardial infarction, heart failure,\r\nmigraine prophylaxis and thyrotoxicosis.</span></p><p><strong>Dosage and administration :</strong></p><p><strong></strong>Hypertension : Initially 100mg tablets\r\ndaily, for maintenance therapy 100-\r\n200mg tablets daily in 1-2 doses for\r\nadults and 25mg tablet once daily for\r\nelderly.\r\nAngina : 50-100mg tablet 2-3 times\r\ndaily.</p><p>\r\nArrhythmias : Usually 50mg tablet 2-3\r\ntimes daily upto 300mg tablets daily in\r\ndivided doses, if necessary.\r\nMyocardial Infarction : If patient can\r\nnot tolerate IV doses then he/she should\r\nbe switched to oral treatment. Starting\r\ndose for such patient is 25mg tablets 6\r\nhourly for 48 hours.</p><p>\r\nHeart Failure : 12.5-25mg once daily.\r\nDose is increased at intervals of 2\r\nweeks, to a maximum of 200mg once\r\ndaily. </p><p>Migraine Prophylaxis : 100-200mg\r\ntablets daily in divided doses.\r\nThyrotoxicosis : 50mg tablet 4 times\r\ndaily. Or as directed by the registered\r\nphysician.</p><p><strong><br></strong></p><p><strong>Use in pregnancy and lactation : </strong>Pregnancy Category C by FDA.</p><p><strong><br></strong></p><p><strong>Packing :</strong></p><p><strong> <em></em></strong><span class="redactor-invisible-space"><span class="redactor-invisible-space">Betaloc : 7 x 14''s tablets in\r\nblister pack. </span></span></p><p><span class="redactor-invisible-space"><span class="redactor-invisible-space">Betaloc-25 : 7 x 14''s tablets in blister\r\npack.</span></span></p>', 'uploads/images/Betaloc-XR.jpg', 1, '2017-11-29 05:23:10', NULL, NULL, '', 'Y', 4, 'uploads/IMG/betaloc.jpg'),
(984, 'Cavelon ', 197, '<p><strong></strong><strong>Composition : </strong>Each Metered dose (Puff) contains Beclometasone Dipropionate 100 mcg.</p><p><strong>Indication : </strong>Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. </p><p><strong>Dosage and administration : </strong>Becovent inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled Becovent appropriate to the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to individual response. Management of chronic asthma (Adults & Children over 12 years): 100-400 mcg twice daily. Maximum 1000 mcg twice daily. Children (5-12 years): 100-200 mcg twice daily. the dose may be adjusted as necessary.</p><p><strong>Use in pregnancy and lactation :</strong> Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.</p><p><strong>Packing : </strong>Becovent HFA Inhaler : Each box contains one inhaler of 200 Puffs</p>', 'uploads/images/Cavelon.jpg', 1, '2017-11-08 23:59:26', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/cavelon.jpg'),
(985, 'Tenobis', 198, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Bisoprolol Fumarate\r\n2.5mg & 5mg Tablet.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">This tablet is indicated for\r\nthe management of hypertension and in\r\nthe treatment of coronary heart disease\r\n(angina pectoris). It may be used alone or\r\nin combination with other antihypertensive\r\nagents.</span></p><p><strong>Dosage and administration :</strong><em> </em><span class="redactor-invisible-space"><em>In\r\nhypertension or Angina Pectoris :</em> The\r\nusual dose of Bisoprolol Fumarate is 5 to\r\n10mg as single daily dose. The maximum\r\nrecommended dose is 20mg daily. In\r\nheart failure : The inItial dose of\r\nbisoprolol Fumarate is 1.25mg once daily.\r\nIf tolerated, the dose should be doubled\r\nafter 1 week and then increased gradually\r\nat 1 to 4 week intervals to the maximum\r\ndose tolerated, this should not exceed\r\n10mg once daily.<em> Patients with Renal or\r\nHepatic Impairment:</em> In patients with\r\nhepatic impairment (hepatitis or cirrhosis)\r\nor renal dysfunction (creatinine clearance\r\n&lt;40 ml/min), the initial daily dose should\r\nbe 2.5 mg and caution should be used in\r\ndose-titration. Since limited data suggest\r\nthat Bisoprolol fumarate is not dialyzable,\r\ndrug replacement is not necessary in\r\npatients undergoing dialysis. Or as\r\ndirected by the registered physician.</span></p><p><br></p><p><strong>Packing :</strong><span class="redactor-invisible-space"> Tenobis-2.5 : 4x14''s tablets in\r\nblister pack.\r\nTenobis-5 : 2x14''s tablets in blister pack</span></p>', 'uploads/images/Tenobis.jpg', 1, '2017-11-27 04:51:33', NULL, NULL, '', 'Y', 4, 'uploads/IMG/tenobis-2.5.jpg'),
(986, 'Tenobis Plus', 199, '<p><strong>Composition :</strong>: Bisoprolol + Hydrochlorothiazide;\r\n(2.5mg+6.25mg), (5mg+6.25mg) & (10mg+6.25mg)\r\nTablet.Each Metered dose (Puff) contains Beclometasone Dipropionate 100 mcg.</p><p><strong>Indication : </strong><span class="redactor-invisible-space">It is indicated in the management of\r\nhypertension.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Bisoprolol is an effective\r\ntreatment of hypertension in once-daily doses of 2.5 to\r\n40 mg, while hydrochlorothiazide is effective in doses of\r\n12.5 to 50 mg . In clinical trials of\r\nbisoprolol/hydrochlorothiazide combination therapy\r\nusing bisoprolol doses of Tenobis Plus 2.5 to 20 mg\r\nand hydrochlorothiazide doses of 6.25 to 25 mg, the\r\nantihypertensive effects increased with increasing\r\ndoses of either component. Initial Therapy :\r\nAntihypertensive therapy may be initiated with the\r\nlowest dose of one 2.5/6.25 mg tablet once daily.\r\nSubsequent titration (14 day intervals) may be carried\r\nout with Tenobis Plus up to the maximum\r\nrecommended dose 20/12.5 mg once daily, as\r\nappropriate. Replacement Therapy : The combination\r\nmay be substituted for the titrated individual\r\ncomponents. Therapy Guided by Clinical Effect : A\r\npatient whose blood pressure is not adequately\r\ncontrolled with 2.5-20 mg bisoprolol daily may instead\r\nbe given Tenobis Plus. Patients whose blood\r\npressures are adequately controlled with 50mg of\r\nhydrochlorothiazide daily, but who experience significant\r\npotassium loss with this regimen, may achieve similar\r\nblood pressure control without electrolyte disturbance if\r\nthey are switched to Tenobis Plus. Or, as directed by\r\nthe registered physician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Pregnancy\r\nCategory C : There are no adequated and wellcontrolled\r\nstudies in pregnant women. Bisoprolol\r\nfumarate and hydrochlorothiazide combination should\r\nbe used during pregnancy only if the potential benefit\r\njustifies the risk to the fetus. Nursing mothers :\r\nBisoprolol fumarate alone or in combination with HCTZ\r\nhas not been studied in nursing mothers. Thiazides are\r\nexcreted in human breast milk. Small amounts of\r\nbisoprolol fumarate have been detected in the milk of\r\nlactating rats. Because of the potential for serious\r\nadverse reactions in nursing infants, a decision should\r\nbe made whether to discontinue nursing or to\r\ndiscontinue the drug, taking in to account the\r\nimportance of the drug to the mother.</span></p><p style="text-align: center;"><strong>Packing :<em> </em></strong><span class="redactor-invisible-space"><em>Tenobis Plus 2.5 : </em>2x14''s, tablets in blister pack.<em>\r\nTenobis Plus 5 :</em> 2x14''s, tablets in blister pack.<em>\r\nTenobis Plus 10 :</em> 1x10''s, tablets in blister pack.</span></p>', 'uploads/images/TenobisPlus10.jpg', 1, '2017-11-27 04:53:59', NULL, NULL, '', 'Y', 4, 'uploads/IMG/tenobis-plus2.5.jpg'),
(987, 'Nebifast', 200, '<p><strong></strong><strong>Composition : </strong>Each Metered dose (Puff) contains Beclometasone Dipropionate 100 mcg.</p><p><strong>Indication : </strong>Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. </p><p><strong>Dosage and administration : </strong>Becovent inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled Becovent appropriate to the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to individual response. Management of chronic asthma (Adults & Children over 12 years): 100-400 mcg twice daily. Maximum 1000 mcg twice daily. Children (5-12 years): 100-200 mcg twice daily. the dose may be adjusted as necessary.</p><p><strong>Use in pregnancy and lactation : </strong>Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.</p><p><strong>Packing :</strong> Becovent HFA Inhaler : Each box contains one inhaler of 200 Puffs</p>', 'uploads/images/Nebifast.jpg', 1, '2017-11-09 00:09:32', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/Nebifast-Tablet.jpg'),
(989, 'Amlocard Plus', 202, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Amlodipine+Atenolol;\r\n(5mg+25mg) & (5mg+50mg) Tablet.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">J Patients with essential\r\nhypertension J Patients with angina\r\npectoris & hypertension as co-existing\r\ndiseases J In post MI patients J In patients\r\nwith refractory angina pectoris where\r\nnitrate therapy has failed.</span></p><p><strong>Dosage and administration :</strong>The therapy\r\nis initiated with a single dose of\r\nAmlodipine 5mg plus Atenolol 50mg\r\ndepending upon the therapeutic\r\nresponse, titration of the dosage is\r\nrecommended. In elderly patients, it is\r\nadvisable to initiate the therapy with 1/2\r\ntablet to fixed dose combination of\r\nAmlodipine & Atenolol i.e. 2.5mg of\r\nAmlodipine & 25mg Atenolol.</p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">The\r\ncombination should be used during\r\npregnancy only if the expected benefit\r\noutweighs the potential fetal risk. The\r\ncombination should not be used by\r\nnursing mothers. If its use is considered\r\nnecessary, breast-feeding should be\r\nstopped.</span></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Amlocard Plus 25 : 4 x 14''s tablets in\r\nblister pack.\r\nAmlocard Plus 50 : 4 x 14''s tablets in\r\nblister pack.</span></p>', 'uploads/images/AmlocardPlus50.jpg', 1, '2017-11-26 06:33:21', NULL, NULL, '', 'Y', 4, 'uploads/IMG/47.jpg'),
(991, 'AV', 203, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Amlodipine+Valsartan;\r\n(5mg+80mg), (5mg+160mg) &\r\n(10mg+160mg) Tablet.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">This tablet is indicated for the\r\ntreatment of hypertension :\r\nl In patients not adequately controlled on\r\nmonotherapy.\r\nl As initial therapy in patients likely to need\r\nmultiple drugs to achieve their blood\r\npressure goals</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Amlodipine\r\nis an effective treatment of hypertension in\r\nonce daily doses of 2.5mg-10mg while\r\nvalsartan is effective in doses of 80mg-\r\n320mg. In clinical trials with amlodipine\r\nand valsartan, the antihypertensive effects\r\nincreased with increasing doses. Or, as\r\ndirected by the registered physician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Pregnancy Category- Amlodipine-C\r\nValsartan-D by FDA.</span></p><p><strong>Packing : </strong><span class="redactor-invisible-space">: AV-5/80 : 3x10''s tablets in blister\r\npack.\r\nAV-10 : 2x14''s tablets in blister pack.	\r\nAV-5 : 2x14''s tablets in blister pack.</span></p>', 'uploads/images/AV-580.jpg', 1, '2017-11-26 06:35:28', NULL, NULL, '', 'Y', 4, 'uploads/IMG/AV-580.jpg'),
(992, 'Cardizem', 204, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Diltiazem Hydrochloride\r\n30mg & 60mg Tablet.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">For the treatment of angina\r\npectoris due to coronary artery spasm,\r\nchronic stable angina in patients who\r\ncan not tolerate therapy with beta\r\nblockers or nitrates, increasing exercise\r\ntolerance. For patients with impaired\r\nventricular function or conduction\r\nabnormalities, in combination with beta\r\nblockers and hypertension (mild to\r\nmoderate cases).</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Adults- 1 tablet 3 times daily\r\nor as advised by the physician.</span></p><p><strong>Use in pregnancy and lactation : </strong>Pregnancy Category C by FDA.</p><p><strong>Packing :</strong></p><p><strong> </strong><span class="redactor-invisible-space">Cardizem 60mg : 10 x 10''s\r\ntablets in blister pack. </span></p><p><span class="redactor-invisible-space">Cardizem 30mg : 7 x 14''s tablets in\r\nblister pack.</span></p>', 'uploads/images/Cardizem-SR.jpg', 1, '2017-11-29 04:38:20', NULL, NULL, '', 'Y', 4, 'uploads/IMG/cardizem.jpg'),
(994, 'Amlocard', 201, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Amlodipine 5mg & 10mg\r\nTablet.</span></p><p><strong>Indication :</strong>Amlocard is used in\r\nsevere and mild to moderate\r\nhypertension, myocardial ischaemia,\r\nangina pectoris. </p><p><strong>Dosage and administration :</strong>: Adult- For\r\nboth hypertension and angina, the\r\nrecommended dose is 5mg Amlocard\r\norally once daily, which may be\r\nincreased to a maximum dose of 10mg.\r\nAmlocard is well tolerated in elderly\r\npatients. Normal dosage is\r\nrecommended in patients with renal\r\nimpairment.\r\nChildren- Use below 18 years is not\r\ncurrently recommended.</p><p><strong>Use in pregnancy and lactation : </strong>Pregnancy Category C by FDA.</p><p><strong>Packing : </strong><span class="redactor-invisible-space">Amlocard-5 : 7 x 14''s tablets\r\nin blister pack.\r\nAmlocard-10 : 4 x 14''s tablets in blister\r\npack.</span></p>', 'uploads/images/Amlocard-10.jpg', 1, '2017-11-26 06:37:20', NULL, NULL, '', 'Y', 4, 'uploads/IMG/44.jpg'),
(995, 'Disartan', 205, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Amlodipine + Olmesartan;\r\n(5mg+20mg) & (5mg+40mg) Tablet</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">This combination drug is\r\nindicated for the treatment of hypertension,\r\nalone or with other antihypertensive agents.\r\nThis fixed combination drug is not indicated\r\nfor the initial therapy of hypertension.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">The usual\r\nstarting dose of Disartan is 5/20mg once\r\ndaily. The dosage can be increased after 1\r\nto 2 weeks of therapy to a maximum dose\r\nof 10/40mg once daily as needed to control\r\nblood pressure. Maximum antihypertensive\r\neffects are attained within 2 weeks after a\r\nchange in dose. Or, as directed by the\r\nregistered physician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">When\r\nused in pregnancy during the second and\r\nthird trimesters, drugs that act directly on\r\nthe rennin-angiotensin system can cause\r\ninjury and even death to the developing\r\nfetus. When pregnancy is detected, this\r\ndrug should be discontinued as soon as\r\npossible.</span></p><p><strong>Packing : </strong></p><p><strong></strong><span class="redactor-invisible-space">Disartan : 2x14''s tablets in\r\nblister pack.</span></p><p><span class="redactor-invisible-space">\r\nDisartan 5/40 : 2x14''s tablets in blister\r\npack.</span></p>', 'uploads/images/Disartan.jpg', 1, '2017-11-29 04:04:10', NULL, NULL, '', 'Y', 4, 'uploads/IMG/disartan.jpg'),
(997, 'Nifecap', 208, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Nifedipine 5mg & 10mg\r\nCapsule.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">Coronary heart disease\r\nand Hypertension.</span></p><p><strong>Dosage and administration : </strong></p><p><strong></strong><span class="redactor-invisible-space">Coronary heart disease:\r\nInitially 1 capsule 3 times daily with or\r\nafter food. Increased to 2 capsules 3\r\ntimes daily if necessary.\r\nHypertension : 1-2 capsule twice daily\r\nafter food, initial one capsule twice daily,\r\nmay be increased to 4 capsules twice\r\ndaily if necessary or as directed by the\r\nphysician.</span></p><p><strong>Use in pregnancy and lactation : </strong>Pregnancy Category C by FDA.</p><p><strong>Packing :</strong></p><p><strong> </strong><span class="redactor-invisible-space">Nifecap-5 : 10 x 10 Soft Capsules in\r\nBlister Pack.</span></p><p><span class="redactor-invisible-space">\r\nNifecap-10 : 30 Capsules in a bottle.</span></p>', 'uploads/images/Nifecap.jpg', 1, '2017-11-28 04:04:42', NULL, NULL, '', 'Y', 4, 'uploads/IMG/nifecap.jpg'),
(998, 'Diretic', 209, '<p><strong></strong><strong>Composition :</strong>Frusemide+\r\nSpironolactone; (20mg+50mg) &\r\n(40mg+50mg) Tablet.</p><p><strong>Indication : </strong><span class="redactor-invisible-space">This tablet is indicated for\r\nthe treatment of congestive heart failure,\r\nliver cirrhosis with (ascites), essential\r\nhypertension, swelling of the body due to\r\nexcess fluid retention (edema),\r\noverproduction of aldosterone\r\n(hyperaldosteronism).</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">1 to 4\r\ntablets daily (50 to 200mg of\r\nSpironolactone and 20 to 80mg of\r\nFrusemide) according to the patient''s\r\nresponse. The product is not suitable for\r\nuse in children.</span></p><p><strong>Use in pregnancy and lactation : </strong>Pregnancy Category C by FDA.</p><p><strong>Packing : </strong></p><p><span class="redactor-invisible-space"> Diretic : 4 x 14''s tablets in\r\nblister pack. </span></p><p><span class="redactor-invisible-space">Diretic-DS : 4 x 14''s tablets in blister\r\npack.</span></p>', 'uploads/images/Diretic.jpg', 1, '2017-11-29 04:02:47', NULL, NULL, '', 'Y', 4, 'uploads/IMG/diretic.jpg'),
(999, 'Indapa-SR', 210, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Indapamide 1.5mg\r\nTablet.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">Indapamide is indicated for\r\nthe treatment of essential hypertension.\r\nIndapamide is also indicated for the\r\ntreatment of edema, salt and fluid\r\nretention associated with congestive\r\nheart failure.</span></p><p><strong>Dosage and administration :</strong>One\r\ntablet daily, preferably in the morning. If\r\nresponse is inadequate, dosage may be\r\nincreased. Or as directed by the\r\nregistered physician.Becovent inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled Becovent appropriate to the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to individual response. Management of chronic asthma (Adults & Children over 12 years): 100-400 mcg twice daily. Maximum 1000 mcg twice daily. Children (5-12 years): 100-200 mcg twice daily. the dose may be adjusted as necessary.</p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">There are no adequate and wellcontrolled\r\nstudies in pregnant woman.\r\nSo indapamide is not recommended.\r\nMothers taking indapamide should not\r\nbreast feed.</span></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Indapa : 5x10''s, tablets in\r\nblister pack.</span></p>', 'uploads/images/Indapa-SR.jpg', 1, '2017-11-27 23:48:05', NULL, NULL, '', 'Y', 4, 'uploads/IMG/Indapa-SR-Tablet.jpg'),
(1000, 'Indapa-Plus ', 211, '<p><strong>Composition : </strong><span class="redactor-invisible-space">Indapamide 1.5mg Tablet.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">Indapamide is indicated for the treatment of essential hypertension. Indapamide is also indicated for the treatment of edema, salt and fluid retention associated with congestive heart failure.</span></p><p><strong>Dosage and administration :</strong>One tablet daily, preferably in the morning. If response is inadequate, dosage may be increased. Or as directed by the registered physician.Becovent inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled Becovent appropriate to the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to individual response. Management of chronic asthma (Adults & Children over 12 years): 100-400 mcg twice daily. Maximum 1000 mcg twice daily. Children (5-12 years): 100-200 mcg twice daily. the dose may be adjusted as necessary.</p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">There are no adequate and wellcontrolled studies in pregnant woman. So indapamide is not recommended. Mothers taking indapamide should not breast feed.</span></p><p><strong>Packing : </strong><span class="redactor-invisible-space" style="background-color: initial;">Indapa : 5x10''s, tablets in blister pack.</span></p>', 'uploads/images/Indapa-SR.jpg', 1, '2017-11-27 23:48:55', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/Indapa-Plus-4--Tablet.jpg'),
(1001, 'Spiretic', 212, '<p><strong></strong><strong>Composition :</strong> Spironolactone 25mg Tablet</p><p><strong>Indication : </strong><span class="redactor-invisible-space">Spironolactone is indicated in the\r\nmanagement of oedema and ascites in hepatic\r\ncirrhosis, malignant ascites, nephrotic syndrome,\r\ncongestive cardiac failure and primary\r\naldosteronism.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Administration of\r\nSpironolactone once daily with a meal is\r\nrecommended.<em>\r\nAdults:</em> Congestive cardiac faliure: Usual dose\r\n100mg/day. In difficult or severe cases the dosage\r\nmay gradually increased up to 400mg/day. When\r\noedema is controlled, the usual maintenance level\r\nis 75mg-200mg/day.\r\nHepatic cirrhosis with ascites and oedema: If\r\nurinary Na+/K+ ratio is greater than 1.0,\r\n100mg/day. If the ratio is less than 1.0, 200-\r\n400mg/day. Maintenance dosage should be\r\nindividually determined.\r\n<em>Malignant ascites:</em> Initial dose usually 100-\r\n200mg/day. In severe cases the dosage may be\r\ngradually increased up to 400mg/day. When\r\noedema is controlled, maintenance dosage should\r\nbe individually determined.\r\nNephrotic syndrome: Usual dose 100-\r\n200mg/day. Spironolactone has not been shown\r\nto be anti-inflammatory, nor to affect the basic\r\npathological process. Its use only advised if\r\nglucocorticords by themselves are insufficiently\r\neffective<em>.<strong>\r\n</strong>Diagnosis and treatment of primary\r\naldosteronism:</em> Spironolactone may employed as\r\nan initial diagnostic measure to provide\r\npresumptive evidence of primary\r\nhyperaldosteronism while patients are on normal\r\ndiets.\r\nLong test : Spironolactone is administered at a\r\ndaily dosage of 400mg for three to four weeks.\r\nCorrection of hypokalamia and of hypertension\r\nprovides presumptive evidence for the diagnosis\r\nof primary hyperaldosteronism.<em>\r\nShort test :</em> Spironolactone is administered at a\r\ndaily dosage of 400mg for four days. If serum\r\npotassium increses during Spironolactone\r\nadministration but drops when Spironolactone is\r\ndiscontinued, a presumptive diagnosis of primary\r\nhyperaldosteronism should be considered.\r\nChildren : Initial daily dosage should provide 3mg\r\nof spironolactone per kilogram body weight given\r\nin divided doses. Dosage should be adjusted on\r\nthe basis of response and tolerance. If necessary\r\na suspension may be prepared by crushing\r\nSpironolactone tablets.</span></p><p><br></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Spiretic : 3 x 10''stablets in blister\r\npack.</span></p>', 'uploads/images/Spiretic.jpg', 1, '2017-11-27 05:17:52', NULL, NULL, '', 'Y', 4, 'uploads/IMG/spiretic.jpg'),
(1002, 'Divastin ', 213, '<p><strong></strong><strong>Composition :</strong>Atorvastatin 10mg, 20mg &\r\n40mg Tablet.</p><p><strong>Indication : </strong><span class="redactor-invisible-space">Atorvastatin is indicated as an\r\nadjunct to diet for reduction of elevated total\r\ncholesterol, LDL cholesterol, apolipoprotein B\r\nand triglycerides in patients with primary\r\nhypercholesterolaemia, heterozygous familial\r\nhypercholesterolaemia or combined\r\nhyperlipidaemia when response to diet and\r\nother nonpharmacological measures are\r\ninadequate.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">The patient\r\nshould be placed on a standard cholesterollowering\r\ndiet before receiving Atorvastatin\r\nand should continue on this diet during\r\ntreatment with Atorvastatin. The usual starting\r\ndose is 10mg once a day. Dosages should be\r\nindividualized according to baseline LDL-C\r\nlevels, the goal of therapy and patient\r\nresponse. Adjustment of dosage should be\r\nmade at intervals of 4 weeks or more. The\r\nmaximum dose is 80mg once a day. Dosages\r\nmay be given at any time of day with or\r\nwithout food. Or, as directed by the registered\r\nphysician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space"> Pregnancy Category X. Not for use in\r\nPregnancy.</span></p><p><strong>Packing :</strong></p><p><strong> </strong>Divastin : 2 x 14''s tablets in blister pack. </p><p>Divastin-20 : 2 x 14''s tablets in blister pack.</p><p><span class="redactor-invisible-space">\r\nDivastin-40 : 2 x 14''s tablets in blister pack.</span></p>', 'uploads/images/Divastin-40.jpg', 1, '2017-11-29 04:01:22', NULL, NULL, '', 'Y', 4, 'uploads/IMG/divastin-plus.jpg'),
(1003, 'Fenatrol', 214, '<p><strong></strong><strong>Composition : <em></em></strong><span class="redactor-invisible-space"><span class="redactor-invisible-space">Fenofibrate 145mg &\r\n200mg Capsule.</span></span></p><p><strong>Indication :</strong>Fenofibrate is indicated as\r\nan adjunctive therapy to diet for the\r\ntreatment of adults with\r\nhypertriglyceridemia (Types IV and V\r\nhyperlipidemia). Fenofibrate is also\r\nindicated in hypercholesterolemia or,\r\nmixed Dislipidemia (type II\r\nhyperlipidemia).Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. </p><p><strong>Dosage and administration :</strong>For the\r\ntreatment of adult patients with\r\nhypercholesterolemia or mixed\r\nhyperlipidemia, the initial dose of\r\nFenatrol is 200mg per day. For adult\r\npatients with hypertriglyceridemia, the\r\ninitial dose is 67 to 200 mg per day.\r\nDose should be individualized according\r\nto patient response. Fenatrol should be\r\ngiven with meal there by, optimizing the\r\nbioavailability of the medication. Or, as\r\ndirected by the registered physician.Becovent inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled Becovent appropriate to the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to individual response. Management of chronic asthma (Adults & Children over 12 years): 100-400 mcg twice daily. Maximum 1000 mcg twice daily. Children (5-12 years): 100-200 mcg twice daily. the dose may be adjusted as necessary.</p><p><br></p><p><strong>Packing : </strong></p><p><strong></strong><span class="redactor-invisible-space">Fenatrol-145 : 3 x 10''s Tablet\r\nin blister pack. </span></p><p><span class="redactor-invisible-space">Fenatrol-200 : 3 x 10''s Capsule in blister\r\npack.</span></p>', 'uploads/images/Fenatrol.jpg', 1, '2017-11-29 03:01:44', NULL, NULL, '', 'Y', 4, 'uploads/IMG/fenatrol.jpg'),
(1004, 'Liploss', 215, '<p><strong></strong><strong>Composition : </strong>Pitavastatin 2mg Tablet.</p><p><strong>Indication :</strong>Pitavastatin is indicated for -\r\nas an adjunctive therapy to diet to reduce\r\nelevated total cholesterol (TC) , Lowdensity\r\nlipoprotein cholesterol (LDL-C),\r\nApolipoprotein B (Apo B), Triglycerides\r\n(TG), and to increase HDL-C in adult\r\npatients with primary hyperlipidemia or\r\nmixed dyslipidemia. </p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">The dose\r\nrange for Pitavastatin is 1 to 4 mg orally\r\nonce daily at any time of the day with or\r\nwithout food. The recommended starting\r\ndose is 2 mg and the maximum dose is 4\r\nmg. The administration starting dose and\r\nmaintence dose should be individualized\r\nto patient characteristics, such as goal of\r\ntherapy and response. Or, as directed by\r\nthe registered physician</span></p><p><br></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Liploss : 2x10''s tablets in\r\nblister pack.</span></p>', 'uploads/images/Acepril5.jpg', 1, '2017-11-28 02:50:24', NULL, NULL, '', 'Y', 4, 'uploads/IMG/liploss.jpg'),
(1005, 'Novastin', 216, '<p><strong></strong><strong>Composition : </strong>Simvastatin 10mg Tablet.</p><p><strong>Indication : </strong><span class="redactor-invisible-space">Novastin is indicated for use in\r\npatients with primary hypercholesterolemia, in\r\nwhom response to diet and other nonpharmacological\r\nmeasures has been\r\ninadequate. Novastin is also indicated for\r\ncoronary heart disease and elevated plasma\r\ncholesterol levels.</span></p><p><strong>Dosage and administration :</strong></p><p><strong> </strong><span class="redactor-invisible-space">The patient\r\nshould be placed on a standard cholesterollowering\r\ndiet before receiving Novastin and\r\nshould continue on this diet during treatment\r\nwith Novastin. </span></p><p><span class="redactor-invisible-space">Hypercholesterolemia : The recommended\r\nstarting dose is 10mg once daily taken in the\r\nevening. The dose range is 10 to 40mg a day in\r\nsingle doses taken at night. A marked response\r\nto Novastin is seen within two weeks and the\r\nmaximum therapeutic response occurs within\r\nfour to six weeks.</span></p><p><span class="redactor-invisible-space">\r\nCoronary heart disease : Patients with coronary\r\nheart disease can be treated with a starting\r\ndose of 20mg/day given as a single dose in the\r\nevening or as directed by the physician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Pregnancy\r\nCategory-X. Not for use in pregnancy.</span></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Novastin : 3 x 10 tablets in blister\r\npack.</span></p>', 'uploads/images/Acepril5.jpg', 1, '2017-11-28 04:07:12', NULL, NULL, '', 'Y', 4, 'uploads/IMG/Acepril5.jpg'),
(1006, 'Niapid XR', 217, '<p><strong></strong><strong>Composition :</strong>Niacin 500mg Tablet.</p><p><strong>Indication :</strong>Niapid is indicated as an\r\nadjunct to diet for reduction of elevated\r\nTC, CDL-C, Apo B and TG levels and to\r\nincrease HDL-C in patients with primary\r\nhypercholesterolemia and mixed\r\ndyslipidemia (Fredrickson Types IIa and\r\nIIb) when the response to an appropriate\r\ndiet has been inadequate. It is also\r\nindicated as an adjunctive therapy for\r\ntreatment of adult patients with very high\r\ntriglyceride levels (Type IV\r\nhyperlipidemia) </p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">: Initially 500mg\r\ntablet at bedtime from 1 to 4 weeks.\r\nMaintenance Dose : the daily dosage\r\nshould not be increased by more than\r\n500mg in any 4 week period. The\r\nrecommended maintenance dose is\r\n1000mg (two tablet) to 2000 mg (4\r\ntablets) once daily at bedtime. Dose\r\ngreater than 2000 mg daily are not\r\nrecommended. Or, as directed by the\r\nregistered physician.</span></p><p><strong>Use in pregnancy and lactation : </strong>Pregnancy Category C by FDA.</p><p><strong>Packing :</strong>Niapid : 3 x 10''s tablets in\r\nblister pack.Becovent HFA Inhaler : Each box contains one inhaler of 200 Puffs</p>', 'uploads/images/Acepril5.jpg', 1, '2017-11-28 04:08:56', NULL, NULL, '', 'Y', 4, 'uploads/IMG/niapid.jpg'),
(1007, 'Rostatin', 218, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">: Rosuvastatin 5mg, 10mg &\r\n20mg Tablet.</span></p><p><strong>Indication :</strong>Rostatin is indicated for -\r\nHeterozygous Hypercholesterolemia\r\n(Familial and Nonfamilial), Homozygous\r\nHypercholesterolemia (Familial), Mixed\r\nDyslipidemia (Fredrickson Type IIa and IIb). </p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Heterozygous Hypercholesterolemia\r\n(Familial and Nonfamilial) and Mixed\r\nDyslipidemia (Fredrickson Type IIa and IIb):\r\nThe usual recommended starting dose of\r\nRostatin is 10mg once daily. Initiation of\r\ntherapy with 5mg once daily may be\r\nconsidered for patients requiring less\r\naggressive LDL-C reductions or who have\r\npredisposing factors for myopathy. For\r\npatients with marked hypercholesterolemia\r\n(LDL-C&gt;190 mg/dL) and aggressive lipid\r\ntargets, a 20mg starting dose may be\r\nconsidered.</span></p><p><span class="redactor-invisible-space"> Homozygous Hypercholesterolemia\r\n(Familial): The recommended\r\nstarting dose of Rostatin is 20mg once daily\r\nin patients with Homozygous FH. The\r\nmaximum recommended daily dose is\r\n40mg. </span></p><p><span class="redactor-invisible-space">Dosage in Patients with Renal\r\nInsufficiency : For patients with severe\r\nrenal impairment (CLcr &lt;30 ml/min/1.73m2)\r\nnot on hemodialysis, dosing of Rostatin\r\nshould be started at 5mg once daily and not\r\nto exceed 10mg once daily.</span></p><p><span class="redactor-invisible-space"> Pediatric\r\npatients : The safety and effectiveness in\r\npediatric patients have not been\r\nestablished. Or, as directed by the\r\nregistered physician.</span></p><p><br></p><p><strong>Packing : </strong></p><p><strong></strong><span class="redactor-invisible-space">Rostatin-5 : 2 X 14''s tablets in\r\nblister pack.</span></p><p><span class="redactor-invisible-space">\r\nRostatin-10 : 2 X 14''s tablets in blister pack. </span></p><p>Rostatin-20 : 1 X 14''s tablets in blister pack.</p>', 'uploads/images/Rostatin-20.jpg', 1, '2017-11-28 05:01:02', NULL, NULL, '', 'Y', 4, 'uploads/IMG/rostatin-5.jpg'),
(1008, 'Angicard', 98, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">: (Sublingual) Nitroglycerin\r\n0.5mg Tablet.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">Angicard is indicated for the\r\nacute relief of an attack or acute prophylaxis\r\nof angina pectoris due to coronary artery\r\ndisease.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">One tablet\r\nshould be dissolved under the tongue at the\r\nfirst sign of an acute anginal attack. The dose\r\nmay be repeated approximately every five\r\nminutes, until relief is obtained. or as directed\r\nby the registered physician.</span></p><p><strong>Packing :</strong>Angicard : 10x10''s tablets in\r\nblister pack.</p>', 'uploads/images/Angicard.jpg', 1, '2017-11-26 06:39:12', NULL, NULL, '', 'Y', 4, 'uploads/IMG/48.jpg'),
(1009, 'Monocard', 220, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Isosorbide-5-Mononitrate\r\n20mg Tablet.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">For the treatment &\r\nprophylaxis of angina pectoris.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">The usual\r\noral dose is 1 tablet (20mg) 2 times daily,\r\nfirst dose in the morning and another 7\r\nhours apart. Although maintenance\r\ndoses ranging from 20mg to 120mg (1-6\r\ntablets), a dose of 10mg (1/2 tablet) is\r\nsuitable when lower dosage is used at\r\nthe starting of treatment or as directed by\r\na registered physician.</span></p><p><br></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Monocard : 10 x 10''s tablets\r\nin blister pack.</span></p>', 'uploads/images/Monocard.jpg', 1, '2017-11-28 03:30:30', NULL, NULL, '', 'Y', 4, 'uploads/IMG/Monocard-SR-Capsule.jpg'),
(1010, 'Nidocard', 221, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Nitroglycerin 2.6mg &\r\n6.4mg Tablet.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">Nidocard is indicated for\r\nthe prophylaxis of angina pectoris due to\r\ncoronary artery diseases. It is indicated\r\nfor the supplementary treatment of heart\r\nfailure refractory to digitalis and diuretic\r\ntreatment. It is not suitable for treating an\r\nattack that has already started as the\r\ntablets will take too long to start working.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">It should be\r\nindividualized depending on the\r\nnitroglycerin sensitivity of the patient, the\r\nseverity of illness and the occurrence of\r\nside effects.</span></p><p><strong>Use in pregnancy and lactation : </strong>Pregnancy Category C by FDA.</p><p><strong>Packing : </strong></p><p><span class="redactor-invisible-space"> Nidocard-Retard-2.6 : 4 x\r\n14''s tablets in blister pack.</span></p><p><span class="redactor-invisible-space">\r\nNidocard-Retard-6.4 : 4 x 14''s tablets in\r\nblister pack.</span></p>', 'uploads/images/Nidocard.jpg', 1, '2017-11-28 04:11:06', NULL, NULL, '', 'Y', 4, 'uploads/IMG/nidocard-retard.jpg'),
(1011, 'Nidocard-Spray', 222, '<p><strong></strong><strong>Composition :</strong>Metered dose Glyceryl\r\nTrinitrate 0.4mg Spray.</p><p><strong>Indication :</strong>Acute angina pectoris.\r\nPrevention of the anginal attack by\r\nadministering the drug before physical\r\nexercise. Adjuvant therapy in emergency\r\ncases of acute left ventricular failure. </p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">By each\r\npressing 0.4mg of Glyceryl Trinitrate, in\r\nthe form of spray, is released from the\r\ncontainer.\r\nAt the onset of the attack: one or two\r\nsprays should be applied sublingually,\r\nthen the mouth should be closed. If\r\nnecessary, three sprays may be used but\r\nnot more than 3 sprays at any one time. </span></p><p><br></p><p><span class="redactor-invisible-space">For prophylaxis: one to two sprays\r\n(0.4mg-0.8mg) immediately prior to an\r\nangina inducing event. Or, as directed by\r\nthe registered physician.</span></p><p><br></p><p><strong>Packing :</strong><em> </em><span class="redactor-invisible-space"><em>Nidocard Spray :</em> Each\r\ncontainer contains 200 metered doses\r\n(12.2ml) solution.</span></p>', 'uploads/images/Nidocard-Spray.jpg', 1, '2017-11-28 04:12:37', NULL, NULL, '', 'Y', 4, 'uploads/IMG/Nidocard-Spray.jpg');
INSERT INTO `drg_medicine_info` (`MEDICINE_ID`, `MEDICINE_NAME`, `GN_GRP_ID`, `MEDICINE_DESC`, `INSERT_FILE`, `CRE_BY`, `CRE_DT`, `UPD_BY`, `UPD_DT`, `IS_LATEST`, `ACTIVE_STATUS`, `CAT_ID`, `PRODUCT_FET_PHOTO`) VALUES
(1012, 'Aclene', 223, '<p><strong></strong><strong>Composition :</strong> Adapalene 0.1%</p><p><strong>Indication : </strong><span class="redactor-invisible-space">Adapalene 0.1% cream is\r\nindicated for topical treatment of acne\r\nvulgaris.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">1. Adapalene 0.1% cream should be\r\napplied to the affected areas of skin,\r\nonce daily at night.\r\n2. A thin film of cream should be applied\r\nto the areas where lesions present, using\r\nenough to cover the entire affected areas\r\nlightly. Or as directed by the registered\r\nphysician.</span></p><p><strong>Use in pregnancy and lactation : </strong>Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.</p><p><strong>Packing : </strong><span class="redactor-invisible-space">Aclene Cream : 10gm in a\r\ntube.</span></p>', 'uploads/images/Acepril5.jpg', 1, '2017-11-26 06:44:02', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/aclene.jpg'),
(1013, 'Aqua Care', 224, '<p><strong></strong><strong>Composition :</strong>Urea 100mg.</p><p><strong>Indication : </strong><span class="redactor-invisible-space">Urea cream is indicated for\r\nIchthyosis and dry skin conditions,\r\ncracked skin of feet, management of\r\neczemas, management of psoriasis.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Urea\r\ncream is applied topically. Wash affected\r\nareas well, rinse off all traces of soap,\r\ndry and apply sparingly twice daily.\r\nOcclusive dressings may be used, but\r\nare usually unnecessary because of the\r\nself-occlusive nature of the cream. Or as\r\ndirected by the registered physician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">: Urea\r\ncream can be used during pregnancy\r\nand lactation.</span></p><p><strong>Packing : </strong><span class="redactor-invisible-space">30 gram\r\nin a tube.</span></p>', 'uploads/images/AquaCare.jpg', 1, '2017-11-26 06:47:06', NULL, NULL, '', 'Y', 4, 'uploads/IMG/aquacare.jpg'),
(1014, 'Benzac', 225, '<p><strong></strong><strong>Composition : </strong>Benzoyl Peroxide 4%.</p><p><strong>Indication :</strong>: It is used alone topically for\r\nmild to moderate acne and as an adjunct\r\nin acne treatment. </p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Wash and\r\ndry affected areas prior to application.\r\nApply sparingly one or more times daily.\r\nOr, as directed by the registered\r\nphysician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">It is\r\nnot known whether benzoyl peroxide can\r\ncause fetal harm when administered to a\r\npregnant woman or can affect\r\nreproduction capacity. Benzoyl peroxide\r\nshould be given to a pregnant woman\r\nonly if clearly needed. It is not known\r\nwhether this drug is excreted in human\r\nmilk. Because many drugs are excreted\r\nin human milk, caution should be\r\nexercised when benzoyl peroxide is\r\nadministered to a nursing woman.\r\nPregnancy Category C.</span></p><p><strong>Packing : <em></em></strong><span class="redactor-invisible-space">Benzac Cream : Each Tube\r\nContains 15gm Cream.</span></p>', 'uploads/images/Benzac.jpg', 1, '2017-11-29 05:21:29', NULL, NULL, '', 'Y', 4, 'uploads/IMG/benzac.jpg'),
(1015, 'Betavate', 226, '<p><strong>Composition : </strong><span class="redactor-invisible-space">Betamethasone (as 17 valerate) 1%. Clotrimazole 1%.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">This ointments combines the broad spectrum antifungal activity of clotrimazole with the sustained antiinflammatory, antipruritic and vasoconstrictive actions of Betamethasone and is indicated for short term topical treatment of the following dermal infections: Trichophyton rubrum, T. mentagrophytes, Epider-mophyton, and Microsporum, candidiasis due to Candida albicans.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Gently massage sufficient ointment into the affected and surrounding skin areas twice daily, in the morning and evening for two weeks in tinea cruris, candidiasis and four weeks in tinea pedis. Or as directed by the registered physician.</span></p><p><br></p><p><strong>Packing :<em> </em></strong><span class="redactor-invisible-space" style="background-color: initial;"><em>Betavate-CL Ointment : </em>10 gram in a tube.</span></p>', 'uploads/images/Betavate-CL.jpg', 1, '2017-11-29 05:20:11', NULL, NULL, '', 'Y', 4, 'uploads/IMG/Betavate-CL.jpg'),
(1016, 'Betavate-N', 227, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Betamethasone (as 17-\r\nvalerate) 0.1% and Neomycin sulphate\r\n0.5%.</span></p><p><strong>Indication :<em> </em></strong><span class="redactor-invisible-space"><em>Betavate-N </em>preparations\r\nare indicated for the treatment of the\r\nfollowing conditions where secondary\r\nbacterial infection is present, suspected,\r\nor likely to occur: eczema in children and\r\nadults, including atopic and discoid\r\neczema, prurigo nodularis; psoriasis\r\n(excluding widespread plaque psoriasis).\r\nneurodermatoses, seborrhoeic dermatitis,\r\ncontact sensitivity reactions and it may be\r\nused as an adjunct to systemic steroid\r\ntherapy in generalised erythroderma. This\r\npreparation can also be used in the\r\nmanagement of secondarily infected\r\ninsect bites and anal and genital\r\nintertrigo.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Apply to\r\nthe affected area once or twice daily until\r\nimprovement occurs. Therapy should be\r\ndiscontinued when control is achieved.\r\nOr as directed by the registered\r\nphysician.</span></p><p><br></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Betavate-N Cream: 10 gram\r\nin a tube.</span></p>', 'uploads/images/Betavate-N.jpg', 1, '2017-11-29 05:19:45', NULL, NULL, '', 'Y', 4, 'uploads/IMG/betavate-N.jpg'),
(1017, 'Champion', 228, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Camphor 4%, Menthol\r\n10% and Methyl Salicylate 30%.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">This cream is used to treat\r\ntemporarily relieve the minor aches and\r\npains of muscles and joints associated\r\nwith: simple backache, bruises, arthritis,\r\nsprains, strains. </span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Adults\r\nand Children 12 years of Age and Older:\r\nApply to affected area not more than 3 to\r\n4 times daily. Or, as directed by the\r\nregistered physician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">There are no well-controlled studies in\r\npregnant and nursing women.</span></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Champion : Each tube\r\ncontains 15gm & 30gm cream</span></p>', 'uploads/images/Champion.jpg', 1, '2017-11-29 04:36:52', NULL, NULL, '', 'Y', 4, 'uploads/IMG/champion.jpg'),
(1018, 'Cinoderm', 62, '<p><strong></strong><strong>Composition : </strong>Each Metered dose (Puff) contains Beclometasone Dipropionate 100 mcg.</p><p><strong>Indication : </strong>Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. </p><p><strong>Dosage and administration : </strong>Becovent inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled Becovent appropriate to the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to individual response. Management of chronic asthma (Adults & Children over 12 years): 100-400 mcg twice daily. Maximum 1000 mcg twice daily. Children (5-12 years): 100-200 mcg twice daily. the dose may be adjusted as necessary.</p><p><strong>Use in pregnancy and lactation : </strong>Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.</p><p><strong>Packing : </strong>Becovent HFA Inhaler : Each box contains one inhaler of 200 Puffs</p>', 'uploads/images/Clodermoint.jpg', 1, '2017-11-09 01:38:08', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/Clodermoint.jpg'),
(1019, 'Clobederm', 244, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Clobetasol propionate\r\n0.05%.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">Clobetasol propionate is a\r\nvery active topical corticosteroid which is\r\nof particular value when used in short\r\ncourses for the treatment of more\r\nresistant dermatoses such as psoriasis\r\n(excluding wide spread plaque\r\npsoriasis), eczema, lichen planus,\r\ndiscoid lupus erythe-matosus, and other\r\nconditions which do not respond\r\nsatisfactorily to less active steroids.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Apply\r\nsparingly to the affected area once or\r\ntwice daily until improvement occurs. As\r\nwith other highly active topical steroid\r\npreparations, therapy should be\r\ndiscontinued when control is achieved. In\r\nthe more responsive conditions this may\r\nbe within a few days. Or as directed by\r\nthe physician.</span></p><p><br></p><p><strong>Packing : </strong></p><p><span class="redactor-invisible-space"> Clobederm Cream : 10 gram\r\nin a tubes. </span></p><p><span class="redactor-invisible-space">Clobederm Ointment : 10 gram in a\r\ntubes.</span></p>', 'uploads/images/Clobederm.jpg', 1, '2017-11-29 04:35:32', NULL, NULL, '', 'Y', 4, 'uploads/IMG/clobederm.jpg'),
(1020, 'Dicot', 231, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Econazole Nitrate 1% &\r\nTriamcinolone Acetonide 0.1%.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">For the topical treatment of\r\ninflammatory dermatomycoses and\r\ninflammatory skin conditions complicated\r\nby or threatened by bacterial or fungal\r\nskin infection.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">The\r\ncream should be applied by gently\r\nrubbing into the skin twice daily for 14\r\ndays or as directed by the registered\r\nphysician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">However, topical steroids should not be\r\nused extensively in pregnancy.\r\nPregnancy Category : Econazole NitrateC\r\n& Triamcinolone Acetonide-C.</span></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Dicot Cream: 10 gm in a\r\ntube</span></p>', 'uploads/images/Dicot.jpg', 1, '2017-11-29 03:59:46', NULL, NULL, '', 'Y', 4, 'uploads/IMG/dicot.jpg'),
(1021, 'Fintop', 232, '<p><strong></strong><strong>Composition : </strong>Butenafine HCl 1%.</p><p><strong>Indication : </strong><span class="redactor-invisible-space">Butenafine cream is\r\nindicated for the topical treatment of\r\nfollowing superficial dermatophytes: tinea\r\npedis (athletes foot), tinea corporis\r\n(ringworm), tinea cruris (jockitch) due to M.\r\nfurfur, E. floccosum, T. mentagrophytes, T.\r\nrubrum, T. tonsurans.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Patients\r\nwith tinea (pityriasis) versicolor should\r\napply butenafine once daily for two weeks.\r\nIn the treatment of interdigital tinea pedis\r\nbutenafine should be applied twice daily\r\nfor 7 days or once daily for 4 weeks.\r\nPatients with tinea corporis or tinea cruris\r\nshould apply butenafine once daily for two\r\nweeks. Or, as directed by the registered\r\nphysician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">No\r\nadequate and well controlled studies that\r\nhave been conducted with topically applied\r\nbutenafine in pregnant women. This drug\r\nshould be used during pregnancy only if\r\nclearly needed. It is not known if\r\nbutenafine HCl is excreted in human milk,\r\ncaution should be exercised in prescribing\r\nbutenafine Cream, to a nursing woman.\r\nPregnancy Category C.\r\n</span></p><p><strong>Packing :<em> </em></strong><em>Fintop Cream : </em>10gm in a tube</p>', 'uploads/images/Fintop.jpg', 1, '2017-11-29 02:59:53', NULL, NULL, '', 'Y', 4, 'uploads/IMG/fintop.jpg'),
(1022, 'Fusibac-H', 233, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Fusidic Acid 2% and\r\nHydrocortisone Acetate 1%.</span></p><p><strong>Indication :</strong>Fusibac-H cream is\r\nindicated in eczema and dermatitis with\r\nsecondary bacterial infections, including\r\natopic eczema, primary irritant dermatitis\r\nand allergic and seborrhoeic dermatitis\r\nwhere the organisms responsible are\r\nknown to be or believed to be sensitive\r\nto fusidic acid.Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. </p><p><strong>Dosage and administration : </strong></p><p><strong>Use in pregnancy and lactation :  </strong><span class="redactor-invisible-space">The\r\nsafety in pregnancy and lactation has not\r\nbeen established for fusidic acid.\r\n</span></p><p><strong>Packing :<em> </em></strong><span class="redactor-invisible-space"><em>Fusibac-H cream : </em>10gm in a\r\ntube.</span></p>', 'uploads/images/Fusibac-H.jpg', 1, '2017-11-29 02:58:17', NULL, NULL, '', 'Y', 4, 'uploads/IMG/fusibac-H.jpg'),
(1024, 'Licerin', 235, '<p><strong></strong><strong>Composition : </strong> Permethrin 5%.</p><p><strong>Indication : </strong><span class="redactor-invisible-space">Licerin cream is indicated\r\nfor the treatment of scabies.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Adults\r\nand children: over 12 years: Up to 30\r\ngm. Children aged : 6-12 years: Up to\r\n15gm. 1-5 years : Up to 7.5 gm. The\r\nmaximum amount of permethrin cream\r\nused in one application should be limited\r\nup to (60 gm of cream) or as directed by\r\nthe registered physician.</span></p><p><br></p><p><strong>Packing :<em> </em></strong><span class="redactor-invisible-space"><strong><em>Licerin Cream : </em></strong>15 gm & 30\r\ngm in a tube.</span></p>', 'uploads/images/Licerin.jpg', 1, '2017-11-28 03:13:39', NULL, NULL, '', 'Y', 4, 'uploads/IMG/licerin.jpg'),
(1025, 'Micoderm', 236, '<p><strong></strong><strong>Composition : </strong>Miconazole 2%</p><p><strong>Indication : </strong><span class="redactor-invisible-space">This gel is indicated for\r\noral treatment and prevention of fungal\r\ninfections of the oropharynx and of super\r\ninfections due to Grampositive bacteria.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">For\r\nlocalized lesions of the mouth, a small\r\namount of gel may be applied directly to\r\nthe affected area with a clean finger. For\r\ntopical treatment of the oropharynx, the\r\ngel should be kept in the mouth for as\r\nlong as possible. Treatment should be\r\ncontinued for up to 2 days after the\r\nsymptoms have cleared. For oral\r\ncandidosis, dental prostheses should be\r\nremoved at night and brushed with the\r\ngel. Or, as directed by the registered\r\nphysician.</span></p><p><br></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Micoderm Oral Gel : 15gm in\r\na tube</span></p>', 'uploads/images/Micoderm.jpg', 1, '2017-11-28 03:32:25', NULL, NULL, '', 'Y', 4, 'uploads/IMG/micoderm.jpg'),
(1026, 'Micoderm HC', 237, '<p><strong>Composition : </strong>Miconazole 2%</p><p><strong>Indication : </strong><span class="redactor-invisible-space">This gel is indicated for oral treatment and prevention of fungal infections of the oropharynx and of super infections due to Grampositive bacteria.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">For localized lesions of the mouth, a small amount of gel may be applied directly to the affected area with a clean finger. For topical treatment of the oropharynx, the gel should be kept in the mouth for as long as possible. Treatment should be continued for up to 2 days after the symptoms have cleared. For oral candidosis, dental prostheses should be removed at night and brushed with the gel. Or, as directed by the registered physician.</span></p><p><br></p><p><strong>Packing : </strong><span class="redactor-invisible-space" style="background-color: initial;">Micoderm Oral Gel : 15gm in a tube</span></p>', 'uploads/images/Micoder_HC.jpg', 1, '2017-11-28 03:33:17', NULL, NULL, '', 'Y', 4, 'uploads/IMG/micoderm-HC.jpg'),
(1027, 'Mycofree', 238, '<p><strong></strong><strong><em></em>Composition : </strong>Terbinafine 1%.</p><p><strong>Indication : </strong><span class="redactor-invisible-space">It is used to treat fungal\r\ninfections of the skin caused by\r\nTrichophyton(e.g.T.Rubrum,T.Mentagrop\r\nhytes, T.Verrucosum, T.Violaceum),\r\nMicrosporum canis and Epidermophyton\r\nfloccosum. It ia also used to treat yeast\r\ninfections of the skin,principally those\r\ncaused by the genus Candida (e.g.\r\nC.albicans).</span></p><p><strong>Dosage and administration :<em> </em></strong><span class="redactor-invisible-space"><em>Adult: </em>It\r\ncan be applied once or twice daily after\r\ndrying the affected areas thoroughly.\r\nApply the cream to the affected skin and\r\nsurrounding area in a thin layer and rub\r\nin lightly. In the case of intertriginous\r\ninfections (submammary, interdigital,\r\nintergluteal, inguinal) the application may\r\nbe covered with a gauze strip, especially\r\nat night. The likely durations of treatment\r\nare as follows. Tinea corporis,cruris: 1 to\r\n2 weeks, Tinea pedis: 1 week, Cutaneous\r\ncandidiasis: 2 weeks,Pityriasis versicolor: 2\r\nweeks. Children: The experience with\r\ntopical cream in children is still limited\r\nand its use cannot therefore be\r\nrecommended. Or as directed by the\r\nregistered physician.</span></p><p><strong>Use in pregnancy and lactation :</strong></p><p><strong><em> </em></strong><span class="redactor-invisible-space"><em>Pregnancy: </em>There is on clinical\r\nexperience with this cream in pregnant\r\nwomen. Therefore, unless the potential\r\nbenefits outweigh any potential risk, this\r\ncream should not be administerad during\r\npregnancy.</span></p><p><span class="redactor-invisible-space"> Lactation: Terbinafine is\r\nexcreted in breast milk and therefore\r\nmothers should not receive this cream\r\nwhilst breast-feeding.</span></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Mycofree Cream : 15gm in a\r\ntube.</span></p>', 'uploads/images/Mycofree.jpg', 1, '2017-11-28 03:36:05', NULL, NULL, '', 'Y', 4, 'uploads/IMG/Mycofree-Tablet.jpg'),
(1028, 'Novirax', 239, '<p><strong></strong><strong> Composition : </strong>Acyclovir 5%.</p><p><strong>Indication : </strong><span class="redactor-invisible-space">Novirax cream is indicated\r\nfor the treatment of Herpes simplex virus\r\ninfections of the skin and mucous\r\nmembranes including initial and\r\nrecurrent genital herpes. Novirax cream\r\nis also indicated for the prophylaxis of\r\nherpes simplex infections in\r\nimmunocompro-mised patients.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Novirax\r\ncream should be used every 4 hours for\r\n5 days in the affected area. If after 5\r\ndays, healing is not complete then\r\ntreatment may be continued for a further\r\n5 days. Or as directed by the physician.</span></p><p><br></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Novirax cream : 5gm in a\r\ntubes</span></p>', 'uploads/images/Novirax.jpg', 1, '2017-11-28 04:14:02', NULL, NULL, '', 'Y', 4, 'uploads/IMG/Novirax.jpg'),
(1029, 'Novirax HC', 240, '<p><strong>Composition : </strong>Acyclovir 5%.</p><p><strong>Indication : </strong><span class="redactor-invisible-space">Novirax cream is indicated for the treatment of Herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes. Novirax cream is also indicated for the prophylaxis of herpes simplex infections in immunocompro-mised patients.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Novirax cream should be used every 4 hours for 5 days in the affected area. If after 5 days, healing is not complete then treatment may be continued for a further 5 days. Or as directed by the physician.</span></p><p><br></p><p><strong>Packing : </strong><span class="redactor-invisible-space" style="background-color: initial;">Novirax cream : 5gm in a tubes</span></p>', 'uploads/images/NoviraxHC.jpg', 1, '2017-11-28 04:14:52', NULL, NULL, '', 'Y', 4, 'uploads/IMG/novirex-HC.jpg'),
(1030, 'Silvec', 241, '<p><strong></strong><strong>Composition : </strong>Each Metered dose (Puff) contains Beclometasone Dipropionate 100 mcg.</p><p><strong>Indication : </strong>Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. </p><p><strong>Dosage and administration : </strong>Becovent inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled Becovent appropriate to the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to individual response. Management of chronic asthma (Adults & Children over 12 years): 100-400 mcg twice daily. Maximum 1000 mcg twice daily. Children (5-12 years): 100-200 mcg twice daily. the dose may be adjusted as necessary.</p><p><strong>Use in pregnancy and lactation : </strong>Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.</p><p><strong>Packing : </strong>Becovent HFA Inhaler : Each box contains one inhaler of 200 Puffs</p>', 'uploads/images/Silvec.jpg', 1, '2017-11-09 03:09:46', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/silvec-cream.jpg'),
(1031, 'Trialon', 242, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Each metered spray\r\ncontains Triamcinolone Acetonide 55 mcg.</span></p><p><strong>Indication :</strong>This nasal spray indicated\r\nfor the treatment of the nasal symptoms\r\nof seasonal and perennial allergic rhinitis\r\nin adults and children 6 years of age and\r\nolder. </p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Adults\r\nand children 12 years of age and\r\nolder: The recommended starting and\r\nmaximum dose is 220 mcg per day as\r\ntwo sprays in each nostril once daily.\r\nChildren 6 to 12 years of age: The\r\nrecommended starting dose is 110 mcg\r\nper day given as one spray in each\r\nnostril once daily. The maximum\r\nrecommended dose is 220 mcg per day\r\nas two sprays per nostril once daily.\r\nChildren 2 to 5 years of age : Starting\r\nand maximum dose 110 mcg per day as\r\none spray in each nostril once daily. Not\r\nrecommended for children under 2 years\r\nof age. Or, as directed by the registered\r\nphysician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Pregnancy category C. There are no\r\nadequate and well controlled studies in\r\npregnant women. Triamcinolone\r\nAcetonide nasal spray, like other\r\ncorticosteroids, should be used during\r\npregnancy only if the potential benefit\r\njustifies the potential risk to the fetus. It is\r\nnot known whether Triamcinolone\r\nAcetonide is excreted in human milk.\r\nBecause other corticosferoids are\r\nexcreted in human milk, caution should\r\nbe exercised when Triamcinolone\r\nAcetonide nasal spray is administered to\r\na nursing woman.</span></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Trialon Nasal Spray : Each\r\nbottle contains 120 metered doses for\r\nsprays.</span></p>', 'uploads/images/Trialon.jpg', 1, '2017-12-04 03:54:55', NULL, NULL, '', 'Y', 4, 'uploads/IMG/trolen.jpg'),
(1037, 'Dovonex Plus', 246, '<p><strong></strong><strong>Composition : </strong>Each Metered dose (Puff) contains Beclometasone Dipropionate 100 mcg.</p><p><strong>Indication : </strong>Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. </p><p><strong>Dosage and administration : </strong>Becovent inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled Becovent appropriate to the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to individual response. Management of chronic asthma (Adults & Children over 12 years): 100-400 mcg twice daily. Maximum 1000 mcg twice daily. Children (5-12 years): 100-200 mcg twice daily. the dose may be adjusted as necessary.</p><p><strong>Use in pregnancy and lactation : </strong>Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.</p><p><strong>Packing : </strong>Becovent HFA Inhaler : Each box contains one inhaler of 200 Puffs</p>', 'uploads/images/Dovonex.jpg', 1, '2017-11-09 03:27:17', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/Dovonex-Plus-Ointment.jpg'),
(1038, 'Flutiderm', 247, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Fluticasone propionate\r\n0.005%.</span></p><p><strong>Indication : </strong>Fluticasone propionate is a\r\nmedium potency corticosteroid indicated\r\nfor the relief of the inflammatory and\r\npruritic manifestations of corticosteroidresponsive\r\ndermatoses eczema &\r\npsoriasis.ent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. </p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Apply a\r\nthin film of Flutiderm Ointment to the\r\naffected skin areas twice daily. Rub in\r\ngently. Or as directed by the physician.</span></p><p><strong>Packing :<em> </em></strong><span class="redactor-invisible-space"><em> Flutiderm ointment : </em>10gm in\r\na tube.</span></p>', 'uploads/images/Aclene Plus.jpg', 1, '2017-11-29 02:56:34', NULL, NULL, '', 'Y', 4, 'uploads/IMG/Flutiderm-Ointment.jpg'),
(1040, 'Happynap', 249, '<p><strong></strong><strong>Composition :</strong>: Zinc Oxide 40%</p><p><strong>Indication : </strong><span class="redactor-invisible-space">It is indicated for\r\npreventing and treating diaper rash as\r\nwell as minor skin irritations (e.g. cuts,\r\nburns, and scrapes, poison ivy). It works\r\nby providing a skin barrier to prevent and\r\nhelp to heal skin irritation.</span> </p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">At first,\r\nwet and soiled diaper should be\r\nchanged. Promptly; the diaper area is\r\ncleaned & allowed drying. A thin layer of\r\nointment should be applied topically\r\nevery 8 hourly. It should be applied\r\nliberally as often as necessary, with each\r\ndiaper change, especially at bedtime or\r\nany time when exposure to wet diapers\r\nmay be prolonged. Or, as directed by the\r\nregistered physician.</span></p><p><br></p><p><strong>Packing : </strong><span class="redactor-invisible-space">15gm ointment in\r\na tube.\r\n</span></p>', 'uploads/images/Happynap.jpg', 1, '2017-11-27 23:38:33', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/happynap.jpg'),
(1041, 'Muron', 250, '<p><strong></strong><strong>Composition : </strong>: Mupirocin 2%.</p><p><strong>Indication : </strong><span class="redactor-invisible-space">Muron ointment 2% is\r\nindicated for the topical treatment of\r\nimpetigo due to : Staphylococcus aureus\r\nand Streptococcus pyogenes.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">A small\r\namount of Muron ointment should be\r\napplied to the affected area three times\r\ndaily. The area may be covered with a\r\ngauze dressing if desired. Or as directed\r\nby the registered physician.</span></p><p><br></p><p><strong>Packing :</strong>Muron Ointment : 10gm in a\r\ntube.</p>', 'uploads/images/Muron.jpg', 1, '2017-11-28 03:39:44', NULL, NULL, '', 'Y', 4, 'uploads/IMG/muron.jpg'),
(1042, 'NEO-B', 251, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Neomycin S ulphate\r\n0.5% & Bacitracin Zinc 1%.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">Neo-B ointment is\r\nindicated in the treatment of topical\r\nbacterial infection. It is particularly\r\neffective in atopic, contact, stasis,\r\neczematoid dermatitis, neurodermatitis,\r\neczema, and anogenital pruritus. It may\r\nalso be useful as an adjunct in certain\r\npyodermas such as impetigo, during\r\nspecific systemic antibiotic therapy for\r\nthese infections.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">A thin film\r\nto be applied 2 to 4 times daily to the\r\naffected area. Or as directed by the\r\nphysician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">There are no adequate and wellcontrolled\r\nstudies in pregnant women.\r\nThis ointment should be used during\r\npregnancy only if the potential benefit\r\njustifies the potential ris k to the fetus.\r\nCaution should be exercised when NeoB\r\nointment is administered to nursing\r\nwomen.</span></p><p><strong>Packing :</strong>Neo-B Ointment : 10gm in\r\na tube</p>', 'uploads/images/NEO-B.jpg', 1, '2017-11-28 04:20:11', NULL, NULL, '', 'Y', 4, 'uploads/IMG/neo-B.jpg'),
(1043, 'NEO-B Plus', 252, '<p><strong>Composition : </strong><span class="redactor-invisible-space">Neomycin S ulphate 0.5% & Bacitracin Zinc 1%.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">Neo-B ointment is indicated in the treatment of topical bacterial infection. It is particularly effective in atopic, contact, stasis, eczematoid dermatitis, neurodermatitis, eczema, and anogenital pruritus. It may also be useful as an adjunct in certain pyodermas such as impetigo, during specific systemic antibiotic therapy for these infections.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">A thin film to be applied 2 to 4 times daily to the affected area. Or as directed by the physician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">There are no adequate and wellcontrolled studies in pregnant women. This ointment should be used during pregnancy only if the potential benefit justifies the potential ris k to the fetus. Caution should be exercised when NeoB ointment is administered to nursing women.</span></p><p><strong>Packing :</strong>Neo-B Ointment : 10gm in a tube</p>', 'uploads/images/NEO-B.jpg', 1, '2017-11-28 04:20:45', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/neo-B_plus.jpg'),
(1044, 'Povicidal', 253, '<p><strong></strong><strong>Composition : </strong>Each Metered dose (Puff) contains Beclometasone Dipropionate 100 mcg.</p><p><strong>Indication : </strong>Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. </p><p><strong>Dosage and administration : </strong>Becovent inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled Becovent appropriate to the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to individual response. Management of chronic asthma (Adults & Children over 12 years): 100-400 mcg twice daily. Maximum 1000 mcg twice daily. Children (5-12 years): 100-200 mcg twice daily. the dose may be adjusted as necessary.</p><p><strong>Use in pregnancy and lactation : </strong>Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.</p><p><strong>Packing : </strong>Becovent HFA Inhaler : Each box contains one inhaler of 200 Puffs</p>', 'uploads/images/povicidal.jpg', 1, '2017-11-09 03:39:29', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/povicidal.jpg'),
(1046, 'Retocain', 255, '<p><strong></strong><strong>Composition : </strong>Each Metered dose (Puff) contains Beclometasone Dipropionate 100 mcg.</p><p><strong>Indication : </strong>Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. </p><p><strong>Dosage and administration : </strong>Becovent inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled Becovent appropriate to the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to individual response. Management of chronic asthma (Adults & Children over 12 years): 100-400 mcg twice daily. Maximum 1000 mcg twice daily. Children (5-12 years): 100-200 mcg twice daily. the dose may be adjusted as necessary.</p><p><strong>Use in pregnancy and lactation : </strong>Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.</p><p><strong>Packing : </strong>Becovent HFA Inhaler : Each box contains one inhaler of 200 Puffs</p>', 'uploads/images/Relitch.jpg', 1, '2017-11-09 03:44:55', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/retocain.jpg'),
(1047, 'Relitch', 254, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Betamethasone (as 17\r\nvalerate) 0.05%,	Phenylephrine\r\nhydrochloride 0.1% &	Lignocaine\r\nhydrochloride 2.5%.</span></p><p><strong>Indication :</strong>Relitch is indicated for:\r\nrelief of the symptoms of itching,\r\nirritation, discomfort or pain associated\r\nwith local non-infective anal or peri-anal\r\nconditions such as external hemorrhoids.Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. </p><p><strong>Dosage and administration :</strong>: a course\r\nof treatment should be limited to 7 days.\r\nApply a small amount of ointment two or\r\nthree times a day initially, using the\r\napplicator if internal administration is\r\nrequired. When inflammation is\r\nsubsiding, once-daily application is\r\nsufficient in most cases. Or as directed\r\nby the physicianBecovent inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled Becovent appropriate to the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to individual response. Management of chronic asthma (Adults & Children over 12 years): 100-400 mcg twice daily. Maximum 1000 mcg twice daily. Children (5-12 years): 100-200 mcg twice daily. the dose may be adjusted as necessary.</p><p><br></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Relitch rectal ointment : 15\r\ngram in a tube.</span></p>', 'uploads/images/Relitch.jpg', 1, '2017-11-28 04:58:40', NULL, NULL, '', 'Y', 4, 'uploads/IMG/relitch.jpg'),
(1048, 'Aclene Plus', 256, '<p><strong></strong><strong>Composition : </strong>Each Metered dose (Puff) contains Beclometasone Dipropionate 100 mcg.</p><p><strong>Indication : </strong>Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. </p><p><strong>Dosage and administration : </strong>Becovent inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled Becovent appropriate to the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to individual response. Management of chronic asthma (Adults & Children over 12 years): 100-400 mcg twice daily. Maximum 1000 mcg twice daily. Children (5-12 years): 100-200 mcg twice daily. the dose may be adjusted as necessary.</p><p><strong>Use in pregnancy and lactation : </strong>Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.</p><p><strong>Packing : </strong>Becovent HFA Inhaler : Each box contains one inhaler of 200 Puffs</p>', 'uploads/images/AclenePlus.jpg', 1, '2017-11-09 03:48:11', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/aclene.jpg'),
(1049, 'Dalacin-B', 257, '<p><strong>Composition : </strong><span class="redactor-invisible-space">Clindamycin Phosphate 1.2% and Tretinoin 0.025%. Indications : This gel is indicated for the topical treatment of acne vulgaris in patients 12 years or older.</span></p><p><br></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Clindamycin & tretinoin gel should be applied once daily in the evening, gently rubbing the medication to lightly cover the entire affected area. Approximately a pea sized amount will be needed for each application. Avoid the eyes, lips, and mucous membranes. Clindamycin & tretinoin gel is not for oral, ophthalmic or intravaginal use. Or, as directered by registered physician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">There are no controlled data in women pregnancy. It can be used in pregnancy if potential benefits outweigh the risk or as directed by the registered physician. Clindamycin is likely to be excreted into the breast milk. A decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the benefit of the drug to the mother. Pregnancy Category B.</span></p><p><strong>Packing : </strong><span class="redactor-invisible-space" style="background-color: initial;">Dalacin Plus Gel : 15gm in a tube.</span></p>', 'uploads/images/DalacinPlus.jpg', 1, '2017-11-29 03:57:53', NULL, NULL, '', 'Y', 4, 'uploads/IMG/dalacin-plus-gel.jpg'),
(1050, 'Dalacin Plus', 258, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Clindamycin Phosphate\r\n1.2% and Tretinoin 0.025%.\r\nIndications : This gel is indicated for the\r\ntopical treatment of acne vulgaris in\r\npatients 12 years or older.</span></p><p><br></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Clindamycin & tretinoin gel should be\r\napplied once daily in the evening, gently\r\nrubbing the medication to lightly cover\r\nthe entire affected area. Approximately a\r\npea sized amount will be needed for\r\neach application. Avoid the eyes, lips,\r\nand mucous membranes. Clindamycin &\r\ntretinoin gel is not for oral, ophthalmic or\r\nintravaginal use. Or, as directered by\r\nregistered physician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">There are no controlled data in women\r\npregnancy. It can be used in pregnancy if\r\npotential benefits outweigh the risk or as\r\ndirected by the registered physician.\r\nClindamycin is likely to be excreted into\r\nthe breast milk. A decision should be\r\nmade whether to discontinue nursing or\r\nto discontinue the drug, taking into\r\naccount the benefit of the drug to the\r\nmother. Pregnancy Category B.</span></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Dalacin Plus Gel : 15gm in a\r\ntube.</span></p>', 'uploads/images/DalacinPlus.jpg', 1, '2017-11-29 03:57:20', NULL, NULL, '', 'Y', 4, 'uploads/IMG/dalacin-plus-gel.jpg'),
(1051, 'Diproxen', 259, '<p><strong>Composition : </strong>: Naproxen Sodium 10%.</p><p><strong>Indication : </strong><span class="redactor-invisible-space">This gel is indicated for treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, tendonitis, bursitis, acute gout, and the management of mild to moderate pain and primary dysmenorrhoea.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Diproxen Gel is to be applied 2-6 times a day as required and is not recommended for use in children. Or, as directed by the registered physician</span></p><p><br></p><p><strong>Packing :</strong>Diproxen Gel : 15gm in a tube.</p>', 'uploads/images/Dovonex.jpg', 1, '2017-12-03 00:10:09', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/diproxen.jpg'),
(1052, 'Micoderm', 260, '<p><strong>Composition : </strong>Miconazole 2%</p><p><strong>Indication : </strong><span class="redactor-invisible-space">This gel is indicated for oral treatment and prevention of fungal infections of the oropharynx and of super infections due to Grampositive bacteria.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">For localized lesions of the mouth, a small amount of gel may be applied directly to the affected area with a clean finger. For topical treatment of the oropharynx, the gel should be kept in the mouth for as long as possible. Treatment should be continued for up to 2 days after the symptoms have cleared. For oral candidosis, dental prostheses should be removed at night and brushed with the gel. Or, as directed by the registered physician.</span></p><p><br></p><p><strong>Packing : </strong><span class="redactor-invisible-space" style="background-color: initial;">Micoderm Oral Gel : 15gm in a tube</span></p>', 'uploads/images/Micoderm.jpg', 1, '2017-11-28 03:33:48', NULL, NULL, '', 'Y', 4, 'uploads/IMG/micoderm-gel.jpg'),
(1053, 'Trialon Oral Paste', 147, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Triamcinolone Acetonide\r\n0.1%.</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">It is indicated for aphthous\r\nulcers, ulcerative stomatitis, denture\r\nstomatitis, desquamative gingivitis,\r\nerosive lichen planus and lesions of the\r\noral mucosa of traumatic origin.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Adults and\r\nChildren : To be applied to the lesion at\r\nbedtime and two to four times daily,\r\npreferably after meals. Apply to the\r\naffected area; do not rub in.\r\nElderly : Corticosteroids should be used\r\nsparingly and for short periods of time. or\r\nas directed by the registered physician</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Triamcinolone should only be prescribed\r\nwhen the benefits to the mother & child\r\noutweigh the risks. Some of\r\ncorticosteroids may pass into breast\r\nmilk, but no data are available for\r\nTriamcinolone Acetonide. Pregnancy\r\nCategory C.</span></p><p><strong>Packing : </strong><span class="redactor-invisible-space">Trialon Oral Paste : 10 gram\r\nin a tube.</span></p>', 'uploads/images/TrialonOralPaste.jpg', 1, '2017-11-27 04:56:07', NULL, NULL, '', 'Y', 4, 'uploads/IMG/trilone.jpg'),
(1054, 'Alocap ', 302, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Each Soft Capsule Contains Aloe Vera Extract 100mg (200:1 Concentrate)</span></p><p><strong>Indication : </strong></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Take one capsule one to three times daily, preferably with a meal. Or, as directed by the\r\nregistered physician.</span></p><p><strong>Use in pregnancy and lactation : </strong>Aloe vera is not recommended for pregnant and lactating women.</p><p><strong>Packing : </strong>Each Box Contains 5 x 10''s soft capsules in blister pack.</p>', 'uploads/images/AclenePlus.jpg', 1, '2017-11-26 06:50:59', NULL, NULL, '', 'Y', 6, 'uploads/IMG/Alocap.jpg'),
(1055, 'Anros', 303, '<p><strong></strong><strong>Composition : </strong>Each capsule contains andrographis (Andrographis paniculata) 200 mg</p><p><strong>Indication :</strong></p><p><strong></strong>Andrographis is indicated in the treatment of following diseases-\r\n* Flu\r\n* Antiviral (Influenza,Hepatitis B,Herpes)\r\n* Common cold\r\n* Sinusitis\r\n* Upper respiratory tract infection (Sore throat, pharyngotonsillitis, bronchitis)\r\n* Stimulates the immune system\r\n* Antihepatotoxic\r\n* Hepato-biliary protective\r\n* Antipyretic\r\n* Antityphoid\r\n* Antifungal\r\n* Antihelminthic</p><p><strong>Dosage and administration : </strong>1-2 Capsules 2-3 times daily after meals or as directed by the registered physician</p><p><strong>Use in pregnancy and lactation : </strong>Do not take during pregnancy.</p><p><strong>Packing : </strong>Each box contains 10 x 4 = 40 capsules in Alu-Alu blister pack.</p>', 'uploads/images/AclenePlus.jpg', 1, '2017-11-30 04:28:31', NULL, NULL, '', 'Y', 6, 'uploads/IMG/ANROS-Capsule.jpg'),
(1056, 'Biloba', 304, '<p><strong></strong><strong>Composition : </strong>Each capsule contains 60 mg standardized extract of Ginkgo biloba.</p><p><strong>Indication : </strong></p><p><span class="redactor-invisible-space">Primary uses\r\nCerebral Insufficiency : Memory deficit, depression, attention and memory loss that occur\r\nwith Alzheimer''s disease and multi-infarct dementia.</span></p><p><strong>Dosage and administration : </strong>1 or 2 Capsule 2 to 3 times daily or as advised by the registered physician.</p><p><strong>Use in pregnancy and lactation : </strong>There is no known restriction of the use of ginkgo in pregnancy and lactation</p><p><strong>Packing : </strong><span class="redactor-invisible-space">Biloba 60mg capsule\r\nEach box contains 32 capsules in 8 X 4 Alu-Alu blister packs.</span></p>', 'uploads/images/AclenePlus.jpg', 1, '2017-11-29 05:17:09', NULL, NULL, '', 'Y', 6, 'uploads/IMG/biloba.jpg');
INSERT INTO `drg_medicine_info` (`MEDICINE_ID`, `MEDICINE_NAME`, `GN_GRP_ID`, `MEDICINE_DESC`, `INSERT_FILE`, `CRE_BY`, `CRE_DT`, `UPD_BY`, `UPD_DT`, `IS_LATEST`, `ACTIVE_STATUS`, `CAT_ID`, `PRODUCT_FET_PHOTO`) VALUES
(1057, 'Biogut', 305, '<p><strong></strong><strong>Composition :</strong></p><p><strong></strong>Biogut 250 : Each Capsule Contains Saccharomyces boulardii 250 mg (Eq.to 5 billion CFU). </p><p>Biogut 500 : Each Capsule Contains Saccharomyces boulardii 500 mg (Eq.to 10 billion CFU).</p><p><strong>Indication :</strong></p><p><strong> </strong><span class="redactor-invisible-space">It is indicatedl\r\nPrevention of diarrhoea associated with antibiotics </span></p><p>Reduction in symptoms of acute diarrhea</p><p><span class="redactor-invisible-space">Prevention of traveler''s diarrhea </span></p><p>Treating diarrhea in infants</p><p><span class="redactor-invisible-space">Prevention of HIV associated diarrhea </span></p><p>Preventing recurring intestinal disease caused by a bacterium called Clostridium difficile </p><p>Reducing side effects of treatment for the ulcer - causing bacterium Helicobacter pylori</p><p><span class="redactor-invisible-space">Treating diarrhea in Crohn''s disease </span></p><p>Treating diarrhea in Ulcerative colitis </p><p>Treating diarrhea in Irritable bowel syndrome (IBS)</p><p><strong>Dosage and administration : </strong></p><p><span class="redactor-invisible-space">Adult : For diarrhea associated with the use of antibiotics : 250-500 mg of Saccharomyces boulardii two to\r\nfour times a day.\r\nFor diarrhea caused by Clostridium difficile : 1 gram of Saccharomyces boulardii daily for 4 weeks along\r\nwith antibiotic treatment.\r\nFor reduction in symptoms of acute diarrhea : 250 mg of Saccharomyces boulardii twice a day for 5 days.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">There is no available information about the safety of taking Saccharomyces boulardii in pregnancy and\r\nlactation. If needed during pregnancy and lactation consult the registered physician.</span></p><p><strong>Packing : </strong></p><p><strong></strong>Biogut 250 : Each box contains 5x4=20 capsules in Alu-Alu blister pack. </p><p>Biogut 500 : Each box contains 5x4=20 capsules in Alu-Alu blister pack.</p>', 'uploads/images/AclenePlus.jpg', 1, '2017-11-30 04:38:16', NULL, NULL, '', 'Y', 6, 'uploads/IMG/Biogut-250.jpg'),
(1058, 'Dalion', 306, '<p><strong></strong><strong>Composition : </strong>Each capsule contains Dandelion 425mg.</p><p><strong>Indication :</strong></p><p><strong></strong>Dandelion is indicated for- </p><p>* Dyspeptic complaints </p><p>* Infection of the urinary tract</p><p>\r\n* Liver & gallbladder complaints </p><p>* Loss of appetiteBecovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids. </p><p><strong>Dosage and administration : </strong>1-2 Capsules 2-3 times daily,Or, as directed by the registered physician</p><p><strong>Use in pregnancy and lactation : </strong>No experience is available about the use of Dandelion in pregnant & lactating mother.</p><p><strong>Packing :</strong>Each box contains 8 x 4 = 32 capsules in Alu-Alu blister pack.</p>', 'uploads/images/AclenePlus.jpg', 1, '2017-11-29 03:49:38', NULL, NULL, '', 'Y', 6, 'uploads/IMG/dalion.jpg'),
(1059, 'Devas', 307, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Each teaspoon full (5 ml) of DEVAS syrup contains extracts of -\r\nAdhatoda vasica 0.68 gm, Piper longum 0.14 gm, Glycyrrhiza glabra 6.78 mg,\r\nTrikatu (Piper nigrum, Zingiber officinale) 20.34 mg, Terminalia chebula 73.24 mg,\r\nVitis venifera 0.14 gm, Acorus calamus 6.78 mg, Saussurea lappa 6.78 mg,\r\nSyzygium aromaticum 6.78 mg, Trizatak (Cinnamomum zeylanicum, Elettaria\r\ncardamomum, Cinnamomum tamala) 20.34 mg, Pistacia integerrima 6.78 mg,\r\nMyrica nagi 6.78 mg,Woodfordia fruticosa 1.14 mg</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">DEVAS syrup liquefies phlegm. It sooths irritation of throat. Helps to relieve hoarseness. It is a remedy for all types of\r\ncough such as dry irritable cough, allergic & smokers cough.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Children under 12 years :1-2 teaspoonful ( 5-10 ml ) 2-3 times a day.Adult :3 teaspoonful ( 15 ml ) 2-3 times a day.\r\nSome warm water may be added for better result.</span></p><p><strong>Use in pregnancy and lactation : </strong>The safety of DEVAS syrup in pregnancy has not been studied. Therefore, it should be used with caution during\r\npregnancy.</p>', 'uploads/images/AclenePlus.jpg', 1, '2017-11-29 03:47:18', NULL, NULL, '', 'Y', 6, 'uploads/IMG/devas.jpg'),
(1060, 'Devas', 307, '<p><strong>Composition : </strong><span class="redactor-invisible-space">Each teaspoon full (5 ml) of DEVAS syrup contains extracts of - Adhatoda vasica 0.68 gm, Piper longum 0.14 gm, Glycyrrhiza glabra 6.78 mg, Trikatu (Piper nigrum, Zingiber officinale) 20.34 mg, Terminalia chebula 73.24 mg, Vitis venifera 0.14 gm, Acorus calamus 6.78 mg, Saussurea lappa 6.78 mg, Syzygium aromaticum 6.78 mg, Trizatak (Cinnamomum zeylanicum, Elettaria cardamomum, Cinnamomum tamala) 20.34 mg, Pistacia integerrima 6.78 mg, Myrica nagi 6.78 mg,Woodfordia fruticosa 1.14 mg</span></p><p><strong>Indication : </strong><span class="redactor-invisible-space">DEVAS syrup liquefies phlegm. It sooths irritation of throat. Helps to relieve hoarseness. It is a remedy for all types of cough such as dry irritable cough, allergic & smokers cough.</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Children under 12 years :1-2 teaspoonful ( 5-10 ml ) 2-3 times a day.Adult :3 teaspoonful ( 15 ml ) 2-3 times a day. Some warm water may be added for better result.</span></p><p><strong>Use in pregnancy and lactation : </strong>The safety of DEVAS syrup in pregnancy has not been studied. Therefore, it should be used with caution during pregnancy.</p>', 'uploads/images/AclenePlus.jpg', 1, '2017-11-29 03:47:40', NULL, NULL, '', 'Y', 6, 'uploads/IMG/devas.jpg'),
(1061, 'Dort', 308, '<p><strong></strong><strong>Composition : </strong>Each capsule contains 300 mg standardized extract of St.John''s wort.</p><p><strong>Indication : </strong> </p><p><span class="redactor-invisible-space">DORT capsule is indicated to Mental depression, Anxiety, Sleeping disturbance (Insomnia),\r\nFatigue, Seasonal affected disorder (SAD). It enhances Memory, Mental concentration &\r\nReceptivity.</span></p><p><strong>Dosage and administration : </strong>1 capsule 3 times daily or as advised by the registered physician.</p>', 'uploads/images/AclenePlus.jpg', 1, '2017-11-29 03:45:53', NULL, NULL, '', 'Y', 6, 'uploads/IMG/dort.jpg'),
(1062, 'Garlicap', 309, '<p><strong></strong><strong>Composition : </strong>Each soft gelatin enteric coated capsule contains Garlic Oil 10 mg.</p><p><strong>Indication : </strong> </p><p>1. Hyperlipidemia </p><p>2. Arteriosclerosis</p><p><span class="redactor-invisible-space">\r\n3. Hypertension</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Hyperlipidemia and arteriosclerosis : 2-3 capsules daily.\r\nHypertension : 1 capsule three times daily.</span></p><p><strong>Use in pregnancy and lactation : </strong>No teratogenic effect is found. Not recommended during lactation.</p><p><br></p>', 'uploads/images/AclenePlus.jpg', 1, '2017-11-28 02:42:06', NULL, NULL, '', 'Y', 6, 'uploads/IMG/garlicap.jpg'),
(1063, 'Ginax', 310, '<p><strong></strong><strong>The pregnant mothers should consult their physician before using Ginax capsule.Composition : </strong>Each capsule contains Panax ginseng 500 mg standardized extract.</p><p><strong>Indication : </strong> </p><p>Ginax is indicated</p><p><span class="redactor-invisible-space">l\r\nTo reduce fatigue and stress</span></p><p><span class="redactor-invisible-space">\r\nl Increase vitality strengthens immunity aphordicise </span></p><p>l Erectile dysfunction and fertility </p><p>l Menopausal symptoms </p><p>l Non-insulin dependent diabetes mellitus </p><p>l Helps to prevents senile dementia.</p><p><strong>Dosage and administration : </strong></p><p>1 Ginax capsule 1 - 2 times a day or as advised by the physician.</p><p><strong>Use in pregnancy and lactation : </strong></p><p>The pregnant mothers should consult their physician before using Ginax capsule.</p><p><br></p>', 'uploads/images/AclenePlus.jpg', 1, '2017-11-28 02:43:50', NULL, NULL, '', 'Y', 6, 'uploads/IMG/GINAX-Capsule.jpg'),
(1064, 'Hepanor', 311, '<p><strong></strong><strong>Composition : </strong></p><p><span class="redactor-invisible-space"><strong>Hepanor 70 :</strong> Each capsule contains Silymarin 70 mg,\r\nwhich is the dried extract of milk thistle fruits<strong>.</strong></span></p><p><span class="redactor-invisible-space"><strong>\r\nHepanor 140 : </strong>Each capsule contains Silymarin USP 140mg,\r\nwhich is the powdered milk thistle extract<strong>.</strong></span></p><p><span class="redactor-invisible-space"><strong>\r\nHepanor 500 : </strong>Each capsule contains Silymarin 500 mg,which is\r\nthe dried extract of milk thistle fruits.</span></p><p><strong>Indication : </strong></p><p>* Toxic liver damage for supportive treatment in patients with jaundice </p><p>* Chronic inflammatory liver conditions, i.e.hepatities </p><p>* Alcoholic liver damage and hepatic cirrhosis.</p><p><strong>Dosage and administration : </strong></p><p><strong>Hepanor 70 :</strong> 1 - 2 capsules 2 to 3 times daily<strong>.</strong></p><p><span class="redactor-invisible-space"><strong>\r\nHepanor 140 : </strong>1 capsule should be taken 2 - 3 times daily.<strong> </strong></span></p><p><span class="redactor-invisible-space"><strong>Hepanor 500 : </strong>1 capsule daily.\r\nThe medication should be continued until the relief of the symptoms according to the advice\r\nof a physician.Or, as directed by the registered physician.</span></p><p><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">No experience is available with regard to the use of silymarin during pregnancy and lactation.\r\nTherefore, it should only be used after an accurate diagnosis has been made by the treating\r\ndoctor</span></p><p><strong>Packing :</strong><em></em></p><p><em>Hepanor-70 : </em>Each box contains 8 X 4 = 32 capsules in Alu-Alu blister pack.<em>\r\nHepanor-140 :</em> Each box contains 5 X 4 = 20 capsules in Alu-Alu blister pack.<em><strong>\r\n</strong>Hepanor-500 :</em> Each box contains 5 X 4 = 20 capsules in Alu-Alu blister pack.</p>', 'uploads/images/AclenePlus.jpg', 1, '2017-11-27 23:42:57', NULL, NULL, 'Y', 'Y', 6, 'uploads/IMG/hepnaor.jpg'),
(1065, 'Melbit', 313, '<p><strong>Composition : </strong>Each capsule contains Bitter Melon (korola) 400mg.</p><p><strong>Indication : </strong><span class="redactor-invisible-space">Regulate Blood sugar level, Improve pancreatic & liver function, boost immunity & natural\r\nsource of vitamin C.Helps in easy digestion.</span></p><p><strong>Dosage and administration :</strong>1-2 Capsules twice daily 20-30 minutes after meals or as advised by the registered physician.Becovent inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled Becovent appropriate to the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to individual response. Management of chronic asthma (Adults & Children over 12 years): 100-400 mcg twice daily. Maximum 1000 mcg twice daily. Children (5-12 years): 100-200 mcg twice daily. the dose may be adjusted as necessary.</p><p><strong>Use in pregnancy and lactation : </strong>Bitter melon should not be used in pregnant & lactating mother.</p><p><strong>Packing :</strong>Each box contains 10 x 4 = 40 Capsules in Alu-Alu blister pack</p>', 'uploads/images/AclenePlus.jpg', 1, '2017-11-28 03:41:44', NULL, NULL, '', 'Y', 6, 'uploads/IMG/AclenePlus.jpg'),
(1066, 'Laxadil', 312, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Laxadil Sachet : Each sachet contains\r\nIspaghula husk 3.50 gm.</span></p><p><strong>Indication :</strong></p><p><strong></strong>l Constipation</p><p>\r\nl Irritable bowels syndrome (IBS )</p><p>\r\nl Rectal bleeding (Piles)</p><p>\r\nl Helps healing ulcer of mucous membrane of stomach</p><p>\r\nl Helps reducing blood cholesterol </p><p><strong>Dosage and administration :</strong><em> Adult : </em>One sachet 1-3 times daily, children : Half dose of an adult or as directed by the\r\nregistered physician.</p>', 'uploads/images/AclenePlus.jpg', 1, '2017-11-28 02:25:38', NULL, NULL, '', 'Y', 6, 'uploads/IMG/laxadil.jpg'),
(1067, 'Mintek', 314, '<p><strong></strong><strong>Composition : </strong>Each Soft Gelatin Enteric Coated Capsule Contains Peppermint Oil 0.2ml.</p><p><strong>Indication : </strong><span class="redactor-invisible-space">Peppermint oil relaxes gastrointestinal smooth muscle and relieves flatulence and colic. It is\r\nalso used in irritable bowel syndrome (IBS).</span></p><p><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Adult : One capsule three times daily for up to 2-3 months, increased to two capsules three\r\ntimes daily if necessary. The capsule should be taken half to one hour before taking food or as\r\ndirected by a registered physician.</span></p><p><strong>Use in pregnancy and lactation : </strong></p><p><span class="redactor-invisible-space">There are no adequate and well-controlled studies in pregnant women. It is not known\r\nwhether peppermint oil is excreted in human milk.</span></p><p><strong>Packing : </strong>Each box contains 5 x 10 = 50 soft capsules in blister pack.</p>', 'uploads/images/AclenePlus.jpg', 1, '2017-11-28 03:43:48', NULL, NULL, '', 'Y', 6, 'uploads/IMG/mintek.jpg'),
(1068, 'Nacea', 315, '<p><strong></strong><strong>Composition : </strong>Each capsule contains Echinacea purpurea 400 mg</p><p><strong>Indication : </strong><span class="redactor-invisible-space">Echinacea is used for cold and chronic infection of the respiratory tract & urinary tract. It may\r\nalso use influenza like infection, Immune modulation and wound healing effects.</span></p><p><strong>Dosage and administration : </strong>1 Capsules twice daily after meals or as directed by the registered physician</p><p><strong>Use in pregnancy and lactation : </strong></p><p>Do not take during pregnancy</p><p><strong>Packing : </strong>Each box contains 8 x 4 = 32 capsules in Alu-Alu blister pack</p>', 'uploads/images/AclenePlus.jpg', 1, '2017-11-28 04:18:29', NULL, NULL, '', 'Y', 6, 'uploads/IMG/nacea.jpg'),
(1069, 'Palmetto', 316, '<p><strong></strong><strong>Composition : </strong>Each capsule contains Saw palmetto (Serenoa repens) fruit 500 mg</p><p><strong>Indication : </strong>Urination problems in benign prostatic hyperplasia stages I & II</p><p><strong>Dosage and administration : </strong>1 to 2 gm (2-4 capsules) in divided doses daily or as advised by the registered physician.</p><p><br></p><p><strong>Packing : </strong>Each box contains 8 x 4 = 32 capsules in Alu-Alu blister pack.</p>', 'uploads/images/AclenePlus.jpg', 1, '2017-11-28 04:35:04', NULL, NULL, '', 'Y', 6, 'uploads/IMG/palmetto.jpg'),
(1071, 'Primacap-1000', 317, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Primacap : Each soft gelatin capsule contains Evening Primrose Oil 500 mg.\r\nPrimacap-1000 : Each soft gelatin capsule contains Evening Primrose Oil 1000 mg</span></p><p><strong></strong></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong>Indication : </strong></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong></strong>* Premenstrual syndrome symptoms (PMS) </p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"="">* Benign breast disease & cyckical mastalgia </p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"="">* Lactation</p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><span class="redactor-invisible-space">\r\n* Atopic, allergic & neurodermatitis</span></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><span class="redactor-invisible-space">\r\n* Psoriasis </span></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"="">* Hypertension</p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><span class="redactor-invisible-space">\r\n* Rheumatoid arthritis </span></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"="">* Thrombosis </p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"="">* Atopic eczema </p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"="">* Dietary aid </p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"="">* Promotes healthy skin, nourishes brittle nail & hair.</p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong>Dosage and administration :</strong> </p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"="">Primacap : One or two capsules two to three times daily or as directed by the registered physician. </p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"="">Primacap-1000 : Atopic & Allergic Dermatitis : Adult Dosage : 1 Capsule 2 Times daily. </p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><span class="redactor-invisible-space">Children Dosage : 1 Capsule 1/2 times daily.\r\nBenign</span></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""> Breast Disease & Mastagia : 1 Capsule 2/3 times daily with or after meal. </p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"="">Premenstrual Syndrome (PMS) : 1 Capsule 2 times daily at morning & night with or after meal. </p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"="">Rheumatoid arthritis : 1 Capsule daily. Or as directed by the registered physician.</p><p><br></p>', 'uploads/images/AclenePlus.jpg', 1, '2017-11-28 04:32:45', NULL, NULL, '', 'Y', 6, 'uploads/IMG/primacap.jpg'),
(1072, 'Spirucap', 319, '<p><strong></strong><strong>Composition : </strong>Each capsule contains Spirulina dry powder 500 mg</p><p><strong></strong></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong>Indication : </strong></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong></strong><span class="redactor-invisible-space">1) Spirucap promotes formation and development of blood cells and thus effective in\r\nanemia. </span></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"="">2) It is hepatoprotective and hypocholesterolemic. </p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"="">3) Spirucap helps to maintain healthy skin and slows aging process.</p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><span class="redactor-invisible-space">\r\n4) Spirucap is antiviral. It improves immunity.</span></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong>Dosage and administration : </strong>4 - 6 capsules per day or as advised by the registered physician</p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><br></p>', 'uploads/images/AclenePlus.jpg', 1, '2017-11-28 05:13:02', NULL, NULL, '', 'Y', 6, 'uploads/IMG/spirucap.jpg'),
(1073, 'Thyvy', 320, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Each 5ml syrup contains Ivy leaf dry extract 37.5mg and\r\nThyme dry extract 50mg.</span></p><p><strong></strong></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong>Indication :</strong></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong></strong>Relieves Cough (chesty & mucosal) </p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"="">Liquefies Mucus\r\nHelps in Bronchitis (Catarrh or inflammation of the respiratory tract) </p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"="">Relieves shortness of breath</p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong>Dosage and administration :</strong> </p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"="">Children (6-9 years) & adolescents (&gt;10 years) : Take 5ml (1 tea spoonful) 3 times daily. </p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"="">Adults : Take 5-7.5ml (1-11/2 tea spoonful) 3 times daily.</p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><span class="redactor-invisible-space">\r\nDuration of treatment : Duration of treatment depends on the type and severity of the\r\nclinical picture; however treatment should continue for at least one week even in minor\r\ninflammations of the respiratory tract. Treatment with this syrup should be maintained for 2-3\r\ndays after symptoms have subsided, in order to insure lasting success of therapy. Or, as\r\ndirected by the registered physician.</span></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong>Use in pregnancy and lactation :</strong> <strong></strong></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><span class="redactor-invisible-space">This medicine should be taken during pregnancy and breast-feeding only after having\r\npreviously consulted doctor.</span></p><p><strong>Packing : </strong>100 ml in PET bottle.</p>', 'uploads/images/AclenePlus.jpg', 1, '2017-12-04 04:01:26', NULL, NULL, '', 'Y', 6, 'uploads/IMG/AclenePlus.jpg'),
(1074, 'Amlabery', 289, '<p><strong></strong><strong>Composition : </strong></p><p><span class="redactor-invisible-space">Each 5ml syrup contains extracts of Phyllanthus emblica 500.00 mg,\r\nPiper nigrum 20.00 mg, Pistacia integerrima 20.00 mg, Chlorophytum arundinaceum 20.00 mg,\r\nMesua Ferrea 20.00 mg, Glycyrrhiza glabra 10.00 mg, Withania somnifera 20.00 mg, Cyperus\r\nrotundus 5.00 mg, Elettaria cardamomum 10.00 mg, Syzygium aromaticum 5.00 mg,\r\nCinnamomum zeylanicum 5.00 mg, Ocimum album 5.00 mg, Potassium Carbonatum 5.00 mg,\r\nAdhatoda vasica 10.00 mg, Lycium barbarum 10.00 mg, Vitex nigundu 10.00 mg, Piper cubeba\r\n10.00 mg, Piper Longum 100.00 mg, Aegle marmelos 10.00 mg, Tribulus terrestris 20.00 mg,\r\nZingiber officinale 50.00 mg & other ingredients q.s.\r\nUses :\r\nVitamin C deficiency diseases, cough, cold, general weakness, nervous debility, mental fatigue,\r\nweakness of memory, indigestion, malnutrition and leanness</span></p><p><strong></strong></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><br></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Adult : 2-4 teaspoonfuls 1-2 times daily after meal.\r\nChildren : 1-2 teaspoonfuls 1-2 times daily after meal. Or, as directed by the registered\r\nphysician.</span></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">The safety of syrup Amlabery in pregnancy has not been studied. Therefore, it should be used\r\nwith caution during pregnancy.</span><strong></strong></p><p><strong>Packing : </strong>450 ml in PET bottle.</p>', 'uploads/images/AclenePlus.jpg', 1, '2017-11-29 05:37:35', NULL, NULL, '', 'Y', 5, 'uploads/IMG/amlaberry.jpg'),
(1075, 'Centrica', 290, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Each capsule contains Centella asiatica 250 mg.\r\n</span></p><p><strong></strong></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong>Indication : </strong><span class="redactor-invisible-space">It is effective in skin diseases, leprosy wound and dysentery. It helps to improve memory and\r\nfunction of brain & regulate blood pressure.</span></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong>Dosage and administration : </strong>1-2 capsules twice daily or as directed by the registered physician.</p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">The safety of penitab in pregnancy has not been established.Therefore, it should be used with\r\ncaution during pregnancy.</span><strong></strong></p><p><br></p>', 'uploads/images/AclenePlus.jpg', 1, '2017-11-29 04:34:19', NULL, NULL, '', 'Y', 5, 'uploads/IMG/Centrica-Capsule.jpg'),
(1076, 'D-Alovera ', 291, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Each 5ml syrup contains 600mg fresh inner leaf gel of Ghritokumari\r\n(Aloevera).</span></p><p><strong></strong></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong>Indication : </strong><span class="redactor-invisible-space">Aloevera is used for the treatment of liver inflammation,weakness of\r\nliver function, general weakness, gastrointestinal disorders, improves\r\nimmune system, constipation, digestion problem,fungal diseases,\r\nskin freshness,skin diseases,weight loss, amenorrhea,worm infestation and infections</span></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Adult: 3 to 5 teaspoonfuls syrup 2 times daily, preferably with a meal.Or as directed by the\r\nregistered physician.</span></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong>Use in pregnancy and lactation : </strong>Aloevera is not recommended for pregnant and lactating women.<strong></strong></p><p><strong>Packing : </strong>100 ml & 450 ml in PET bottle.</p>', 'uploads/images/AclenePlus.jpg', 1, '2017-11-29 03:44:42', NULL, NULL, '', 'Y', 5, 'uploads/IMG/D-alovera.jpg'),
(1077, 'Difans', 292, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Each 5ml syrup contains extract of\r\nPiper nigrum 150mg, Trachyspermum ammi 100mg, Citrus aurantifolia 100mg, Cinnamomum\r\nzeylanicum 50mg, Emblica officinalis 50mg, Terminalia belerica 38mg, Terminalia chebula\r\n38mg, Zingiber officinale 10mg, Sea salt 8mg and other ingrediets QS. Ref: B.N.U.F.</span></p><p><strong></strong></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong>Indication : </strong><span class="redactor-invisible-space">Digestive and carminative to correct indigestion, dyspepsia, flatulence, constipation,\r\nabdominal pain due to gases,stomach and liver disorders.</span></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong>Dosage and administration :</strong><em> </em></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><em>Adults : </em>2 teaspoonfuls 2-3 times daily<em>.</em></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><em>\r\nChildren : </em>1/2 - 1 teaspoonful 2-3 times daily or as directed by the registered physician.<br></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong>Use in pregnancy and lactation :</strong> The safety of Hazmina in pregnancy has not been established. Therefore, it should be used\r\nwith caution during pregnancy.</p>', 'uploads/images/AclenePlus.jpg', 1, '2017-11-29 03:43:19', NULL, NULL, '', 'Y', 5, 'uploads/IMG/difans.jpg'),
(1078, 'D-sefa', 293, '<p><strong></strong><strong>Composition : </strong>Each soft gelatin capsule contains Black Seed Oil 500mg.</p><p><strong></strong></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong>Indication : </strong><span class="redactor-invisible-space">D-Sefa is indicated for the treatment of common cold, cough, asthma, bronchitis,\r\nmuscle spasm,fever, dyspepsia, vomiting, gout, insufficient breast milk, eczema and wound. It is\r\nalso used to improve immune system, reduce blood sugar, blood pressure & stop hair loss.</span></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong>Dosage and administration : </strong><span class="redactor-invisible-space">1 capsule 2-3 times daily.\r\nOr, as directed by the registered physician.</span></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Black seed oil is not recommended during pregnancy. In lactating mother it should be taken to\r\nincrease breast milk of mother.</span><strong></strong></p><p><br></p>', 'uploads/images/AclenePlus.jpg', 1, '2017-11-29 03:41:42', NULL, NULL, '', 'Y', 5, 'uploads/IMG/d-sefa.jpg'),
(1079, 'Hemosaf', 294, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Each 5 ml Syrup contains extract ofCassia\r\nangustifolia 17.00 mg, Rheum emodi 13.00\r\nmg, Cassia sophera 12.50 mg, Ocimum sanctum 2.50\r\nmg, Operculina turpethum 2.00 mg, Rosa damascena\r\n2.00 mg, Sphaeranthus indicus 2.00 mg, Gentiana\r\nkurroo 2.00 mg, Fumaria parviflora 2.00 mg, Clitoria\r\nternatea 2.00 mg, Artemisia absinthium 2.00 mg,\r\nNymphaea alba 1.25 mg, Dalbergia sissoo 1.25 mg,\r\nPterocarpus santalinus 1.25 mg, Tinospora cordifolia\r\n1.25 mg, Terminalia chebula 1.25 mg, Zingiber zerumbet 1.25mg, Swertia chirata 1.25\r\nmg, Andographis paniculata 1.25 mg, Bauhinia racemosa 1.25 mg, Azadirachta indica\r\n1.25 mg, Curcuma longa 1.25 mg and other ingredients QS.</span></p><p><strong></strong></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong>Indication : </strong><span class="redactor-invisible-space">Acne vulgaris, pimples and boils, skin eruptions, impurities in blood, chronic\r\n& temporary constipation, general lassitude, heat rash and itching, epistaxis, measles,\r\nburning sensation during urination and also as an immunostimulant.</span></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong>Dosage and administration : </strong>: 2-4 teaspoonfuls 1-2 times daily.</p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><br></p>', 'uploads/images/AclenePlus.jpg', 1, '2017-11-28 02:46:20', NULL, NULL, 'Y', 'Y', 5, 'uploads/IMG/hemosaf.jpg'),
(1080, 'Jarira', 295, '<p><strong></strong><strong>Composition : </strong>Each Capsule Contains Chirata (Swertia chirata) 250mg.</p><p><strong></strong></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong>Indication : </strong></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"="">* Dyspepsia,Appetite Suppressant, gastric juice secretion & gastrointestinal tract disturbance. </p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"="">* Control acidity, gas, indigestion, naturally.</p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"="">\r\n* Controls blood sugar.</p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"="">\r\n* Reduce intermittent & remittent fever.</p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"="">\r\n* Reduce obesity & cholesterol naturally. </p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"="">* Anti-allergic agent & protects liver & kidney naturally. </p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"="">* lt is useful in skin diseases like acne, pimples and other infections of skin.</p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"="">\r\n* Develops immunity. </p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"="">* Long term uses of Jarira capsule destroy intestinal worms.<br></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong>Dosage and administration :</strong><span class="redactor-invisible-space">1-2 Capsules 2-3 times daily.\r\nOr, as directed by the registered physician.</span> </p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong>Use in pregnancy and lactation :</strong> Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.<strong></strong></p><p><strong>Packing : </strong>Becovent HFA Inhaler : Each box contains one inhaler of 200 Puffs</p>', 'uploads/images/AclenePlus.jpg', 1, '2017-11-28 02:48:44', NULL, NULL, '', 'Y', 5, 'uploads/IMG/jarira.jpg'),
(1081, 'Livro', 296, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Each 5ml syrup contains extract of Cichorium endivia\r\n(Root) 400mg, Cichorium endivia (Seed) 200mg, Rosa\r\ndamascena 200mg, Nymphaea alba 100mg, Borago officinalis 100mg, Cuscuta reflexa 150mg,\r\nRheum emodi 125mg.</span></p><p><strong></strong></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong>Indication : </strong>Hepatitis,Obstructive Jaundice,Ascitis,Constipation, Pleurisy & Metritis</p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Adults: 2-3 teaspoonfuls twice daily.\r\nChildren : 1/2-1 teaspoonful twice daily after meal or as directed by the registered physician.</span></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">No experience is available with regard to the use during pregnancy and lactation. Therefore, it\r\nshould only be used after an accurate diagnosis has been made by the treating doctor.</span><strong></strong></p><p><br></p>', 'uploads/images/AclenePlus.jpg', 1, '2017-11-28 02:51:41', NULL, NULL, '', 'Y', 5, 'uploads/IMG/Livro-Syrup.jpg'),
(1082, 'Naturovit', 297, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Each 5ml syrup contains extract of Daucus carota 200mg, Emblica officinalis 100mg, Aquilaria\r\nagallocha 50mg, Amomum subulatum 50mg, Coriandrum sativum 50mg, Cyperus rotundus\r\n50mg, E lettaria cardamomum 50mg, Eugenia caryophyllus 50mg, Nardostachys jatamansi\r\n50mg, Zingiber zerumbet 50mg, Cinnamomum zeylanicum 50mg, Rosa damascena 50mg,\r\nSantalumalbum50mg, Ocimumsactum50mg, Usnea longissima 50mg</span></p><p><strong></strong></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong>Indication : </strong></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"="">* Nutritional Therapy </p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"="">* Anemia during Pregnancy</p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><span class="redactor-invisible-space">\r\n* Growth of Children </span></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"="">* L ack of Appetite</p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><span class="redactor-invisible-space">\r\n* Elemental Deficiencies </span></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"="">* Nervousness</p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><span class="redactor-invisible-space">\r\n* Mental Performance</span></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><span class="redactor-invisible-space">\r\n* V itamin Deficiencies</span></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><span class="redactor-invisible-space">\r\n* Increased Stamina </span></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"="">* L oss of Weight </p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"="">* Stress and Acute Illness </p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"="">* V itamin Deficiency due to Antibiotic Therapy</p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong>Dosage and administration :</strong> </p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><span class="redactor-invisible-space">Adults : 6 teaspoonfuls twice daily.\r\nChildren : 2 teaspoonfuls twice daily or as directed by the registered physician.</span></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><br></p>', 'uploads/images/AclenePlus.jpg', 1, '2017-11-28 04:16:47', NULL, NULL, '', 'Y', 5, 'uploads/IMG/22.jpg'),
(1083, 'Ridex', 298, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Each capsule containsMyristica\r\nfragrans (arillus)	66.66 mg\r\nLacerta agilis	66.66 mg\r\nArgyreia speciosa	33.33 mg\r\nMyristica fragrans (nut)	33.33 mg\r\nCalcined silver	16.66 mg\r\nCrocus sativus	16.66 mg\r\nMineral bezoar	8.33 mg\r\nCastoreum	8.33 mg\r\nand other ingredients\r\nRef: Habbe Nishat\r\nBangladesh National Unani Formulary</span></p><p><strong></strong></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong>Indication : </strong><span class="redactor-invisible-space">Sexual weakness, Premature ejaculation, Nervous debility, General\r\nweakness.</span></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Usually one capsule in the morning and one capsule at\r\nbed time or two capsules to be taken with milk or honey 2 hours before coitus daily or as\r\ndirected by the registered physician. Ridex should be continued at least 3-4 weeks for\r\noptimum result. For better result patients are advised following mode of administration:\r\n2+0+2 Capsules for 5 days then 2+0+1 capsules for 10 days followed by 1+0+1 capsule\r\nas maintenance dose. Continuous use of Ridex may serve as a good general restorative\r\ntonic. For complete functional impotence it is necessary to increase the above dosage of\r\nRidex to 2 capsules t.i.d. This should be done under constant supervision. or, as directed\r\nby the registered physician.</span></p><br><p><strong>Packing :</strong><em> </em><span class="redactor-invisible-space"><em>Ridex : </em>Each box contains 5 x 4 = 20 capsules in Alu-Alu blister pack.\r\n</span></p>', 'uploads/images/AclenePlus.jpg', 1, '2017-11-28 04:56:37', NULL, NULL, '', 'Y', 5, 'uploads/IMG/ridex.jpg');
INSERT INTO `drg_medicine_info` (`MEDICINE_ID`, `MEDICINE_NAME`, `GN_GRP_ID`, `MEDICINE_DESC`, `INSERT_FILE`, `CRE_BY`, `CRE_DT`, `UPD_BY`, `UPD_DT`, `IS_LATEST`, `ACTIVE_STATUS`, `CAT_ID`, `PRODUCT_FET_PHOTO`) VALUES
(1084, 'Tifal', 299, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Each 5ml syrup containsPimpinella\r\nanisum (Anise)\r\nAnethum sowa (Sowa Seed) 0.002 ml\r\nAmomum subulatum (Greater cardamom)\r\nMentha arvensis (Mint)\r\nAnise oil (Anise oil) 0.0035 ml\r\nHordeum vulgare (Barley) 40.00 mg\r\nand other ingredients QS\r\nReference : BNUF</span></p><p><strong></strong></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong>Indication : </strong><span class="redactor-invisible-space">Flatulence, diarrhea and indigestion,stomach disorder & discomfort of infants & children\r\nduring teething.</span></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong>Dosage and administration : </strong></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"="">Up to 6 months :</p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><span class="redactor-invisible-space"> 1/2 teaspoonfull syrup 3 - 4 times daily.6 months to 1 year :\r\n1 teaspoonfull syrup 3 - 4 times daily.1 to 2 year : 1 - 2 teaspoonfull syrup 3 - 4 times daily.Or\r\nas directed by the registered physician.</span></p><p><strong>Packing : </strong>100 ml in PET bottle.</p>', 'uploads/images/AclenePlus.jpg', 1, '2017-12-04 03:59:32', NULL, NULL, '', 'Y', 5, 'uploads/IMG/tifal.jpg'),
(1085, 'Tims', 300, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Each 5ml syrup contains extract ofSaraca\r\nindica (Ashok) 250.00mg\r\nWithania somnifera (Winter cherry) 125.00mg\r\nSmilax china (China root) 62.50mg\r\nAbroma augusta (Devil''s cotton) 62.50mg\r\nRauwolfia serpentina (Snake root) 50.00mg\r\nFerrum (Iron) 10.00mg</span></p><p><strong></strong></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong>Indication : </strong></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"="">Menstrual irregularities</p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"="">Dysmenorrhoea </p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"="">Amenorrhoea </p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"="">Leucorrhoea</p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"="">Metritis</p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"="">Uterine inflammation & anaemia</p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong>Dosage and administration : </strong><span class="redactor-invisible-space">2 tea-spoonfuls at bedtime with lukewarm water. In chronic cases additional 2 tea-spoonfuls in\r\nthe morning as well. If necessary 4 tea spoonfuls twice daily can be given with the\r\nrecommendation of the registered physician.Not recommended for children. or, as directed by\r\nthe registered physician.</span></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><br></p>', 'uploads/images/AclenePlus.jpg', 1, '2017-12-04 03:58:08', NULL, NULL, '', 'Y', 5, 'uploads/IMG/tims.jpg'),
(1086, 'Zurid', 301, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Each 5ml syrup contains extract ofCichorium\r\nintybus (Root) 250.00 mg\r\nCucumis melo (Seed) 250.00 mg\r\nFoeniculum vulgare (Root) 125.00 mg\r\nFoeniculum vulgare (Seed) 125.00 mg\r\nCichorium intybus (Seed) 125.00 mg\r\nTribulusterrestris 125.00 mg</span></p><p><strong></strong></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong>Indication :</strong></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong></strong>* Pyrexia\r\n* Oliguria </p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"="">* Amenorrhoea </p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"="">* Hepatitis </p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"="">* Obstructive jaundice </p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"="">* It is very effective to clear the morbid substances from the kidney and urinary bladder.</p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><br></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong>Dosage and administration :</strong><span class="redactor-invisible-space">Adult : 2-4 teaspoonfuls two to four times daily.\r\nChildren : 1-2 teaspoonfuls two to four times daily.\r\nOr, as directed by the registered physician.\r\n</span></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><br></p>', 'uploads/images/AclenePlus.jpg', 1, '2017-11-28 02:02:11', NULL, NULL, '', 'Y', 5, 'uploads/IMG/zurid.jpg'),
(1087, 'Ferozi-CI', 323, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Each Time Release\r\nCapsule Contains Elemental Iron 50mg\r\n(as Carbony Iron), Folic Acid 0.50mg and\r\nZinc Sulphate Monohydrate 61.80mg.</span></p><p><strong></strong></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong>Indication :</strong>It is indicated for the\r\ntreatment and prophylaxis of Iron, Folic\r\nAcid and Zinc deficiency specially during\r\npregnancy and lactation.Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids.</p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong>Dosage and administration : </strong><span class="redactor-invisible-space">Adults:\r\nOne capsule daily before food. Or as\r\ndirected by the registered physician.</span></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong>Use in pregnancy and lactation : </strong><span class="redactor-invisible-space">Use\r\nof any drug during the first trimester of\r\npregnancy should be avoided if possible.\r\nThus administration of iron during the\r\nfirst trimester requires definite evidence\r\nof iron deficiency. Prophylaxis of iron\r\ndeficiency where inadequate diet calls\r\nfor supplementary zinc and folic acid is\r\njustified during the remainder of\r\npregnancy.</span><strong></strong></p><p><strong>Packing :<em> </em></strong><span class="redactor-invisible-space"><em>Ferozi-CI TR Capsule :\r\n</em>5x10''s capsules in blister pack.</span></p>', 'uploads/images/ferozi_ci.jpg', 1, '2017-11-29 02:55:11', NULL, NULL, '', 'Y', 4, 'uploads/IMG/ferozi-ci.jpg'),
(1088, 'Ferospan', 321, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Ferospan timed release\r\ncapsule is a combination of blended\r\npellets of dried Ferrous Sulphate 150mg\r\nand Folic Acid 500mcg.</span></p><p><strong></strong></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong>Indication : </strong><span class="redactor-invisible-space">Ferospan is indicated for\r\nthe treatment and prophylaxis of iron and\r\nfolic acid deficiency, specially during\r\npregnancy and lactation.\r\n</span></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong>Dosage and administration : </strong><span class="redactor-invisible-space">1 capsule\r\ndaily throughout pregnancy and lactation\r\nor as directed by the physician.</span></p><br><p><strong>Packing : </strong><span class="redactor-invisible-space">Ferospan 6 x 10''s capsules in\r\nblister pack.</span></p>', 'uploads/images/ferospan.jpg', 1, '2017-11-29 02:53:34', NULL, NULL, '', 'Y', 4, 'uploads/IMG/ferospan.jpg'),
(1089, 'Ferozi', 322, '<p><strong></strong><strong>Composition : </strong><span class="redactor-invisible-space">Ferozi timed release\r\ncapsule is a combination of blended\r\npellets of dried Ferrous Sulphate 150mg,\r\nFolic Acid 500mcg & Zinc Sulphate\r\nMonohydrate 61.8mg (Eq to 22.5mg\r\nzinc).</span></p><p><strong></strong></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong>Indication : </strong><span class="redactor-invisible-space">Ferozi is indicated for the\r\ntreatment and prophylaxis of iron, folic\r\nacid and zinc deficiency, specially during\r\npregnancy and lactation.</span></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, " helvetica="" neue",="" helvetica,="" arial,="" sans-serif;"=""><strong>Dosage and administration : </strong><span class="redactor-invisible-space">1 capsule\r\ndaily throughout pregnancy and lactation\r\nor as directed by the physician.</span></p><p><strong>Packing </strong><strong>:</strong>  <em>Ferozi : </em>6 x 10''s capsules in blister pack.</p>', 'uploads/images/ferozi.jpg', 1, '2017-11-29 02:52:03', NULL, NULL, '', 'Y', 4, 'uploads/IMG/ferozi.jpg'),
(1090, 'Neoplat', 37, '<p><strong></strong><strong>Composition : </strong>Each Metered dose (Puff) contains Beclometasone Dipropionate 100 mcg.</p><p><strong></strong></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, &quot;Helvetica Neue&quot;, Helvetica, Arial, sans-serif;"><strong>Indication : </strong>Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids.</p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, &quot;Helvetica Neue&quot;, Helvetica, Arial, sans-serif;"><strong>Dosage and administration :</strong> Becovent inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled Becovent appropriate to the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to individual response. Management of chronic asthma (Adults & Children over 12 years): 100-400 mcg twice daily. Maximum 1000 mcg twice daily. Children (5-12 years): 100-200 mcg twice daily. the dose may be adjusted as necessary.</p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, &quot;Helvetica Neue&quot;, Helvetica, Arial, sans-serif;"><strong>Use in pregnancy and lactation :</strong> Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.<strong></strong></p><p><strong>Packing : </strong>Becovent HFA Inhaler : Each box contains one inhaler of 200 Puffs</p>', 'uploads/images/neoplat.jpg', 1, '2017-11-09 23:10:26', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/neoplat.jpg'),
(1091, 'Carplatin', 18, '<p><strong></strong><strong>Composition : </strong>Each Metered dose (Puff) contains Beclometasone Dipropionate 100 mcg.</p><p><strong></strong></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, &quot;Helvetica Neue&quot;, Helvetica, Arial, sans-serif;"><strong>Indication : </strong>Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids.</p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, &quot;Helvetica Neue&quot;, Helvetica, Arial, sans-serif;"><strong>Dosage and administration :</strong> Becovent inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled Becovent appropriate to the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to individual response. Management of chronic asthma (Adults & Children over 12 years): 100-400 mcg twice daily. Maximum 1000 mcg twice daily. Children (5-12 years): 100-200 mcg twice daily. the dose may be adjusted as necessary.</p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, &quot;Helvetica Neue&quot;, Helvetica, Arial, sans-serif;"><strong>Use in pregnancy and lactation :</strong> Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.<strong></strong></p><p><strong>Packing : </strong>Becovent HFA Inhaler : Each box contains one inhaler of 200 Puffs</p>', 'uploads/images/ferozi.jpg', 1, '2017-11-09 23:27:19', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/carplatin-150.jpg'),
(1092, 'Ontaxel', 103, '<p><strong></strong><strong>Composition : </strong>Each Metered dose (Puff) contains Beclometasone Dipropionate 100 mcg.</p><p><strong></strong></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, &quot;Helvetica Neue&quot;, Helvetica, Arial, sans-serif;"><strong>Indication : </strong>Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids.</p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, &quot;Helvetica Neue&quot;, Helvetica, Arial, sans-serif;"><strong>Dosage and administration :</strong> Becovent inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled Becovent appropriate to the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to individual response. Management of chronic asthma (Adults & Children over 12 years): 100-400 mcg twice daily. Maximum 1000 mcg twice daily. Children (5-12 years): 100-200 mcg twice daily. the dose may be adjusted as necessary.</p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, &quot;Helvetica Neue&quot;, Helvetica, Arial, sans-serif;"><strong>Use in pregnancy and lactation :</strong> Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.<strong></strong></p><p><strong>Packing : </strong>Becovent HFA Inhaler : Each box contains one inhaler of 200 Puffs</p>', 'uploads/images/ferozi.jpg', 1, '2017-11-09 23:28:59', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/ontaxel-100.jpg'),
(1093, 'Vinstin', 148, '<p><strong></strong><strong>Composition : </strong>Each Metered dose (Puff) contains Beclometasone Dipropionate 100 mcg.</p><p><strong></strong></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, &quot;Helvetica Neue&quot;, Helvetica, Arial, sans-serif;"><strong>Indication : </strong>Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids.</p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, &quot;Helvetica Neue&quot;, Helvetica, Arial, sans-serif;"><strong>Dosage and administration :</strong> Becovent inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled Becovent appropriate to the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to individual response. Management of chronic asthma (Adults & Children over 12 years): 100-400 mcg twice daily. Maximum 1000 mcg twice daily. Children (5-12 years): 100-200 mcg twice daily. the dose may be adjusted as necessary.</p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, &quot;Helvetica Neue&quot;, Helvetica, Arial, sans-serif;"><strong>Use in pregnancy and lactation :</strong> Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.<strong></strong></p><p><strong>Packing : </strong>Becovent HFA Inhaler : Each box contains one inhaler of 200 Puffs</p>', 'uploads/images/ferozi.jpg', 1, '2017-11-09 23:29:51', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/vinstin.jpg'),
(1094, 'Toposar', 59, '<p><strong></strong><strong>Composition : </strong>Each Metered dose (Puff) contains Beclometasone Dipropionate 100 mcg.</p><p><strong></strong></p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, &quot;Helvetica Neue&quot;, Helvetica, Arial, sans-serif;"><strong>Indication : </strong>Becovent is indicated in the maintenance treatment of asthma as prophylactic therapy in patients 5 years of age and older. Becovent is also indicated for asthma patients who require systemic corticosteroid administration, where adding Becovent may reduce or eliminate the need for the systemic corticosteroids.</p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, &quot;Helvetica Neue&quot;, Helvetica, Arial, sans-serif;"><strong>Dosage and administration :</strong> Becovent inhaler is for oral inhalation use only. Patients should be given a starting dose of inhaled Becovent appropriate to the severity of their disease. The dose may then be adjusted until control is achieved or reduced to the minimum effective dose according to individual response. Management of chronic asthma (Adults & Children over 12 years): 100-400 mcg twice daily. Maximum 1000 mcg twice daily. Children (5-12 years): 100-200 mcg twice daily. the dose may be adjusted as necessary.</p><p style="margin-bottom: 10px; background-color: rgb(255, 255, 255); color: rgb(68, 68, 68); font-family: Roboto, &quot;Helvetica Neue&quot;, Helvetica, Arial, sans-serif;"><strong>Use in pregnancy and lactation :</strong> Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.<strong></strong></p><p><strong>Packing : </strong>Becovent HFA Inhaler : Each box contains one inhaler of 200 Puffs</p>', 'uploads/images/ferozi.jpg', 1, '2017-11-09 23:30:47', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/toposar.jpg'),
(1152, 'Cabita', 3, '<p>Use in pregnancy and lactation : Administration of drugs during pregnancy and lactation should only be considered if the expected benefit to the mother is greater than any possible risk to the foetus or child. There is insufficient experience of the use of Salmeterol Xinafoate and Fluticasone Propionate in human pregnancy and lactation. There are no data available for human breast milk.</p>', 'uploads/IMG/cabita.jpg', 1, '2017-12-05 05:49:22', NULL, NULL, '', 'Y', 4, 'uploads/IMG/cabita.jpg'),
(1153, 'Fluracil', 66, '<p style="margin-bottom: 10px; color: rgb(68, 68, 68); font-family: Roboto, &quot;Helvetica Neue&quot;, Helvetica, Arial, sans-serif; background-color: rgb(255, 255, 255);">Composition : Fexofenadine Hydrochloride 60mg, 120mg, 180mg Tablet & 30mg/5ml Suspension.</p><p style="margin-bottom: 10px; color: rgb(68, 68, 68); font-family: Roboto, &quot;Helvetica Neue&quot;, Helvetica, Arial, sans-serif; background-color: rgb(255, 255, 255);">Indication : Fexofenadine Hydrochloride is indicated for the relief from physical symptoms associated with seasonal allergic rhinitis and treatment of chronic idiopathic urticaria. It is not cure totally but prevents the aggravation of rhinitis and urticaria. It reduces the severity of the symptoms and providing much relief from repeated sneezing, runny nose, itchy eyes and general body fatigue caused by rhinitis and urticaria.</p><p style="margin-bottom: 10px; color: rgb(68, 68, 68); font-family: Roboto, &quot;Helvetica Neue&quot;, Helvetica, Arial, sans-serif; background-color: rgb(255, 255, 255);">Dosage and administration : Fexofast tablets: Seasonal allergic rhinitis and chronic idiopathic urticaria: Adults and Children 12 Years and Older: The recommended dose of Fexofenadine Hydrochloride is 60 mg twice daily or 180 mg once daily with water. A dose of 60 mg once daily is recommended as the starting dose in patients with decreased renal function. Children 6 to 11 Years: 30 mg twice daily with water. A dose of 30 mg once daily is recommended as the starting dose in patients with decreased renal function.<br></p><p style="margin-bottom: 10px; color: rgb(68, 68, 68); font-family: Roboto, &quot;Helvetica Neue&quot;, Helvetica, Arial, sans-serif; background-color: rgb(255, 255, 255);">Use in pregnancy and lactation : Fexofenadine has been assigned to pregnancy category C by the FDA.<br></p><p style="margin-bottom: 10px; color: rgb(68, 68, 68); font-family: Roboto, &quot;Helvetica Neue&quot;, Helvetica, Arial, sans-serif; background-color: rgb(255, 255, 255);">Packing :</p><p style="margin-bottom: 10px; color: rgb(68, 68, 68); font-family: Roboto, &quot;Helvetica Neue&quot;, Helvetica, Arial, sans-serif; background-color: rgb(255, 255, 255);">Fexofast-60 : 5x 10''s tablets in blister pack.</p><p style="margin-bottom: 10px; color: rgb(68, 68, 68); font-family: Roboto, &quot;Helvetica Neue&quot;, Helvetica, Arial, sans-serif; background-color: rgb(255, 255, 255);">Fexofast-120 : 3x 10''s tablets in blister pack.</p><p style="margin-bottom: 10px; color: rgb(68, 68, 68); font-family: Roboto, &quot;Helvetica Neue&quot;, Helvetica, Arial, sans-serif; background-color: rgb(255, 255, 255);">Fexofast-180 : 2x10''s tablets in blister pack.</p><p>Fexofast Suspension : 50ml suspension.Fluracil</p>', 'uploads/IMG/Fluracil.jpg', 1, '2017-12-05 05:59:53', NULL, NULL, '', 'Y', 4, 'uploads/IMG/Fluracil.jpg'),
(1154, 'Dobixin', 54, '<p>Dosage and administration : Fexofast tablets: Seasonal allergic rhinitis and chronic idiopathic urticaria: Adults and Children 12 Years and Older: The recommended dose of Fexofenadine Hydrochloride is 60 mg twice daily or 180 mg once daily with water. A dose of 60 mg once daily is recommended as the starting dose in patients with decreased renal function. Children 6 to 11 Years: 30 mg twice daily with water. A dose of 30 mg once daily is recommended as the starting dose in patients with decreased renal function.</p>', 'uploads/IMG/ANROS-Capsule.jpg', 1, '2017-12-05 06:08:16', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/ANROS-Capsule.jpg'),
(1156, 'Flunac ', 63, '<p><strong></strong><strong>Composition : </strong>Fluconazole 50mg,150mg Capsule & 50mg/5ml Dry Powder for Suspension.<strong></strong></p><p><strong>Indications : </strong>Flunac is used for the treatment of oropharyngeal, oesophageal, vaginal mucosal or systemic candidiasis, oesophagitis,</p><p>candiduria and meningitis. <strong></strong></p><p><strong>Dosage and administration : </strong>Flunac is administered orally. Adults & patients over 18 years : Mucosal candidiasis (except vaginal</p><p>candidiasis)-Oropharyngeal candidiasis : the recommended dose is 50mg once daily for 7 to 14 days. For other candidal infections of the mucosa e.g. oesophagitis, non-invasive bronchopulmonary infections, candiduria, mucocutaneous candidiasis etc.: the recommended dose is 50mg daily, given for 14 to 30 days. In unusually difficult cases of mucosal candidal infections the dose can be increased to 100mg daily. Vaginal candidiasis : 150mg single oral</p><p>dose. Systemic candidiasis (Cryptococcal infections e.g., meningitis) : 400mg initially, then 200mg daily. The dose can be increased upto 400mg daily if necessary. Treatment should continue according to patient''s response. Child over 1 year : Superficial candidal infections, 1-2 mg/kg daily; systemic candidiasis and Cryptococcal infections- 3-6mg/kg daily. In serious life threatening infections upto 12mg/kg daily has been given to children aged 5-13 years, max- 400mg daily. Or, as directed by the registered physician<strong>.</strong></p><p><strong>Use in pregnancy and lactation : </strong>FDA approved Pregnancy Category C. </p><p><strong><br></strong></p><p><strong></strong><strong>Package quantities : </strong>Flunac-50 Capsule : 3x10''s capsules in blister pack. Flunac-150 Capsule : 2x10''s capsules in blister pack. Flunac Suspension : 35ml suspension.</p>', 'uploads/IMG/flunac.jpg', 1, '2017-12-07 05:24:15', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/flunac.jpg'),
(1157, 'Mycofree', 137, '', 'uploads/IMG/mycofree.jpg', 1, '2017-12-07 05:27:48', NULL, NULL, '', 'Y', 4, 'uploads/IMG/mycofree.jpg'),
(1158, 'Hopso', 130, '<p>Hopso</p>', 'uploads/IMG/hopso.jpg', 1, '2017-12-07 05:29:39', NULL, NULL, '', 'Y', 4, 'uploads/IMG/hopso.jpg'),
(1159, 'Opegus', 118, '<p>Opegus</p>', 'uploads/IMG/opegus.jpg', 1, '2017-12-07 05:31:01', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/opegus.jpg'),
(1160, 'Novirax', 6, '<p><strong></strong><strong>Composition :</strong>Acyclovir 200mg & 400mg Tablet<strong>.</strong></p><p><strong></strong></p><p><strong><br></strong></p><p><strong>Indications : </strong>Novirax tablet is indicated for the treatment of viral infections due to</p><p>herpes simplex virus (type I & II) and vericella zoster virus (herpes zoster &</p><p>chicken pox). It is indicated for the treatment of herpes simplex virus infections of the skin and mucous membranes including initial and recurrent genital herpes. Novirax tablet is also indicated for the prophylaxis of herpes simplex infections in immunocompromised patients<strong>.</strong></p><p><strong><br></strong></p><p><strong>Dosage & administration :</strong>Oral : Herpes simplex initial therapy :200mg 5 times daily for 10 days. Herpes simplex chronic suppressive therapy : 200-400mg 2 to 4 times daily for 12 months. Herpes Zoster : 800mg 5 times at 4 hrs intervals for 7-10 days. Varicela Zoster : 20mg/kg (not more than 800mg) 4 times daily for 5 days.</p><p>Children : Under 2 years should be given half of these doses. Elderly : Dosage may also be reduced as required. Or as directed by the physician.</p><p><strong><br></strong></p><p><strong>Use in pregnancy and lactation : </strong>There are no adequate and well controlled studies in pregnant women. Novirax should be administered to a</p><p>nursing mother with caution and only when indicated. Novirax should be used</p><p>during pregnancy only if the potential benefit justifies the potential risk to the</p><p>fetus.<strong></strong></p><p><strong>Packing :</strong>	</p><p>Novirax-200 : 3 x 10''s tablets in blister</p><p>pack.</p><p>Novirax-400 : 2 x 10''s tablets in blister</p><p>pack.<br></p>', 'uploads/IMG/novirex.jpg', 1, '2017-12-07 05:37:42', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/novirex.jpg'),
(1161, 'Entavir ', 56, '<p><strong></strong><strong>Composition :</strong>Entecavir 0.5mg & 1mg Tablet.</p><p><strong><br></strong></p><p><strong> </strong><strong>Indications : </strong>This tablet is indicated for the treatment of chronic hepatitis B virus infection in adults with evidence of active viral replication and either evidence of persistent elevations in serum aminotransferases or histologically active disease<strong>. </strong></p><p><strong></strong><strong>Dosage and administration : </strong>The recommended dose of Entecavir for chronic hepatitis B virus infection in nucleoside-treatment-naive adults and adolescents 16 years of age and older is 0.5mg once daily. The recommended dose of Entecavir in adults and adolescents (&gt;16 years of age) with a history of hepatitis B viremia while receiving lamivudine is 1mg once daily. Entecavir should be administered on an empty stomach (at least 2 hours after a meal and 2 hours before the next meal). Or, as directed by the registered physician<strong>.</strong></p><p><strong>Packing :</strong></p><p>Entavir-0.5 : 1x14''s tablets in blister</p><p>pack.</p><p>Entavir-1 : 1x14''s tablets in blister pack.<br></p>', 'uploads/IMG/entavir.jpg', 1, '2017-12-07 05:42:10', NULL, NULL, '', 'Y', 4, 'uploads/IMG/entavir.jpg'),
(1162, 'T-fovir', 136, '<p><strong></strong><strong>Composition : </strong>Tenofovir Disoproxil Fumarate 300mg Tablet.</p><p><strong><br></strong></p><p><strong></strong><strong>Indications : </strong>This tablet is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection and also indicated for the treatment of chronic hepatitis B. <strong></strong></p><p><strong></strong><strong>Dosage and administration : </strong>For the treatment of HIV-1 or chronic hepatitis B:</p><p>The recommended dose of Tenofovir is 300mg once daily taken orally with or without food.<strong></strong></p><p><strong>Use in Pregnancy and lactation : </strong>There are no adequate and well-controlled studies in pregnant women. Tenofovir should be used during pregnancy only if clearly needed and after careful consideration of the risks and benefits.<span></span></p><p><strong><br></strong></p><p><strong>Packing : </strong>T-fovir : 1 x 7''s tablets in alu</p><p>alu blister pack.<br></p>', 'uploads/IMG/t-fovir.jpg', 1, '2017-12-07 05:45:37', NULL, NULL, '', 'Y', 4, 'uploads/IMG/t-fovir.jpg'),
(1163, 'AH', 7, '<p><strong></strong><strong>Composition : </strong>Albendazole 400mg Chewable Tablet & 200mg/5ml Oral</p><p>Suspension.<strong></strong></p><p><strong>Indications : </strong>a) Albendazole is indicated in single and mixed infestations, sush as-</p><p>1. Hookworm (Ancylostoma, Necator), 2.Roundworm (Ascaris), 3. Threadworm</p><p>(Enterobius), 4. Whipworm (Trichuris), 5.Strongyloides, 6. Tapeworm (Taenia sp.),</p><p>7. Opistorchis, 8. Hydatid disease (Echinococcus), 9. Neurocysticercosis,</p><p>10. Systemic nematodes, 11. Giardiasis, 12. Microsporidiosis<strong>.</strong></p><p><strong>Dosage and administration : </strong>Adults or children over 2 years of age : 400mg (1 AH tablet or 10ml suspension) as a single dose in cases of Enterobius</p><p>vermicularis, Trichuris trichiura, Ascaris lumbricoides, Ancylostoma duodenale and Necator americanus. In cases of strongyloidiasis or taeniasis, 400mg (1 AH tablet or 10ml suspension) as a single dose should be given for 3 consecutive days. If the patient is not cured on follow-up after three weeks, a second course of treatment is indicated. AH 400mg tablets must be chewed. Both the preparations may be crushed and mixed with food. Children under 2 years of age : Not recommended.<span></span></p><p><strong>Use in pregnancy and lactation :</strong></p><p>Pregnancy Category C by FDA.</p><p><strong>Packing :</strong></p><p>AH Chewable Tablet : 10 x 2''s tablets in</p><p>blister pack.</p><p>AH Oral Suspension : 10ml bottle.<br></p>', 'uploads/IMG/AH.jpg', 1, '2017-12-07 05:54:21', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/AH.jpg'),
(1164, 'Nitanid ', 97, '<p><strong></strong><strong>Composition : </strong>Nitazoxanide 500mg Tablet & 100mg/5ml Suspension<strong>.</strong></p><p><strong>Indications : </strong>1. Diarrhoea caused by Cryptosporidium parvum and Giardia lamblia. 2. Amebiasis and helminth infections.</p><p><strong><br></strong></p><p><strong> </strong><strong>Dosage & administration : </strong>Age 1-3 years : 5ml (100 mg) twice daily for 3 days Age 4-11 years : 10ml (200 mg) twice daily for 3 days Age 12 years : 500mg or one tablet twice daily for 3 days Nitanid should be taken with food. Or, as directed by the registered physician<strong>.</strong><strong></strong></p><p><strong>Use in pregnancy & lactation : </strong>Pregnancy Category B.</p><p><strong><br></strong></p><p><strong>Packing : </strong>Nitanid-500 : 2 x 10''s tablets</p><p>in blister pack.</p><p>Nitanid suspension : Bottle containing</p><p>dry powder to reconstitute 60ml</p><p>suspension.<br></p>', 'uploads/IMG/nitanid.jpg', 1, '2017-12-07 05:59:27', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/nitanid.jpg'),
(1165, 'Ornid', 102, '<p><strong></strong><strong>Composition : </strong>Ornidazole 500mg Tablet.</p><p><strong><br></strong></p><p><strong>Indications : </strong>Ornid is indicated in the treatment of susceptible protozoal infections and prophylaxis of anaerobic bacterial infections.</p><p><strong><br></strong></p><p><strong>Use in pregnancy and lactation :</strong></p><p>Pregnancy Category C by FDA.</p><p><strong><br></strong></p><p><strong>Packing : </strong>Ornid : 5 x 10''s tablets in blister</p><p>pack.<br></p>', 'uploads/IMG/ornid.jpg', 1, '2017-12-07 06:01:48', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/ornid.jpg'),
(1166, 'Cikolin', 38, '<p><strong></strong><strong>Composition : </strong>Citicoline 500mg Tablet.</p><p><strong><br></strong></p><p><strong>Indications : </strong>It is indicated in the treatment of Alzheimer''s disease and other types of dementia, head trauma, amblyopia, cerebrovascular disease such as ischaemic stroke, age-related</p><p>memory loss, Parkinson''s disease, attention deficit-hyperactive disorder (ADHD) and glaucoma.</p><p><strong></strong></p><p><br></p><p><strong>Dosage and administration : </strong>i) For decline in thinking skills due to age: 1000-2000mg of Citicoline per day. ii) For ongoing disease of the blood vessels that serve the brain (chronic cerebrovascular disease): 600mg of Citicoline per day. iii) For immediate treatment of stroke due to a clot (ischemic stroke): 500-2000mg of Citicoline per day starting within 24 hours of stroke. Or, as directed by the registered physician.<span></span></p><p><strong><br></strong></p><p><strong>Use in pregnancy and lactation :</strong></p><p>Pregnancy: There is not enough reliable</p><p>information about the safety of taking</p><p>Citicoline to pregnant women. Therefore, it</p><p>should be used during pregnancy only if</p><p>clearly needed.<br></p><p><strong><br></strong></p><p><strong>Packing : </strong>Cikolin-500 : 1 x 7''s tablets in</p><p>blister pack.<br></p>', 'uploads/IMG/cikolin.jpg', 1, '2017-12-07 06:14:31', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/cikolin.jpg'),
(1167, 'D-Dopa', 79, '<p><strong></strong><strong>Composition : </strong>Levodopa+Carbidopa; (100mg+10mg) & (250mg+25mg) Tablet.</p><p><strong><br></strong></p><p><strong>Indications : </strong>D-dopa is indicated for the treatment of idiopathic Parkinson''s disease, post-encephalitic parkinsonism and symptomatic parkinsonism which may follow injury to the nervous system by carbon monoxide intoxication or manganese intoxication.</p><p><strong><br></strong></p><p><strong>Dosage and administration : </strong>Dosage is initiated with 50-100mg Levodopa and 10- 12.5mg Carbidopa 3-4 times daily. If necessary dosage may be increased by 50-100mg daily or on alternate days according to response upto Levodopa 800mg and Carbidopa 80-100mg daily in divided doses. Or, as directed by the registered physician.<strong></strong></p><p><strong>Packing :</strong></p><p>D-dopa 110 : 3x10''s tablets in blister pack.</p><p>D-dopa 275 : 5x10''s tablets in blister pack.<br></p>', 'uploads/IMG/d-dopa110.jpg', 1, '2017-12-07 06:18:22', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/d-dopa110.jpg'),
(1168, 'Diconten', 67, '<p><strong></strong><strong>Composition : </strong>Flupentixol+melitracen; (0.5mg+10mg) Tablet.</p><p><strong></strong></p><p><strong>Indications : </strong>Psychogenic depression, Depressive neuroses, Psychosomatic affections accompanied by anxiety and apathy, menopausal depression, depression in alcoholics and drugaddicts<strong>.</strong></p><p><strong>Dosage & administration : </strong>Adults: Usually 2 tablets daily: morning and noon. In severe cases the morning dose may be increased to 2 tablets. Elderly patients: 1 tablet in the morning. Maintenance dose: Usually 1 tablet in the morning or as directed by the physician.</p><p><strong><br></strong></p><p><strong>Packing :</strong></p><p>Diconten : 4 x 14''s tablets in blister</p><p>pack.<br></p>', 'uploads/IMG/diconten.jpg', 1, '2017-12-07 06:21:19', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/diconten.jpg'),
(1169, 'Prelin', 115, '<p><strong></strong><strong>Composition : </strong>Pregabalin 25mg, 50mg, 75mg & 150mg Capsule.</p><p><strong><br></strong></p><p><strong>Indications : </strong>Pregabalin is indicated for the treatment of Neuropathic pain associated with diabetic peripheral neuropathy, Fibromyalgia, Post herpetic neuralgia, Generalized anxiety disorder in adults. It can be also used as adjunctive therapy in adults with partial onset seizures with or without secondary generalization.</p><p><strong><br></strong></p><p><strong>Dosage and administration : </strong>Diabetic neuropathic pain : Adult over 18 years: initially 150 mg daily, increased if necessary after 3-7 days to 300 mg daily,increased further if necessary after 7days to max. 600</p><p>mg daily in divided doses. Post herpetic neuralgia: Adult over 18 years: The</p><p>recommended dose of pregabalin is 75 to 150 mg two times a day and may be increased to 300 mg/day within 1 week based on efficacy and tolerability. Fibromyalgia: Adult over 18 years: The recommended dose for fibromyalgia is 300 to 450 mg/day. Dosing should begin at 75 mg two times a day (150</p><p>mg/day) and may be increased up to 150mg two times a day (300 mg/day) within 1 week based on efficacy and tolerability. Generalized</p><p>anxiety disorder: Adult over 18 years: Initially</p><p>150 mg daily, increased if necessary at 7 day intervals in steps of 150 mg daily; maximum 600 mg daily in divided doses. Epilepsy: Adult over 18 years: The recommended dose of Pregabalin is 150 to 600 mg/ day as adjunctive therapy in the treatment of partial onset seizures in adults. Or, as prescribed by the registered physician.<span></span></p><p><strong><br></strong></p><p><strong>Use in pregnancy and lactation : </strong>Pregnancy</p><p>Category C by FDA.<br></p><p><strong><br></strong></p><p><strong>Packing : </strong>Each box contains</p><p>Prelin-25 : 3x10''s capsules in blister pack.</p><p>Prelin-50 : 2x10''s capsules in blister pack.</p><p>Prelin-75 : 2x10''s capsules in blister pack.</p><p>Prelin-150 : 1x10''s capsules in blister pack.<br></p>', 'uploads/IMG/prelin.jpg', 1, '2017-12-07 06:26:28', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/prelin.jpg'),
(1170, 'Sertal', 127, '<p><strong></strong><strong>Composition : </strong>Sertraline HCl 25mg, 50mg &</p><p>100mg Tablet.</p><p><strong>Indications : </strong>Sertal is indicated for the treatment of symptoms of depressive illness, including accompanying symptoms of anxiety. Following satisfactory response continuation with Sertal therapy is effective in preventing relapse of the initial episode of depression or recurrence of further depressive episodes, including accompanying symptoms of anxiety.</p><p><strong>Dosage and administration : </strong>Dosage for Adult : Major Depressive Disorder and Obsessive- Compulsive Disorder-Sertal treatment should be administered at a dose of 50mg once daily. Panic Disorder, Posttraumatic Stress Disorder and Social</p><p>Anxiety Disorder- Sertal treatment should be initiated with a dose of 25mg once daily. After one week, the dose should be increased to 50mg once daily. Prementstrual Dysphoric Disorder- Sertal treatment should be initiated with a dose of 50mg/day, either daily throughout the menstrual cycle or limited to the luteal phase of the menstrual cycle, depending on physician assessment.</p><p><strong><br></strong></p><p><strong>Dosage for Pediatric Population : </strong>Sertal treatment should be initiated with a dose of 25mg once daily in children (ages 6-12) and at a dose of 50mg once daily in adolescents (ages 13-17). Sertal should be administered once daily, either in the morning or evening. Or as directed by the</p><p>physician.<strong></strong></p><p><strong>Use in pregnancy and lactation : </strong>There are no adequate and well controlled studies in pregnant women, since animal reproduction studies are not always predictive of human response. Sertal should be used during pregnancy only if the perceived benefits outweigh the risks. Limited data concerning sertraline levels in breast milk are available, hence it is not recommended in nursing mother. Pregnancy Category C by FDA.</p><p><strong><br></strong></p><p><strong>Packing : </strong>Each box contains</p><p>Sertal-25 : 5 x 10''s tablets in blister pack.</p><p>Sertal-50 : 5 x 10''s tablets in blister pack.</p><p>Sertal-100 : 3 x 10''s tablets in blister pack.<br></p>', 'uploads/IMG/sertal-25.jpg', 1, '2017-12-07 06:30:45', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/sertal-25.jpg'),
(1171, 'Resco', 120, '<p><strong></strong><strong>Composition : </strong>Risperidone 1.0mg &</p><p>2.0mg Tablet</p><p><strong><br></strong></p><p><strong>Indications : </strong>Resco (Risperidone) is</p><p>indicated for the treatment of - Acute andchronic schizophrenic psychosis, and other psychotic conditions, in which positive symptoms (such as hallucinations,</p><p>delusions, thought disturbances, hostility,</p><p>suspiciousness) and/or negative symptoms (such as blunted affect, emotional and social withdrawal, poverty of speech) are prominent. Risperidone</p><p>also alleviates affective symptoms (such</p><p>as depression, guilt feelings, anxiety) associated with schizophrenia. Also</p><p>indicated at behavioral disturbances in patients with dementia where aggressive</p><p>symptoms (verbal outbursts, physical violence), activity disturbances (agitation, wandering) or psychotic symptoms are prominent.</p><p><strong><br></strong></p><p><strong>Dosage and administration : </strong>Adults :</p><p>Resco can be given in 1 or 2 divided doses daily. The usual initial dose of Resco is 2mg on the first day, 4mg on the second day and 6mg on the third day. Further dosage adjustment may be needed and should generally be made at intervals of not less than one week; usual maintenance dose is 4 to 6mg daily.</p><p>Extrapyramidal symptoms may be more likely with doses above 10mg daily.</p><p>Behavioral disturbances in patients with dementia : Start 0.25mg bd; adjust by 0.25mg bd, every other day. Optimum 0.5mg bd, some may benefit from 1mg bd. Once target reached, consider once daily dosing. Elderly & renal or liver disease : A starting dose of 0.5mg bd is recommended. This doses can be increased 1 to 2mg bd. Or, as directed by the physician.<span></span></p><p><strong><br></strong></p><p><strong>Use in pregnancy and lactation :</strong></p><p>Pregnancy Category C by FDA.</p><p><strong>Packing : </strong>Each box contains</p><p>Resco-1 : 5 x 10''s tablets in blister pack.</p><p>Resco-2 : 5 x 10''s tablets in blister pack.<br></p>', 'uploads/IMG/resco-1.jpg', 1, '2017-12-07 06:35:11', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/resco-1.jpg'),
(1172, 'D-pira ', 109, '<p><strong></strong><strong>Composition : </strong>Piracetam 800 mg</p><p>Tablet.<strong></strong></p><p><strong>Indications : </strong>Piracetam is indicated for patients suffering from myoclonus of cortical origin. Cerebral vascular accidents like stroke, head injuries and</p><p>other acute cases. Aging disorders such as reduced cerebral functioning</p><p>evidenced by memory loss, intellectual decay, character disorders, psychomotor</p><p>disorders etc. It is also used for the treatment of mental retardation in hildren.</p><p><strong>Dosage and administration :</strong> Initially<br></p><p>7.2 gm daily in 2-3 divided dose, increased according to response by 4.8</p><p>gm every 3-4 days to max. 24gm daily (subsequently, attempts should be made to reduce dose of concurrent therapy). Child under 16 years not recommended. Or, as directed by the registered physicians.<span></span></p><p><strong><br></strong></p><p><strong>Use in pregnancy and lactation : </strong>There are no adequate and wellcontrolled studies in pregnant women. Piracetam passes into breast milk. Piracetam is to be avoided during pregnancy and lactation.<span></span></p><p><strong>Packing :</strong></p><p>D-pira : 3 x 10''s tablets in blister pack.<br></p>', 'uploads/IMG/d-pira.jpg', 1, '2017-12-07 06:39:02', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/d-pira.jpg');
INSERT INTO `drg_medicine_info` (`MEDICINE_ID`, `MEDICINE_NAME`, `GN_GRP_ID`, `MEDICINE_DESC`, `INSERT_FILE`, `CRE_BY`, `CRE_DT`, `UPD_BY`, `UPD_DT`, `IS_LATEST`, `ACTIVE_STATUS`, `CAT_ID`, `PRODUCT_FET_PHOTO`) VALUES
(1173, 'D-Toin ', 108, '<p><strong></strong><strong>Composition : </strong>Phenytoin 100mg Tablet.</p><p><strong><br></strong></p><p><strong>Indications : </strong>Phenytoin is an anticonvulsant which is used in the treatment of status epilepticus of the grandmal type. It may also be used in</p><p>the prevention and treatment of seizures occur during neurosurgery.</p><p><strong><br></strong></p><p><strong>Dosage and administration : </strong>Adults:</p><p>150-300mg (as a single dose or in 2 divided doses) daily increased to 400mg (Maximum 600mg/day) daily in divided doses or 3-4mg/kg daily in divided doses. For adult patients (who have received no previous medication) the treatment is one tablet three times daily. Children: Initially, 5mg/kg per day in two or three equally dosage with subsequent dosage individualized to a maximum 300mg daily. A recommended daily</p><p>maintenance dosage is usually 4 to 8 mg/kg. Or, as directed by the registered physicians.<span></span></p><p><strong><br></strong></p><p><strong>Use in Pregnancy and lactation :</strong></p><p>Phenytoin is not recommended for</p><p>pregnant and lactating women.<br></p><p><strong><br></strong></p><p><strong>Packing : </strong>D-Toin : 10 x 10''s tablets in</p><p>blister pack.<br></p>', 'uploads/IMG/d-dopa110.jpg', 1, '2017-12-07 06:42:41', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/d-dopa110.jpg'),
(1174, 'Neuropen', 68, '<p><strong></strong><strong>Composition : </strong>Gabapentin 300mg</p><p>Tablet.<strong></strong></p><p><strong>Indications : </strong>Neuropen (gabapentin) is indicated for the management of postherpetic neuralgia in adults. Neuropen (gabapentin) is indicated as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in patients over 12 years of age with epilepsy. Neuropen is also indicated as adjunctive therapy in the treatment of partial seizures in pediatric patients age 3-12 years.</p><p><strong><br></strong></p><p><strong>Dosage and administration :</strong></p><p>Postherpetic Neuralgia : In adults with postherpetic neuralgia, Neuropen</p><p>therapy may be initiated as a single 300mg dose on day 1, 600 mg /day on day 2 (divided BID), and 900 mg/day on day 3 (divided TID). The dose can</p><p>subsequently be titrated up to as needed for pain relief to a daily dose of 1800 mg. Epilepsy : Patients &gt;12 years of age : The effective dose of Neuropen is 900 to 1800 mg /day and given in divided doses</p><p>(three times a day). The starting dose is 300 mg three times a day. In case of Children 3-12 years : The</p><p>starting dose should range from 10-15 mg /kg/day in 3 divided doses. The effective dose of Neuropen in patients 5 years of age and older is 25-35</p><p>mg/kg/day and given in divided doses. Or, as directed by the registered physicians.<span></span></p><p><strong><br></strong></p><p><strong>Packing :</strong> Neuropen : 3x10''s tablets in</p><p>blister pack.<br></p>', 'uploads/IMG/neuropen.jpg', 1, '2017-12-07 06:46:08', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/neuropen.jpg'),
(1175, 'Resant ', 90, '<p>Resant </p>', 'uploads/IMG/resant.jpg', 1, '2017-12-07 06:47:32', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/resant.jpg'),
(1184, 'shad', 284, '<p>dfhdh</p>', 'uploads/IMG/Acepril1013.jpg', 1, '2018-01-01 23:01:38', NULL, NULL, 'Y', 'Y', 4, 'uploads/IMG/Acepril1013.jpg');

-- --------------------------------------------------------

--
-- Table structure for table `drg_medicine_strength`
--

CREATE TABLE IF NOT EXISTS `drg_medicine_strength` (
  `MS_ID` int(10) unsigned NOT NULL AUTO_INCREMENT,
  `MEDICINE_ID` int(10) unsigned NOT NULL DEFAULT '0',
  `TYPE_ID` int(10) unsigned NOT NULL DEFAULT '0',
  `UOM_ID` int(10) unsigned NOT NULL DEFAULT '0',
  `STRENGTH` varchar(255) NOT NULL DEFAULT '0',
  `CRE_BY` int(10) unsigned DEFAULT NULL,
  `CRE_DT` timestamp NOT NULL DEFAULT '0000-00-00 00:00:00',
  `UPD_BY` int(10) unsigned DEFAULT NULL,
  `UPD_DT` datetime DEFAULT NULL,
  `ACTIVE_STATUS` enum('Y','N') NOT NULL DEFAULT 'Y',
  `MEDICINE_IMG` varchar(255) DEFAULT NULL,
  `INSERT_FILE` varchar(255) DEFAULT NULL,
  PRIMARY KEY (`MS_ID`),
  KEY `FK_drg_medicine_strength_1` (`MEDICINE_ID`),
  KEY `FK_drg_medicine_strength_2` (`TYPE_ID`),
  KEY `FK_drg_medicine_strength_3` (`UOM_ID`)
) ENGINE=InnoDB  DEFAULT CHARSET=utf8 AUTO_INCREMENT=2073 ;

--
-- Dumping data for table `drg_medicine_strength`
--

INSERT INTO `drg_medicine_strength` (`MS_ID`, `MEDICINE_ID`, `TYPE_ID`, `UOM_ID`, `STRENGTH`, `CRE_BY`, `CRE_DT`, `UPD_BY`, `UPD_DT`, `ACTIVE_STATUS`, `MEDICINE_IMG`, `INSERT_FILE`) VALUES
(1428, 717, 31, 57, '5', 1, '2017-11-02 00:16:51', NULL, NULL, 'Y', 'uploads/images/ASLOR.jpg', 'uploads/pdf/ASLOR.pdf'),
(1429, 718, 31, 57, '10', 1, '2017-11-02 00:21:19', NULL, NULL, 'Y', 'uploads/images/CETRIN.jpg', 'uploads/pdf/CETRIN.pdf'),
(1430, 719, 31, 57, '5', 1, '2017-11-02 00:23:42', NULL, NULL, 'Y', 'uploads/images/CLARIGEN.jpg', 'uploads/pdf/CLARIGEN.pdf'),
(1431, 720, 31, 57, '10', 1, '2017-11-02 00:26:45', NULL, NULL, 'Y', 'uploads/images/DIPA.jpg', 'uploads/pdf/DIPA.pdf'),
(1434, 723, 31, 57, '1', 1, '2017-11-02 00:39:06', NULL, NULL, 'Y', 'uploads/images/FENAT.jpg', 'uploads/pdf/FENAT.pdf'),
(1435, 723, 30, 67, '1', 1, '2017-11-02 00:39:06', NULL, NULL, 'Y', 'uploads/images/FENAT.jpg', 'uploads/pdf/FENAT.pdf'),
(1440, 728, 28, 67, '30', 1, '2017-11-02 01:56:39', NULL, NULL, 'Y', 'uploads/images/FEXOFAST-50ml.jpg', 'uploads/pdf/fexofast.pdf'),
(1441, 728, 31, 57, '60', 1, '2017-11-02 02:00:43', NULL, NULL, 'Y', 'uploads/images/FEXOFAST-60.jpg', 'uploads/pdf/fexofast.pdf'),
(1442, 728, 31, 57, '120', 1, '2017-11-02 02:03:38', NULL, NULL, 'Y', 'uploads/images/FEXOFAST-120.jpg', 'uploads/pdf/fexofast.pdf'),
(1443, 728, 31, 72, '180', 1, '2017-11-02 02:06:00', NULL, NULL, 'Y', 'uploads/images/FEXOFAST-180.jpg', 'uploads/pdf/fexofast.pdf'),
(1444, 732, 31, 57, '10', 1, '2017-11-02 02:35:38', NULL, NULL, 'Y', 'uploads/images/LORAT.jpg', 'uploads/pdf/LORAT.pdf'),
(1445, 733, 31, 57, '200', 1, '2017-11-02 02:41:21', NULL, NULL, 'Y', 'uploads/images/DOXOMA-200.jpg', 'uploads/pdf/doxoma.pdf'),
(1446, 733, 31, 57, '400', 1, '2017-11-02 02:41:21', NULL, NULL, 'Y', 'uploads/images/FENAT.jpg', 'uploads/pdf/doxoma.pdf'),
(1447, 733, 30, 67, '100', 1, '2017-11-02 02:41:21', NULL, NULL, 'Y', 'uploads/images/FEXOFAST-180.jpg', 'uploads/pdf/doxoma.pdf'),
(1451, 735, 31, 57, '4', 1, '2017-11-02 02:52:45', NULL, NULL, 'Y', 'uploads/images/M-KAST-4.jpg', 'uploads/pdf/m-kast.pdf'),
(1452, 735, 31, 57, '5', 1, '2017-11-02 02:52:45', NULL, NULL, 'Y', 'uploads/images/M-KAST-5.jpg', 'uploads/pdf/m-kast.pdf'),
(1453, 735, 31, 57, '10', 1, '2017-11-02 02:52:45', NULL, NULL, 'Y', 'uploads/images/M-KAST-10.jpg', 'uploads/pdf/m-kast.pdf'),
(1454, 735, 9, 57, '10', 1, '2017-11-02 02:52:45', NULL, NULL, 'Y', 'uploads/images/M-KAST-10C.jpg', 'uploads/pdf/m-kast.pdf'),
(1456, 737, 31, 57, '200', 1, '2017-11-02 02:58:13', NULL, NULL, 'Y', 'uploads/images/THEOVENT SR-300.jpg', 'uploads/pdf/THEOVENT_SR.pdf'),
(1457, 737, 31, 57, '300', 1, '2017-11-02 02:58:13', NULL, NULL, 'Y', 'uploads/images/THEOVENT SR-200.jpg', 'uploads/pdf/THEOVENT_SR.pdf'),
(1458, 737, 31, 57, '400', 1, '2017-11-02 02:58:14', NULL, NULL, 'Y', 'uploads/images/THEOVENT SR-400.jpg', 'uploads/pdf/THEOVENT_SR.pdf'),
(1459, 738, 17, 55, '100', 1, '2017-11-02 03:05:56', NULL, NULL, 'Y', 'uploads/images/ventil.jpg', 'uploads/pdf/VENTIL.pdf'),
(1460, 739, 17, 55, '120', 1, '2017-11-02 03:08:50', NULL, NULL, 'Y', 'uploads/images/VENTIL_ PLUS.jpg', 'uploads/pdf/VENTIL_PLUS.pdf'),
(1463, 742, 17, 55, '275', 1, '2017-11-02 04:10:47', NULL, NULL, 'Y', 'uploads/images/seraflo.jpg', 'uploads/pdf/SERAFLO.pdf'),
(1464, 742, 17, 55, '150', 1, '2017-11-02 04:10:47', NULL, NULL, 'Y', 'uploads/images/seraflo_1.jpg', 'uploads/pdf/SERAFLO.pdf'),
(1465, 743, 17, 55, '25', 1, '2017-11-02 04:14:58', NULL, NULL, 'Y', 'uploads/images/SERAVENT.jpg', 'uploads/pdf/SERAVENT.pdf'),
(1466, 744, 17, 55, '100', 1, '2017-11-02 04:17:31', NULL, NULL, 'Y', 'uploads/images/BECOVENT.jpg', 'uploads/pdf/BECOVENT.pdf'),
(1467, 745, 20, 56, '50', 1, '2017-11-02 04:27:44', NULL, NULL, 'Y', 'uploads/images/M-Son.jpg', 'uploads/pdf/m-son.pdf'),
(1468, 746, 20, 56, '100', 1, '2017-11-02 04:31:00', NULL, NULL, 'Y', 'uploads/images/Rhinocort.jpg', 'uploads/pdf/rhinocort.jpg'),
(1469, 747, 20, 56, '55', 1, '2017-11-02 04:34:34', NULL, NULL, 'Y', 'uploads/images/trialon.jpg', 'uploads/pdf/THEOVENT SR.pdf'),
(1470, 748, 31, 57, '5', 1, '2017-11-02 04:39:12', NULL, NULL, 'Y', 'uploads/images/PEDNISOL.jpg', 'uploads/pdf/PEDNISODL.pdf'),
(1471, 748, 31, 57, '10', 1, '2017-11-02 04:39:12', NULL, NULL, 'Y', 'uploads/images/Pednisol-20.jpg', 'uploads/pdf/PEDNISODL.pdf'),
(1472, 748, 31, 57, '20', 1, '2017-11-02 04:39:12', NULL, NULL, 'Y', 'uploads/images/Pednisol-5.jpg', 'uploads/pdf/PEDNISODL.pdf'),
(1473, 749, 18, 71, '100', 1, '2017-11-02 04:41:51', NULL, NULL, 'Y', 'uploads/images/VENTIL_PLUS.jpg', 'uploads/pdf/ASLOR.pdf'),
(1477, 752, 31, 57, '250', 1, '2017-11-04 23:19:46', NULL, NULL, 'Y', 'uploads/images/azimex_15ml.jpg', 'uploads/pdf/azimex.pdf'),
(1478, 752, 31, 57, '500', 1, '2017-11-04 23:19:46', NULL, NULL, 'Y', 'uploads/images/azimex_500.jpg', 'uploads/pdf/azimex.pdf'),
(1483, 762, 31, 57, '250', 1, '2017-11-05 00:08:28', NULL, NULL, 'Y', 'uploads/images/clarin_250.jpg', 'uploads/pdf/clarin.pdf'),
(1484, 762, 31, 57, '500', 1, '2017-11-05 00:08:28', NULL, NULL, 'Y', 'uploads/images/clarin_250.jpg', 'uploads/pdf/clarin.pdf'),
(1485, 763, 31, 57, '250', 1, '2017-11-05 00:13:07', NULL, NULL, 'Y', 'uploads/images/Erybac_250.jpg', 'uploads/pdf/Erybac.pdf'),
(1486, 763, 31, 57, '500', 1, '2017-11-05 00:13:07', NULL, NULL, 'Y', 'uploads/images/Erybac_500.jpg', 'uploads/pdf/Erybac.pdf'),
(1487, 764, 28, 67, '125', 1, '2017-11-05 00:16:39', NULL, NULL, 'Y', 'uploads/images/Erybac_sus.jpg', 'uploads/pdf/Erybac.pdf'),
(1488, 765, 18, 51, '500', 1, '2017-11-05 00:20:11', NULL, NULL, 'Y', 'uploads/images/Perinem-500.jpg', 'uploads/pdf/perinem.pdf'),
(1489, 766, 18, 51, '500', 1, '2017-11-05 00:22:28', NULL, NULL, 'Y', 'uploads/images/Ropenem_500.jpg', 'uploads/pdf/ropenem.pdf'),
(1490, 766, 18, 51, '1', 1, '2017-11-05 00:25:59', NULL, NULL, 'Y', 'uploads/images/Ropenem_1.jpg', 'uploads/pdf/ropenem.pdf'),
(1491, 768, 8, 57, '250', 1, '2017-11-05 00:30:04', NULL, NULL, 'Y', 'uploads/images/Demoxil_500.jpg', 'uploads/pdf/Demoxil.pdf'),
(1492, 768, 8, 57, '500', 1, '2017-11-05 00:30:04', NULL, NULL, 'Y', 'uploads/images/Demoxil_250.jpg', 'uploads/pdf/Demoxil.pdf'),
(1493, 768, 28, 67, '125', 1, '2017-11-05 00:30:04', NULL, NULL, 'Y', 'uploads/images/Demoxil_500.jpg', 'uploads/pdf/Demoxil.pdf'),
(1494, 768, 28, 67, '250', 1, '2017-11-05 00:30:04', NULL, NULL, 'Y', 'uploads/images/Demoxil_250.jpg', 'uploads/pdf/Demoxil.pdf'),
(1495, 769, 8, 57, '250', 1, '2017-11-05 00:43:26', NULL, NULL, 'Y', 'uploads/images/Flupen_250.jpg', 'uploads/pdf/Flupen.pdf'),
(1496, 769, 8, 57, '500', 1, '2017-11-05 00:43:26', NULL, NULL, 'Y', 'uploads/images/Flupen_250.jpg', 'uploads/pdf/Demoxil.pdf'),
(1497, 770, 10, 67, '125', 1, '2017-11-05 00:47:04', NULL, NULL, 'Y', 'uploads/images/Flupen_dr.jpg', 'uploads/pdf/Flupen.pdf'),
(1498, 771, 10, 57, '400', 1, '2017-11-05 00:50:55', NULL, NULL, 'Y', 'uploads/images/Butibac_cap.jpg', 'uploads/pdf/butibac_cap.pdf'),
(1499, 771, 8, 67, '90', 1, '2017-11-05 00:50:55', NULL, NULL, 'Y', 'uploads/images/Butibac_sus.jpg', 'uploads/pdf/butibac_cap.pdf'),
(1503, 774, 28, 67, '40', 1, '2017-11-05 01:05:28', NULL, NULL, 'Y', 'uploads/images/ceforan_ds.jpg', 'uploads/pdf/ceforan.pdf'),
(1504, 774, 28, 67, '80', 1, '2017-11-05 01:05:28', NULL, NULL, 'Y', 'uploads/images/ceforan_200.jpg', 'uploads/pdf/ceforan.pdf'),
(1505, 775, 31, 62, '162', 1, '2017-11-05 01:13:10', NULL, NULL, 'Y', 'uploads/images/Clavuran_100.jpg', 'uploads/pdf/Clavuran.pdf'),
(1506, 775, 31, 62, '325', 1, '2017-11-05 01:13:10', NULL, NULL, 'Y', 'uploads/images/Clavuran_100.jpg', 'uploads/pdf/Clavuran.pdf'),
(1507, 776, 8, 57, '250', 1, '2017-11-05 01:23:21', NULL, NULL, 'Y', 'uploads/images/Dicef_250.jpg', 'uploads/pdf/Dicef.pdf'),
(1508, 776, 28, 67, '125', 1, '2017-11-05 01:23:21', NULL, NULL, 'Y', 'uploads/images/Dicef_500.jpg', 'uploads/pdf/Dicef.pdf'),
(1509, 776, 24, 63, '125', 1, '2017-11-05 01:23:21', NULL, NULL, 'Y', 'uploads/images/Dicef_forte.jpg', 'uploads/pdf/Dicef.pdf'),
(1510, 776, 28, 67, '250', 1, '2017-11-05 01:23:21', NULL, NULL, 'Y', 'uploads/images/Dicef_pd.jpg', 'uploads/pdf/Dicef.pdf'),
(1511, 776, 8, 57, '500', 1, '2017-11-05 01:23:21', NULL, NULL, 'Y', 'uploads/images/Dicef_sus.jpg', 'uploads/pdf/Dicef.pdf'),
(1512, 777, 18, 50, '250', 1, '2017-11-05 01:29:22', NULL, NULL, 'Y', 'uploads/images/Dicephin_1.jpg', 'uploads/pdf/Dicephin.pdf'),
(1513, 777, 18, 51, '500', 1, '2017-11-05 01:29:22', NULL, NULL, 'Y', 'uploads/images/Dicephin_2.jpg', 'uploads/pdf/Dicephin.pdf'),
(1514, 777, 18, 50, '1', 1, '2017-11-05 01:29:22', NULL, NULL, 'Y', 'uploads/images/Dicephin_250.jpg', 'uploads/pdf/Dicephin.pdf'),
(1515, 777, 18, 51, '2', 1, '2017-11-05 01:29:22', NULL, NULL, 'Y', 'uploads/images/Dicephin_500.jpg', 'uploads/pdf/Dicephin.pdf'),
(1516, 778, 28, 68, '166', 1, '2017-11-05 01:48:05', NULL, NULL, 'Y', 'uploads/images/Fuclav.jpg', 'uploads/pdf/Fuclav.pdf'),
(1517, 778, 31, 62, '166', 1, '2017-11-05 01:48:05', NULL, NULL, 'Y', 'uploads/images/Fuclav_125.jpg', 'uploads/pdf/Fuclav.pdf'),
(1518, 778, 31, 62, '312', 1, '2017-11-05 01:48:05', NULL, NULL, 'Y', 'uploads/images/Fuclav_250.jpg', 'uploads/pdf/Fuclav.pdf'),
(1519, 778, 31, 62, '625', 1, '2017-11-05 01:48:05', NULL, NULL, 'Y', 'uploads/images/Fuclav.jpg', 'uploads/pdf/Fuclav.pdf'),
(1520, 779, 31, 57, '250', 1, '2017-11-05 02:01:16', NULL, NULL, 'Y', 'uploads/images/Furex_250.jpg', 'uploads/pdf/Furex.pdf'),
(1521, 779, 31, 57, '500', 1, '2017-11-05 02:01:16', NULL, NULL, 'Y', 'uploads/images/Furex_1.5.jpg', 'uploads/pdf/Furex.pdf'),
(1522, 779, 28, 67, '125', 1, '2017-11-05 02:01:16', NULL, NULL, 'Y', 'uploads/images/Furex_70.jpg', 'uploads/pdf/Furex.pdf'),
(1523, 779, 18, 52, '750', 1, '2017-11-05 02:01:16', NULL, NULL, 'Y', 'uploads/images/Furex_1.5.jpg', 'uploads/pdf/Furex.pdf'),
(1524, 779, 18, 51, '1.5', 1, '2017-11-05 02:01:16', NULL, NULL, 'Y', 'uploads/images/Furex_70.jpg', 'uploads/pdf/Furex.pdf'),
(1525, 780, 8, 57, '500', 1, '2017-11-05 02:05:56', NULL, NULL, 'Y', 'uploads/images/sefanid_sus.jpg', 'uploads/pdf/sefanid.pdf'),
(1526, 780, 28, 67, '125', 1, '2017-11-05 02:05:56', NULL, NULL, 'Y', 'uploads/images/sefanid_sus.jpg', 'uploads/pdf/sefanid.pdf'),
(1527, 781, 8, 57, '200', 1, '2017-11-05 02:14:21', NULL, NULL, 'Y', 'uploads/images/T-cef_200.jpg', 'uploads/pdf/T-cef.pdf'),
(1528, 781, 8, 57, '400', 1, '2017-11-05 02:14:21', NULL, NULL, 'Y', 'uploads/images/T-cef_400.jpg', 'uploads/pdf/T-cef.pdf'),
(1529, 781, 28, 67, '100', 1, '2017-11-05 02:14:21', NULL, NULL, 'Y', 'uploads/images/T-cef_ds.jpg', 'uploads/pdf/T-cef.pdf'),
(1530, 781, 28, 67, '200', 1, '2017-11-05 02:14:21', NULL, NULL, 'Y', 'uploads/images/T-cef_pd.jpg', 'uploads/pdf/T-cef.pdf'),
(1531, 781, 24, 69, '25', 1, '2017-11-05 02:14:21', NULL, NULL, 'Y', 'uploads/images/T-cef_sus.jpg', 'uploads/pdf/T-cef.pdf'),
(1532, 782, 18, 61, '250', 1, '2017-11-05 02:19:54', NULL, NULL, 'Y', 'uploads/images/Trum 3_1.jpg', 'uploads/pdf/Trum_3.pdf'),
(1533, 782, 18, 61, '500', 1, '2017-11-05 02:19:54', NULL, NULL, 'Y', 'uploads/images/Trum_3_250.jpg', 'uploads/pdf/Trum_3.pdf'),
(1534, 782, 18, 61, '1', 1, '2017-11-05 02:19:54', NULL, NULL, 'Y', 'uploads/images/Trum 3_500.jpg', 'uploads/pdf/Trum_3.pdf'),
(1535, 783, 18, 61, '500', 1, '2017-11-05 02:50:10', NULL, NULL, 'Y', 'uploads/images/azimex_15ml.jpg', 'uploads/pdf/Unipim.pdf'),
(1536, 783, 18, 52, '1', 1, '2017-11-05 02:50:10', NULL, NULL, 'Y', 'uploads/images/Trum_3_250.jpg', 'uploads/pdf/Unipim.pdf'),
(1537, 784, 31, 57, '250', 1, '2017-11-05 02:55:16', NULL, NULL, 'Y', 'uploads/images/Ciprozid_250.jpg', 'uploads/pdf/Ciprozid.pdf'),
(1538, 784, 31, 57, '750', 1, '2017-11-05 02:55:16', NULL, NULL, 'Y', 'uploads/images/Ciprozid_750.jpg', 'uploads/pdf/Ciprozid.pdf'),
(1539, 784, 31, 57, '500', 1, '2017-11-05 02:55:16', NULL, NULL, 'Y', 'uploads/images/Ciprozid_250.jpg', 'uploads/pdf/Ciprozid.pdf'),
(1540, 784, 29, 67, '250', 1, '2017-11-05 02:55:16', NULL, NULL, 'Y', 'uploads/images/Ciprozid_750.jpg', 'uploads/pdf/Ciprozid.pdf'),
(1542, 785, 31, 57, '400', 1, '2017-11-05 03:01:36', NULL, NULL, 'Y', 'uploads/images/Floxalone.jpg', 'uploads/pdf/Floxalone.pdf'),
(1543, 786, 31, 57, '320', 1, '2017-11-05 03:04:15', NULL, NULL, 'Y', 'uploads/images/Gelcin.jpg', 'uploads/pdf/Gelcin.pdf'),
(1544, 787, 31, 57, '500', 1, '2017-11-05 03:07:37', NULL, NULL, 'Y', 'uploads/images/Levoflox_500.jpg', 'uploads/pdf/Levoflox.pdf'),
(1545, 787, 31, 57, '750', 1, '2017-11-05 03:07:38', NULL, NULL, 'Y', 'uploads/images/Levoflox_500.jpg', 'uploads/pdf/Levoflox.pdf'),
(1546, 788, 31, 57, '200', 1, '2017-11-05 03:10:49', NULL, NULL, 'Y', 'uploads/images/Oflacin_200.jpg', 'uploads/pdf/oflacin.pdf'),
(1547, 788, 31, 57, '400', 1, '2017-11-05 03:10:49', NULL, NULL, 'Y', 'uploads/images/Oflacin_400.jpg', 'uploads/pdf/oflacin.pdf'),
(1548, 789, 31, 57, '400', 1, '2017-11-05 03:13:32', NULL, NULL, 'Y', 'uploads/images/peflox.jpg', 'uploads/pdf/peflox.pdf'),
(1549, 790, 31, 57, '200', 1, '2017-11-05 03:15:36', NULL, NULL, 'Y', 'uploads/images/Sparonex.jpg', 'uploads/pdf/Sparonex.pdf'),
(1550, 791, 8, 57, '300', 1, '2017-11-05 03:20:23', NULL, NULL, 'Y', 'uploads/images/Dalacin_300.jpg', 'uploads/pdf/Dalacin.pdf'),
(1551, 791, 18, 65, '300', 1, '2017-11-05 03:20:23', NULL, NULL, 'Y', 'uploads/images/Dalacin_cap.jpg', 'uploads/pdf/Dalacin.pdf'),
(1552, 791, 18, 66, '600', 1, '2017-11-05 03:20:23', NULL, NULL, 'Y', 'uploads/images/Dalacin_600.jpg', 'uploads/pdf/Dalacin.pdf'),
(1553, 792, 31, 57, '200', 1, '2017-11-05 03:24:10', NULL, NULL, 'Y', 'uploads/images/Faxan_200.jpg', 'uploads/pdf/Faxan.pdf'),
(1554, 792, 31, 57, '550', 1, '2017-11-05 03:24:10', NULL, NULL, 'Y', 'uploads/images/Faxan_550.jpg', 'uploads/pdf/Faxan.pdf'),
(1555, 793, 25, 53, '170020', 1, '2017-11-05 03:28:58', NULL, NULL, 'Y', 'uploads/images/Gynomix.jpg', 'uploads/pdf/Gynomix.pdf'),
(1556, 794, 18, 65, '100', 1, '2017-11-05 03:37:58', NULL, NULL, 'Y', 'uploads/images/Psudonil_100.jpg', 'uploads/pdf/psudonil.pdf'),
(1557, 794, 17, 65, '250', 1, '2017-11-05 03:37:58', NULL, NULL, 'Y', 'uploads/images/Psudonil_250.jpg', 'uploads/pdf/psudonil.pdf'),
(1558, 794, 18, 65, '500', 1, '2017-11-05 03:37:58', NULL, NULL, 'Y', 'uploads/images/Psudonil_500.jpg', 'uploads/pdf/psudonil.pdf'),
(1559, 795, 31, 57, '100', 1, '2017-11-05 03:41:18', NULL, NULL, 'Y', 'uploads/images/Rantoin.jpg', 'uploads/pdf/rantoin.pdf'),
(1563, 797, 8, 57, '15', 1, '2017-11-05 03:47:55', NULL, NULL, 'Y', 'uploads/images/Lansec_15.jpg', 'uploads/pdf/Lansec.pdf'),
(1564, 797, 8, 57, '30', 1, '2017-11-05 03:47:55', NULL, NULL, 'Y', 'uploads/images/Lansec_30.jpg', 'uploads/pdf/Lansec.pdf'),
(1565, 798, 31, 57, '20', 1, '2017-11-05 03:51:26', NULL, NULL, 'Y', 'uploads/images/Pansec_20.jpg', 'uploads/pdf/Pansec.pdf'),
(1566, 798, 31, 57, '40', 1, '2017-11-05 03:51:26', NULL, NULL, 'Y', 'uploads/images/Pansec_40.jpg', 'uploads/pdf/Pansec.pdf'),
(1567, 798, 18, 60, '40', 1, '2017-11-05 03:51:26', NULL, NULL, 'Y', 'uploads/images/Pansec_inj.jpg', 'uploads/pdf/Pansec.pdf'),
(1568, 799, 31, 57, '20', 1, '2017-11-05 03:55:20', NULL, NULL, 'Y', 'uploads/images/Pronex_20c.jpg', 'uploads/pdf/Pronex.pdf'),
(1569, 799, 31, 57, '40', 1, '2017-11-05 03:55:20', NULL, NULL, 'Y', 'uploads/images/Pronex_20t.jpg', 'uploads/pdf/Pronex.pdf'),
(1570, 799, 8, 57, '20', 1, '2017-11-05 03:55:20', NULL, NULL, 'Y', 'uploads/images/Pronex_40c.jpg', 'uploads/pdf/Pronex.pdf'),
(1571, 799, 8, 57, '40', 1, '2017-11-05 03:55:20', NULL, NULL, 'Y', 'uploads/images/Pronex_40t.jpg', 'uploads/pdf/Pronex.pdf'),
(1572, 799, 18, 60, '40', 1, '2017-11-05 03:55:20', NULL, NULL, 'Y', 'uploads/images/Pronex_inj.jpg', 'uploads/pdf/Pronex.pdf'),
(1573, 800, 31, 57, '20', 1, '2017-11-05 03:57:06', NULL, NULL, 'Y', 'uploads/images/Rabesec.jpg', 'uploads/pdf/Rabesec.pdf'),
(1574, 801, 31, 57, '20', 1, '2017-11-05 03:59:00', NULL, NULL, 'Y', 'uploads/images/Famotid.jpg', 'uploads/pdf/Famotid.pdf'),
(1575, 801, 31, 57, '40', 1, '2017-11-05 03:59:00', NULL, NULL, 'Y', 'uploads/images/Famotid_20.jpg', 'uploads/pdf/Famotid.pdf'),
(1576, 802, 31, 57, '150', 1, '2017-11-05 04:09:12', NULL, NULL, 'Y', 'uploads/images/Ulcar.jpg', 'uploads/pdf/Ulcar.pdf'),
(1577, 802, 31, 57, '300', 1, '2017-11-05 04:09:12', NULL, NULL, 'Y', 'uploads/images/Ulcar_150.jpg', 'uploads/pdf/Ulcar.pdf'),
(1578, 803, 24, 69, '67', 1, '2017-11-05 04:12:20', NULL, NULL, 'Y', 'uploads/images/Semecon.jpg', 'uploads/pdf/Semecon.pdf'),
(1597, 817, 31, 57, '200', 1, '2017-11-06 03:26:26', NULL, NULL, 'Y', 'uploads/images/anilic.jpg', 'uploads/pdf/anilic.pdf'),
(1599, 819, 8, 57, '300', 1, '2017-11-06 03:37:55', NULL, NULL, 'Y', 'uploads/images/bufen_SR.jpg', 'uploads/pdf/bufen_SR.pdf'),
(1600, 820, 31, 57, '400', 1, '2017-11-06 03:39:41', NULL, NULL, 'Y', 'uploads/images/canasa.jpg', 'uploads/pdf/anilic.pdf'),
(1601, 821, 18, 69, '40', 1, '2017-11-06 03:42:58', NULL, NULL, 'Y', 'uploads/images/depomed_40.jpg', 'uploads/pdf/depomed.pdf'),
(1602, 821, 18, 64, '80', 1, '2017-11-06 03:42:58', NULL, NULL, 'Y', 'uploads/images/depomed_80.jpg', 'uploads/pdf/depomed.pdf'),
(1606, 823, 31, 57, '200', 1, '2017-11-06 04:22:32', NULL, NULL, 'Y', 'uploads/images/Diproxen.jpg', 'uploads/pdf/diproxen.pdf'),
(1607, 823, 31, 57, '500', 1, '2017-11-06 04:22:32', NULL, NULL, 'Y', 'uploads/images/Diproxen.jpg', 'uploads/pdf/diproxen.pdf'),
(1608, 823, 31, 57, '500', 1, '2017-11-06 04:22:33', NULL, NULL, 'Y', 'uploads/images/Diproxen.jpg', 'uploads/pdf/diproxen.pdf'),
(1609, 824, 31, 57, '500', 1, '2017-11-06 04:24:33', NULL, NULL, 'Y', 'uploads/images/fenaton.jpg', 'uploads/pdf/fenaton.pdf'),
(1610, 825, 31, 57, '362', 1, '2017-11-06 04:26:16', NULL, NULL, 'Y', 'uploads/images/fevedol.jpg', 'uploads/pdf/fevedol.pdf'),
(1611, 826, 8, 57, '50', 1, '2017-11-06 04:33:04', NULL, NULL, 'Y', 'uploads/images/kingdol.jpg', 'uploads/pdf/kingdol.pdf'),
(1614, 828, 31, 57, '395', 1, '2017-11-06 04:37:52', NULL, NULL, 'Y', 'uploads/images/napsec375.jpg', 'uploads/pdf/napsec.pdf'),
(1615, 828, 31, 57, '520', 1, '2017-11-06 04:37:52', NULL, NULL, 'Y', 'uploads/images/napsec_500.jpg', 'uploads/pdf/napsec.pdf'),
(1616, 829, 31, 57, '100', 1, '2017-11-06 04:39:32', NULL, NULL, 'Y', 'uploads/images/nofenac.jpg', 'uploads/pdf/nofenac.pdf'),
(1617, 830, 31, 57, '25', 1, '2017-11-06 04:41:19', NULL, NULL, 'Y', 'uploads/images/nopain25.jpg', 'uploads/pdf/nopain.pdf'),
(1618, 830, 31, 57, '50', 1, '2017-11-06 04:41:19', NULL, NULL, 'Y', 'uploads/images/nopain50.jpg', 'uploads/pdf/nopain.pdf'),
(1619, 831, 31, 57, '50', 1, '2017-11-06 04:44:27', NULL, NULL, 'Y', 'uploads/images/nopainextra50.jpg', 'uploads/pdf/nopain_extra.pdf'),
(1620, 831, 31, 57, '75.2', 1, '2017-11-06 04:44:27', NULL, NULL, 'Y', 'uploads/images/nopainextra75.jpg', 'uploads/pdf/nopain_extra.pdf'),
(1621, 832, 31, 57, '10', 1, '2017-11-06 04:46:33', NULL, NULL, 'Y', 'uploads/images/pair.jpg', 'uploads/pdf/pair.pdf'),
(1622, 832, 17, 69, '30', 1, '2017-11-06 04:46:33', NULL, NULL, 'Y', 'uploads/images/pair-30.jpg', 'uploads/pdf/pair.pdf'),
(1623, 833, 31, 57, '100', 1, '2017-11-06 04:49:05', NULL, NULL, 'Y', 'uploads/images/sudac_100.jpg', 'uploads/pdf/sudac.pdf'),
(1624, 833, 31, 57, '200', 1, '2017-11-06 04:49:05', NULL, NULL, 'Y', 'uploads/images/sudac_200.jpg', 'uploads/pdf/sudac.pdf'),
(1625, 834, 31, 57, '500', 1, '2017-11-06 04:50:38', NULL, NULL, 'Y', 'uploads/images/sulfacol.jpg', 'uploads/pdf/sulfacol.pdf'),
(1627, 836, 8, 57, '20', 1, '2017-11-06 04:58:16', NULL, NULL, 'Y', 'uploads/images/Cosec20.jpg', 'uploads/pdf/Cosec.pdf'),
(1628, 836, 8, 57, '40', 1, '2017-11-06 04:58:16', NULL, NULL, 'Y', 'uploads/images/Cosec40.jpg', 'uploads/pdf/Cosec.pdf'),
(1629, 836, 18, 60, '40', 1, '2017-11-06 04:58:16', NULL, NULL, 'Y', 'uploads/images/Cosec_inj.jpg', 'uploads/pdf/Cosec.pdf'),
(1648, 844, 30, 69, '3', 1, '2017-11-06 23:25:30', NULL, NULL, 'Y', 'uploads/images/d-lac_50.jpg', 'uploads/pdf/D-lac.pdf'),
(1649, 844, 30, 69, '3.35', 1, '2017-11-06 23:25:30', NULL, NULL, 'Y', 'uploads/images/d-lac_100.jpg', 'uploads/pdf/D-lac.pdf'),
(1650, 844, 30, 69, '3.35', 1, '2017-11-06 23:25:30', NULL, NULL, 'Y', 'uploads/images/d-lac_200.jpg', 'uploads/pdf/D-lac.pdf'),
(1651, 845, 31, 57, '8', 1, '2017-11-06 23:29:57', NULL, NULL, 'Y', 'uploads/images/ONDASON.jpg', 'uploads/pdf/ondason tablet.pdf'),
(1652, 845, 18, 70, '2', 1, '2017-11-06 23:29:57', NULL, NULL, 'Y', 'uploads/images/ONDASON.jpg', 'uploads/pdf/ondason tablet.pdf'),
(1653, 845, 30, 67, '4', 1, '2017-11-06 23:29:57', NULL, NULL, 'Y', 'uploads/images/ONDASON.jpg', 'uploads/pdf/ondason_injection.pdf'),
(1655, 847, 31, 57, '10', 1, '2017-11-06 23:36:04', NULL, NULL, 'Y', 'uploads/images/Paridon.jpg', 'uploads/pdf/Paridon.pdf'),
(1656, 847, 28, 67, '5', 1, '2017-11-06 23:36:04', NULL, NULL, 'Y', 'uploads/images/Paridon.jpg', 'uploads/pdf/Paridon.pdf'),
(1657, 848, 31, 57, '50', 1, '2017-11-06 23:37:35', NULL, NULL, 'Y', 'uploads/images/Nomosic.jpg', 'uploads/pdf/nomosic.pdf'),
(1660, 850, 31, 57, '1', 1, '2017-11-07 00:16:09', NULL, NULL, 'Y', 'uploads/images/D-FEN1_5.jpg', 'uploads/pdf/D-FEN.pdf'),
(1661, 850, 31, 57, '0.5', 1, '2017-11-07 00:16:09', NULL, NULL, 'Y', 'uploads/images/D-FEN1_5.jpg', 'uploads/pdf/D-FEN.pdf'),
(1662, 851, 31, 57, '2', 1, '2017-11-07 00:18:31', NULL, NULL, 'Y', 'uploads/images/Miotrol.jpg', 'uploads/pdf/miotrol.pdf'),
(1663, 852, 31, 57, '5', 1, '2017-11-07 00:20:30', NULL, NULL, 'Y', 'uploads/images/Miotrol.jpg', 'uploads/pdf/paricap.pdf'),
(1664, 852, 31, 57, '10', 1, '2017-11-07 00:20:30', NULL, NULL, 'Y', 'uploads/images/Miotrol.jpg', 'uploads/pdf/paricap.pdf'),
(1665, 853, 31, 57, '135', 1, '2017-11-07 00:26:34', NULL, NULL, 'Y', 'uploads/images/mebev135.jpg', 'uploads/pdf/mebeverin.pdf'),
(1666, 853, 27, 57, '200', 1, '2017-11-07 00:26:34', NULL, NULL, 'Y', 'uploads/images/mebev135.jpg', 'uploads/pdf/mebeverin.pdf'),
(1667, 854, 31, 57, '50', 1, '2017-11-07 00:29:02', NULL, NULL, 'Y', 'uploads/images/viso50.jpg', 'uploads/pdf/visonium.pdf'),
(1668, 854, 18, 69, '5.2', 1, '2017-11-07 00:29:02', NULL, NULL, 'Y', 'uploads/images/visoninj.jpg', 'uploads/pdf/visonium.pdf'),
(1669, 858, 31, 57, '5', 1, '2017-11-07 00:37:55', NULL, NULL, 'Y', 'uploads/images/bacmax5.jpg', 'uploads/pdf/bacmax.pdf'),
(1670, 858, 31, 57, '10', 1, '2017-11-07 00:37:55', NULL, NULL, 'Y', 'uploads/images/bacmax10.jpg', 'uploads/pdf/bacmax.pdf'),
(1671, 859, 31, 57, '50', 1, '2017-11-07 00:39:28', NULL, NULL, 'Y', 'uploads/images/lexaton.jpg', 'uploads/pdf/lexaton.pdf'),
(1672, 860, 8, 57, '25', 1, '2017-11-07 00:41:02', NULL, NULL, 'Y', 'uploads/images/trolen.jpg', 'uploads/pdf/trolen-25.pdf'),
(1673, 866, 11, 73, '5', 1, '2017-11-07 01:22:32', NULL, NULL, 'Y', 'uploads/images/EYETEAR.jpg', 'uploads/pdf/FENATE.pdf'),
(1674, 869, 7, 73, '0.03', 1, '2017-11-07 01:32:56', NULL, NULL, 'Y', 'uploads/images/FENATE.jpg', 'uploads/pdf/FENATE.pdf'),
(1675, 870, 21, 73, '0.10%', 1, '2017-11-07 01:34:57', NULL, NULL, 'Y', 'uploads/images/F-Lon.jpg', 'uploads/pdf/LEVOFLOX.pdf'),
(1676, 871, 14, 73, '0.50', 1, '2017-11-07 01:37:39', NULL, NULL, 'Y', 'uploads/images/FLOXALONE.jpg', 'uploads/pdf/FLOXALONE.pdf'),
(1677, 872, 7, 73, '0.50', 1, '2017-11-07 01:40:21', NULL, NULL, 'Y', 'uploads/images/LEVOFLOX.jpg', 'uploads/pdf/LEVOFLOX.pdf'),
(1679, 874, 7, 73, '0.10', 1, '2017-11-07 01:45:11', NULL, NULL, 'Y', 'uploads/images/NOPAIN.jpg', 'uploads/pdf/NOPAINED.pdf'),
(1680, 875, 22, 74, '0.1,3500,6000', 1, '2017-11-07 01:47:57', NULL, NULL, 'Y', 'uploads/images/NEO-DP.jpg', 'uploads/pdf/NEO-DP.pdf'),
(1681, 876, 11, 73, '0.50', 1, '2017-11-07 01:49:40', NULL, NULL, 'Y', 'uploads/images/OPTHACOL.jpg', 'uploads/pdf/OPTHACOL.pdf'),
(1682, 877, 7, 73, '0.50', 1, '2017-11-07 01:51:10', NULL, NULL, 'Y', 'uploads/images/OPTHAFLOX.jpg', 'uploads/pdf/OPTHAFLOX.pdf'),
(1684, 879, 7, 73, '0.5&0.1', 1, '2017-11-07 02:26:13', NULL, NULL, 'Y', 'uploads/images/STENICOL.jpg', 'uploads/pdf/STENICOL.pdf'),
(1685, 880, 21, 73, '0.3 & 0.1', 1, '2017-11-07 02:28:19', NULL, NULL, 'Y', 'uploads/images/TEXA.jpg', 'uploads/pdf/TEXA.pdf'),
(1686, 881, 15, 73, '0.1,0.3', 1, '2017-11-07 02:32:13', NULL, NULL, 'Y', 'uploads/images/SYNTAR.jpg', 'uploads/pdf/SYNTAR.pdf'),
(1687, 882, 31, 57, '330', 1, '2017-11-07 02:35:02', NULL, NULL, 'Y', 'uploads/images/CARNITEN.jpg', 'uploads/pdf/CARNITEN.pdf'),
(1688, 883, 8, 57, '30', 1, '2017-11-07 02:36:50', NULL, NULL, 'Y', 'uploads/images/COZYME6.jpg', 'uploads/pdf/CARNITEN.pdf'),
(1689, 883, 8, 57, '60', 1, '2017-11-07 02:36:50', NULL, NULL, 'Y', 'uploads/images/COZYME6.jpg', 'uploads/pdf/CARNITEN.pdf'),
(1690, 884, 31, 57, '30+10', 1, '2017-11-07 02:38:57', NULL, NULL, 'Y', 'uploads/images/ALBASINE.jpg', 'uploads/pdf/ALBASINE.pdf'),
(1692, 886, 31, 57, '500', 1, '2017-11-07 02:43:13', NULL, NULL, 'Y', 'uploads/images/ALBASINE.jpg', 'uploads/pdf/ALBASINE.pdf'),
(1695, 888, 8, 57, '0.4,0.5', 1, '2017-11-07 03:01:17', NULL, NULL, 'Y', 'uploads/images/Combomax.jpg', 'uploads/pdf/Dutamax.pdf'),
(1696, 889, 26, 57, '0.5', 1, '2017-11-07 03:02:55', NULL, NULL, 'Y', 'uploads/images/Dutamax.jpg', 'uploads/pdf/Dutamax.pdf'),
(1697, 890, 19, 57, '0.4', 1, '2017-11-07 03:04:35', NULL, NULL, 'Y', 'uploads/images/Prostam.jpg', 'uploads/pdf/Prostam.pdf'),
(1698, 891, 31, 57, '0.5', 1, '2017-11-07 03:08:33', NULL, NULL, 'Y', 'uploads/images/Palnoxi.jpg', 'uploads/pdf/palnox.pdf'),
(1699, 891, 18, 69, '0.25', 1, '2017-11-07 03:08:33', NULL, NULL, 'Y', 'uploads/images/Palnoxi.jpg', 'uploads/pdf/palnox.pdf'),
(1700, 892, 15, 73, '0.30', 1, '2017-11-07 03:13:13', NULL, NULL, 'Y', 'uploads/images/CIPROZI.jpg', 'uploads/pdf/CIPROZID.pdf'),
(1701, 893, 15, 73, '0.00', 1, '2017-11-07 03:14:57', NULL, NULL, 'Y', 'uploads/images/CELUDEX.jpg', 'uploads/pdf/Avro.pdf'),
(1702, 894, 12, 73, '0.3,0.1', 1, '2017-11-07 03:17:18', NULL, NULL, 'Y', 'uploads/images/CIPROZID-DX.jpg', 'uploads/pdf/CIPROZID-DX.pdf'),
(1703, 895, 23, 73, '0.3,1', 1, '2017-11-07 03:21:09', NULL, NULL, 'Y', 'uploads/images/CIPROCORT.jpg', 'uploads/pdf/CIPROCORT.pdf'),
(1704, 896, 11, 73, '0.10', 1, '2017-11-07 03:23:19', NULL, NULL, 'Y', 'uploads/images/CELUDEX.jpg', 'uploads/pdf/CELUDEX.pdf'),
(1712, 902, 16, 57, '5', 1, '2017-11-07 04:15:01', NULL, NULL, 'Y', 'uploads/images/ALBASINE.jpg', 'uploads/pdf/ALBASINE.pdf'),
(1714, 904, 31, 57, '500', 1, '2017-11-07 04:26:55', NULL, NULL, 'Y', 'uploads/images/Blt-500.jpg', 'uploads/pdf/block-t.pdf'),
(1715, 904, 18, 61, '500', 1, '2017-11-07 04:26:55', NULL, NULL, 'Y', 'uploads/images/Blt-500.jpg', 'uploads/pdf/block-t.pdf'),
(1716, 905, 31, 57, '30', 1, '2017-11-07 04:41:28', NULL, NULL, 'Y', 'uploads/images/Eja-30.jpg', 'uploads/pdf/eja.pdf'),
(1717, 905, 31, 57, '60', 1, '2017-11-07 04:41:28', NULL, NULL, 'Y', 'uploads/images/Eja-60.jpg', 'uploads/pdf/eja.pdf'),
(1718, 906, 31, 57, '450', 1, '2017-11-07 04:43:46', NULL, NULL, 'Y', 'uploads/images/Glut.jpg', 'uploads/pdf/glut.pdf'),
(1719, 907, 31, 57, '800', 1, '2017-11-07 04:45:36', NULL, NULL, 'Y', 'uploads/images/glmax.jpg', 'uploads/pdf/glut.pdf'),
(1720, 908, 31, 57, '1', 1, '2017-11-07 04:47:06', NULL, NULL, 'Y', 'uploads/images/Omg.jpg', 'uploads/pdf/omg.pdf'),
(1721, 909, 31, 57, '100', 1, '2017-11-07 04:49:05', NULL, NULL, 'Y', 'uploads/images/pancil.jpg', 'uploads/pdf/pu.pdf'),
(1722, 910, 31, 57, '150', 1, '2017-11-07 04:52:36', NULL, NULL, 'Y', 'uploads/images/urso.jpg', 'uploads/pdf/urso.pdf'),
(1723, 910, 31, 57, '300', 1, '2017-11-07 04:52:36', NULL, NULL, 'Y', 'uploads/images/urso-150.jpg', 'uploads/pdf/urso.pdf'),
(1724, 910, 28, 69, '255', 1, '2017-11-07 04:52:36', NULL, NULL, 'Y', 'uploads/images/urso-300.jpg', 'uploads/pdf/urso.pdf'),
(1725, 911, 31, 57, '500', 1, '2017-11-07 04:54:43', NULL, NULL, 'Y', 'uploads/images/feri.jpg', 'uploads/pdf/feri.pdf'),
(1726, 912, 31, 57, '100', 1, '2017-11-07 04:56:33', NULL, NULL, 'Y', 'uploads/images/pu_100.jpg', 'uploads/pdf/pu.pdf'),
(1727, 912, 31, 57, '300', 1, '2017-11-07 04:56:33', NULL, NULL, 'Y', 'uploads/images/pu_300.jpg', 'uploads/pdf/pu.pdf'),
(1729, 914, 31, 57, '500', 1, '2017-11-07 05:25:46', NULL, NULL, 'Y', 'uploads/images/oramet.jpg', 'uploads/pdf/oramet.pdf'),
(1730, 914, 31, 57, '850', 1, '2017-11-07 05:25:46', NULL, NULL, 'Y', 'uploads/images/oramet850.jpg', 'uploads/pdf/oramet.pdf'),
(1731, 915, 31, 57, '1', 1, '2017-11-07 05:27:29', NULL, NULL, 'Y', 'uploads/images/Oramet-S1.jpg', 'uploads/pdf/Oramet-SR.pdf'),
(1732, 916, 31, 57, '50', 1, '2017-11-07 05:29:15', NULL, NULL, 'Y', 'uploads/images/Dialiptin.jpg', 'uploads/pdf/Dialiptin.pdf'),
(1733, 917, 31, 57, '500+50', 1, '2017-11-07 05:32:38', NULL, NULL, 'Y', 'uploads/images/Dialipt-M5.jpg', 'uploads/pdf/Dialiptin-M.pdf'),
(1734, 917, 31, 57, '850+50', 1, '2017-11-07 05:32:38', NULL, NULL, 'Y', 'uploads/images/Dialipt-M5.jpg', 'uploads/pdf/Dialiptin-M.pdf'),
(1735, 918, 31, 57, '5', 1, '2017-11-07 05:34:37', NULL, NULL, 'Y', 'uploads/images/Linarol.jpg', 'uploads/pdf/Linarol.pdf'),
(1736, 919, 31, 57, '2.5+500', 1, '2017-11-08 02:16:21', NULL, NULL, 'Y', 'uploads/images/Linarol-M1.jpg', 'uploads/pdf/linarol-M.pdf'),
(1737, 919, 31, 57, '2.5+850', 1, '2017-11-08 02:16:21', NULL, NULL, 'Y', 'uploads/images/Linarol-M1.jpg', 'uploads/pdf/linarol-M.pdf'),
(1738, 919, 31, 57, '2.5+1000', 1, '2017-11-08 02:16:21', NULL, NULL, 'Y', 'uploads/images/Linarol-M1.jpg', 'uploads/pdf/linarol-M.pdf'),
(1739, 920, 31, 57, '2.5', 1, '2017-11-08 02:18:31', NULL, NULL, 'Y', 'uploads/images/Sixtin-2_5.jpg', 'uploads/pdf/sixtin.pdf'),
(1740, 920, 31, 57, '5', 1, '2017-11-08 02:18:31', NULL, NULL, 'Y', 'uploads/images/Sixtin-5.jpg', 'uploads/pdf/sixtin.pdf'),
(1741, 924, 31, 57, '25', 1, '2017-11-08 02:21:41', NULL, NULL, 'Y', 'uploads/images/Sliptin-100.jpg', 'uploads/pdf/sliptin.pdf'),
(1742, 924, 31, 57, '50', 1, '2017-11-08 02:21:41', NULL, NULL, 'Y', 'uploads/images/Sliptin-M1000.jpg', 'uploads/pdf/sliptin.pdf'),
(1743, 924, 31, 57, '100', 1, '2017-11-08 02:21:41', NULL, NULL, 'Y', 'uploads/images/sliptin.jpg', 'uploads/pdf/sliptin.pdf'),
(1744, 924, 31, 57, '1050', 1, '2017-11-08 02:27:02', NULL, NULL, 'Y', 'uploads/images/Sliptin-M500_ER.jpg', 'uploads/pdf/Sliptin-M ER.pdf'),
(1745, 924, 31, 57, '550', 1, '2017-11-08 02:27:02', NULL, NULL, 'Y', 'uploads/images/Sliin-M500.jpg', 'uploads/pdf/Sliptin-M ER.pdf'),
(1748, 924, 31, 57, '550', 1, '2017-11-08 02:39:40', NULL, NULL, 'Y', 'uploads/images/Sliptin-M1000ER.jpg', 'uploads/pdf/sliptin.pdf'),
(1749, 924, 31, 57, '1050', 1, '2017-11-08 02:39:40', NULL, NULL, 'Y', 'uploads/images/Sliptin-50.jpg', 'uploads/pdf/sliptin.pdf'),
(1750, 925, 31, 57, '80', 1, '2017-11-08 02:43:59', NULL, NULL, 'Y', 'uploads/images/Dimerol.jpg', 'uploads/pdf/Dimerol.pdf'),
(1751, 926, 31, 57, '30', 1, '2017-11-08 03:01:32', NULL, NULL, 'Y', 'uploads/images/Dimerol-MR30.jpg', 'uploads/pdf/Dimerol-MR.pdf'),
(1752, 926, 31, 57, '60', 1, '2017-11-08 03:01:32', NULL, NULL, 'Y', 'uploads/images/Dimerol-MR60.jpg', 'uploads/pdf/Dimerol-MR.pdf'),
(1753, 927, 31, 57, '1', 1, '2017-11-08 03:19:52', NULL, NULL, 'Y', 'uploads/images/Limpet-1.jpg', 'uploads/pdf/Limpet.pdf'),
(1754, 927, 31, 57, '2', 1, '2017-11-08 03:19:52', NULL, NULL, 'Y', 'uploads/images/Limpet-2.jpg', 'uploads/pdf/Limpet.pdf'),
(1755, 927, 31, 57, '3', 1, '2017-11-08 03:19:52', NULL, NULL, 'Y', 'uploads/images/Limpet-3.jpg', 'uploads/pdf/Limpet.pdf'),
(1756, 927, 31, 57, '4', 1, '2017-11-08 03:19:52', NULL, NULL, 'Y', 'uploads/images/Limpet-4.jpg', 'uploads/pdf/Limpet.pdf'),
(1757, 928, 31, 57, '5', 1, '2017-11-08 03:21:36', NULL, NULL, 'Y', 'uploads/images/Daparol.jpg', 'uploads/pdf/daparol.pdf'),
(1758, 929, 31, 57, '100', 1, '2017-11-08 03:22:56', NULL, NULL, 'Y', 'uploads/images/Canarol-100.jpg', 'uploads/pdf/Dialiptin.pdf'),
(1759, 930, 25, 57, '2', 1, '2017-11-08 04:22:35', NULL, NULL, 'Y', 'uploads/images/asta_2.jpg', 'uploads/pdf/asta.pdf'),
(1760, 930, 25, 57, '4', 1, '2017-11-08 04:22:35', NULL, NULL, 'Y', 'uploads/images/asta_4.jpg', 'uploads/pdf/asta.pdf'),
(1762, 932, 31, 57, '500', 1, '2017-11-08 04:26:44', NULL, NULL, 'Y', 'uploads/images/caldil.jpg', 'uploads/pdf/caldil.pdf'),
(1763, 933, 31, 60, '500+200', 1, '2017-11-08 04:32:05', NULL, NULL, 'Y', 'uploads/images/Caldil_p.jpg', 'uploads/pdf/Caldil_p.pdf'),
(1764, 934, 18, 72, '200000', 1, '2017-11-08 04:34:29', NULL, NULL, 'Y', 'uploads/images/Calci.jpg', 'uploads/pdf/calci.pdf'),
(1765, 935, 31, 57, '400', 1, '2017-11-08 04:38:29', NULL, NULL, 'Y', 'uploads/images/caldilo.jpg', 'uploads/pdf/caldil0.pdf'),
(1766, 936, 25, 53, '800', 1, '2017-11-08 04:41:24', NULL, NULL, 'Y', 'uploads/images/D_cap.jpg', 'uploads/pdf/d-cap.pdf'),
(1767, 937, 25, 54, '0.25', 1, '2017-11-08 04:43:09', NULL, NULL, 'Y', 'uploads/images/Dical.jpg', 'uploads/pdf/Dical.pdf'),
(1768, 938, 31, 54, '252+0.25', 1, '2017-11-08 04:46:29', NULL, NULL, 'Y', 'uploads/images/Diplus.jpg', 'uploads/pdf/Diplus.pdf'),
(1770, 940, 25, 53, '200', 1, '2017-11-08 04:51:04', NULL, NULL, 'Y', 'uploads/images/E_2.jpg', 'uploads/pdf/E_cap.pdf'),
(1771, 940, 25, 53, '400', 1, '2017-11-08 04:51:04', NULL, NULL, 'Y', 'uploads/images/E_4.jpg', 'uploads/pdf/E_cap.pdf'),
(1772, 941, 25, 57, '200+250', 1, '2017-11-08 04:54:48', NULL, NULL, 'Y', 'uploads/images/E_pl.jpg', 'uploads/pdf/E_cap.pdf'),
(1774, 943, 31, 57, '0.5', 1, '2017-11-08 04:58:36', NULL, NULL, 'Y', 'uploads/images/asta_2.jpg', 'uploads/pdf/Meco.pdf'),
(1775, 944, 25, 54, '1', 1, '2017-11-08 05:00:18', NULL, NULL, 'Y', 'uploads/images/Pari.jpg', 'uploads/pdf/asta.pdf'),
(1776, 945, 25, 53, '50000', 1, '2017-11-08 05:02:42', NULL, NULL, 'Y', 'uploads/images/rati.jpg', 'uploads/pdf/rati.pdf'),
(1777, 946, 31, 51, '500+200', 1, '2017-11-08 05:05:39', NULL, NULL, 'Y', 'uploads/images/sed.jpg', 'uploads/pdf/asta.pdf'),
(1778, 946, 31, 51, '600+400', 1, '2017-11-08 05:05:39', NULL, NULL, 'Y', 'uploads/images/Sedx.jpg', 'uploads/pdf/asta.pdf'),
(1779, 947, 25, 53, '54654', 1, '2017-11-08 05:07:43', NULL, NULL, 'Y', 'uploads/images/Supvit.jpg', 'uploads/pdf/supravit-S.pdf'),
(1780, 947, 25, 66, '5645', 1, '2017-11-08 05:09:50', NULL, NULL, 'Y', 'uploads/images/SupvitM.jpg', 'uploads/pdf/supravit-S.pdf'),
(1781, 949, 30, 72, '100', 1, '2017-11-08 05:12:09', NULL, NULL, 'Y', 'uploads/images/Supracod.jpg', 'uploads/pdf/Supracod.pdf'),
(1782, 950, 31, 65, '100+200+200', 1, '2017-11-08 05:13:45', NULL, NULL, 'Y', 'uploads/images/Suprab.jpg', 'uploads/pdf/suprab.pdf'),
(1783, 947, 25, 67, '6543', 1, '2017-11-08 05:16:28', NULL, NULL, 'Y', 'uploads/images/Supvit.jpg', 'uploads/pdf/supvit.pdf'),
(1784, 947, 30, 72, '100', 1, '2017-11-08 05:18:34', NULL, NULL, 'Y', 'uploads/images/suprag.jpg', 'uploads/pdf/suprag.pdf'),
(1785, 947, 25, 65, '54', 1, '2017-11-08 05:20:43', NULL, NULL, 'Y', 'uploads/images/SupvitM.jpg', 'uploads/pdf/supvit.pdf'),
(1786, 947, 25, 65, '325', 1, '2017-11-08 05:22:05', NULL, NULL, 'Y', 'uploads/images/SupvitM.jpg', 'uploads/pdf/supvit.pdf'),
(1787, 955, 25, 67, '456', 1, '2017-11-08 05:23:11', NULL, NULL, 'Y', 'uploads/images/tannoxp.jpg', 'uploads/pdf/tannoxp.pdf'),
(1788, 956, 30, 53, '4124', 1, '2017-11-08 05:24:51', NULL, NULL, 'Y', 'uploads/images/Ziton.jpg', 'uploads/pdf/ziton.pdf'),
(1791, 958, 31, 57, '5', 1, '2017-11-08 05:29:07', NULL, NULL, 'Y', 'uploads/images/Acepril5.jpg', 'uploads/pdf/Acepril.pdf'),
(1792, 958, 31, 57, '10', 1, '2017-11-08 05:29:07', NULL, NULL, 'Y', 'uploads/images/Acepril10.jpg', 'uploads/pdf/Acepril.pdf'),
(1793, 959, 31, 57, '25', 1, '2017-11-08 05:30:48', NULL, NULL, 'Y', 'uploads/images/Acetor.jpg', 'uploads/pdf/acetor.pdf'),
(1794, 960, 31, 57, '1.25', 1, '2017-11-08 05:33:11', NULL, NULL, 'Y', 'uploads/images/Ramicard_1.25.JPG', 'uploads/pdf/Ramicard.pdf'),
(1795, 960, 31, 57, '2.5', 1, '2017-11-08 05:33:11', NULL, NULL, 'Y', 'uploads/images/Ramicard-2.5.JPG', 'uploads/pdf/Ramicard.pdf'),
(1796, 960, 31, 57, '5', 1, '2017-11-08 05:33:11', NULL, NULL, 'Y', 'uploads/images/Ramicard-5.JPG', 'uploads/pdf/Ramicard.pdf'),
(1797, 961, 31, 57, '2.5+12.5', 1, '2017-11-08 05:35:59', NULL, NULL, 'Y', 'uploads/images/Ramicpl5.jpg', 'uploads/pdf/Ramicard.pdf'),
(1798, 961, 31, 57, '5+25', 1, '2017-11-08 05:35:59', NULL, NULL, 'Y', 'uploads/images/Ramicpl2_5.jpg', 'uploads/pdf/Ramicard.pdf'),
(1799, 962, 31, 57, '80', 1, '2017-11-08 05:37:17', NULL, NULL, 'Y', 'uploads/images/Cardival.jpg', 'uploads/pdf/Cardival.pdf'),
(1800, 963, 31, 57, '80+12.5', 1, '2017-11-08 23:03:04', NULL, NULL, 'Y', 'uploads/images/Cardival.jpg', 'uploads/pdf/CardivalPlus.pdf'),
(1801, 963, 31, 57, '160+12.5', 1, '2017-11-08 23:03:04', NULL, NULL, 'Y', 'uploads/images/Cardival.jpg', 'uploads/pdf/CardivalPlus.pdf'),
(1802, 964, 31, 57, '25', 1, '2017-11-08 23:06:10', NULL, NULL, 'Y', 'uploads/images/Losardil_25.Jpg', 'uploads/pdf/Losardil.pdf'),
(1803, 964, 31, 57, '50', 1, '2017-11-08 23:06:10', NULL, NULL, 'Y', 'uploads/images/Losardil50.jpg', 'uploads/pdf/Losardil.pdf'),
(1804, 964, 31, 57, '100', 1, '2017-11-08 23:06:10', NULL, NULL, 'Y', 'uploads/images/Losardil100.jpg', 'uploads/pdf/Losardil.pdf'),
(1805, 965, 31, 57, '25+12.5', 1, '2017-11-08 23:11:10', NULL, NULL, 'Y', 'uploads/images/Losardil25_12.5.jpg', 'uploads/pdf/Losardil.pdf'),
(1806, 965, 31, 57, '50+12.5', 1, '2017-11-08 23:11:10', NULL, NULL, 'Y', 'uploads/images/Losardil50_12.5.Jpg', 'uploads/pdf/Losardil.pdf'),
(1807, 965, 31, 57, '100+12.5', 1, '2017-11-08 23:11:10', NULL, NULL, 'Y', 'uploads/images/Losardil100_12.5.Jpg', 'uploads/pdf/Losardil.pdf'),
(1808, 965, 31, 57, '100+25', 1, '2017-11-08 23:11:10', NULL, NULL, 'Y', 'uploads/images/Losardil100.Jpg', 'uploads/pdf/Losardil.pdf'),
(1809, 966, 31, 57, '20', 1, '2017-11-08 23:13:17', NULL, NULL, 'Y', 'uploads/images/Olmetic.jpg', 'uploads/pdf/Olmetic.pdf'),
(1810, 967, 31, 57, '20+12.5', 1, '2017-11-08 23:15:10', NULL, NULL, 'Y', 'uploads/images/OlmeticPlus.jpg', 'uploads/pdf/OlmeticPlus.pdf'),
(1811, 968, 31, 57, '40', 1, '2017-11-08 23:17:31', NULL, NULL, 'Y', 'uploads/images/Tanzil.jpg', 'uploads/pdf/tanzil.pdf'),
(1812, 969, 31, 57, '20', 1, '2017-11-08 23:20:46', NULL, NULL, 'Y', 'uploads/images/Trimet.jpg', 'uploads/pdf/Trimet.pdf'),
(1813, 970, 31, 57, '35', 1, '2017-11-08 23:22:09', NULL, NULL, 'Y', 'uploads/images/Trimet-MR.jpg', 'uploads/pdf/Trimet.pdf'),
(1814, 971, 18, 57, '40', 1, '2017-11-08 23:23:44', NULL, NULL, 'Y', 'uploads/images/Cardinex-40.jpg', 'uploads/pdf/Cardinex.pdf'),
(1817, 974, 31, 57, '75', 1, '2017-11-08 23:28:28', NULL, NULL, 'Y', 'uploads/images/Clopid.jpg', 'uploads/pdf/clopid.pdf'),
(1818, 975, 31, 57, '75+75', 1, '2017-11-08 23:30:40', NULL, NULL, 'Y', 'uploads/images/Clopid_As.jpg', 'uploads/pdf/Clopid_as.pdf'),
(1819, 976, 31, 57, '200', 1, '2017-11-08 23:32:42', NULL, NULL, 'Y', 'uploads/images/Cardiron.jpg', 'uploads/pdf/Cardinex.pdf'),
(1820, 977, 31, 57, '5', 1, '2017-11-08 23:35:08', NULL, NULL, 'Y', 'uploads/images/Camiton.jpg', 'uploads/pdf/Cardinex.pdf'),
(1821, 978, 18, 67, '200', 1, '2017-11-08 23:37:17', NULL, NULL, 'Y', 'uploads/images/D-Dopamine.jpg', 'uploads/pdf/Acepril.pdf'),
(1822, 979, 18, 53, '500', 1, '2017-11-08 23:39:41', NULL, NULL, 'Y', 'uploads/images/Amlocard.jpg', 'uploads/pdf/Acepril.pdf'),
(1823, 980, 31, 57, '5', 1, '2017-11-08 23:42:55', NULL, NULL, 'Y', 'uploads/images/Acepril5.jpg', 'uploads/pdf/Ivaten.pdf'),
(1824, 980, 31, 57, '7.5', 1, '2017-11-08 23:42:55', NULL, NULL, 'Y', 'uploads/images/Acepril5.jpg', 'uploads/pdf/Ivaten.pdf'),
(1825, 981, 31, 57, '5', 1, '2017-11-08 23:45:19', NULL, NULL, 'Y', 'uploads/images/Prapid-5.jpg', 'uploads/pdf/Prapid.pdf'),
(1826, 981, 31, 57, '10', 1, '2017-11-08 23:45:19', NULL, NULL, 'Y', 'uploads/images/Prapid-5.jpg', 'uploads/pdf/Prapid.pdf'),
(1827, 982, 31, 57, '90', 1, '2017-11-08 23:48:58', NULL, NULL, 'Y', 'uploads/images/Tigarol.jpg', 'uploads/pdf/Tigarol.pdf'),
(1828, 983, 31, 57, '25', 1, '2017-11-08 23:55:25', NULL, NULL, 'Y', 'uploads/images/Betaloc-25.jpg', 'uploads/pdf/Betaloc.pdf'),
(1829, 983, 31, 57, '50', 1, '2017-11-08 23:55:25', NULL, NULL, 'Y', 'uploads/images/Betaloc-XR.jpg', 'uploads/pdf/Betaloc.pdf'),
(1830, 984, 31, 57, '6.25', 1, '2017-11-08 23:59:26', NULL, NULL, 'Y', 'uploads/images/Cavelon.jpg', 'uploads/pdf/Cavelon.pdf'),
(1831, 984, 31, 57, '12.5', 1, '2017-11-08 23:59:26', NULL, NULL, 'Y', 'uploads/images/Cavelon.jpg', 'uploads/pdf/Cavelon.pdf'),
(1832, 985, 31, 57, '2.5', 1, '2017-11-09 00:01:46', NULL, NULL, 'Y', 'uploads/images/Tenobis-5.jpg', 'uploads/pdf/Tenobis.pdf'),
(1833, 985, 31, 57, '5', 1, '2017-11-09 00:01:46', NULL, NULL, 'Y', 'uploads/images/Tenobis.jpg', 'uploads/pdf/Tenobis.pdf'),
(1834, 986, 31, 57, '2.5+6.25', 1, '2017-11-09 00:06:22', NULL, NULL, 'Y', 'uploads/images/Tenobis Plus- 2.5.jpg', 'uploads/pdf/Tenobi_pl.pdf'),
(1835, 986, 31, 57, '5+6.25', 1, '2017-11-09 00:06:22', NULL, NULL, 'Y', 'uploads/images/Tenobis Plus-5.jpg', 'uploads/pdf/Tenobi_pl.pdf'),
(1836, 986, 31, 57, '10+6.25', 1, '2017-11-09 00:06:22', NULL, NULL, 'Y', 'uploads/images/Tenobis Plus-10.jpg', 'uploads/pdf/Tenobi_pl.pdf'),
(1837, 987, 31, 57, '2.5', 1, '2017-11-09 00:09:32', NULL, NULL, 'Y', 'uploads/images/Nebifast-2.5.jpg', 'uploads/pdf/nebifast.pdf'),
(1838, 987, 31, 57, '5', 1, '2017-11-09 00:09:32', NULL, NULL, 'Y', 'uploads/images/Nebifast-2.5.jpg', 'uploads/pdf/nebifast.pdf'),
(1841, 989, 31, 57, '5+25', 1, '2017-11-09 00:13:42', NULL, NULL, 'Y', 'uploads/images/AmlocardPlus25.jpg', 'uploads/pdf/Amlocard_pl.pdf'),
(1842, 989, 31, 57, '5+50', 1, '2017-11-09 00:13:42', NULL, NULL, 'Y', 'uploads/images/AmlocardPlus50.jpg', 'uploads/pdf/Amlocard_pl.pdf'),
(1845, 991, 31, 57, '5+160', 1, '2017-11-09 00:18:49', NULL, NULL, 'Y', 'uploads/images/AV-5.jpg', 'uploads/pdf/AV.pdf'),
(1846, 991, 31, 57, '10+160', 1, '2017-11-09 00:18:49', NULL, NULL, 'Y', 'uploads/images/AV-10.jpg', 'uploads/pdf/AV.pdf'),
(1847, 991, 31, 57, '5+80', 1, '2017-11-09 00:18:49', NULL, NULL, 'Y', 'uploads/images/AV-580.jpg', 'uploads/pdf/AV.pdf'),
(1848, 992, 31, 57, '30', 1, '2017-11-09 00:21:53', NULL, NULL, 'Y', 'uploads/images/Cardizem-30.jpg', 'uploads/pdf/Cardizem.pdf'),
(1849, 992, 31, 57, '660', 1, '2017-11-09 00:21:53', NULL, NULL, 'Y', 'uploads/images/Cardizem-60.jpg', 'uploads/pdf/Cardizem.pdf'),
(1850, 992, 31, 57, '90', 1, '2017-11-09 00:21:53', NULL, NULL, 'Y', 'uploads/images/Cardizem-SR.jpg', 'uploads/pdf/Cardizem.pdf'),
(1851, 992, 31, 57, '120', 1, '2017-11-09 00:21:53', NULL, NULL, 'Y', 'uploads/images/Cardizem-SR9.jpg', 'uploads/pdf/Cardizem.pdf'),
(1854, 994, 31, 57, '5', 1, '2017-11-09 00:30:36', NULL, NULL, 'Y', 'uploads/images/Amlocard.jpg', 'uploads/pdf/Amlocard.pdf'),
(1855, 994, 31, 57, '10', 1, '2017-11-09 00:30:36', NULL, NULL, 'Y', 'uploads/images/Amlocard-10.jpg', 'uploads/pdf/Amlocard.pdf'),
(1856, 995, 31, 57, '5+20', 1, '2017-11-09 00:33:30', NULL, NULL, 'Y', 'uploads/images/Disartan.jpg', 'uploads/pdf/Disartan.pdf'),
(1857, 995, 31, 57, '5+40', 1, '2017-11-09 00:33:30', NULL, NULL, 'Y', 'uploads/images/Disartan.jpg', 'uploads/pdf/Disartan.pdf'),
(1860, 997, 25, 57, '10', 1, '2017-11-09 00:40:03', NULL, NULL, 'Y', 'uploads/images/Nifecap.jpg', 'uploads/pdf/Nifecap.pdf'),
(1861, 998, 31, 57, '20+20', 1, '2017-11-09 00:42:45', NULL, NULL, 'Y', 'uploads/images/Diretic.jpg', 'uploads/pdf/Diretic.pdf'),
(1862, 998, 31, 57, '40+50', 1, '2017-11-09 00:42:45', NULL, NULL, 'Y', 'uploads/images/Diretic.jpg', 'uploads/pdf/Diretic.pdf'),
(1863, 999, 31, 57, '1.5', 1, '2017-11-09 00:46:03', NULL, NULL, 'Y', 'uploads/images/Indapa-SR.jpg', 'uploads/pdf/Indapa.pdf'),
(1864, 1000, 31, 57, '0.625+2.00', 1, '2017-11-09 00:48:38', NULL, NULL, 'Y', 'uploads/images/Indapa-SR.jpg', 'uploads/pdf/Indapa.pdf'),
(1865, 1000, 31, 57, '1.25+4.00', 1, '2017-11-09 00:48:38', NULL, NULL, 'Y', 'uploads/images/Indapa-SR.jpg', 'uploads/pdf/Indapa.pdf'),
(1866, 1001, 31, 57, '25', 1, '2017-11-09 00:50:46', NULL, NULL, 'Y', 'uploads/images/Spiretic.jpg', 'uploads/pdf/Spiretic.pdf'),
(1867, 1002, 31, 57, '10', 1, '2017-11-09 00:54:10', NULL, NULL, 'Y', 'uploads/images/Divastin-10.jpg', 'uploads/pdf/Divastin.pdf'),
(1868, 1002, 31, 57, '20', 1, '2017-11-09 00:54:10', NULL, NULL, 'Y', 'uploads/images/Divastin-10.jpg', 'uploads/pdf/Divastin.pdf'),
(1869, 1002, 31, 57, '40', 1, '2017-11-09 00:54:10', NULL, NULL, 'Y', 'uploads/images/Divastin-10.jpg', 'uploads/pdf/Divastin.pdf'),
(1870, 1003, 31, 57, '145', 1, '2017-11-09 00:56:26', NULL, NULL, 'Y', 'uploads/images/Fenatrol.jpg', 'uploads/pdf/Fenatrol.pdf'),
(1871, 1003, 31, 57, '200', 1, '2017-11-09 00:56:26', NULL, NULL, 'Y', 'uploads/images/Fenatrol.jpg', 'uploads/pdf/Fenatrol.pdf'),
(1872, 1004, 31, 57, '2', 1, '2017-11-09 00:59:19', NULL, NULL, 'Y', 'uploads/images/Acepril5.jpg', 'uploads/pdf/Liploss.pdf'),
(1873, 1005, 31, 57, '10', 1, '2017-11-09 01:01:12', NULL, NULL, 'Y', 'uploads/images/Acepril5.jpg', 'uploads/pdf/Novastin.pdf'),
(1874, 1006, 31, 57, '500', 1, '2017-11-09 01:05:05', NULL, NULL, 'Y', 'uploads/images/Acepril5.jpg', 'uploads/pdf/Niapid.pdf'),
(1875, 1007, 31, 57, '5', 1, '2017-11-09 01:08:13', NULL, NULL, 'Y', 'uploads/images/Rostatin-5.jpg', 'uploads/pdf/Rostatin.pdf'),
(1876, 1007, 31, 57, '10', 1, '2017-11-09 01:08:13', NULL, NULL, 'Y', 'uploads/images/Rostatin-10.jpg', 'uploads/pdf/Rostatin.pdf'),
(1877, 1007, 31, 57, '20', 1, '2017-11-09 01:08:13', NULL, NULL, 'Y', 'uploads/images/Rostatin-20.jpg', 'uploads/pdf/Rostatin.pdf'),
(1878, 1008, 31, 57, '0.5', 1, '2017-11-09 01:10:31', NULL, NULL, 'Y', 'uploads/images/Angicard.jpg', 'uploads/pdf/Angicard.pdf'),
(1879, 1009, 31, 57, '20', 1, '2017-11-09 01:13:44', NULL, NULL, 'Y', 'uploads/images/Monocard.jpg', 'uploads/pdf/Monocard.pdf'),
(1880, 1009, 8, 57, '50', 1, '2017-11-09 01:13:44', NULL, NULL, 'Y', 'uploads/images/Monocard.jpg', 'uploads/pdf/Monocard.pdf'),
(1881, 1010, 31, 57, '2.6', 1, '2017-11-09 01:18:21', NULL, NULL, 'Y', 'uploads/images/Nidocard.jpg', 'uploads/pdf/Nidocard-Retard.pdf'),
(1882, 1010, 31, 57, '6.4', 1, '2017-11-09 01:18:21', NULL, NULL, 'Y', 'uploads/images/Nidocard.jpg', 'uploads/pdf/Nidocard-Retard.pdf'),
(1883, 1010, 18, 67, '50', 1, '2017-11-09 01:18:21', NULL, NULL, 'Y', 'uploads/images/Nidocard.jpg', 'uploads/pdf/Nidocard-Retard.pdf'),
(1884, 1011, 30, 57, '0.4', 1, '2017-11-09 01:20:41', NULL, NULL, 'Y', 'uploads/images/Nidocard-Spray.jpg', 'uploads/pdf/Nidocard-Spray.pdf'),
(1885, 1012, 32, 57, '0.1%', 1, '2017-11-09 01:28:31', NULL, NULL, 'Y', 'uploads/images/Aclene.jpg', 'uploads/pdf/Aclene.pdf'),
(1886, 1013, 32, 57, '10%', 1, '2017-11-09 01:29:51', NULL, NULL, 'Y', 'uploads/images/AquaCare.jpg', 'uploads/pdf/Aqua_Care_.pdf'),
(1887, 1014, 32, 57, '4%', 1, '2017-11-09 01:31:22', NULL, NULL, 'Y', 'uploads/images/Benzac.jpg', 'uploads/pdf/Benzac.pdf'),
(1888, 1015, 32, 57, '0.1%', 1, '2017-11-09 01:32:49', NULL, NULL, 'Y', 'uploads/images/Betavate-CL.jpg', 'uploads/pdf/Betavate-CL.pdf'),
(1889, 1016, 32, 57, '0.1%+0.5%', 1, '2017-11-09 01:34:45', NULL, NULL, 'Y', 'uploads/images/Betavate-N.jpg', 'uploads/pdf/Betavate-N.pdf'),
(1890, 1017, 32, 57, '4%+10%+30%', 1, '2017-11-09 01:36:15', NULL, NULL, 'Y', 'uploads/images/Champion.jpg', 'uploads/pdf/Champion.pdf'),
(1891, 1018, 32, 57, '0.025%', 1, '2017-11-09 01:38:08', NULL, NULL, 'Y', 'uploads/images/Clodermoint.jpg', 'uploads/pdf/Aclene Plus.PDF.pdf'),
(1892, 1019, 32, 57, '0.05%', 1, '2017-11-09 01:40:40', NULL, NULL, 'Y', 'uploads/images/Clobederm.jpg', 'uploads/pdf/Clobederm.pdf'),
(1893, 1020, 32, 57, '1%+0.1%', 1, '2017-11-09 01:42:25', NULL, NULL, 'Y', 'uploads/images/Dicot.jpg', 'uploads/pdf/Dicot.pdf'),
(1894, 1021, 32, 57, '1%', 1, '2017-11-09 02:53:19', NULL, NULL, 'Y', 'uploads/images/Fintop.jpg', 'uploads/pdf/Fintop.pdf'),
(1895, 1022, 32, 57, '2%+1%', 1, '2017-11-09 02:54:49', NULL, NULL, 'Y', 'uploads/images/Fusibac-H.jpg', 'uploads/pdf/Fusibac-H.pdf'),
(1897, 1024, 32, 57, '5% w/w', 1, '2017-11-09 02:58:16', NULL, NULL, 'Y', 'uploads/images/Licerin.jpg', 'uploads/pdf/Licerin.pdf'),
(1898, 1025, 32, 57, '2% w/w', 1, '2017-11-09 02:59:54', NULL, NULL, 'Y', 'uploads/images/Micoderm.jpg', 'uploads/pdf/Micoderm.pdf'),
(1899, 1026, 32, 57, '(2% + 1%) w/w', 1, '2017-11-09 03:02:47', NULL, NULL, 'Y', 'uploads/images/Micoder_HC.jpg', 'uploads/pdf/Micoderm.pdf'),
(1900, 1027, 32, 57, '1% w/w', 1, '2017-11-09 03:04:40', NULL, NULL, 'Y', 'uploads/images/Mycofree.jpg', 'uploads/pdf/Mycofree.pdf'),
(1901, 1028, 32, 57, '5% w/w', 1, '2017-11-09 03:05:55', NULL, NULL, 'Y', 'uploads/images/Novirax.jpg', 'uploads/pdf/novirax-hc.pdf'),
(1902, 1029, 32, 57, '(5% + 1%) w/w', 1, '2017-11-09 03:08:15', NULL, NULL, 'Y', 'uploads/images/NoviraxHC.jpg', 'uploads/pdf/novirax-hc.pdf'),
(1903, 1030, 32, 57, '1% w/w', 1, '2017-11-09 03:09:46', NULL, NULL, 'Y', 'uploads/images/Silvec.jpg', 'uploads/pdf/silvec.pdf'),
(1904, 1031, 32, 57, '0.1% w/w', 1, '2017-11-09 03:11:54', NULL, NULL, 'Y', 'uploads/images/Trialon.jpg', 'uploads/pdf/trialon.pdf'),
(1910, 1037, 33, 57, '(0.05% + 0.005%) w/w', 1, '2017-11-09 03:27:17', NULL, NULL, 'Y', 'uploads/images/Dovonex.jpg', 'uploads/pdf/dovonex.pdf'),
(1911, 1038, 33, 57, '0.005% w/w ', 1, '2017-11-09 03:29:28', NULL, NULL, 'Y', 'uploads/images/Aclene Plus.jpg', 'uploads/pdf/Flutiderm.pdf'),
(1913, 1040, 33, 57, '40% w/w ', 1, '2017-11-09 03:32:45', NULL, NULL, 'Y', 'uploads/images/Happynap.jpg', 'uploads/pdf/Happynap.pdf'),
(1914, 1041, 33, 57, '2% w/w', 1, '2017-11-09 03:34:26', NULL, NULL, 'Y', 'uploads/images/Muron.jpg', 'uploads/pdf/Muron.pdf'),
(1915, 1042, 33, 57, '0.5% + 1%', 1, '2017-11-09 03:36:18', NULL, NULL, 'Y', 'uploads/images/NEO-B.jpg', 'uploads/pdf/NEO-B.pdf'),
(1916, 1043, 33, 57, '(3.5mg + 400 I.U + 5000 I.U.)/gm', 1, '2017-11-09 03:37:45', NULL, NULL, 'Y', 'uploads/images/NEO-B.jpg', 'uploads/pdf/NEO-B.pdf'),
(1917, 1044, 33, 57, '5% w/w', 1, '2017-11-09 03:39:29', NULL, NULL, 'Y', 'uploads/images/povicidal.jpg', 'uploads/pdf/povicidal.pdf'),
(1919, 1046, 34, 57, '(0.5%+0.5%+1%+1%) w/w', 1, '2017-11-09 03:44:55', NULL, NULL, 'Y', 'uploads/images/Relitch.jpg', 'uploads/pdf/retocain.pdf'),
(1920, 1047, 33, 57, '(0.05% + 0.1% +2.5%) w/w', 1, '2017-11-09 03:46:04', NULL, NULL, 'Y', 'uploads/images/Relitch.jpg', 'uploads/pdf/Relitch.PDF.pdf'),
(1921, 1048, 35, 57, '(0.1% + 2.5%) w/w', 1, '2017-11-09 03:48:11', NULL, NULL, 'Y', 'uploads/images/AclenePlus.jpg', 'uploads/pdf/AclenePlus.PDF.pdf'),
(1922, 1049, 35, 57, '(1% + 5%) w/w', 1, '2017-11-09 03:49:51', NULL, NULL, 'Y', 'uploads/images/DalacinPlus.jpg', 'uploads/pdf/DalacinPlus.pdf'),
(1923, 1050, 35, 57, '(1.2% + 0.025%) w/w', 1, '2017-11-09 03:51:33', NULL, NULL, 'Y', 'uploads/images/DalacinPlus.jpg', 'uploads/pdf/DalacinPlus.pdf'),
(1924, 1051, 35, 57, '10% w/w', 1, '2017-11-09 03:52:47', NULL, NULL, 'Y', 'uploads/images/Diproxen_250.jpg', 'uploads/pdf/Diproxen.pdf'),
(1925, 1052, 35, 57, '2% w/w', 1, '2017-11-09 03:54:37', NULL, NULL, 'Y', 'uploads/images/Micodgel.jpg', 'uploads/pdf/Micoderm.pdf');
INSERT INTO `drg_medicine_strength` (`MS_ID`, `MEDICINE_ID`, `TYPE_ID`, `UOM_ID`, `STRENGTH`, `CRE_BY`, `CRE_DT`, `UPD_BY`, `UPD_DT`, `ACTIVE_STATUS`, `MEDICINE_IMG`, `INSERT_FILE`) VALUES
(1926, 1053, 37, 57, ' 0.1% w/w', 1, '2017-11-09 04:06:23', NULL, NULL, 'Y', 'uploads/images/Trialon Oral Paste.jpg', 'uploads/pdf/TrialonPaste.pdf'),
(1927, 1054, 25, 57, '100', 1, '2017-11-09 04:56:21', NULL, NULL, 'Y', 'uploads/images/alocap.jpg', 'uploads/pdf/alocap.pdf'),
(1928, 1055, 8, 57, '200', 1, '2017-11-09 04:58:43', NULL, NULL, 'Y', 'uploads/images/anros.jpg', 'uploads/pdf/anros.pdf'),
(1929, 1056, 8, 57, '60', 1, '2017-11-09 04:59:40', NULL, NULL, 'Y', 'uploads/images/biloba.jpg', 'uploads/pdf/biloba.pdf'),
(1930, 1057, 8, 57, '250', 1, '2017-11-09 05:00:42', NULL, NULL, 'Y', 'uploads/images/Biogut.jpg', 'uploads/pdf/biogut.pdf'),
(1931, 1057, 8, 57, '500', 1, '2017-11-09 05:00:42', NULL, NULL, 'Y', 'uploads/images/Biogut.jpg', 'uploads/pdf/biogut.pdf'),
(1932, 1058, 8, 57, '425', 1, '2017-11-09 05:01:55', NULL, NULL, 'Y', 'uploads/images/dalion.jpg', 'uploads/pdf/dalion.pdf'),
(1933, 1059, 30, 72, '100', 1, '2017-11-09 05:03:05', NULL, NULL, 'Y', 'uploads/images/Devas.jpg', 'uploads/pdf/devas.pdf'),
(1934, 1060, 30, 72, '100', 1, '2017-11-09 05:04:26', NULL, NULL, 'Y', 'uploads/images/Devas.jpg', 'uploads/pdf/devas.pdf'),
(1935, 1060, 30, 72, '200', 1, '2017-11-09 05:04:26', NULL, NULL, 'Y', 'uploads/images/Devas.jpg', 'uploads/pdf/devas.pdf'),
(1936, 1061, 8, 57, '300', 1, '2017-11-09 05:05:20', NULL, NULL, 'Y', 'uploads/images/dort.jpg', 'uploads/pdf/dort.pdf'),
(1937, 1062, 25, 57, '10', 1, '2017-11-09 05:06:15', NULL, NULL, 'Y', 'uploads/images/garl.jpg', 'uploads/pdf/garl.pdf'),
(1938, 1063, 8, 57, '500', 1, '2017-11-09 05:07:07', NULL, NULL, 'Y', 'uploads/images/ginax.jpg', 'uploads/pdf/ginax.pdf'),
(1939, 1064, 8, 57, '500', 1, '2017-11-09 05:08:41', NULL, NULL, 'Y', 'uploads/images/Hepanor.jpg', 'uploads/pdf/hepanor.pdf'),
(1940, 1064, 8, 57, '70', 1, '2017-11-09 05:08:41', NULL, NULL, 'Y', 'uploads/images/Hepanor.jpg', 'uploads/pdf/hepanor.pdf'),
(1941, 1064, 8, 57, '140', 1, '2017-11-09 05:08:41', NULL, NULL, 'Y', 'uploads/images/Hepanor.jpg', 'uploads/pdf/hepanor.pdf'),
(1942, 1065, 8, 57, '400', 1, '2017-11-09 05:10:27', NULL, NULL, 'Y', 'uploads/images/melbit.jpg', 'uploads/pdf/melbit.pdf'),
(1943, 1066, 38, 57, '2.5', 1, '2017-11-09 05:11:36', NULL, NULL, 'Y', 'uploads/images/laxadil.jpg', 'uploads/pdf/laxadil.pdf'),
(1944, 1067, 25, 72, '0.2', 1, '2017-11-09 05:12:46', NULL, NULL, 'Y', 'uploads/images/mintek.jpg', 'uploads/pdf/mintek.pdf'),
(1945, 1068, 8, 57, '400', 1, '2017-11-09 05:13:47', NULL, NULL, 'Y', 'uploads/images/nacea.jpg', 'uploads/pdf/nacea.pdf'),
(1946, 1069, 8, 57, '500', 1, '2017-11-09 05:14:51', NULL, NULL, 'Y', 'uploads/images/palmetto.jpg', 'uploads/pdf/palmetto.pdf'),
(1948, 1071, 25, 57, '500', 1, '2017-11-09 22:16:16', NULL, NULL, 'Y', 'uploads/images/pri_1000.jpg', 'uploads/pdf/prima.pdf'),
(1949, 1071, 25, 57, '1000', 1, '2017-11-09 22:16:16', NULL, NULL, 'Y', 'uploads/images/pri_500.jpg', 'uploads/pdf/prima.pdf'),
(1950, 1072, 8, 57, '500', 1, '2017-11-09 22:19:15', NULL, NULL, 'Y', 'uploads/images/spiru.jpg', 'uploads/pdf/spiru.pdf'),
(1951, 1073, 30, 72, '100', 1, '2017-11-09 22:20:37', NULL, NULL, 'Y', 'uploads/images/thyvy.jpg', 'uploads/pdf/thyvy.pdf'),
(1952, 1074, 30, 72, '450', 1, '2017-11-09 22:23:04', NULL, NULL, 'Y', 'uploads/images/Amlab.jpg', 'uploads/pdf/Amlab.pdf'),
(1953, 1075, 8, 57, '250', 1, '2017-11-09 22:24:05', NULL, NULL, 'Y', 'uploads/images/cent.jpg', 'uploads/pdf/cent.pdf'),
(1954, 1076, 30, 72, '100', 1, '2017-11-09 22:25:41', NULL, NULL, 'Y', 'uploads/images/D-Aloevera.jpg', 'uploads/pdf/D-alo.pdf'),
(1955, 1076, 30, 72, '450', 1, '2017-11-09 22:25:41', NULL, NULL, 'Y', 'uploads/images/D-Aloevera.jpg', 'uploads/pdf/D-alo.pdf'),
(1956, 1077, 30, 72, '100', 1, '2017-11-09 22:27:28', NULL, NULL, 'Y', 'uploads/images/difans.jpg', 'uploads/pdf/difans.pdf'),
(1957, 1077, 30, 72, '450', 1, '2017-11-09 22:27:28', NULL, NULL, 'Y', 'uploads/images/difans.jpg', 'uploads/pdf/difans.pdf'),
(1958, 1078, 25, 57, '500', 1, '2017-11-09 22:30:29', NULL, NULL, 'Y', 'uploads/images/D-sefa.jpg', 'uploads/pdf/D-sefa.pdf'),
(1959, 1079, 30, 72, '100', 1, '2017-11-09 22:32:51', NULL, NULL, 'Y', 'uploads/images/Hemo.jpg', 'uploads/pdf/Hemo.pdf'),
(1960, 1079, 30, 72, '450', 1, '2017-11-09 22:32:51', NULL, NULL, 'Y', 'uploads/images/Hemosaf.jpg', 'uploads/pdf/Hemosaf.pdf'),
(1961, 1080, 8, 57, '250', 1, '2017-11-09 22:35:10', NULL, NULL, 'Y', 'uploads/images/Jarira.jpg', 'uploads/pdf/Jarira.pdf'),
(1962, 1081, 30, 72, '100', 1, '2017-11-09 22:37:11', NULL, NULL, 'Y', 'uploads/images/Livro.jpg', 'uploads/pdf/Livro.pdf'),
(1963, 1081, 30, 72, '450', 1, '2017-11-09 22:37:11', NULL, NULL, 'Y', 'uploads/images/Livro.jpg', 'uploads/pdf/Livro.pdf'),
(1964, 1082, 30, 72, '100', 1, '2017-11-09 22:39:09', NULL, NULL, 'Y', 'uploads/images/Nat.jpg', 'uploads/pdf/Nat.pdf'),
(1965, 1082, 30, 72, '450', 1, '2017-11-09 22:39:09', NULL, NULL, 'Y', 'uploads/images/Nat.jpg', 'uploads/pdf/Nat.pdf'),
(1966, 1083, 30, 67, '6456', 1, '2017-11-09 22:40:15', NULL, NULL, 'Y', 'uploads/images/ridex.jpg', 'uploads/pdf/ridex.pdf'),
(1967, 1084, 30, 72, '100', 1, '2017-11-09 22:41:23', NULL, NULL, 'Y', 'uploads/images/tifal.jpg', 'uploads/pdf/tifal.pdf'),
(1968, 1085, 30, 72, '100', 1, '2017-11-09 22:42:50', NULL, NULL, 'Y', 'uploads/images/tims.jpg', 'uploads/pdf/tims.pdf'),
(1969, 1085, 30, 72, '450', 1, '2017-11-09 22:42:50', NULL, NULL, 'Y', 'uploads/images/tims.jpg', 'uploads/pdf/tims.pdf'),
(1970, 1086, 30, 57, '100', 1, '2017-11-09 22:49:57', NULL, NULL, 'Y', 'uploads/images/zurid.jpg', 'uploads/pdf/zurid.pdf'),
(1971, 1086, 30, 57, '450', 1, '2017-11-09 22:49:57', NULL, NULL, 'Y', 'uploads/images/zurid.jpg', 'uploads/pdf/zurid.pdf'),
(1972, 1087, 8, 57, '50+0.50+61.8', 1, '2017-11-09 22:55:16', NULL, NULL, 'Y', 'uploads/images/ferozi_ci.jpg', 'uploads/pdf/ferozi_ci.pdf'),
(1973, 1088, 8, 75, '150+500', 1, '2017-11-09 23:01:29', NULL, NULL, 'Y', 'uploads/images/ferospan.jpg', 'uploads/pdf/ferospan.pdf'),
(1974, 1089, 8, 76, '150+500+61.8', 1, '2017-11-09 23:04:05', NULL, NULL, 'Y', 'uploads/images/ferozi.jpg', 'uploads/pdf/ferozi.pdf'),
(1975, 1090, 18, 69, '50/50', 1, '2017-11-09 23:10:26', NULL, NULL, 'Y', 'uploads/images/neoplat.jpg', 'uploads/pdf/neoplat.pdf'),
(1976, 1091, 18, 69, '150/15', 1, '2017-11-09 23:27:20', NULL, NULL, 'Y', 'uploads/images/carplatin15.jpg', 'uploads/pdf/carplatin.pdf'),
(1977, 1091, 18, 69, '450/50', 1, '2017-11-09 23:27:20', NULL, NULL, 'Y', 'uploads/images/carplatin15.jpg', 'uploads/pdf/carplatin.pdf'),
(1978, 1092, 18, 69, '100/16.7', 1, '2017-11-09 23:28:59', NULL, NULL, 'Y', 'uploads/images/ontaxel1.jpg', 'uploads/pdf/ontaxel.pdf'),
(1979, 1092, 18, 69, '300/50', 1, '2017-11-09 23:28:59', NULL, NULL, 'Y', 'uploads/images/ontaxel1.jpg', 'uploads/pdf/ontaxel.pdf'),
(1980, 1093, 18, 69, '2,2', 1, '2017-11-09 23:29:51', NULL, NULL, 'Y', 'uploads/images/vinstin.jpg', 'uploads/pdf/vinstin.pdf'),
(1981, 1094, 18, 69, '100/20', 1, '2017-11-09 23:30:47', NULL, NULL, 'Y', 'uploads/images/toposar1.jpg', 'uploads/pdf/toposar1.pdf'),
(1982, 752, 31, 57, '500', 1, '2017-11-04 23:19:46', NULL, NULL, 'Y', 'uploads/images/azimex_30ml.jpg', 'uploads/pdf/azimex.pdf'),
(1983, 752, 31, 57, '500', 1, '2017-11-04 23:19:46', NULL, NULL, 'Y', 'uploads/images/azimex_50ml.jpg', 'uploads/pdf/azimex.pdf'),
(1984, 752, 31, 57, '500', 1, '2017-11-04 23:19:46', NULL, NULL, 'Y', 'uploads/images/azimex_250.jpg', 'uploads/pdf/azimex.pdf'),
(1985, 774, 28, 67, '80', 1, '2017-11-05 01:05:28', NULL, NULL, 'Y', 'uploads/images/ceforan_100.jpg', 'uploads/pdf/ceforan.pdf'),
(1989, 971, 18, 57, '60', 1, '2017-11-08 23:24:54', NULL, NULL, 'Y', 'uploads/images/Cardinex-60.jpg', 'uploads/pdf/Cardinex.pdf'),
(1990, 971, 31, 57, '80', 1, '2017-11-08 23:26:13', NULL, NULL, 'Y', 'uploads/images/Cardinex-80.jpg', 'uploads/pdf/Cardinex.pdf'),
(1991, 791, 8, 57, '300', 1, '2017-11-05 03:20:23', NULL, NULL, 'Y', 'uploads/images/Dalacin_Plus.jpg', 'uploads/pdf/Dalacin.pdf'),
(1992, 916, 31, 57, '50', 1, '2017-11-07 05:29:15', NULL, NULL, 'Y', 'uploads/images/Dialipt-M5.jpg', 'uploads/pdf/Dialiptin.pdf'),
(1993, 872, 7, 73, '0.50', 1, '2017-11-07 01:40:21', NULL, NULL, 'Y', 'uploads/images/Levoflox_500.jpg', 'uploads/pdf/LEVOFLOX.pdf'),
(1994, 872, 7, 73, '0.50', 1, '2017-11-07 01:40:21', NULL, NULL, 'Y', 'uploads/images/Levoflox_750.jpg', 'uploads/pdf/LEVOFLOX.pdf'),
(1995, 915, 31, 57, '1', 1, '2017-11-07 05:27:29', NULL, NULL, 'Y', 'uploads/images/Oramet-S5.jpg', 'uploads/pdf/Oramet-SR.pdf'),
(1996, 778, 31, 62, '166', 1, '2017-11-05 01:48:05', NULL, NULL, 'Y', 'uploads/images/Fuclav_500.jpg', 'uploads/pdf/Fuclav.pdf'),
(1997, 824, 31, 57, '500', 1, '2017-11-06 04:24:33', NULL, NULL, 'Y', 'uploads/images/Fenatrol.jpg', 'uploads/pdf/fenaton.pdf'),
(1998, 978, 18, 67, '200', 1, '2017-11-08 23:37:17', NULL, NULL, 'Y', 'uploads/images/d-dopa_110.jpg', 'uploads/pdf/Acepril.pdf'),
(1999, 978, 18, 67, '200', 1, '2017-11-08 23:37:17', NULL, NULL, 'Y', 'uploads/images/d-dopa_275.jpg', 'uploads/pdf/Acepril.pdf'),
(2003, 1152, 31, 57, '500', 1, '2017-12-05 05:49:22', NULL, NULL, 'Y', 'uploads/images/Cabita.jpg', 'uploads/pdf/Cabita_Insert.pdf'),
(2004, 1153, 18, 49, '500', 1, '2017-12-05 05:57:24', NULL, NULL, 'Y', 'uploads/images/Fluracil.jpg', 'uploads/pdf/Fluracil_IV_Injection- Insert.pdf'),
(2005, 1154, 18, 58, '10', 1, '2017-12-05 06:08:16', NULL, NULL, 'Y', 'uploads/images/Dobixin_1.jpg', 'uploads/pdf/Dobixin_Insert.pdf'),
(2006, 1154, 18, 58, '50', 1, '2017-12-05 06:08:16', NULL, NULL, 'Y', 'uploads/images/Dobixin_5.jpg', 'uploads/pdf/Dobixin_Insert.pdf'),
(2009, 1156, 28, 69, '50/5', 1, '2017-12-07 05:24:15', NULL, NULL, 'Y', 'uploads/images/Flunac-35.jpg', 'uploads/pdf/Flunac.pdf'),
(2010, 1156, 31, 57, '50', 1, '2017-12-07 05:24:15', NULL, NULL, 'Y', 'uploads/images/D-Pira.jpg', 'uploads/pdf/Flunac.pdf'),
(2011, 1156, 8, 57, '150', 1, '2017-12-07 05:24:15', NULL, NULL, 'Y', 'uploads/images/D-Pira.jpg', 'uploads/pdf/Flunac.pdf'),
(2012, 1157, 31, 57, '250', 1, '2017-12-07 05:27:49', NULL, NULL, 'Y', 'uploads/images/Mycofree.jpg', 'uploads/pdf/Novirax.pdf'),
(2013, 1158, 31, 57, '400', 1, '2017-12-07 05:29:40', NULL, NULL, 'Y', 'uploads/images/Hopso.jpg', 'uploads/pdf/Nitanid.pdf'),
(2014, 1159, 8, 57, '200', 1, '2017-12-07 05:31:01', NULL, NULL, 'Y', 'uploads/images/Opegus.jpg', 'uploads/pdf/Diconten.pdf'),
(2015, 1160, 31, 57, '200', 1, '2017-12-07 05:37:42', NULL, NULL, 'Y', 'uploads/images/Novirax-200.jpg', 'uploads/pdf/Novirax.pdf'),
(2016, 1160, 31, 57, '400', 1, '2017-12-07 05:37:42', NULL, NULL, 'Y', 'uploads/images/D-Pira.jpg', 'uploads/pdf/Novirax.pdf'),
(2017, 1161, 31, 57, '0.5', 1, '2017-12-07 05:42:10', NULL, NULL, 'Y', 'uploads/images/Entavir-0.5.jpg', 'uploads/pdf/Entavir.pdf'),
(2018, 1161, 31, 57, '1', 1, '2017-12-07 05:42:10', NULL, NULL, 'Y', 'uploads/images/D-Pira.jpg', 'uploads/pdf/Entavir.pdf'),
(2019, 1162, 31, 57, '300', 1, '2017-12-07 05:45:37', NULL, NULL, 'Y', 'uploads/images/T-fovir.jpg', 'uploads/pdf/T-fovir.pdf'),
(2020, 1163, 31, 57, '400', 1, '2017-12-07 05:54:21', NULL, NULL, 'Y', 'uploads/images/AH.jpg', 'uploads/pdf/AH.pdf'),
(2021, 1163, 28, 69, '200/5', 1, '2017-12-07 05:54:21', NULL, NULL, 'Y', 'uploads/images/D-Pira.jpg', 'uploads/pdf/AH.pdf'),
(2022, 1164, 31, 57, '500', 1, '2017-12-07 05:59:27', NULL, NULL, 'Y', 'uploads/images/Nitanid.jpg', 'uploads/pdf/Nitanid.pdf'),
(2023, 1164, 28, 69, '100/5', 1, '2017-12-07 05:59:27', NULL, NULL, 'Y', 'uploads/images/D-Pira.jpg', 'uploads/pdf/Nitanid.pdf'),
(2024, 1165, 31, 57, '500', 1, '2017-12-07 06:01:48', NULL, NULL, 'Y', 'uploads/images/Ornid.jpg', 'uploads/pdf/Ornid.pdf'),
(2025, 1166, 31, 57, '500', 1, '2017-12-07 06:14:31', NULL, NULL, 'Y', 'uploads/images/Cikolin_i.jpg', 'uploads/pdf/Cikolin.pdf'),
(2026, 1166, 18, 69, '500/4', 1, '2017-12-07 06:14:31', NULL, NULL, 'Y', 'uploads/images/D-Pira.jpg', 'uploads/pdf/Cikolin.pdf'),
(2027, 1167, 31, 57, '100+10', 1, '2017-12-07 06:18:22', NULL, NULL, 'Y', 'uploads/images/D-Dopa-110.jpg', 'uploads/pdf/D-Dopa.pdf'),
(2028, 1167, 31, 57, '250+25', 1, '2017-12-07 06:18:22', NULL, NULL, 'Y', 'uploads/images/D-Pira.jpg', 'uploads/pdf/D-Dopa.pdf'),
(2029, 1168, 31, 57, '0.5+10', 1, '2017-12-07 06:21:19', NULL, NULL, 'Y', 'uploads/images/Diconten.jpg', 'uploads/pdf/Diconten.pdf'),
(2030, 1169, 8, 57, '25', 1, '2017-12-07 06:26:28', NULL, NULL, 'Y', 'uploads/images/Prelin-25.jpg', 'uploads/pdf/Prelin.pdf'),
(2031, 1169, 8, 57, '50', 1, '2017-12-07 06:26:28', NULL, NULL, 'Y', 'uploads/images/D-Pira.jpg', 'uploads/pdf/Prelin.pdf'),
(2032, 1169, 8, 57, '75', 1, '2017-12-07 06:26:28', NULL, NULL, 'Y', 'uploads/images/D-Pira.jpg', 'uploads/pdf/Prelin.pdf'),
(2033, 1169, 8, 57, '150', 1, '2017-12-07 06:26:28', NULL, NULL, 'Y', 'uploads/images/D-Pira.jpg', 'uploads/pdf/Prelin.pdf'),
(2034, 1170, 31, 57, '25', 1, '2017-12-07 06:30:45', NULL, NULL, 'Y', 'uploads/images/Sertal-25.jpg', 'uploads/pdf/Sertal.pdf'),
(2035, 1170, 31, 57, '50', 1, '2017-12-07 06:30:45', NULL, NULL, 'Y', 'uploads/images/D-Pira.jpg', 'uploads/pdf/Sertal.pdf'),
(2036, 1170, 31, 57, '100', 1, '2017-12-07 06:30:45', NULL, NULL, 'Y', 'uploads/images/D-Pira.jpg', 'uploads/pdf/Sertal.pdf'),
(2037, 1171, 31, 57, '1', 1, '2017-12-07 06:35:11', NULL, NULL, 'Y', 'uploads/images/Resco-1.jpg', 'uploads/pdf/Resco.pdf'),
(2038, 1171, 31, 57, '2', 1, '2017-12-07 06:35:11', NULL, NULL, 'Y', 'uploads/images/D-Pira.jpg', 'uploads/pdf/Resco.pdf'),
(2039, 1172, 31, 57, '800', 1, '2017-12-07 06:39:02', NULL, NULL, 'Y', 'uploads/images/D-Pira.jpg', 'uploads/pdf/D-Pira.pdf'),
(2040, 1173, 31, 57, '100', 1, '2017-12-07 06:42:41', NULL, NULL, 'Y', 'uploads/images/D-Toin.jpg', 'uploads/pdf/D-Toin.pdf'),
(2041, 1174, 31, 57, '300', 1, '2017-12-07 06:46:08', NULL, NULL, 'Y', 'uploads/images/Neuropen.jpg', 'uploads/pdf/Neuropen.pdf'),
(2042, 1175, 31, 57, '15', 1, '2017-12-07 06:47:32', NULL, NULL, 'Y', 'uploads/images/Resant.jpg', 'uploads/pdf/Resco.pdf'),
(2056, 736, 11, 52, 'fgdfg', 1, '2017-12-29 23:47:34', NULL, NULL, 'Y', 'uploads/test/0231.jpg', 'uploads/test2/acetor3.pdf'),
(2072, 1184, 21, 64, 'dfgd', 1, '2018-01-01 23:01:38', NULL, NULL, 'Y', 'uploads/test/103.jpg', 'uploads/test2/acetor2.pdf');

-- --------------------------------------------------------

--
-- Table structure for table `drg_medicine_type`
--

CREATE TABLE IF NOT EXISTS `drg_medicine_type` (
  `TYPE_ID` int(10) unsigned NOT NULL AUTO_INCREMENT,
  `TYPE_NAME` varchar(255) NOT NULL DEFAULT '',
  `TYPE_DESC` text,
  `ACTIVE_STATUS` enum('Y','N') NOT NULL DEFAULT 'Y',
  `CRE_BY` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP ON UPDATE CURRENT_TIMESTAMP,
  `CRE_DT` int(10) unsigned NOT NULL DEFAULT '0',
  `UPD_BY` int(10) unsigned DEFAULT NULL,
  `UPD_DT` datetime DEFAULT NULL,
  `UOM_ID` int(10) unsigned DEFAULT NULL,
  PRIMARY KEY (`TYPE_ID`)
) ENGINE=InnoDB  DEFAULT CHARSET=utf8 AUTO_INCREMENT=39 ;

--
-- Dumping data for table `drg_medicine_type`
--

INSERT INTO `drg_medicine_type` (`TYPE_ID`, `TYPE_NAME`, `TYPE_DESC`, `ACTIVE_STATUS`, `CRE_BY`, `CRE_DT`, `UPD_BY`, `UPD_DT`, `UOM_ID`) VALUES
(7, ' Eye Drop', NULL, 'Y', '2017-10-29 10:07:57', 0, NULL, NULL, NULL),
(8, 'Capsule', NULL, 'Y', '2017-10-29 10:07:57', 0, NULL, NULL, NULL),
(9, 'Chewable Tablet', NULL, 'Y', '2017-10-29 10:07:57', 0, NULL, NULL, NULL),
(10, 'Dry Syrup', NULL, 'Y', '2017-10-29 10:07:57', 0, NULL, NULL, NULL),
(11, 'Eye & Ear Drop', NULL, 'Y', '2017-10-29 10:07:57', 0, NULL, NULL, NULL),
(12, 'Eye & Ear Drops', NULL, 'Y', '2017-10-29 10:07:57', 0, NULL, NULL, NULL),
(13, 'Eye & Nosal drop ', NULL, 'Y', '2017-10-29 10:07:57', 0, NULL, NULL, NULL),
(14, 'Eye Drop', NULL, 'Y', '2017-10-29 10:07:57', 0, NULL, NULL, NULL),
(15, 'Eye Drops', NULL, 'Y', '2017-10-29 10:07:57', 0, NULL, NULL, NULL),
(16, 'Film Coated Tablet', NULL, 'Y', '2017-10-29 10:07:57', 0, NULL, NULL, NULL),
(17, 'Inhaler', NULL, 'Y', '2017-10-29 10:07:57', 0, NULL, NULL, NULL),
(18, 'Injection', NULL, 'Y', '2017-10-29 10:07:57', 0, NULL, NULL, NULL),
(19, 'Modified Release Capsule', NULL, 'Y', '2017-10-29 10:07:57', 0, NULL, NULL, NULL),
(20, 'NASAL SPRAY', NULL, 'Y', '2017-10-29 10:07:57', 0, NULL, NULL, NULL),
(21, 'Ophthalmic Suspension', NULL, 'Y', '2017-10-29 10:07:57', 0, NULL, NULL, NULL),
(22, 'Opthalmic Suspension', NULL, 'Y', '2017-10-29 10:07:57', 0, NULL, NULL, NULL),
(23, 'Otic Suspension', NULL, 'Y', '2017-10-29 10:07:57', 0, NULL, NULL, NULL),
(24, 'Paediatric Drops', NULL, 'Y', '2017-10-29 10:07:57', 0, NULL, NULL, NULL),
(25, 'Soft Capsule', NULL, 'Y', '2017-10-29 10:07:57', 0, NULL, NULL, NULL),
(26, 'Soft gelatin capsule', NULL, 'Y', '2017-10-29 10:07:57', 0, NULL, NULL, NULL),
(27, 'SR Capsule', NULL, 'Y', '2017-10-29 10:07:57', 0, NULL, NULL, NULL),
(28, 'Suspension ', NULL, 'Y', '2017-10-29 10:07:57', 0, NULL, NULL, NULL),
(29, 'Suspention', NULL, 'Y', '2017-10-29 10:07:57', 0, NULL, NULL, NULL),
(30, 'Syrup', NULL, 'Y', '2017-10-29 10:07:57', 0, NULL, NULL, NULL),
(31, 'Tablet', NULL, 'Y', '2017-10-29 10:07:57', 0, NULL, NULL, NULL),
(32, 'Cream', NULL, 'Y', '2017-10-29 10:07:57', 0, NULL, NULL, NULL),
(33, 'Ointment', NULL, 'Y', '2017-10-29 10:07:57', 0, NULL, NULL, NULL),
(34, 'Rectal Ointment', NULL, 'Y', '2017-10-29 10:07:57', 0, NULL, NULL, NULL),
(35, 'Gel', NULL, 'Y', '2017-10-29 10:07:57', 0, NULL, NULL, NULL),
(36, 'IU', NULL, 'Y', '2017-10-29 10:07:57', 0, NULL, NULL, NULL),
(37, 'Oral Paste', NULL, 'Y', '2017-10-29 10:07:57', 0, NULL, NULL, NULL),
(38, 'Sachet', NULL, 'Y', '2017-10-29 10:07:57', 0, NULL, NULL, NULL);

-- --------------------------------------------------------

--
-- Table structure for table `drg_raw_table`
--

CREATE TABLE IF NOT EXISTS `drg_raw_table` (
  `BRAND_NAME` varchar(255) DEFAULT NULL,
  `GENERIC_NAME` varchar(255) DEFAULT NULL,
  `THERAPEDIC_NAME` varchar(255) DEFAULT NULL,
  `MEDICINE_DESC` varchar(255) DEFAULT NULL,
  `STRENGTH` varchar(255) DEFAULT NULL,
  `UOM` varchar(255) DEFAULT NULL,
  `MEDICINE_CATEGORY` varchar(255) DEFAULT NULL,
  `MEDICINE_TYPE` varchar(255) DEFAULT NULL,
  `IS_LATEST` varchar(255) DEFAULT NULL,
  `SPECIAL_PROD` varchar(255) DEFAULT NULL,
  `MEDICINE_IMG` varchar(255) DEFAULT NULL,
  `INSERT_FILE` varchar(255) DEFAULT NULL,
  `ID_RT` int(10) unsigned NOT NULL AUTO_INCREMENT,
  PRIMARY KEY (`ID_RT`)
) ENGINE=InnoDB  DEFAULT CHARSET=latin1 AUTO_INCREMENT=277 ;

--
-- Dumping data for table `drg_raw_table`
--

INSERT INTO `drg_raw_table` (`BRAND_NAME`, `GENERIC_NAME`, `THERAPEDIC_NAME`, `MEDICINE_DESC`, `STRENGTH`, `UOM`, `MEDICINE_CATEGORY`, `MEDICINE_TYPE`, `IS_LATEST`, `SPECIAL_PROD`, `MEDICINE_IMG`, `INSERT_FILE`, `ID_RT`) VALUES
('AZIMEX', 'Azithromycin Dihydrate USP', 'Antibiotic', 'Desc Of Azimex', '250', 'mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'azimex.jpg', 'azimex.pdf', 1),
('AZIMEX', 'Azithromycin Dihydrate USP', 'Antibiotic', 'Desc Of Azimex', '500', 'mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'azimex.jpg', 'azimex.pdf', 2),
('AZIMEX', 'Azithromycin Dihydrate USP', 'Antibiotic', 'Desc Of Azimex', '200', 'mg/5ml', 'Pharmaceuticals', 'Suspension ', 'N', NULL, 'azimex 15ml.jpg', 'azimex 15ml.pdf', 3),
('AZIMEX', 'Azithromycin USP', 'Antibiotic', 'Desc Of Azimex', '200', 'mg/5ml', 'Pharmaceuticals', 'Suspension ', 'N', NULL, 'azimex 30ml.jpg', 'azimex 30ml.pdf', 4),
('AZIMEX', 'Azithromycin USP', 'Antibiotic', 'Desc Of Azimex', '200', 'mg/5ml', 'Pharmaceuticals', 'Suspension ', 'N', NULL, 'azimex 50ml.jpg', 'azimex 50ml.pdf', 5),
('CLARIN  ', 'Clarithromycin USP', 'Antibiotic', 'Desc Of CLARIN  ', '250', 'mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'clarin.jpg', 'clarin.pdf', 6),
('CLARIN  ', 'Clarithromycin USP', 'Antibiotic', 'Desc Of CLARIN  ', '500', 'mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'clarin.jpg', 'clarin.pdf', 7),
('ERYBAC ', 'Erythromycin BP ', 'Antibiotic', 'Desc Of Erybac', '250', 'mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Erybac.jpg', 'Erybac.pdf', 8),
('ERYBAC ', 'Erythromycin BP ', 'Antibiotic', 'Desc Of Erybac', '500', 'mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Erybac.jpg', 'Erybac.pdf', 9),
('ERYBAC ', 'Erythromycin BP ', 'Antibiotic', 'Desc Of Erybac', '125', 'mg/5ml', 'Pharmaceuticals', 'Suspension ', 'N', NULL, 'Erybac.jpg', 'Erybac.pdf', 10),
('Perinem-500', 'Doripenem Monohydrate INN', 'Antibiotic', 'Desc Of Perinem-500', '500', 'mg(IV)', 'Pharmaceuticals', 'Injection', 'N', NULL, 'Perinem-500.jpg', 'Perinem-500.pdf', 11),
('Ropenem', 'Meropenem Trihydrate USP ', 'Antibiotic', 'Desc Of Ropenem ', '500', 'mg(IV)', 'Pharmaceuticals', 'Injection', 'N', NULL, 'Ropenem.jpg', 'Ropenem.pdf', 12),
('Ropenem', 'Meropenem Trihydrate USP ', 'Antibiotic', 'Desc Of Ropenem ', '1', 'gm(IV)', 'Pharmaceuticals', 'Injection', 'N', NULL, 'Ropenem.jpg', 'Ropenem.pdf', 13),
('DEMOXIL ', 'Amoxycylline Trihydrate BP', 'Antibiotic', 'Desc Of Demoxil', '250', 'mg', 'Pharmaceuticals', 'Capsule', 'N', NULL, 'Demoxil.jpg', 'Demoxil.Pdf', 14),
('DEMOXIL ', 'Amoxycylline Trihydrate BP', 'Antibiotic', 'Desc Of Demoxil', '500', 'mg', 'Pharmaceuticals', 'Capsule', 'N', NULL, 'Demoxil.jpg', 'Demoxil.Pdf', 15),
('DEMOXIL ', 'Amoxycylline Trihydrate BP', 'Antibiotic', 'Desc Of Demoxil', '125', 'mg/5ml', 'Pharmaceuticals', 'Suspension ', 'N', NULL, 'Demoxil.jpg', 'Demoxil.Pdf', 16),
('DEMOXIL -DS', 'Amoxycylline Trihydrate BP', 'Antibiotic', 'Desc Of Demoxil', '250', 'mg/5ml', 'Pharmaceuticals', 'Suspension ', 'N', NULL, 'Demoxil.jpg', 'Demoxil.Pdf', 17),
('DEMOXICLAVE-375 ', 'Amoxycylline  Trihydrate USP with Clavulanate Acid USP', 'Antibiotic', 'Desc Of Demoxilclave-375', '250+125', 'mg+mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Demoxiclave.jpg', 'Demoxiclave.Pdf', 18),
('DEMOXICLAVE-625', 'Amoxycylline  Trihydrate USP with Clavulanate Acid USP', 'Antibiotic', 'Desc Of Demoxilclave-625', '500+125', 'mg+mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Demoxiclave.jpg', 'Demoxiclave.Pdf', 19),
('DEMOXICLAVE-Forte', 'Amoxycylline  Trihydrate USP with Clavulanate Acid USP', 'Antibiotic', 'Desc Of Demoxilclave-Forte', '400+57.5', 'mg/5ml+mg/5ml', 'Pharmaceuticals', 'Suspension ', 'N', NULL, 'Demoxiclave.jpg', 'Demoxiclave.Pdf', 20),
('DEMOXICLAVE', 'Amoxycylline  Trihydrate USP with Clavulanate Acid USP', 'Antibiotic', 'Desc Of Demoxilclave', '125+31.25', 'mg/5ml+mg/5ml', 'Pharmaceuticals', 'Suspension ', 'N', NULL, 'Demoxiclave.jpg', 'Demoxiclave.Pdf', 21),
('FLUPEN ', 'Flucloxacillin Sodium BP', 'Antibiotic', 'Desc Of Flupen', '250', 'mg', 'Pharmaceuticals', 'Capsule', 'N', NULL, 'Flupen.jpg', 'Flupen.pdf', 22),
('FLUPEN ', 'Flucloxacillin Sodium BP', 'Antibiotic', 'Desc Of Flupen', '500', 'mg', 'Pharmaceuticals', 'Capsule', 'N', NULL, 'Flupen.jpg', 'Flupen.pdf', 23),
('FLUPEN ', 'Flucloxacillin Sodium BP', 'Antibiotic', 'Desc Of Flupen', '125', 'mg/5ml', 'Pharmaceuticals', 'Dry Syrup', 'N', NULL, 'Flupen.jpg', 'Flupen.pdf', 24),
('Butibac', 'Cefditoren Dihydrate INN', 'Antibiotic', 'Desc Of Butibac', '400', 'mg', 'Pharmaceuticals', 'Capsule', 'N', NULL, 'Butibac.jpg', 'butibac.pdf', 25),
('Butibac', 'Cefditoren Dihydrate INN', 'Antibiotic', 'Desc Of Butibac', '90', 'mg/5ml', 'Pharmaceuticals', 'Suspension ', 'N', NULL, 'Butibac.jpg', 'butibac.pdf', 26),
('CEFORAN', 'Cefpodoxime USP', 'Antibiotic', 'Desc Of Ceforan', '100', 'mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'ceforan.jpg', 'ceforan.pdf', 27),
('CEFORAN', 'Cefpodoxime USP', 'Antibiotic', 'Desc Of Ceforan', '200', 'mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'ceforan.jpg', 'ceforan.pdf', 28),
('CEFORAN', 'Cefpodoxime USP', 'Antibiotic', 'Desc Of Ceforan', '40', 'mg/5ml', 'Pharmaceuticals', 'Suspension ', 'N', NULL, 'ceforan 50ml.jpg', 'ceforan.pdf', 29),
('CEFORAN', 'Cefpodoxime USP', 'Antibiotic', 'Desc Of Ceforan', '40', 'mg/5ml', 'Pharmaceuticals', 'Suspension ', 'N', NULL, 'ceforan 100ml.jpg', 'ceforan.pdf', 30),
('CEFORAN-ds', 'Cefpodoxime USP', 'Antibiotic', 'Desc Of Ceforan-ds', '80', 'mg/5ml', 'Pharmaceuticals', 'Suspension ', 'N', NULL, 'ceforan.jpg', 'ceforan.pdf', 31),
('Clavuran 100', 'Cefpodoxime USP with Clavulanic Acid USP', 'Antibiotic', 'Desc Of Clavuran', '100+62.5', 'mg+mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Clavuran.jpg', 'Clavuran.pdf', 32),
('Clavuran 200', 'Cefpodoxime USP with Clavulanic Acid USP', 'Antibiotic', 'Desc Of Clavuran', '200+125', 'mg+mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Clavuran.jpg', 'Clavuran.pdf', 33),
('Dicef', 'Cephradine USP', 'Antibiotic', 'Desc Of Dicef', '250', 'mg', 'Pharmaceuticals', 'Capsule', 'N', NULL, 'Dicef.jpg', 'Dicef.pdf', 34),
('Dicef', 'Cephradine USP', 'Antibiotic', 'Desc Of Dicef', '500', 'mg', 'Pharmaceuticals', 'Capsule', 'N', NULL, 'Dicef.jpg', 'Dicef.pdf', 35),
('Dicef', 'Cephradine USP', 'Antibiotic', 'Desc Of Dicef', '125', 'mg/5ml', 'Pharmaceuticals', 'Suspension ', 'N', NULL, 'Dicef.jpg', 'Dicef.pdf', 36),
('Dicef', 'Cephradine USP', 'Antibiotic', 'Desc Of Dicef', '125', 'mg/1.25ml', 'Pharmaceuticals', 'Paediatric Drops', 'N', NULL, 'Dicef.jpg', 'Dicef.pdf', 37),
('Dicef-forte', 'Cephradine USP', 'Antibiotic', 'Desc Of Dicef', '250', 'mg/5ml', 'Pharmaceuticals', 'Suspension ', 'N', NULL, 'Dicef.jpg', 'Dicef.pdf', 38),
('Dicephin ', 'Ceftriaxone Sodium USP', 'Antibiotic', 'Desc Of Dicephin', '250', 'mg(IV)', 'Pharmaceuticals', 'Injection', 'N', NULL, 'Dicephin.jpg', 'Dicephin.pdf', 39),
('Dicephin ', 'Ceftriaxone Sodium USP', 'Antibiotic', 'Desc Of Dicephin', '250', 'mg(IM)', 'Pharmaceuticals', 'Injection', 'N', NULL, 'Dicephin.jpg', 'Dicephin.pdf', 40),
('Dicephin ', 'Ceftriaxone Sodium USP', 'Antibiotic', 'Desc Of Dicephin', '500', 'mg(IV)', 'Pharmaceuticals', 'Injection', 'N', NULL, 'Dicephin.jpg', 'Dicephin.pdf', 41),
('Dicephin ', 'Ceftriaxone Sodium USP', 'Antibiotic', 'Desc Of Dicephin', '500', 'mg(IM)', 'Pharmaceuticals', 'Injection', 'N', NULL, 'Dicephin.jpg', 'Dicephin.pdf', 42),
('Dicephin ', 'Ceftriaxone Sodium USP', 'Antibiotic', 'Desc Of Dicephin', '1', 'gm(IV)', 'Pharmaceuticals', 'Injection', 'N', NULL, 'Dicephin.jpg', 'Dicephin.pdf', 43),
('Dicephin ', 'Ceftriaxone Sodium USP', 'Antibiotic', 'Desc Of Dicephin', '1', 'gm(IM)', 'Pharmaceuticals', 'Injection', 'N', NULL, 'Dicephin.jpg', 'Dicephin.pdf', 44),
('Dicephin ', 'Ceftriaxone Sodium USP', 'Antibiotic', 'Desc Of Dicephin', '2', 'gm(IV)', 'Pharmaceuticals', 'Injection', 'N', NULL, 'Dicephin.jpg', 'Dicephin.pdf', 45),
('Fuclav', 'Cefuroxime USP with Clavulanic Acid USP ', 'Antibiotic', 'Desc Of Fuclav', '125+31.25', 'mg/5ml+mg/5ml', 'Pharmaceuticals', 'Suspension ', 'N', NULL, 'Fuclav.jpg', 'Fuclav.pdf', 46),
('Fuclav-125', 'Cefuroxime USP with Clavulanic Acid USP ', 'Antibiotic', 'Desc Of Fuclav', '125+31.25', 'mg+mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Fuclav.jpg', 'Fuclav.pdf', 47),
('Fuclav-250', 'Cefuroxime USP with Clavulanic Acid USP ', 'Antibiotic', 'Desc Of Fuclav', '250+62.50', 'mg+mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Fuclav.jpg', 'Fuclav.pdf', 48),
('Fuclav-500', 'Cefuroxime USP with Clavulanic Acid USP ', 'Antibiotic', 'Desc Of Fuclav', '500+125', 'mg+mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Fuclav.jpg', 'Fuclav.pdf', 49),
('Furex', 'Cefuroxime USP ', 'Antibiotic', 'Desc Of Furex', '250', 'mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Furex.jpg', 'Furex.pdf', 50),
('Furex', 'Cefuroxime USP ', 'Antibiotic', 'Desc Of Furex', '500', 'mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Furex.jpg', 'Furex.pdf', 51),
('Furex', 'Cefuroxime USP ', 'Antibiotic', 'Desc Of Furex', '125', 'mg/5ml', 'Pharmaceuticals', 'Suspension ', 'N', NULL, 'Furex.jpg', 'Furex.pdf', 52),
('Furex', 'Cefuroxime USP ', 'Antibiotic', 'Desc Of Furex', '750', 'mg(IV/IM)', 'Pharmaceuticals', 'Injection', 'N', NULL, 'Furex.jpg', 'Furex.pdf', 53),
('Furex', 'Cefuroxime USP ', 'Antibiotic', 'Desc Of Furex', '1.5', 'gm(IV)', 'Pharmaceuticals', 'Injection', 'N', NULL, 'Furex.jpg', 'Furex.pdf', 54),
('SEFANID ', 'Cefadroxil Monohydrate USP', 'Antibiotic', 'Desc Of Sefanid', '500', 'mg', 'Pharmaceuticals', 'Capsule', 'N', NULL, 'sefanid.jpg', 'sefanid.pdf', 55),
('SEFANID ', 'Cefadroxil Monohydrate USP', 'Antibiotic', 'Desc Of Sefanid', '125', 'mg/5ml', 'Pharmaceuticals', 'Suspension ', 'N', NULL, 'sefanid.jpg', 'sefanid.pdf', 56),
('T-CEF ', 'Cefixime Trihydrate USP', 'Antibiotic', 'Desc Of T-cef', '200', 'mg', 'Pharmaceuticals', 'Capsule', 'N', NULL, 'T-cef.jpg', 'T-cef.pdf', 57),
('T-CEF ', 'Cefixime Trihydrate USP', 'Antibiotic', 'Desc Of T-cef', '400', 'mg', 'Pharmaceuticals', 'Capsule', 'N', NULL, 'T-cef.jpg', 'T-cef.pdf', 58),
('T-CEF ', 'Cefixime Trihydrate USP', 'Antibiotic', 'Desc Of T-cef', '100', 'mg/5ml', 'Pharmaceuticals', 'Suspension ', 'N', NULL, 'T-cef.jpg', 'T-cef.pdf', 59),
('T-CEF ', 'Cefixime Trihydrate USP', 'Antibiotic', 'Desc Of T-cef', '100', 'mg/5ml', 'Pharmaceuticals', 'Suspension ', 'N', NULL, 'T-cef.jpg', 'T-cef.pdf', 60),
('T-CEF DS', 'Cefixime Trihydrate USP', 'Antibiotic', 'Desc Of T-cef', '200', 'mg/5ml', 'Pharmaceuticals', 'Suspension ', 'N', NULL, 'T-cef.jpg', 'T-cef.pdf', 61),
('T-CEF  ', 'Cefixime Trihydrate USP', 'Antibiotic', 'Desc Of T-cef', '25', 'mg/ml', 'Pharmaceuticals', 'Paediatric Drops', 'N', NULL, 'T-cef.jpg', 'T-cef.pdf', 62),
('Trum 3', 'Ceftazidime Pentahydrate USP', 'Antibiotic', 'Desc Of Trum 3', '250', 'mg(IV/IM)', 'Pharmaceuticals', 'Injection', 'N', NULL, 'Trum 3.jpg', 'Trum 3.pdf', 63),
('Trum 3', 'Ceftazidime Pentahydrate USP', 'Antibiotic', 'Desc Of Trum 3', '500', 'mg(IV/IM)', 'Pharmaceuticals', 'Injection', 'N', NULL, 'Trum 3.jpg', 'Trum 3.pdf', 64),
('Trum 3', 'Ceftazidime Pentahydrate USP', 'Antibiotic', 'Desc Of Trum 3', '1', 'gm(IV/IM)', 'Pharmaceuticals', 'Injection', 'N', NULL, 'Trum 3.jpg', 'Trum 3.pdf', 65),
('Unipim', 'Cefepime USP', 'Antibiotic', 'Desc Of Unipim', '500', 'mg(IV/IM)', 'Pharmaceuticals', 'Injection', 'N', NULL, 'Unipim.jpg', 'Unipim.pdf', 66),
('Unipim', 'Cefepime USP', 'Antibiotic', 'Desc Of Unipim', '1', 'gm(IV/IM)', 'Pharmaceuticals', 'Injection', 'N', NULL, 'Unipim.jpg', 'Unipim.pdf', 67),
('CIPROZID', 'Ciprofloxacin USP', 'Antibiotic', 'Desc Of Ciprozid', '250', 'mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Ciprozid.jpg', 'Ciprozid.pdf', 68),
('CIPROZID', 'Ciprofloxacin USP', 'Antibiotic', 'Desc Of Ciprozid', '750', 'mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Ciprozid.jpg', 'Ciprozid.pdf', 69),
('CIPROZID DS', 'Ciprofloxacin USP', 'Antibiotic', 'Desc Of Ciprozid', '500', 'mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Ciprozid.jpg', 'Ciprozid.pdf', 70),
('CIPROZID', 'Ciprofloxacin USP', 'Antibiotic', 'Desc Of Ciprozid', '250', 'mg/5ml', 'Pharmaceuticals', 'Suspension ', 'N', NULL, 'Ciprozid.jpg', 'Ciprozid.pdf', 71),
('CIPROZID XR 1000', 'Ciprofloxacin USP', 'Antibiotic', 'Desc Of Ciprozid', '1000', 'mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Ciprozid.jpg', 'Ciprozid.pdf', 72),
('Floxalone ', 'Moxifloxacin Hydrochloride BP', 'Antibiotic', 'Desc Of Floxalone', '400', 'mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Floxalone.jpg', 'Floxalone.pdf', 73),
('Gelcin', 'Gemifloxacin INN', 'Antibiotic', 'Desc Of Gelcin', '320', 'mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Gelcin.jpg', 'Gelcin.pdf', 74),
('Levoflox', 'Levofloxacin INN', 'Antibiotic', 'Desc Of Levoflox', '500', 'mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Levoflox.jpg', 'Levoflox.pdf', 75),
('Levoflox', 'Levofloxacin INN', 'Antibiotic', 'Desc Of Levoflox', '750', 'mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Levoflox.jpg', 'Levoflox.pdf', 76),
('Oflacin', 'Ofloxacin INN', 'Antibiotic', 'Desc Of Oflacin', '200', 'mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Oflacin.jpg', 'oflacin.pdf', 77),
('Oflacin', 'Ofloxacin INN', 'Antibiotic', 'Desc Of Oflacin', '400', 'mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Oflacin.jpg', 'oflacin.pdf', 78),
('Peflox', 'Pefloxacin INN', 'Antibiotic', 'Desc Of Peflox', '400', 'mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'peflox.jpg', 'peflox.pdf', 79),
('Sparonex', 'Sparfloxacin INN', 'Antibiotic', 'Desc Of Sparonex', '200', 'mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Sparonex.jpg', 'Sparonex.pdf', 80),
('Dalacin', 'Clindamycin USP', 'Antibiotic', 'Desc Of Dalacin', '300', 'mg', 'Pharmaceuticals', 'Capsule', 'N', NULL, 'Dalacin.jpg ', 'Dalacin.pdf', 81),
('Dalacin', 'Clindamycin USP', 'Antibiotic', 'Desc Of Dalacin', '300', 'mg/2ml(IV/IM)', 'Pharmaceuticals', 'Injection', 'N', NULL, 'Dalacin.jpg ', 'Dalacin.pdf', 82),
('Dalacin', 'Clindamycin USP', 'Antibiotic', 'Desc Of Dalacin', '600', 'mg/4ml(IV/IM)', 'Pharmaceuticals', 'Injection', 'N', NULL, 'Dalacin.jpg ', 'Dalacin.pdf', 83),
('Faxan', 'Rifaximin BP', 'Antibiotic', 'Desc Of Faxan', '200', 'mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Faxan.jpg', 'Faxan.pdf', 84),
('Faxan', 'Rifaximin BP', 'Antibiotic', 'Desc Of Faxan', '550', 'mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Faxan.jpg', 'Faxan.pdf', 85),
('Gunamix', '(Neomycin Sulphate+Polymyxin B-Sulphate+Nystatin+Metronidazole)BP', 'Antibiotic', 'Desc Of Gynomix', '35000+35000+100000+200', 'I.U+I.U+I.U+mg', 'Pharmaceuticals', 'Soft Capsule', 'N', 'Special 1', 'Gynomix.jpg', 'Gynomix.pdf', 86),
('Psudonil', 'Amikacin USP', 'Antibiotic', 'Desc Of Psudonil', '100', 'mg/2ml(IV/IM)', 'Pharmaceuticals', 'Injection', 'N', NULL, 'Psudonil.jpg', 'psudonil.pdf', 87),
('Psudonil', 'Amikacin USP', 'Antibiotic', 'Desc Of Psudonil', '250', 'mg/2ml(IV/IM)', 'Pharmaceuticals', 'Injection', 'N', NULL, 'Psudonil.jpg', 'psudonil.pdf', 88),
('Psudonil', 'Amikacin USP', 'Antibiotic', 'Desc Of Psudonil', '500', 'mg/2ml(IV/IM)', 'Pharmaceuticals', 'Injection', 'N', NULL, 'Psudonil.jpg', 'psudonil.pdf', 89),
('Rantoin', 'Nitrofurantoin USP', 'Antibiotic', 'Desc Of Rantoin', '100', 'mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Rantoin.jpg', 'Rantoin.pdf', 90),
('COSEC ', 'Omeprazole BP', 'Anti-acid & Ulcer Healing', 'Desc Of Cosec', '20', 'mg', 'Pharmaceuticals', 'Capsule', 'N', NULL, 'Cosec.jpg', 'Cosec.pdf', 91),
('COSEC ', 'Omeprazole BP', 'Anti-acid & Ulcer Healing', 'Desc Of Cosec', '40', 'mg', 'Pharmaceuticals', 'Capsule', 'N', NULL, 'Cosec.jpg', 'Cosec.pdf', 92),
('COSEC ', 'Omeprazole BP', 'Anti-acid & Ulcer Healing', 'Desc Of Cosec', '40', 'mg(IV)', 'Pharmaceuticals', 'Injection', 'N', NULL, 'Cosec.jpg', 'Cosec.pdf', 93),
('LANSEC', 'Lansoprazole USP', 'Anti-acid & Ulcer Healing', 'Desc Of Lansec', '15', 'mg', 'Pharmaceuticals', 'Capsule', 'N', NULL, 'Lansec.jpg', 'Lansec.pdf', 94),
('LANSEC', 'Lansoprazole USP', 'Anti-acid & Ulcer Healing', 'Desc Of Lansec', '30', 'mg', 'Pharmaceuticals', 'Capsule', 'N', NULL, 'Lansec.jpg', 'Lansec.pdf', 95),
('PANSEC ', 'Pantroprazole BP', 'Anti-acid & Ulcer Healing', 'Desc Of Pansec', '20', 'mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Pansec.jpg', 'Pansec.pdf', 96),
('PANSEC ', 'Pantroprazole BP', 'Anti-acid & Ulcer Healing', 'Desc Of Pansec', '40', 'mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Pansec.jpg', 'Pansec.pdf', 97),
('PANSEC ', 'Pantroprazole BP', 'Anti-acid & Ulcer Healing', 'Desc Of Pansec', '40', 'mg(IV)', 'Pharmaceuticals', 'Injection', 'N', NULL, 'Pansec.jpg', 'Pansec.pdf', 98),
('PRONEX ', 'Esomeprazole INN', 'Anti-acid & Ulcer Healing', 'Desc Of Pronex', '20', 'mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Pronex.jpg', 'Pronex.pdf', 99),
('PRONEX ', 'Esomeprazole INN', 'Anti-acid & Ulcer Healing', 'Desc Of Pronex', '40', 'mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Pronex.jpg', 'Pronex.pdf', 100),
('PRONEX ', 'Esomeprazole INN', 'Anti-acid & Ulcer Healing', 'Desc Of Pronex', '20', 'mg', 'Pharmaceuticals', 'Capsule', 'N', NULL, 'Pronex.jpg', 'Pronex.pdf', 101),
('PRONEX ', 'Esomeprazole INN', 'Anti-acid & Ulcer Healing', 'Desc Of Pronex', '40', 'mg', 'Pharmaceuticals', 'Capsule', 'N', NULL, 'Pronex.jpg', 'Pronex.pdf', 102),
('PRONEX ', 'Esomeprazole INN', 'Anti-acid & Ulcer Healing', 'Desc Of Pronex', '40', 'mg(IV)', 'Pharmaceuticals', 'Injection', 'N', NULL, 'Pronex.jpg', 'Pronex.pdf', 103),
('RABESEC ', 'Rabeprazole Sodium INN ', 'Anti-acid & Ulcer Healing', 'Desc Of Rabesec', '20', 'mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Rabesec.jpg', 'Rabesec.pdf', 104),
('FAMOTID ', 'Famotidine USP', 'Anti-acid & Ulcer Healing', 'Desc Of Famotid', '20', 'mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Famotid.jpg', 'Famotid.pdf', 105),
('FAMOTID ', 'Famotidine USP', 'Anti-acid & Ulcer Healing', 'Desc Of Famotid', '40', 'mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Famotid.jpg', 'Famotid.pdf', 106),
('ULCAR ', 'Ranitidine USP', 'Anti-acid & Ulcer Healing', 'Desc Of Ulcar', '150', 'mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Ulcar.jpg', 'Ulcar.pdf', 107),
('ULCAR ', 'Ranitidine USP', 'Anti-acid & Ulcer Healing', 'Desc Of Ulcar', '300', 'mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Ulcar.jpg', 'Ulcar.pdf', 108),
('Semecon', 'Simethicone USP', 'Anti-acid & Ulcer Healing', 'Desc Of Semecon', '67', 'mg/ml', 'Pharmaceuticals', 'Paediatric Drops', 'N', NULL, 'Semecon.jpg', 'Semecon.pdf', 109),
('Meverine', 'Mebeverine HCl BP', 'Antispasmodic ', 'Desc of Mebeverine', '135', 'mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'mebeverine.jpg', 'mebeverine.pdf', 110),
('Meverine-SR', 'Mebeverine HCl BP', 'Antispasmodic ', 'Desc of Mebeverine', '200', 'mg', 'Pharmaceuticals', 'SR Capsule', 'N', NULL, 'mebeverine.jpg', 'mebeverine.pdf', 111),
('Visonium', 'Tiemonium Methylsulfate INN', 'Antispasmodic ', 'Desc of Tiemonium Methylsulfate INN', '50', 'mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'visonium.jpg', 'visonium.pdf', 112),
('Visonium', 'Tiemonium Methylsulfate INN', 'Antispasmodic ', 'Desc of Tiemonium Methylsulfate INN', '2017-05-02 00:00:00', 'mg/ml', 'Pharmaceuticals', 'Injection', 'N', NULL, 'visonium.jpg', 'visonium.pdf', 113),
('D-Lac', 'Lactulose BP', 'Laxative', 'Desc of Lactulose ', '3.35/5', 'mg/ml', 'Pharmaceuticals', 'Syrup', 'N', NULL, 'd-lac.jpg', 'd-lac.pdf', 114),
('D-Lac', 'Lactulose BP', 'Laxative', 'Desc of Lactulose ', '3.35/5', 'mg/ml', 'Pharmaceuticals', 'Syrup', 'N', NULL, 'd-lac.jpg', 'd-lac.pdf', 115),
('D-Lac', 'Lactulose BP', 'Laxative', 'Desc of Lactulose ', '3.35/5', 'mg/ml', 'Pharmaceuticals', 'Syrup', 'N', NULL, 'd-lac.jpg', 'd-lac.pdf', 116),
('Bacmax-5', 'Baclofen USP', 'Muscle Relaxant', 'Decs of Baclofen ', '5', 'mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'bacmax.jpg', 'bacmax.pdf', 117),
('Bacmax-10', 'Baclofen USP', 'Muscle Relaxant', 'Decs of Baclofen ', '10', 'mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'bacmax.jpg', 'bacmax.pdf', 118),
('Lexaton', 'Tolperisone Hydrochloride INN', 'Muscle Relaxant', 'Desc of Tolperisone Hydrochloride', '50', 'mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'lexaton.jpg', 'lexaton.pdf', 119),
('Trolen-25', 'Dantrolene Sodium USP', 'Muscle Relaxant', 'Desc of Tolperisone Hydrochloride', '25', 'mg', 'Pharmaceuticals', 'Capsule', 'N', NULL, 'trolen.jpg', 'trolen.pdf', 120),
('Ardium ', 'Diosmin BP+ Hesperidine BP', 'Others', 'Decs of Diosmin & Hesperidine', '500', 'mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'ardium.jpg', 'ardium.pdf', 121),
('Neoplat', 'Cisplatin BP', 'Oncology', 'Desc of Cisplatin', '50/50', 'mg/ml', 'Pharmaceuticals', 'Injection', 'Y', 'Special', 'neoplat.jpg', 'neoplat.pdf', 122),
('Carplatin-150', 'Carboplatin BP', 'Oncology', 'Desc of Carboplatin', '150/15', 'mg/ml', 'Pharmaceuticals', 'Injection', 'Y', 'Special', 'carplatin.jpg', 'carplatin.pdf', 123),
('Carplatin-450', 'Carboplatin BP', 'Oncology', 'Desc of Carboplatin', '450/50', 'mg/ml', 'Pharmaceuticals', 'Injection', 'Y', 'Special', 'carplatin.jpg', 'carplatin.pdf', 124),
('Ontaxel', 'Paclitaxel USP', 'Oncology', 'Decs of Paclitaxel', '100/16.7', 'mg/ml', 'Pharmaceuticals', 'Injection', 'Y', 'Special', 'ontaxel.jpg', 'ontaxel.pdf', 125),
('Ontaxel', 'Paclitaxel USP', 'Oncology', 'Decs of Paclitaxel', '300/50', 'mg/ml', 'Pharmaceuticals', 'Injection', 'Y', 'Special', 'ontaxel.jpg', 'ontaxel.pdf', 126),
('Vinstin', 'Vincristine SulphateUSP', 'Oncology', 'Desc of Vincristine', '2017-02-02 00:00:00', 'mg/ml', 'Pharmaceuticals', 'Injection', 'Y', 'Special', 'vinstin.jpg', 'vinstin.pdf', 127),
('Toposar', 'Etoposide USP', 'Oncology', 'Desc of Etoposide', '100/20', 'mg/ml', 'Pharmaceuticals', 'Injection', 'Y', 'Special', 'toposar.jpg', 'toposar.pdf', 128),
('Toposar', 'Etoposide USP', 'Oncology', 'Desc of Etoposide', '50', 'mg', 'Pharmaceuticals', 'Injection', 'Y', 'Special', 'toposar.jpg', 'toposar.pdf', 129),
('Avro ', 'Travoprost USP ', 'Eye Drops', 'Desc Of Avro ', '0.00004', 'w/v', 'Pharmaceuticals', 'Eye Drops', 'N', 'Special 1', 'Avro.jpg', 'Avro.pdf', 130),
('CIPROZID ', 'Ciprofloxacin Hcl. USP ', 'Eye Drops', 'Desc Of CIPROZID', '0.003', 'w/v', 'Pharmaceuticals', 'Eye Drops', 'N', 'Special 1', 'CIPROZID.jpg', 'CIPROZID.pdf', 131),
('CIPROZID-DX   ', 'Ciprofloxacin USP & Dexamethasone USP', 'Eye & Ear Drop', 'Desc Of CIPROZID-DX', '0.3% & 0.1%', 'w/v', 'Pharmaceuticals', 'Eye & Ear Drop', 'N', 'Special 1', 'CIPROZID-DX.jpg', 'CIPROZID-DX.pdf', 132),
('CIPROCORT', 'Ciprofloxacin USP & Hydrocortisone BP', 'Otic Suspension', 'Desc Of CIPROCORT', '0.3% & 1%', 'w/v', 'Pharmaceuticals', 'Otic Suspension', 'N', 'Special 1', 'CIPROCORT.jpg', 'CIPROCORT.pdf', 133),
('CELUDEX', 'Dexamethasone BP', 'Eye & Ear Drop', 'Desc Of CELUDEX', '0.001', 'w/v', 'Pharmaceuticals', 'Eye & Ear Drop', 'N', 'Special 1', 'CELUDEX.jpg', 'CELUDEX.pdf', 134),
('EYETEAR', 'Povidone BP', 'Eye Drops', 'Desc Of EYETEAR', '0.05', 'w/v', 'Pharmaceuticals', 'Eye & Ear Drops', 'N', 'Special 1', 'EYETEAR.jpg', 'EYETEAR.pdf', 135),
('F-Lon', 'Fluorometholone USP', 'Ophthalmic suspension', 'Desc Of F-LON', '0.001', 'W/V', 'Pharmaceuticals', 'Ophthalmic Suspension', 'N', 'Special 1', 'F-Lon.jpg', 'F-Lon.pdf', 136),
('FENAT', 'Ketotifen BP', 'Eye Drop', 'Desc Of FENAT', '0.00025', 'w/v', 'Pharmaceuticals', 'Eye Drop', 'N', 'Special 1', 'FENAT.jpg', 'FENAT.pdf', 137),
('FLOXALONE', 'Moxifloxacin BP ', 'Eye Drop', 'Desc Of FLOXALONE', '0.005', 'w/v', 'Pharmaceuticals', 'Eye Drop', 'N', 'Special 1', 'FLOXALONE.jpg', 'FLOXALONE.pdf', 138),
('LEVOFLOX', 'Levofloxacin INN', 'Eye Drop', 'Desc Of LEVOFLOX', '0.005', 'w/v', 'Pharmaceuticals', 'Eye Drop', 'N', 'Special 1', 'LEVOFLOX.jpg', 'LEVOFLOX.pdf', 139),
('NASOCHROM', 'Sodium Cromoglycate', 'Eye & Nosal drop ', 'Desc Of NASOCHROM', '0.02', 'w/v', 'Pharmaceuticals', 'Eye & Nosal drop ', 'N', 'Special 1', 'NASOCHROM.jpg', 'NASOCHROM.pdf', 140),
('NOPAIN ', 'Diclofenac Sodium BP', 'Eye Drop ', 'Desc Of NOPAIN', '0.001', 'w/v', 'Pharmaceuticals', 'Eye Drop ', 'N', 'Special 1', 'NOPAIN.jpg', 'NOPAIN.pdf', 141),
('NEO-DP ', 'Dexamethasone USP,Neomycin sulphate USP&', 'Opthalmic Suspension-', 'Desc Of NEO-DP', '0.1%, 3500,6000', 'w/v, IU/ml, IU/ml', 'Pharmaceuticals', 'Opthalmic Suspension', 'N', 'Special 1', 'NEO-DP.jpg', 'NEO-DP.pdf', 142),
(NULL, 'Polymyxin B Sulphate', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 143),
('OPTHACOL', 'Chloramphenicol BP', 'Eye & Ear Drop', 'Desc Of OPTHACOL', '0.005', 'w/v', 'Pharmaceuticals', 'Eye & Ear Drop', 'N', 'Special 1', 'OPTHACOL.jpg', 'OPTHACOL.pdf', 144),
('OPTHAFLOX', 'Lomefloxacin INN ', ' Eye Drop', 'Desc Of OPTHAFLOX', '0.003', 'w/v', 'Pharmaceuticals', ' Eye Drop', 'N', 'Special 1', 'OPTHAFLOX.jpg', 'OPTHAFLOX.pdf', 145),
('PAIR', 'ketorolac Tromethamine USP', 'Eye Drop', 'Desc Of PAIR', '0.005', 'w/v', 'Pharmaceuticals', ' Eye Drop', 'N', 'Special 1', 'PAIR.jpg', 'PAIR.pdf', 146),
('PEDNISOL', 'Prednisolone Acetate USP', 'Eye Drop', 'Desc Of PEDNISOL', '0.01', 'w/v', 'Pharmaceuticals', ' Eye Drop', 'N', 'Special 1', 'PEDNISOL.jpg', 'PEDNISOL.pdf', 147),
('STENICOL', 'Chloramphenicol BP & ', ' EYE DROP', 'Desc Of STENICOL', '0.5% & 0.1%', 'w/v', 'Pharmaceuticals', ' EYE DROP', 'N', 'Special 1', 'STENICOL.jpg', 'STENICOL.pdf', 148),
(NULL, 'Dexamethasone Phosphate USP', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 149),
('TEXA ', 'Tobramycin + Dexamethasone', 'Opthalmic Susp', 'Desc Of TEXA', '0.3% & 0.1%', 'w/v', 'Pharmaceuticals', 'Opthalmic Suspension', 'N', 'Special 1', 'TEXA.jpg', 'TEXA.pdf', 150),
('SYNTAR', 'Dextran 70 USP + Hyorimellose USP ', 'Eye drops', 'Desc Of SYNTAR', '0.1% & 0.3%', 'w/v', 'Pharmaceuticals', 'Eye drops', 'N', 'Special 1', 'SYNTAR.jpg', 'SYNTAR.pdf', 151),
('Cabita', ' Capecitabine USP', 'Anti- cancer', 'Desc of Cabita', '500', 'mg', 'Pharmaceuticals', 'Tablet', 'Y', 'Special 1', 'Cabita.JPG', 'Cabita.PDF', 152),
('Fluracil', 'Fluorouracil USP', 'Anti- cancer', 'Desc of Fluracil', '500', ' mg (50 mg/ml)', 'Pharmaceuticals', 'Injection', 'Y', 'Special 1', 'Fluracil.JPG', 'Fluracil.PDF', 153),
('Dobixin', 'Doxorubicin HCL USP', 'Anti- cancer', 'Desc of Dobixin', '10', 'mg (2 mg/ml)', 'Pharmaceuticals', 'Injection', 'Y', 'Special 1', 'Dobixin- 10.JPG', 'Dobixin- 10.PDF', 154),
('Dobixin', 'Doxorubicin HCL USP', 'Anti- cancer', 'Desc of Dobixin', '50', 'mg (2 mg/ml)', 'Pharmaceuticals', 'Injection', 'Y', 'Special 1', 'Dobixin- 50.JPG', 'Dobixin- 50.PDF', 155),
('Meth', 'Methotrexate USP', 'Anti- cancer', 'Desc of Meth', '2.5', 'mg', 'Pharmaceuticals', 'Tablet', 'Y', 'Special 1', 'Meth- 2.5.JPG', 'Meth- 2.5.PDF', 156),
('Meth', 'Methotrexate USP', 'Anti- cancer', 'Desc of Meth', '10', 'mg', 'Pharmaceuticals', 'Tablet', 'Y', 'Special 1', 'Meth- 10.JPG', 'Meth- 10.PDF', 157),
('Flunac ', 'Fluconazole', 'Antifungal', 'Desc Of Flunac', '50', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Flunac-50 .Jpg', 'Flunac-50.Pdf', 158),
('Flunac ', 'Fluconazole', 'Antifungal', 'Desc Of Flunac', '150', 'Mg', 'Pharmaceuticals', 'Capsule', 'N', NULL, 'Flunac-150.Jpg', 'Flunac-150.Pdf', 159),
('Flunac ', 'Fluconazole', 'Antifungal', 'Desc Of Flunac', '50/5', 'Mg/ml', 'Pharmaceuticals', 'Suspention', 'N', NULL, 'Flunac-35.Jpg', 'Flunac-35.Pdf', 160),
('Mycofree', 'Terbinafine Hcl', 'Antifungal', 'Desc Of Mycofree', '250', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Mycofree.Jpg', 'Mycofree.Pdf', 161),
('Hopso', 'Sofosbuvir', 'Antiviral', 'Desc Of Hopso', '400', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Hopso.Jpg', 'Hopso.Pdf', 162),
('Opegus', 'Ribavirin', 'Antiviral', 'Desc  Of Opegus', '200', 'Mg', 'Pharmaceuticals', 'Capsule', 'N', NULL, 'Opegus.Jpg', 'Opegus.Pdf', 163),
('Novirax', 'Aciclovir', 'Antiviral', 'Desc Of Novirax', '200', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Novirax-200.Jpg', 'Novirax-200.Pdf', 164),
('Novirax', 'Aciclovir', 'Antiviral', 'Desc Of Novirax', '400', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Novirax-400.Jpg', 'Novirax-400.Pdf', 165),
('Entavir ', 'Entecavir', 'Antiviral', 'Desc Of Entavir', '0.5', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Entavir-0.5.Jpg', 'Entavir-0.5.Pdf', 166),
('Entavir ', 'Entecavir', 'Antiviral', 'Desc Of Entavir', '1', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Entavir-1.Jpg', 'Entavir-1.Pdf', 167),
('T-fovir', 'Tenofovir', 'Antiviral', 'Desc Of  T-fovir', '300', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'T-fovir.Jpg', 'T-fovir.Pdf', 168),
('AH', 'Albendazole', 'Antiprotozoal', 'Desc Of AH', '400', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'AH-400.Jpg', 'AH-400.Pdf', 169),
('AH', 'Albendazole', 'Antiprotozoal', 'Desc Of AH', '200/5', 'Mg/ml', 'Pharmaceuticals', 'Suspention', 'N', NULL, 'AH.Jpg', 'AH.Pdf', 170),
('Nitanid ', 'Nitazoxanide', 'Antiprotozoal', 'Desc of Nitanid', '500', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Nitanid.Jpg', 'Nitanid.pdf', 171),
('Nitanid ', 'Nitazoxanide', 'Antiprotozoal', 'Desc of Nitanid', '100/5', 'Mg/ml', 'Pharmaceuticals', 'Suspention', 'N', NULL, 'Nitanid.Jpg', 'Nitanid.pdf', 172),
('Ornid', 'Ornidazole', 'Antiprotozoal', 'Desc Of Ornid', '500', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Ornid.Jpg', 'Ornid.Pdf', 173),
('Cikolin', 'Citicoline', 'CNS', 'Desc Of Cikolin', '500', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Cikolin.Jpg', 'Cikolin.Pdf', 174),
('Cikolin', 'Citicoline', 'CNS', 'Desc Of Cikolin', '500/4', 'Mg/ml', 'Pharmaceuticals', 'Injection', 'N', NULL, 'Cikolin.Jpg', 'Cikolin.Pdf', 175),
('D-Dopa', 'Levodopa & Carbidopa', 'CNS', 'Desc Of D-Dopa', '100+10', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'D-Dopa-110.Jpg', 'D-Dopa-110.Pdf', 176),
('D-Dopa', 'Levodopa & Carbidopa', 'CNS', 'Desc Of D-Dopa', '250+25', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'D-Dopa-275.Jpg', 'D-Dopa-275.Pdf', 177),
('Diconten', 'Flupentixol & Melitracen', 'CNS', 'Desc Of Diconten', '0.5+10', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Diconten.jpg', 'Diconten.Pdf', 178),
('D-pira ', 'Piracetam', 'CNS', 'Desc Of D-pira', '800', 'MG', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'D-Pira.Jpg', 'D-Pira.Pdf', 179),
('D-Toin ', 'Phenytoin', 'CNS', 'Desc Of D-Toin ', '100', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'D-Toin.Jpg', 'D-Toin.Pdf', 180),
('Neuropen', 'Gabapentin', 'CNS', 'Desc Of Neuropen ', '300', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Neuropen.Jpg', 'Neuropen.Pdf', 181),
('Prelin', 'Pregabalin', 'CNS', 'Desc Of Prelin', '25', 'Mg', 'Pharmaceuticals', 'Capsule', 'N', NULL, 'Prelin-25.jpg', 'Prelin-25.pdf', 182),
('Prelin', 'pregabelin', 'CNS', 'Desc Of Prelin', '50', 'Mg', 'Pharmaceuticals', 'Capsule', 'N', NULL, 'Prelin-50.jpg', 'Prelin-50.pdf', 183),
('Prelin', 'Pregabelin', 'CNS', 'Desc Of Prelin', '75', 'Mg', 'Pharmaceuticals', 'Capsule', 'N', NULL, 'Prelin-75.Jpg', 'Prelin-75.Pdf', 184),
('Prelin', 'Pregabelin', 'CNS', 'Desc Of Prelin', '150', 'Mg', 'Pharmaceuticals', 'Capsule', 'N', NULL, ' Prelin-150jpg', 'Prelin-150.Pdf', 185),
('Resco', 'Risperidone', 'CNS', 'Desc Of Resco', '1', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Resco-1.Jpg', 'Resco-1.Pdf', 186),
('Resco', 'Risperidone', 'CNS', 'Desc Of Resco', '2', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Resco-2.Jpg', 'Resco-2.Pdf', 187),
('Resant ', 'Mirtazapine ', 'CNS', 'Desc Of Resant', '15', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Resant.Jpg', 'Resant.Pdf', 188),
('Sertal', 'Sertraline', 'CNS', 'Desc Of Sertal', '25', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Sertal-25.Jpg', 'Sertal-25.pdf', 189),
('Sertal', 'Sertraline', 'CNS', 'Desc Of Sertal', '50', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Sertal-50.Jpg', 'Sertal-50.pdf', 190),
('Sertal', 'Sertraline', 'CNS', 'Desc Of Sertal', '100', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Sertal-100.jpg', 'Sertal-100.Pdf', 191),
('Anilic', 'Tolfenamic Acid BP', 'Analgesic & Anti-inflammatory', 'Desc Of Anilic', '200', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'anilic.jpg', 'anilic.pdf', 192),
('Bufen SR', 'Ibuprofen BP', 'Analgesic & Anti-inflammatory', 'Desc Of Bufen SR', '300', 'Mg', 'Pharmaceuticals', 'Capsule', 'N', NULL, 'bufen SR.jpg', 'bufen SR.pdf', 193),
('Canasa', 'Mesalamine USP', 'Analgesic & Anti-inflammatory', 'Desc Of Canasa', '400', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'canasa.jpg', 'canasa.pdf', 194),
('Depomed ', 'Methylprednisolone Acetate USP', 'Analgesic & Anti-inflammatory', 'Desc Of Depomed', '40', 'Mg/ml', 'Pharmaceuticals', 'Injection', 'N', NULL, 'depomed 40.jpg', 'depomed 40.pdf', 195),
('Depomed ', 'Methylprednisolone Acetate USP', 'Analgesic & Anti-inflammatory', 'Desc Of Depomed', '80', 'Mg/2ml', 'Pharmaceuticals', 'Injection', 'N', NULL, 'depomed 80.jpg', 'depomed 80.pdf', 196),
('Diproxen ', 'Naproxen BP', 'Analgesic & Anti-inflammatory', 'Desc Of Diproxen', '250', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'diproxen 250.jpg', 'diproxen 250.pdf', 197),
('Diproxen ', 'Naproxen BP', 'Analgesic & Anti-inflammatory', 'Desc Of Diproxen', '500', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'diproxen 500.jpg', 'diproxen 500.pdf', 198),
('Diproxen-CR 500', 'Naproxen BP', 'Analgesic & Anti-inflammatory', 'Desc Of Diproxen', '500', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'diproxen CR 500.jpg', 'diproxen CR 500.pdf', 199),
('Fenaton ', 'Mefenamic Acid USP', 'Analgesic & Anti-inflammatory', 'Desc Of Fenaton', '500', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'fenaton.jpg', 'fenaton.pdf', 200),
('Fevedol', 'Paracetamol BP + Tramadol HCl USP', 'Analgesic & Anti-inflammatory', 'Desc Of Fevedol', '               325 + 37.5', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'fevedol.jpg', 'fevedol.pdf', 201),
('Kingdol', 'Tramadol HCl BP', 'Analgesic & Anti-inflammatory', 'Desc Of Kingdol', '50', 'Mg', 'Pharmaceuticals', 'Capsule', 'N', NULL, 'kingdol.jpg', 'kingdol.pdf', 202),
('Napsec', 'Naproxen USP + Esomeprazole USP', 'Analgesic & Anti-inflammatory', 'Desc Of Napsec', '                 375 + 20', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'napsec 375.jpg', 'napsec 375.pdf', 203),
('Napsec', 'Naproxen USP + Esomeprazole USP', 'Analgesic & Anti-inflammatory', 'Desc Of Napsec', '                 500 + 20', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'napsec 500.jpg', 'napsec 500.pdf', 204),
('Nofenac ', 'Aceclofenac BP', 'Analgesic & Anti-inflammatory', 'Desc Of Nofenac', '100', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'nofenac.jpg', 'nofenac.pdf', 205),
('Nopain', 'Diclofenac Potassium BP', 'Analgesic & Anti-inflammatory', 'Desc Of Nopain', '25', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'nopain 25.jpg', 'nopain 25.pdf', 206),
('Nopain', 'Diclofenac Potassium BP', 'Analgesic & Anti-inflammatory', 'Desc Of Nopain', '50', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'nopain 50.jpg', 'nopain 50.pdf', 207),
('Nopain Extra', 'Diclofenac Sodium USP + Misoprostol BP ', 'Analgesic & Anti-inflammatory', 'Desc Of Nopain Extra', '                   50 + 0.2', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'nopain extra 50.jpg', 'nopain extra 50.pdf', 208),
('Nopain Extra', 'Diclofenac Sodium USP + Misoprostol BP ', 'Analgesic & Anti-inflammatory', 'Desc Of Nopain Extra', '                   75 + 0.2', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'nopain extra 75.jpg', 'nopain extra 75.pdf', 209),
('Pair', 'Ketorolac Tromethamine USP', 'Analgesic & Anti-inflammatory', 'Desc of Pair', '10', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'pair.jpg', 'pair.pdf', 210),
('Pair-30', 'Ketorolac Tromethamine USP', 'Analgesic & Anti-inflammatory', 'Desc Of Pair', '30', 'Mg/ml', 'Pharmaceuticals', 'Injection', 'N', NULL, 'pair-30.jpg', 'pair-30.pdf', 211),
('Sudac', 'Sulindac USP', 'Analgesic & Anti-inflammatory', 'Desc Of Sudac', '100', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'sudac 100.jpg', 'sudac 100.pdf', 212),
('Sudac', 'Sulindac USP', 'Analgesic & Anti-inflammatory', 'Desc Of Sudac', '200', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'sudac 200.jpg', 'sudac 200.pdf', 213),
('Sulfacol', 'Sulfasalazine USP', 'Analgesic & Anti-inflammatory', 'Desc Of Sulfacol', '500', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'sulfacol.jpg', 'sulfacol.pdf', 214),
('Trialon ', 'Triamcinolone Acetonide USP', 'Analgesic & Anti-inflammatory', 'Desc Of Trialon', '40', 'Mg/ml', 'Pharmaceuticals', 'Injection', 'N', NULL, 'trialon.jpg', 'trialon.pdf', 215),
('Combomax', 'Tamsulosin HCl USP & Dutasteride INN', 'BPH', 'Desc Of Combomax', '0.4+0.5', 'Mg', 'Pharmaceuticals', 'Capsule', 'N', 'Special 1', 'Combomax.jpg', 'Combomax.pdf', 216),
('Dutamax', 'Dutasteride INN', 'BPH', 'Desc Of dutamax', '0.5', 'Mg', 'Pharmaceuticals', 'Soft gelatin capsule', 'N', 'Special 1', 'Dutamax.jpg', 'Dutamax.pdf', 217),
('Prostam', 'Tamsulosin HCl USP', 'BPH', 'Desc Of Prostam', '0.4', 'Mg', 'Pharmaceuticals', 'Modified Release Capsule', 'N', 'Special 1', 'Prostam.jpg', 'Prostam.pdf', 218),
('D-FEN 1.5', 'Pizotifen BP', 'Antimigraine', 'Desc Of D-FEN', '1.5', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', 'Special 1', 'D-FEN.jpg', 'D-FEN.pdf', 219),
('D-FEN -0.5', 'Pizotifen BP', 'Antimigraine', 'Desc Of D-FEN', '0.5', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', 'Special 1', 'D-FEN.jpg', 'D-FEN.pdf', 220),
('Miotrol', 'Zolmitriptan INN', 'Antimigraine', 'Desc Of Miotrol', '2.5', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', 'Special 1', 'Miotrol.jpg', 'Miotrol.pdf', 221),
('Migon', 'Flunarizine Dihydrochloride BP', 'Antimigraine', 'Desc Of Migon', '5', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Migon.jpg', 'Migon.pdf', 222),
('Migon', 'Flunarizine Dihydrochloride BP', 'Antimigraine', 'Desc Of Migon', '10', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Migon.jpg', 'Migon.pdf', 223),
('ONDASON-8', 'Ondansetron USP', 'Antiemetic', 'Desc Of ONDASON', '8', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'ONDASON.jpg', 'ONDASON.pdf', 224),
('ONDASON', 'Ondansetron USP', 'Antiemetic', 'Desc Of ONDASON', '2', 'mg/ml (IV/IM)', 'Pharmaceuticals', 'Injection', 'N', NULL, 'ONDASON.jpg', 'ONDASON.pdf', 225),
('ONDASON', 'Ondansetron USP', 'Antiemetic', 'Desc Of ONDASON', '1900-01-04 00:00:00', 'mg/5ml ', 'Pharmaceuticals', 'Syrup', 'N', NULL, 'ONDASON.jpg', 'ONDASON.pdf', 226),
('Palnox 0.5', 'Palonosetron HCl INN', 'Antiemetic', 'Desc Of Palnox', '0.5', 'mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Palnox.jpg', 'Palnox.pdf', 227),
('Palnox 0.25', 'Palonosetron HCl INN', 'Antiemetic', 'Desc Of Palnox', '0.25', 'mg/ml ', 'Pharmaceuticals', 'Injection', 'N', NULL, 'Palnox.jpg', 'Palnox.pdf', 228),
('Paridon', 'Domperidone BP', 'Antiemetic', 'Desc Of Paridon', '10', 'mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Paridon.jpg', 'Paridon.pdf', 229),
('Paridon', 'Domperidone BP', 'Antiemetic', 'Desc Of Paridon', '5', 'mg/5ml ', 'Pharmaceuticals', 'Suspension', 'N', NULL, 'Paridon.jpg', 'Paridon.pdf', 230),
('Nomosic ', 'Meclizine HCl USP', 'Antiemetic', 'Desc Of Nomosic', '50', 'mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'Nomosic.jpg', 'Nomosic.pdf', 231),
('CARNITEN', 'Levocarnitine USP', 'Others', 'Desc Of CARNITEN', '330', 'mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'CARNITEN.jpg', 'CARNITEN.pdf', 233),
('COZYME', 'Coenzyme Q10  USP', 'Others', 'Desc Of COZYME', '30', 'mg', 'Pharmaceuticals', 'Capsule', 'N', NULL, 'COZYME.jpg', 'COZYME.pdf', 234),
('COZYME', 'Coenzyme Q10  USP', 'Others', 'Desc Of COZYME', '60', 'mg', 'Pharmaceuticals', 'Capsule', 'N', NULL, 'COZYME.jpg', 'COZYME.pdf', 235),
('ALBASINE', 'Almitrine Bismesylate INN & Raubasine INN', 'Others', 'Desc Of ALBASINE', '30+10', 'mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'ALBASINE.jpg', 'ALBASINE.pdf', 236),
('Tocit', 'Tofacitinib INN', 'Others', 'Desc Of Tocit', '5', 'mg', 'Pharmaceuticals', 'Film Coated Tablet', 'Y', NULL, 'Tocit.jpg', 'Tocit.pdf', 237),
('AZIMEX', 'Azithromycin', 'Antibiotic', 'Desc Of Azimex', '250', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', 'Special 1', 'azimex.jpg', 'azimex.pdf', 238),
('ASLOR ', 'Desloratadine ', 'ANTIHISTAMINES', 'Desc Of ASLOR ', '5', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'ASLOR.jpg', 'ASLOR.pdf', 239),
('CETRIN  ', 'Cetrizine Dihydrochloride ', 'ANTIHISTAMINES', 'Desc Of CETRIN ', '10', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'CETRIN.jpg  ', 'CETRIN.pdf  ', 240),
('CLARIGEN ', 'Levocetirizine Dihydrochloride ', 'ANTIHISTAMINES', 'Desc Of CLARIGEN ', '5', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'CLARIGEN.jpg ', 'CLARIGEN.pdf ', 241),
('DIPA ', 'Rupatadine Fumarate ', 'ANTIHISTAMINES', 'Desc Of DIPA ', '10', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'DIPA.jpg ', 'DIPA.pdf ', 242),
('FENAT ', 'Ketotifen Fumerate ', 'ANTIHISTAMINES', 'Desc Of FENAT ', '1', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'FENAT.jpg ', 'FENAT.pdf', 243),
('FENAT ', 'Ketotifen Fumerate ', 'ANTIHISTAMINES', 'Desc Of FENAT ', '1', 'Mg/5ml', 'Pharmaceuticals', 'Syrup', 'N', NULL, 'FENAT-100ml.jpg', 'FENAT.pdf', 244),
('FENAT ', 'Ketotifen Fumerate ', 'ANTIHISTAMINES', 'Desc Of FENAT ', '1', 'Mg/5ml', 'Pharmaceuticals', 'Syrup', 'N', NULL, 'FENAT-200ml.jpg ', 'FENAT.pdf ', 245),
('FEXOFAST-60  ', 'Fexofenadine Hcl ', 'ANTIHISTAMINES', 'Desc Of FEXOFAST-60  ', '60', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'FEXOFAST-60.jpg', 'FEXOFAST-60.pdf', 246),
('FEXOFAST-120 ', 'Fexofenadine Hcl ', 'ANTIHISTAMINES', 'Desc Of FEXOFAST-120 ', '120', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'FEXOFAST-120.jpg', 'FEXOFAST120.pdf', 247),
('FEXOFAST-180 ', 'Fexofenadine Hcl  ', 'ANTIHISTAMINES', 'Desc Of FEXOFAST-180 ', '180', 'ML', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'FEXOFAST-180.jpg', 'FEXOFAST-180.pdf', 248),
('FEXOFAST', 'Fexofenadine Hcl ', 'ANTIHISTAMINES', 'Desc Of FEXOFAST', '30', 'Mg/5ml', 'Pharmaceuticals', 'Suspension', 'N', NULL, 'FEXOFAST-50ml.jpg', 'FEXOFAST.pdf', 249),
('LORAT ', 'Loratadine ', 'ANTIHISTAMINES', 'Desc Of LORAT ', '10', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'LORAT.jpg ', 'LORAT.pdf', 250),
('DOXOMA-200', 'Doxophylline ', 'BRONCHODILATOR', 'Desc Of DOXOMA-200', '200', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'DOXOMA-200.jpg ', 'DOXOMA-200.pdf', 251),
('DOXOMA', 'Doxophylline ', 'BRONCHODILATOR', 'Desc Of DOXOMA', '400', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'DOXOMA.jpg ', 'DOXOMA.pdf', 252),
('DOXOMA', 'Doxophylline ', 'BRONCHODILATOR', 'Desc Of DOXOMA-100ml', '100', 'Mg/5ml', 'Pharmaceuticals', 'Syrup', 'N', NULL, 'DOXOMA.jpg ', 'DOXOMA.pdf', 253),
('M-KAST-4 ', 'Montelukast ', 'BRONCHODILATOR', 'Desc Of M-KAST-4 ', '4', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'M-KAST-4.jpg', 'M-KAST-4.pdf', 254),
('M-KAST-5 ', 'Montelukast ', 'BRONCHODILATOR', 'Desc Of M-KAST-5 ', '5', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'M-KAST-5.jpg', 'M-KAST-5.pdf', 255),
('M-KAST-10 ', 'Montelukast ', 'BRONCHODILATOR', 'Desc Of M-KAST-10 ', '10', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'M-KAST-10.jpg', 'M-KAST-10.pdf', 256),
('M-KAST-10C ', 'Montelukast  ', 'BRONCHODILATOR', 'Desc Of M-KAST-10C ', '10', 'Mg', 'Pharmaceuticals', 'Chewable Tablet', 'N', NULL, 'M-KAST-10C.jpg', 'M-KAST-10C.pdf', 257),
('ROFUMIL', 'Roflumilast ', 'BRONCHODILATOR', 'Desc Of ROFUMIL', '500', 'Mcg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'ROFUMIL.jpg ', 'ROFUMIL.pdf ', 258),
('THEOVENT SR-200 ', 'Theophylline ', 'BRONCHODILATOR', 'Desc Of THEOVENT SR-200', '200', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'THEOVENT SR-200.jpg', 'THEOVENT SR-200.pdf', 259),
('THEOVENT SR-300 ', 'Theophylline ', 'BRONCHODILATOR', 'Desc Of THEOVENT SR-300 ', '300', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'THEOVENT SR-300.jpg', 'THEOVENT SR-300.pdf', 260),
('THEOVENT SR-400', 'Theophylline ', 'BRONCHODILATOR', 'Desc Of THEOVENT SR-300 ', '400', 'Mg', 'Pharmaceuticals', 'Tablet', 'N', NULL, 'THEOVENT SR-400.jpg ', 'THEOVENT SR-400.pdf', 261),
(NULL, NULL, NULL, 'Desc Of THEOVENT SR-400', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 262),
('VENTIL ', 'Salbutamol', 'INHALER', 'Desc Of VENTIL', '100', 'mcg/puf', 'Pharmaceuticals', 'Inhaler', 'N', 'Special 1', 'VENTIL.jpg ', 'VENTIL.pdf', 263),
('VENTIL PLUS ', 'Salbutamol + Ipratropium Bromiide ', 'INHALER', 'Desc Of VENTIL PLUS', '(100+20)', 'mcg/puf', 'Pharmaceuticals', 'Inhaler', 'N', 'Special 1', 'VENTIL PLUS.jpg ', 'VENTIL PLUS.pdf ', 264),
('SERAFLO', 'Salmeterol+Fluticasone Propionate', 'INHALER', 'Desc Of SERAFLO', '   (25+250) ', 'mcg/puf', 'Pharmaceuticals', 'Inhaler', 'N', 'Special 1', 'SERAFLO.jpg ', 'SERAFLO.pdf', 265),
('SERAFLO 25/125', 'Salmeterol+Fluticasone Propionate', 'INHALER', 'Desc Of SERAFLO 25/125', '   (25+125) ', 'mcg/puf', 'Pharmaceuticals', 'Inhaler', 'N', 'Special 1', 'SERAFLO 25/125.jpg', 'SERAFLO 25/125.pdf', 266),
('SERAVENT', 'Salmeterol ', 'INHALER', 'Desc Of SERAVENT', '25', 'mcg/puf', 'Pharmaceuticals', 'Inhaler', 'N', 'Special 1', 'SERAVENT.jpg', 'SERAVENT.pdf', 267),
('BECOVENT ', 'Beclometasone Dipropionate  ', 'INHALER', 'Desc Of BECOVENT ', '100', 'mcg/puf', 'Pharmaceuticals', 'Inhaler', 'N', 'Special 1', 'BECOVENT.jpg', 'BECOVENT.pdf', 268),
('M-Son', 'Mometasone Furoate', 'NASAL SPRAY', 'Desc Of M-Son', '50', 'mcg/Spray', 'Pharmaceuticals', 'NASAL SPRAY', 'N', 'Special 1', 'M-Son.jpg', 'M-Son.pdf', 269),
('Rhinocort', 'Budesonide', 'NASAL SPRAY', 'Desc Of Rhinocort', '100', 'mcg/Spray', 'Pharmaceuticals', 'NASAL SPRAY', 'N', 'Special 1', 'Rhinocort.jpg', 'Rhinocort.pdf', 270),
('Trialon', 'Triamcinolone Acetonide', 'NASAL SPRAY', 'Desc Of Trialon', '55', 'mcg/Spray', 'Pharmaceuticals', 'NASAL SPRAY', 'Y', 'Special 1', 'Trialon.jpg', 'Trialon.pdf', 271),
('Pednisol-5', 'Prednisolone', 'STEROID', 'Desc Of Pednisol-5', '5', 'Mg', 'Pharmaceuticals', 'Tablet', 'Y', NULL, 'Pednisol-5.jpg', 'Pednisol-5.pdf', 272),
('Pednisol-10', 'Prednisolone', 'STEROID', 'Desc Of Pednisol-10', '10', 'Mg', 'Pharmaceuticals', 'Tablet', 'Y', NULL, 'Pednisol-10.jpg', 'Pednisol-10.pdf', 273),
('Pednisol-20', 'Prednisolone', 'STEROID', 'Desc Of Pednisol-20', '20', 'Mg', 'Pharmaceuticals', 'Tablet', 'Y', NULL, 'Pednisol-20.jpg', 'Pednisol-20.pdf', 274),
('Hydrasone', 'Hydrocortisone Sodium Succinate', 'STEROID', 'Desc Of Hydrasone', '100', 'Mg/Vial', 'Pharmaceuticals', 'Injection', 'Y', NULL, 'Hydrasone.jpg', 'Hydrasone.pdf', 275),
(NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'Inhaler', NULL, NULL, NULL, NULL, 276);

-- --------------------------------------------------------

--
-- Table structure for table `drg_special_medicine`
--

CREATE TABLE IF NOT EXISTS `drg_special_medicine` (
  `SP_MED_ID` int(10) unsigned NOT NULL AUTO_INCREMENT,
  `MEDICINE_ID` int(10) unsigned NOT NULL DEFAULT '0',
  `SPECIAL_ID` int(10) unsigned NOT NULL DEFAULT '0',
  PRIMARY KEY (`SP_MED_ID`),
  KEY `FK_drg_special_medicine_1` (`MEDICINE_ID`),
  KEY `FK_drg_special_medicine_2` (`SPECIAL_ID`)
) ENGINE=InnoDB  DEFAULT CHARSET=utf8 AUTO_INCREMENT=8 ;

--
-- Dumping data for table `drg_special_medicine`
--

INSERT INTO `drg_special_medicine` (`SP_MED_ID`, `MEDICINE_ID`, `SPECIAL_ID`) VALUES
(3, 744, 1),
(4, 742, 1),
(5, 743, 1),
(6, 738, 1),
(7, 739, 1);

-- --------------------------------------------------------

--
-- Table structure for table `drg_special_prod_cat`
--

CREATE TABLE IF NOT EXISTS `drg_special_prod_cat` (
  `SPECIAL_ID` int(10) unsigned NOT NULL AUTO_INCREMENT,
  `SPECIAL_NAME` varchar(255) NOT NULL DEFAULT '',
  `SPECIAL_DESC` text NOT NULL,
  `INSERT_FILES` varchar(45) NOT NULL,
  `ACTIVE_STATUS` enum('Y','N') NOT NULL DEFAULT 'Y',
  `CRE_BY` int(10) unsigned DEFAULT NULL,
  `CRE_DT` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP ON UPDATE CURRENT_TIMESTAMP,
  `UPD_BY` int(10) unsigned DEFAULT NULL,
  `UPD_DT` datetime DEFAULT NULL,
  `ORDER_NO` int(10) NOT NULL,
  PRIMARY KEY (`SPECIAL_ID`)
) ENGINE=InnoDB  DEFAULT CHARSET=utf8 AUTO_INCREMENT=9 ;

--
-- Dumping data for table `drg_special_prod_cat`
--

INSERT INTO `drg_special_prod_cat` (`SPECIAL_ID`, `SPECIAL_NAME`, `SPECIAL_DESC`, `INSERT_FILES`, `ACTIVE_STATUS`, `CRE_BY`, `CRE_DT`, `UPD_BY`, `UPD_DT`, `ORDER_NO`) VALUES
(1, 'SOFT CAPSULE', 'desc of', 'uploads/special/e-cap.jpg', 'Y', 1, '2017-12-12 08:09:54', NULL, NULL, 0),
(2, 'MDI', 'desc of', 'uploads/special/ventil.jpg', 'Y', 1, '2017-12-12 08:09:59', NULL, NULL, 0),
(3, 'NASAL SPRAY', 'desc of', 'uploads/special/m-son.jpg', 'Y', 1, '2017-12-12 08:10:03', NULL, NULL, 0),
(4, 'PRE-FILLED SYRINGE', 'desc of', 'uploads/special/cardinex.jpg', 'Y', 1, '2017-12-12 08:10:07', NULL, NULL, 0),
(5, 'EYE DROPS', 'desc of', 'uploads/special/eyetear.jpg', 'Y', 1, '2017-12-12 08:10:11', NULL, NULL, 0),
(6, 'ONCOLOGY', 'desc of', 'uploads/special/Fluracil.jpg', 'Y', 1, '2017-12-12 08:10:15', NULL, NULL, 0),
(7, 'ORAL SPRAY', 'desc of', 'uploads/special/nidocard.jpg', 'Y', 1, '2017-12-12 08:10:20', NULL, NULL, 0),
(8, 'NANOPARTICULATE TABLET', 'Nanoparticulate Tablet', 'uploads/special/fenatrol.jpg', 'Y', 1, '2017-12-12 08:10:24', NULL, NULL, 0);

-- --------------------------------------------------------

--
-- Table structure for table `drg_therapeutic_group`
--

CREATE TABLE IF NOT EXISTS `drg_therapeutic_group` (
  `TH_GRP_ID` int(10) unsigned NOT NULL AUTO_INCREMENT,
  `TH_GRP_NAME` varchar(255) NOT NULL DEFAULT '',
  `TH_GRP_SL_NO` int(10) unsigned NOT NULL DEFAULT '0',
  `TH_GRP_DESC` text,
  `ACTIVE_STATUS` enum('Y','N') NOT NULL DEFAULT 'Y',
  `CRE_BY` int(10) unsigned DEFAULT NULL,
  `CRE_DT` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP ON UPDATE CURRENT_TIMESTAMP,
  `UPD_BY` int(10) unsigned zerofill DEFAULT NULL,
  `UPD_DT` datetime DEFAULT NULL,
  `CAT_ID` int(10) unsigned DEFAULT NULL,
  PRIMARY KEY (`TH_GRP_ID`),
  KEY `FK_drg_therapeutic_group_1` (`CAT_ID`)
) ENGINE=InnoDB  DEFAULT CHARSET=utf8 AUTO_INCREMENT=102 ;

--
-- Dumping data for table `drg_therapeutic_group`
--

INSERT INTO `drg_therapeutic_group` (`TH_GRP_ID`, `TH_GRP_NAME`, `TH_GRP_SL_NO`, `TH_GRP_DESC`, `ACTIVE_STATUS`, `CRE_BY`, `CRE_DT`, `UPD_BY`, `UPD_DT`, `CAT_ID`) VALUES
(0, '', 1, NULL, 'Y', NULL, '2017-12-21 08:53:22', NULL, NULL, 4),
(34, ' Eye Drop', 1, NULL, 'Y', NULL, '2017-12-20 12:13:46', NULL, NULL, 4),
(35, 'Analgesic & Anti-inflammatory', 1, NULL, 'Y', NULL, '2017-12-20 12:13:51', NULL, NULL, 4),
(36, 'Anti- cancer', 1, NULL, 'Y', NULL, '2017-12-20 12:13:54', NULL, NULL, 4),
(37, 'Anti-acid & Ulcer Healing', 1, NULL, 'Y', NULL, '2017-12-20 12:13:57', NULL, NULL, 4),
(38, 'Antibiotic', 1, NULL, 'Y', NULL, '2017-12-20 12:13:59', NULL, NULL, 4),
(39, 'Antiemetic', 1, NULL, 'Y', NULL, '2017-12-20 12:14:03', NULL, NULL, 4),
(40, 'Antifungal', 1, NULL, 'Y', NULL, '2017-12-20 12:14:06', NULL, NULL, 4),
(41, 'ANTIHISTAMINES', 1, NULL, 'Y', NULL, '2017-12-20 12:14:09', NULL, NULL, 4),
(42, 'Antimigraine', 1, NULL, 'Y', NULL, '2017-12-20 12:14:13', NULL, NULL, 4),
(43, 'Antiprotozoal', 1, NULL, 'Y', NULL, '2017-12-20 12:14:17', NULL, NULL, 4),
(44, 'Antispasmodic ', 1, NULL, 'Y', NULL, '2017-12-20 12:14:20', NULL, NULL, 4),
(45, 'Antiviral', 1, NULL, 'Y', NULL, '2017-12-20 12:14:23', NULL, NULL, 4),
(46, 'BPH', 1, NULL, 'Y', NULL, '2017-12-20 12:14:26', NULL, NULL, 4),
(47, 'BRONCHODILATOR', 1, NULL, 'Y', NULL, '2017-12-20 12:14:33', NULL, NULL, 4),
(48, 'CNS', 1, NULL, 'Y', NULL, '2017-12-20 12:14:30', NULL, NULL, 4),
(49, 'Eye & Ear Drop', 1, NULL, 'Y', NULL, '2017-12-20 12:14:43', NULL, NULL, 4),
(50, 'Eye & Nosal drop ', 1, NULL, 'Y', NULL, '2017-12-20 12:14:46', NULL, NULL, 4),
(51, 'ghf', 1, NULL, 'Y', NULL, '2017-12-21 08:53:16', NULL, NULL, 4),
(53, 'INHALER', 1, NULL, 'Y', NULL, '2017-12-20 12:14:53', NULL, NULL, 4),
(54, 'Laxative', 1, NULL, 'Y', NULL, '2017-12-20 12:14:49', NULL, NULL, 4),
(55, 'Muscle Relaxant', 1, NULL, 'Y', NULL, '2017-12-20 12:15:53', NULL, NULL, 4),
(56, 'NASAL SPRAY', 1, NULL, 'Y', NULL, '2017-12-20 12:15:45', NULL, NULL, 4),
(57, 'Oncology', 1, NULL, 'Y', NULL, '2017-12-20 12:15:50', NULL, NULL, 4),
(58, 'Ophthalmic suspension', 1, NULL, 'Y', NULL, '2017-12-20 12:15:42', NULL, NULL, 4),
(59, 'Opthalmic Susp', 1, NULL, 'Y', NULL, '2017-12-20 12:15:38', NULL, NULL, 4),
(60, 'Opthalmic Suspension-', 1, 'Desc Of', 'Y', NULL, '2017-12-20 12:15:33', NULL, NULL, 4),
(61, 'Others', 1, 'Desc Of', 'Y', NULL, '2017-12-20 12:15:30', NULL, NULL, 4),
(62, 'Otic Suspension', 1, 'Desc Of', 'Y', NULL, '2017-12-20 12:15:27', NULL, NULL, 4),
(63, 'STEROID', 1, 'Desc Of', 'Y', NULL, '2017-12-20 12:15:24', NULL, NULL, 4),
(64, 'Antidiabetic', 0, 'Desc Of', 'Y', 1, '2017-11-07 05:07:31', NULL, NULL, 4),
(65, 'Cardiovascular', 0, 'Desc Of', 'Y', 1, '2017-11-08 03:25:57', NULL, NULL, 4),
(66, 'Topocal ', 0, 'Desc Of\r\n', 'Y', 1, '2017-11-08 03:45:50', NULL, NULL, 4),
(67, 'Vitamin & Mineral', 0, 'Desc Of', 'Y', 1, '2017-11-08 04:06:24', NULL, NULL, 4),
(68, 'General Tonic & Appetizer', 0, 'Desc of', 'Y', 1, '2017-11-09 04:12:35', NULL, NULL, 5),
(69, 'Brain Tonic', 0, 'Desc of', 'Y', 1, '2017-11-09 04:12:57', NULL, NULL, 5),
(70, 'Hepatoprotective & Digestive', 0, 'Desc Of', 'Y', 1, '2017-11-09 04:13:19', NULL, NULL, 5),
(71, 'Natural Digestive & Carminative ', 0, 'Desc oF', 'Y', 1, '2017-11-09 04:13:47', NULL, NULL, 5),
(72, 'Immune Stimulant', 0, 'Desc Of', 'Y', 1, '2017-11-09 04:14:07', NULL, NULL, 5),
(73, 'Natural Blood purifier', 0, 'Desc Of', 'Y', 1, '2017-11-09 04:14:28', NULL, NULL, 5),
(74, 'Liver Tonic', 0, 'Desc of', 'Y', 1, '2017-11-09 04:14:47', NULL, NULL, 5),
(75, 'Hepatoprotective ', 0, 'Desc Of', 'Y', 1, '2017-11-09 04:15:08', NULL, NULL, 5),
(76, 'Natural Vitamin', 0, 'Desc Of', 'Y', 1, '2017-11-09 04:15:24', NULL, NULL, 5),
(77, 'Sexual tonic', 0, 'Desc Of', 'Y', 1, '2017-11-09 04:15:42', NULL, NULL, 5),
(78, 'Baby carminative & Digestive', 0, 'Desc Of', 'Y', 1, '2017-11-09 04:16:01', NULL, NULL, 5),
(79, 'Uterotonic', 0, 'Desc Of', 'Y', 1, '2017-11-09 04:16:16', NULL, NULL, 5),
(80, 'Antipyretic & Diuretic ', 0, 'Desc Of', 'Y', 1, '2017-11-09 04:16:43', NULL, NULL, 5),
(81, 'Hepatoprotective & Digestive', 0, 'Desc of', 'Y', 1, '2017-11-09 04:26:20', NULL, NULL, 6),
(82, 'Stimulates the immune system', 0, 'Desc Of', 'Y', 1, '2017-11-09 04:26:42', NULL, NULL, 6),
(83, 'Brain Tonic', 0, 'Desc of', 'Y', 1, '2017-11-09 04:27:01', NULL, NULL, 6),
(84, 'Anti-diarrheal', 0, 'Desc of', 'Y', 1, '2017-11-09 04:27:20', NULL, NULL, 6),
(85, 'Diuretic', 0, 'Desc Of', 'Y', 1, '2017-11-09 04:27:38', NULL, NULL, 6),
(86, 'Nonsedating Herbal Cough Syrup', 0, 'Desc Of', 'Y', 1, '2017-11-09 04:27:55', NULL, NULL, 6),
(87, 'Anti-depressant', 0, 'Desc Of', 'Y', 1, '2017-11-09 04:33:04', NULL, NULL, 6),
(88, 'Antihyperlipidemic', 0, 'Desc Of', 'Y', 1, '2017-11-09 04:33:27', NULL, NULL, 6),
(89, 'Stimulant & Aphrodisiac', 0, 'Desc of', 'Y', 1, '2017-11-09 04:33:51', NULL, NULL, 6),
(90, 'Hepatoprotective ', 0, 'Desc Of', 'Y', 1, '2017-11-09 04:34:09', NULL, NULL, 6),
(91, 'Hepatoprotective', 0, 'Desc Of', 'Y', 1, '2017-11-09 04:34:27', NULL, NULL, 6),
(92, 'Bulk forming Laxative', 0, 'Desc Of', 'Y', 1, '2017-11-09 04:35:25', NULL, NULL, 6),
(93, 'Anti-diabetic', 0, 'Desc Of', 'Y', 1, '2017-11-09 04:35:41', NULL, NULL, 6),
(94, 'Carminative & Digestive', 0, 'Desc Of', 'Y', 1, '2017-11-09 04:36:01', NULL, NULL, 6),
(95, 'Antibiotic & Stimulates the immune System', 0, 'Desc Of', 'Y', 1, '2017-11-09 04:36:20', NULL, NULL, 6),
(96, 'Natural Solution of BPH', 0, 'Desc Of', 'Y', 1, '2017-11-09 04:36:38', NULL, NULL, 6),
(97, 'Anti-inflammatory', 0, 'Desc Of', 'Y', 1, '2017-11-09 04:36:55', NULL, NULL, 6),
(98, 'Anti-diarrheal', 0, 'Desc of', 'Y', 1, '2017-11-09 04:37:17', NULL, NULL, 6),
(99, 'Natural Vitamin & protein supplement', 0, 'Desc Of', 'Y', 1, '2017-11-09 04:37:41', NULL, NULL, 6),
(100, 'Mucolytic & Cough Relieving', 0, 'Desc Of', 'Y', 1, '2017-11-09 04:38:01', NULL, NULL, 6),
(101, 'Haematinic', 0, 'Desc Of', 'Y', 1, '2017-11-09 22:51:14', NULL, NULL, 4);

-- --------------------------------------------------------

--
-- Table structure for table `drg_uom`
--

CREATE TABLE IF NOT EXISTS `drg_uom` (
  `UOM_ID` int(10) unsigned NOT NULL AUTO_INCREMENT,
  `UOM_NAME` varchar(255) NOT NULL DEFAULT '',
  `ACTIVE_STATUS` enum('Y','N') NOT NULL DEFAULT 'Y',
  `CRE_BY` int(10) unsigned DEFAULT NULL,
  `CRE_DT` timestamp NOT NULL DEFAULT '0000-00-00 00:00:00',
  `UPD_BY` int(10) unsigned DEFAULT NULL,
  `UPD_DT` datetime DEFAULT NULL,
  PRIMARY KEY (`UOM_ID`)
) ENGINE=InnoDB  DEFAULT CHARSET=utf8 AUTO_INCREMENT=77 ;

--
-- Dumping data for table `drg_uom`
--

INSERT INTO `drg_uom` (`UOM_ID`, `UOM_NAME`, `ACTIVE_STATUS`, `CRE_BY`, `CRE_DT`, `UPD_BY`, `UPD_DT`) VALUES
(49, ' mg (50 mg/ml)', 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(50, 'gm(IM)', 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(51, 'gm(IV)', 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(52, 'gm(IV/IM)', 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(53, 'I.U+I.U+I.U+mg', 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(54, 'Mcg', 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(55, 'mcg/puf', 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(56, 'mcg/Spray', 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(57, 'mg', 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(58, 'mg (2 mg/ml)', 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(59, 'mg(IM)', 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(60, 'mg(IV)', 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(61, 'mg(IV/IM)', 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(62, 'mg+mg', 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(63, 'mg/1.25ml', 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(64, 'Mg/2ml', 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(65, 'mg/2ml(IV/IM)', 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(66, 'mg/4ml(IV/IM)', 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(67, 'mg/5ml', 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(68, 'mg/5ml+mg/5ml', 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(69, 'mg/ml', 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(70, 'mg/ml (IV/IM)', 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(71, 'Mg/Vial', 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(72, 'ML', 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(73, 'w/v', 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(74, 'w/v, IU/ml, IU/ml', 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(75, 'mg+mcg', 'Y', NULL, '2017-11-07 18:00:00', NULL, NULL),
(76, 'mg+mcg+mg', 'Y', NULL, '2017-11-07 18:00:00', NULL, NULL);

-- --------------------------------------------------------

--
-- Table structure for table `drug_contuct`
--

CREATE TABLE IF NOT EXISTS `drug_contuct` (
  `CONTUCT_ID` int(11) NOT NULL AUTO_INCREMENT COMMENT 'Primary Key',
  `NAME` varchar(50) DEFAULT NULL COMMENT 'Primary Key of sa_user_group table. Group may be created against org',
  `EMAIL` varchar(50) DEFAULT NULL COMMENT 'Name of the Group',
  `MESSAGE` varchar(50) NOT NULL,
  `ACTIVE_STATUS` tinyint(1) DEFAULT '1' COMMENT 'It keeps boolean value representing Active/Inactive. e.g. 1 = Active, 0 = Inactive',
  `CRE_BY` int(10) unsigned DEFAULT NULL,
  `CRE_DT` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP,
  `UPD_BY` int(10) unsigned DEFAULT NULL,
  `UPD_DT` datetime DEFAULT NULL,
  PRIMARY KEY (`CONTUCT_ID`),
  KEY `FK03_ORG_ID` (`NAME`)
) ENGINE=InnoDB  DEFAULT CHARSET=utf8 COMMENT='Application user divided into multiple group ' AUTO_INCREMENT=6 ;

--
-- Dumping data for table `drug_contuct`
--

INSERT INTO `drug_contuct` (`CONTUCT_ID`, `NAME`, `EMAIL`, `MESSAGE`, `ACTIVE_STATUS`, `CRE_BY`, `CRE_DT`, `UPD_BY`, `UPD_DT`) VALUES
(4, 'ghdfh', 'shahadot20@gmail.com', 'fdghdf', 1, NULL, '2017-12-14 00:01:02', NULL, NULL),
(5, 'ghdfh', 'shahadot20@gmail.com', 'fdghdf', 1, NULL, '2017-12-14 00:01:20', NULL, NULL);

-- --------------------------------------------------------

--
-- Table structure for table `home_slider`
--

CREATE TABLE IF NOT EXISTS `home_slider` (
  `HOME_SLIDER_ID` int(10) unsigned NOT NULL AUTO_INCREMENT COMMENT 'Primary Key',
  `INSERT_FILES` varchar(255) NOT NULL DEFAULT '' COMMENT 'Category name',
  `SLIDER_DESC` varchar(2000) NOT NULL DEFAULT '' COMMENT 'Category short description',
  `ACTIVE_STATUS` enum('Y','N') NOT NULL DEFAULT 'Y' COMMENT 'Y=Active, N=Inactive',
  `CRE_BY` int(10) unsigned NOT NULL DEFAULT '0' COMMENT 'Who Created the row',
  `CRE_DT` timestamp NOT NULL DEFAULT '0000-00-00 00:00:00' COMMENT 'Created  Date and Time',
  `UPD_BY` int(10) unsigned DEFAULT NULL COMMENT 'Who Updated the row',
  `UPD_DT` datetime DEFAULT NULL COMMENT 'Last Update Date and Time',
  `ORDER_NO` int(10) unsigned NOT NULL DEFAULT '0',
  PRIMARY KEY (`HOME_SLIDER_ID`)
) ENGINE=InnoDB  DEFAULT CHARSET=utf8 AUTO_INCREMENT=41 ;

--
-- Dumping data for table `home_slider`
--

INSERT INTO `home_slider` (`HOME_SLIDER_ID`, `INSERT_FILES`, `SLIDER_DESC`, `ACTIVE_STATUS`, `CRE_BY`, `CRE_DT`, `UPD_BY`, `UPD_DT`, `ORDER_NO`) VALUES
(32, 'uploads/slider/1.jpg', 'slider1', 'Y', 1, '2017-12-10 04:31:14', NULL, NULL, 0),
(33, 'uploads/slider/2.jpg', 'slider2', 'Y', 1, '2017-12-10 04:32:08', NULL, NULL, 0),
(34, 'uploads/slider/3.jpg', 'slider3', 'Y', 1, '2017-12-10 04:32:19', NULL, NULL, 0),
(35, 'uploads/slider/4.jpg', 'slider4', 'Y', 1, '2017-12-10 04:32:31', NULL, NULL, 0),
(36, 'uploads/slider/5.jpg', 'slider5', 'Y', 1, '2017-12-10 04:32:44', NULL, NULL, 0),
(37, 'uploads/slider/6.jpg', 'slider6', 'Y', 1, '2017-12-10 04:32:55', NULL, NULL, 0),
(38, 'uploads/slider/7.jpg', 'slider7', 'Y', 1, '2017-12-10 04:33:06', NULL, NULL, 0),
(39, 'uploads/slider/8.jpg', 'slider8', 'Y', 1, '2017-12-10 04:33:16', NULL, NULL, 0),
(40, 'uploads/slider/9.jpg', 'slider9', 'Y', 1, '2017-12-10 04:33:26', NULL, NULL, 0);

-- --------------------------------------------------------

--
-- Table structure for table `image_department`
--

CREATE TABLE IF NOT EXISTS `image_department` (
  `PHOTO_GALLERY_ID` int(10) unsigned NOT NULL AUTO_INCREMENT,
  `DEPARTMENT_NAME` varchar(255) NOT NULL DEFAULT '',
  `ACTIVE_STATUS` enum('Y','N') NOT NULL DEFAULT 'Y',
  `CRE_BY` int(10) unsigned DEFAULT NULL,
  `CRE_DT` timestamp NOT NULL DEFAULT '0000-00-00 00:00:00',
  `UPD_BY` int(10) unsigned DEFAULT NULL,
  `UPD_DT` datetime DEFAULT NULL,
  PRIMARY KEY (`PHOTO_GALLERY_ID`)
) ENGINE=InnoDB  DEFAULT CHARSET=utf8 AUTO_INCREMENT=5 ;

--
-- Dumping data for table `image_department`
--

INSERT INTO `image_department` (`PHOTO_GALLERY_ID`, `DEPARTMENT_NAME`, `ACTIVE_STATUS`, `CRE_BY`, `CRE_DT`, `UPD_BY`, `UPD_DT`) VALUES
(1, 'General Building', 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(2, 'Cephalospirin Building', 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(3, 'Penicilline Building', 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL),
(4, 'Oncology Building', 'Y', NULL, '0000-00-00 00:00:00', NULL, NULL);

-- --------------------------------------------------------

--
-- Table structure for table `image_gallery`
--

CREATE TABLE IF NOT EXISTS `image_gallery` (
  `IMG_ID` int(11) NOT NULL AUTO_INCREMENT,
  `PHOTO_GALLERY_ID` int(11) NOT NULL,
  `INSERTS_FILES` varchar(250) NOT NULL,
  `PHOTO_DESC` text NOT NULL,
  `ACTIVE_STATUS` enum('Y','N') NOT NULL,
  `CRE_BY` int(10) NOT NULL,
  `CRE_DT` timestamp NOT NULL,
  `UPD_BY` int(10) NOT NULL,
  `UPD_DT` datetime NOT NULL,
  PRIMARY KEY (`IMG_ID`)
) ENGINE=InnoDB  DEFAULT CHARSET=utf8 AUTO_INCREMENT=63 ;

--
-- Dumping data for table `image_gallery`
--

INSERT INTO `image_gallery` (`IMG_ID`, `PHOTO_GALLERY_ID`, `INSERTS_FILES`, `PHOTO_DESC`, `ACTIVE_STATUS`, `CRE_BY`, `CRE_DT`, `UPD_BY`, `UPD_DT`) VALUES
(31, 4, 'uploads/photogallery/_DSC6665.JPG', 'DESC OF', 'Y', 1, '2017-11-21 01:17:03', 0, '0000-00-00 00:00:00'),
(32, 4, 'uploads/photogallery/_DSC6679.JPG', 'DESC OF', 'Y', 1, '2017-11-21 01:17:12', 0, '0000-00-00 00:00:00'),
(33, 4, 'uploads/photogallery/_DSC6685.JPG', 'DESC OF', 'Y', 1, '2017-11-21 01:17:20', 0, '0000-00-00 00:00:00'),
(34, 4, 'uploads/photogallery/_DSC6688.JPG', 'DESC OF', 'Y', 1, '2017-11-21 01:17:29', 0, '0000-00-00 00:00:00'),
(36, 4, 'uploads/photogallery/_DSC6692.JPG', 'DESC OF', 'Y', 1, '2017-11-21 01:17:58', 0, '0000-00-00 00:00:00'),
(37, 4, 'uploads/photogallery/_DSC6695.JPG', 'DESC OF', 'Y', 1, '2017-11-21 01:18:10', 0, '0000-00-00 00:00:00'),
(38, 4, 'uploads/photogallery/_DSC6698.JPG', 'DESC OF', 'Y', 1, '2017-11-21 01:18:19', 0, '0000-00-00 00:00:00'),
(39, 4, 'uploads/photogallery/_DSC6700.JPG', 'DESC OF', 'Y', 1, '2017-11-21 01:18:27', 0, '0000-00-00 00:00:00'),
(40, 4, 'uploads/photogallery/_DSC6703.JPG', 'DESC OF', 'Y', 1, '2017-11-21 01:18:38', 0, '0000-00-00 00:00:00'),
(41, 4, 'uploads/photogallery/_DSC6704.JPG', 'DESC OF', 'Y', 1, '2017-11-21 01:18:47', 0, '0000-00-00 00:00:00'),
(42, 4, 'uploads/photogallery/_DSC6704.JPG', 'DESC OF', 'Y', 1, '2017-11-21 01:18:57', 0, '0000-00-00 00:00:00'),
(43, 4, 'uploads/photogallery/_DSC6706.JPG', 'DESC OF', 'Y', 1, '2017-11-21 01:19:06', 0, '0000-00-00 00:00:00'),
(44, 4, 'uploads/photogallery/_DSC6710.JPG', 'DESC OF', 'Y', 1, '2017-11-21 01:19:14', 0, '0000-00-00 00:00:00'),
(45, 4, 'uploads/photogallery/_DSC6713.JPG', 'DESC OF', 'Y', 1, '2017-11-21 01:19:23', 0, '0000-00-00 00:00:00'),
(46, 4, 'uploads/photogallery/_DSC6713.JPG', 'DESC OF', 'Y', 1, '2017-11-21 01:19:34', 0, '0000-00-00 00:00:00'),
(47, 4, 'uploads/photogallery/_DSC6714.JPG', 'DESC OF', 'Y', 1, '2017-11-21 01:19:44', 0, '0000-00-00 00:00:00'),
(48, 4, 'uploads/photogallery/_DSC6716.JPG', 'DESC OF', 'Y', 1, '2017-11-21 01:19:53', 0, '0000-00-00 00:00:00'),
(49, 4, 'uploads/photogallery/_DSC6722.JPG', 'DESC OF', 'Y', 1, '2017-11-21 01:20:03', 0, '0000-00-00 00:00:00'),
(50, 4, 'uploads/photogallery/_DSC6730.JPG', 'DESC OF', 'Y', 1, '2017-11-21 01:20:14', 0, '0000-00-00 00:00:00'),
(51, 4, 'uploads/photogallery/DSC_6531.jpg', 'DESC OF', 'Y', 1, '2017-11-21 01:21:31', 0, '0000-00-00 00:00:00'),
(52, 4, 'uploads/photogallery/JIP_5356.JPG', 'DESC OF', 'Y', 1, '2017-11-21 01:21:43', 0, '0000-00-00 00:00:00'),
(53, 4, 'uploads/photogallery/JIP_5359.JPG', 'DESC OF', 'Y', 1, '2017-11-21 01:21:53', 0, '0000-00-00 00:00:00'),
(54, 4, 'uploads/photogallery/JIP_5363.JPG', 'DESC OF', 'Y', 1, '2017-11-21 01:22:04', 0, '0000-00-00 00:00:00'),
(55, 4, 'uploads/photogallery/JIP_5377.JPG', 'DESC OF', 'Y', 1, '2017-11-21 01:22:14', 0, '0000-00-00 00:00:00'),
(56, 4, 'uploads/photogallery/JIP_5382.JPG', 'DESC OF', 'Y', 1, '2017-11-21 01:22:24', 0, '0000-00-00 00:00:00'),
(57, 4, 'uploads/photogallery/JIP_5410.JPG', 'DESC OF', 'Y', 1, '2017-11-21 01:22:33', 0, '0000-00-00 00:00:00'),
(58, 4, 'uploads/photogallery/JIP_5420.JPG', 'DESC OF', 'Y', 1, '2017-11-21 01:22:42', 0, '0000-00-00 00:00:00'),
(59, 4, 'uploads/photogallery/JIP_5426.JPG', 'DESC OF', 'Y', 1, '2017-11-21 01:22:51', 0, '0000-00-00 00:00:00'),
(60, 4, 'uploads/photogallery/JIP_5428.JPG', 'DESC OF', 'Y', 1, '2017-11-21 01:23:00', 0, '0000-00-00 00:00:00'),
(61, 4, 'uploads/photogallery/JIP_5433.JPG', 'DESC OF', 'Y', 1, '2017-11-21 01:23:12', 0, '0000-00-00 00:00:00'),
(62, 4, 'uploads/photogallery/JIP_5444.JPG', 'DESC OF', 'Y', 1, '2017-11-21 01:23:23', 0, '0000-00-00 00:00:00');

-- --------------------------------------------------------

--
-- Table structure for table `image_gallery_unit1`
--

CREATE TABLE IF NOT EXISTS `image_gallery_unit1` (
  `IMG_ID` int(11) NOT NULL AUTO_INCREMENT,
  `INSERTS_FILES` varchar(250) NOT NULL,
  `PHOTO_DESC` text NOT NULL,
  `ACTIVE_STATUS` enum('Y','N') NOT NULL,
  `CRE_BY` int(10) NOT NULL,
  `CRE_DT` timestamp NOT NULL,
  `UPD_BY` int(10) NOT NULL,
  `UPD_DT` datetime NOT NULL,
  PRIMARY KEY (`IMG_ID`)
) ENGINE=InnoDB  DEFAULT CHARSET=utf8 AUTO_INCREMENT=35 ;

--
-- Dumping data for table `image_gallery_unit1`
--

INSERT INTO `image_gallery_unit1` (`IMG_ID`, `INSERTS_FILES`, `PHOTO_DESC`, `ACTIVE_STATUS`, `CRE_BY`, `CRE_DT`, `UPD_BY`, `UPD_DT`) VALUES
(31, 'uploads/photogallery/_DSC6665.JPG', 'DESC OF', 'Y', 1, '2017-11-21 01:17:03', 0, '0000-00-00 00:00:00'),
(32, 'uploads/photogallery/_DSC6679.JPG', 'DESC OF', 'Y', 1, '2017-11-21 01:17:12', 0, '0000-00-00 00:00:00'),
(33, 'uploads/photogallery/_DSC6685.JPG', 'DESC OF', 'Y', 1, '2017-11-21 01:17:20', 0, '0000-00-00 00:00:00'),
(34, 'uploads/photogallery/_DSC6688.JPG', 'DESC OF', 'Y', 1, '2017-11-21 01:17:29', 0, '0000-00-00 00:00:00');

-- --------------------------------------------------------

--
-- Table structure for table `oncology_unit`
--

CREATE TABLE IF NOT EXISTS `oncology_unit` (
  `ONCOLOGY_ID` int(10) unsigned NOT NULL AUTO_INCREMENT COMMENT 'Primary Key',
  `INSERTS1_FILES` varchar(255) NOT NULL DEFAULT '' COMMENT 'Category name',
  `ONCOLOGY_DESC` varchar(2000) NOT NULL DEFAULT '' COMMENT 'Category short description',
  `ACTIVE_STATUS` enum('Y','N') NOT NULL DEFAULT 'Y' COMMENT 'Y=Active, N=Inactive',
  `CRE_BY` int(10) unsigned NOT NULL DEFAULT '0' COMMENT 'Who Created the row',
  `CRE_DT` timestamp NOT NULL DEFAULT '0000-00-00 00:00:00' COMMENT 'Created  Date and Time',
  `UPD_BY` int(10) unsigned DEFAULT NULL COMMENT 'Who Updated the row',
  `UPD_DT` datetime DEFAULT NULL COMMENT 'Last Update Date and Time',
  `ORDER_NO` int(10) unsigned NOT NULL DEFAULT '0',
  PRIMARY KEY (`ONCOLOGY_ID`)
) ENGINE=InnoDB  DEFAULT CHARSET=utf8 AUTO_INCREMENT=29 ;

--
-- Dumping data for table `oncology_unit`
--

INSERT INTO `oncology_unit` (`ONCOLOGY_ID`, `INSERTS1_FILES`, `ONCOLOGY_DESC`, `ACTIVE_STATUS`, `CRE_BY`, `CRE_DT`, `UPD_BY`, `UPD_DT`, `ORDER_NO`) VALUES
(21, 'uploads/oncology/_DSC6679.JPG', 'DESC OF', 'Y', 1, '2017-11-16 04:03:06', NULL, NULL, 0),
(22, 'uploads/oncology/_DSC6665.JPG', 'DESC OF', 'Y', 1, '2017-11-16 04:03:31', NULL, NULL, 0),
(23, 'uploads/oncology/_DSC6685.JPG', 'DESC OF', 'Y', 1, '2017-11-16 04:03:59', NULL, NULL, 0),
(24, 'uploads/oncology/_DSC6688.JPG', 'DESC OF', 'Y', 1, '2017-11-16 04:06:08', NULL, NULL, 0),
(25, 'uploads/oncology/_DSC6692.JPG', 'DSEC OF', 'Y', 1, '2017-11-16 04:06:46', NULL, NULL, 0),
(26, 'uploads/oncology/_DSC6698.JPG', 'DESC OF', 'Y', 1, '2017-11-16 04:07:25', NULL, NULL, 0),
(27, 'uploads/oncology/_DSC6722.JPG', 'DESC OF', 'Y', 1, '2017-11-16 04:07:58', NULL, NULL, 0),
(28, 'uploads/oncology/_DSC6713.JPG', 'DESC OF', 'Y', 1, '2017-11-16 04:08:38', NULL, NULL, 0);

-- --------------------------------------------------------

--
-- Table structure for table `sa_lookup_data`
--

CREATE TABLE IF NOT EXISTS `sa_lookup_data` (
  `LOOKUP_DATA_ID` int(8) NOT NULL AUTO_INCREMENT COMMENT 'Primary key of sa_lookup_data table.',
  `LOOKUP_GRP_ID` tinyint(3) DEFAULT NULL COMMENT 'Parent Group of each Look up data',
  `LOOKUP_DATA_NAME` varchar(60) NOT NULL COMMENT 'Lookup data name',
  `CHAR_LOOKUP` varchar(40) DEFAULT NULL COMMENT 'Character identification value',
  `NUMB_LOOKUP` tinyint(2) DEFAULT NULL COMMENT 'Number Identification value',
  `ORDER_SL_NO` tinyint(3) DEFAULT NULL COMMENT 'Ascending order',
  `UD_LKPDATA_ID` varchar(20) DEFAULT NULL COMMENT 'User Define Lookup data Id',
  `ACTIVE_FLAG` tinyint(1) NOT NULL DEFAULT '1' COMMENT 'It keeps boolean value representing Active/Inactive. e.g. 1 = Active, 0 = Inactive',
  `CRE_BY` int(10) unsigned DEFAULT NULL,
  `CRE_DT` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP,
  `UPD_BY` int(10) unsigned DEFAULT NULL,
  `UPD_DT` datetime DEFAULT NULL,
  PRIMARY KEY (`LOOKUP_DATA_ID`),
  KEY `FK01_LOOKUP_GRP_ID` (`LOOKUP_GRP_ID`)
) ENGINE=InnoDB  DEFAULT CHARSET=utf8 COMMENT='Group wise detail data entry i.e Male, female for gender group ' AUTO_INCREMENT=254 ;

--
-- Dumping data for table `sa_lookup_data`
--

INSERT INTO `sa_lookup_data` (`LOOKUP_DATA_ID`, `LOOKUP_GRP_ID`, `LOOKUP_DATA_NAME`, `CHAR_LOOKUP`, `NUMB_LOOKUP`, `ORDER_SL_NO`, `UD_LKPDATA_ID`, `ACTIVE_FLAG`, `CRE_BY`, `CRE_DT`, `UPD_BY`, `UPD_DT`) VALUES
(1, 1, 'Propeitor', 'PR', 0, 1, NULL, 1, NULL, '2015-05-13 06:00:00', NULL, '2015-05-25 03:01:04'),
(2, 1, 'Partnership', 'PA', 0, 2, NULL, 1, NULL, '2015-05-13 06:00:00', NULL, '2015-05-14 17:18:04'),
(3, 1, 'Private Limited', 'LI', 0, 3, NULL, 1, NULL, '2015-05-13 06:00:00', NULL, '2015-05-19 10:40:09'),
(4, 2, 'Supplier', NULL, NULL, 1, NULL, 1, NULL, '2015-05-13 22:59:32', NULL, '2015-05-24 19:12:18'),
(5, 2, 'Manufacturer', NULL, NULL, 2, NULL, 1, NULL, '2015-05-13 22:59:57', NULL, '2015-05-24 19:12:43'),
(10, 2, 'Importer', NULL, NULL, 7, NULL, 1, NULL, '2015-05-13 23:01:54', NULL, '2015-05-14 17:01:54'),
(11, 2, 'Exporter', NULL, NULL, 8, NULL, 1, NULL, '2015-05-13 23:02:13', NULL, '2015-05-24 19:18:08'),
(12, 4, 'Islam', 'I', 0, 1, NULL, 1, NULL, '2015-05-17 15:57:32', NULL, '2015-05-18 14:47:25'),
(13, 4, 'Hinduism', 'H', NULL, 2, NULL, 1, NULL, '2015-05-17 15:58:42', NULL, '2015-05-18 14:47:28'),
(14, 4, 'Buddhist', 'B', NULL, 3, NULL, 1, NULL, '2015-05-17 16:17:57', NULL, '2015-05-18 14:47:30'),
(15, 4, 'Christian', 'C', NULL, 4, NULL, 1, NULL, '2015-05-17 16:18:54', NULL, '2015-05-18 14:47:33'),
(19, 5, 'Group 1 to 12 (Except 4 and 10) for Local & Foreign', '', 2, 2, NULL, 1, NULL, '2015-05-17 16:28:44', NULL, '2015-12-27 16:45:04'),
(20, 5, 'Group 1 to 12 (Except 4 and 10) for Local only', '', 1, 1, NULL, 1, NULL, '2015-05-17 16:29:20', NULL, '2015-12-27 16:45:17'),
(21, 5, 'All Groups', 'AG', 5, 5, NULL, 1, NULL, '2015-05-17 16:29:34', NULL, '2015-11-22 12:34:19'),
(22, 5, 'Group 1 to 12 (Except 10) for Local & Foreign', '', 4, 4, NULL, 1, NULL, '2015-05-17 16:29:46', NULL, '2015-12-27 16:45:26'),
(24, 3, 'Boddho', NULL, NULL, 0, NULL, 1, NULL, '2015-05-17 17:26:06', NULL, '2017-09-10 06:15:29'),
(26, 4, 'Others', 'O', NULL, 5, NULL, 1, NULL, '2015-05-17 20:34:26', NULL, '2015-05-18 00:00:00'),
(27, 6, 'S.S.C', NULL, NULL, 0, NULL, 1, NULL, '2015-05-18 17:26:51', NULL, '2015-11-22 00:00:00'),
(28, 6, 'H.S.C', NULL, NULL, 0, NULL, 1, NULL, '2015-05-18 17:27:01', NULL, '2017-09-10 06:15:29'),
(29, 6, 'B.Sc', NULL, NULL, 0, NULL, 1, NULL, '2015-05-18 17:27:14', NULL, '2015-05-21 00:00:00'),
(30, 6, 'M.sc', NULL, NULL, 0, NULL, 1, NULL, '2015-05-18 17:27:23', NULL, '2017-09-10 06:15:29'),
(31, 7, 'Science', NULL, NULL, 0, NULL, 1, NULL, '2015-05-18 17:29:14', NULL, '2017-09-10 06:15:29'),
(32, 7, 'Arts', NULL, NULL, 0, NULL, 1, NULL, '2015-05-18 17:29:21', NULL, '2017-09-10 06:15:29'),
(33, 7, 'Commerce', NULL, NULL, 0, NULL, 1, NULL, '2015-05-18 17:29:30', NULL, '2017-09-10 06:15:29'),
(34, 8, 'Saving Account', NULL, NULL, 0, NULL, 1, NULL, '2015-05-18 20:59:35', NULL, '2017-09-10 06:15:29'),
(35, 8, 'Current Account', NULL, NULL, 0, NULL, 1, NULL, '2015-05-18 20:59:48', NULL, '2017-09-10 06:15:29'),
(36, 8, 'Company Account', NULL, NULL, 0, NULL, 1, NULL, '2015-05-18 20:59:57', NULL, '2017-09-10 06:15:29'),
(37, 8, 'Personal Account', NULL, NULL, 0, NULL, 1, NULL, '2015-05-18 21:00:07', NULL, '2017-09-10 06:15:29'),
(38, 9, 'Uttara', NULL, NULL, 0, NULL, 1, NULL, '2015-05-18 21:00:58', NULL, '2015-05-21 00:00:00'),
(39, 9, 'Banani', NULL, NULL, 0, NULL, 1, NULL, '2015-05-18 21:01:07', NULL, '2017-09-10 06:15:29'),
(40, 9, 'Gulshan', NULL, NULL, 0, NULL, 1, NULL, '2015-05-18 21:01:15', NULL, '2017-09-10 06:15:29'),
(41, 9, 'Mohakhali', NULL, NULL, 0, NULL, 1, NULL, '2015-05-18 21:01:29', NULL, '2017-09-10 06:15:29'),
(42, 10, 'Mr.', NULL, NULL, 0, NULL, 1, NULL, '2015-05-21 18:48:44', NULL, '2017-09-10 06:15:29'),
(43, 10, 'Mrs.', NULL, NULL, 0, NULL, 1, NULL, '2015-05-21 18:48:53', NULL, '2017-09-10 06:15:29'),
(44, 10, 'Miss', NULL, NULL, 0, NULL, 1, NULL, '2015-05-21 18:50:02', NULL, '2015-12-27 16:45:58'),
(45, 6, 'BA', NULL, NULL, 0, NULL, 1, NULL, '2015-06-01 00:34:05', NULL, '2015-06-01 18:34:13'),
(46, 11, 'Executive', NULL, NULL, 0, NULL, 1, NULL, '2015-11-20 18:45:09', NULL, '2015-11-21 00:00:00'),
(47, 11, 'SFC', NULL, NULL, 0, NULL, 1, NULL, '2015-11-20 18:45:18', NULL, '2015-11-21 00:00:00'),
(48, 5, 'Group 1 to 12 (Except 4 ) for Local & Foreign', 'OE4', 3, 3, NULL, 0, NULL, '2015-11-21 17:08:18', NULL, '2015-12-27 16:45:34'),
(49, 12, 'Group 1 to 12 (Except 4 and 10)', NULL, 1, 1, NULL, 1, NULL, '2015-11-21 18:13:10', NULL, '2015-12-27 16:46:10'),
(50, 12, 'Group 4 and 10', NULL, 2, 2, NULL, 1, NULL, '2015-11-21 18:14:09', NULL, '2015-11-22 12:16:53'),
(51, 12, 'Group 4', NULL, 3, 3, NULL, 1, NULL, '2015-11-21 18:14:25', NULL, '2015-11-22 12:16:55'),
(52, 12, 'Group 13', NULL, 4, 4, NULL, 1, NULL, '2015-11-21 18:14:39', NULL, '2015-11-22 12:16:59'),
(53, 13, 'In Progress', NULL, NULL, 1, NULL, 1, NULL, '2015-11-22 22:13:10', NULL, '2015-11-23 16:14:46'),
(54, 13, 'Completed', NULL, NULL, 2, NULL, 1, NULL, '2015-11-22 22:13:27', NULL, '2015-11-23 16:14:51'),
(55, 13, 'Incomplete', NULL, NULL, 3, NULL, 1, NULL, '2015-11-22 22:13:55', NULL, '2015-11-23 16:14:55'),
(56, 14, 'Trade License', 'TL', NULL, 0, NULL, 1, NULL, '2015-12-08 17:45:58', NULL, '2015-12-09 11:47:14'),
(57, 14, 'Importer Registration Certificate', 'IL', NULL, 0, NULL, 1, NULL, '2015-12-08 17:46:22', NULL, '2015-12-09 11:47:21'),
(60, 16, 'Own', 'O', 0, 1, NULL, 1, NULL, '2015-12-16 18:52:56', NULL, '2015-12-17 00:00:00'),
(61, 16, 'Wife', 'W', 0, 3, NULL, 1, NULL, '2015-12-16 18:53:13', NULL, '2015-12-17 15:27:07'),
(62, 16, 'Son', 'S', 0, 4, NULL, 1, NULL, '2015-12-16 18:53:19', NULL, '2015-12-17 15:27:09'),
(63, 16, 'Daughter', 'D', 0, 5, NULL, 1, NULL, '2015-12-16 18:53:34', NULL, '2015-12-17 15:27:12'),
(64, 17, 'Immovable', NULL, NULL, 1, NULL, 1, NULL, '2015-12-16 20:15:09', NULL, '2015-12-17 15:27:14'),
(65, 17, 'Movable', NULL, NULL, 2, NULL, 1, NULL, '2015-12-16 20:15:31', NULL, '2015-12-17 15:27:16'),
(66, 18, 'Trade License Image', NULL, NULL, 1, NULL, 1, NULL, '2015-12-18 20:35:27', NULL, '2015-12-19 15:08:42'),
(67, 18, 'Undertaking Certificate', NULL, NULL, 2, NULL, 1, NULL, '2015-12-18 20:36:01', NULL, '2015-12-19 00:00:00'),
(68, 18, 'Loyalty Certificate', NULL, NULL, 3, NULL, 1, NULL, '2015-12-18 20:36:55', NULL, '2015-12-19 15:10:30'),
(69, 18, 'Affidavit Certificate', NULL, NULL, 4, NULL, 1, NULL, '2015-12-18 20:37:48', NULL, '2015-12-19 15:10:33'),
(70, 18, 'Education Certificate', NULL, NULL, 5, NULL, 1, NULL, '2015-12-18 20:45:17', NULL, '2015-12-19 15:10:39'),
(71, 18, 'Court/Police Case Certificate', NULL, NULL, 6, NULL, 1, NULL, '2015-12-18 20:46:01', NULL, '2015-12-19 15:10:41'),
(72, 18, 'Character Certificate', NULL, NULL, 7, NULL, 1, NULL, '2015-12-18 20:46:32', NULL, '2015-12-19 15:10:44'),
(73, 18, 'Property Statement', NULL, NULL, 8, NULL, 1, NULL, '2015-12-18 20:47:25', NULL, '2015-12-19 15:10:46'),
(74, 18, 'Bank Solvency Certificate', NULL, NULL, 9, NULL, 1, NULL, '2015-12-18 20:48:15', NULL, '2015-12-19 15:10:48'),
(75, 18, 'Bank Statement', NULL, NULL, 10, NULL, 1, NULL, '2015-12-18 20:48:53', NULL, '2015-12-19 15:10:50'),
(76, 18, 'Memorandum of Articles', NULL, NULL, 11, NULL, 1, NULL, '2015-12-18 20:50:15', NULL, '2015-12-19 15:10:53'),
(77, 18, 'Partnership deed', NULL, NULL, 12, NULL, 1, NULL, '2015-12-18 20:51:07', NULL, '2015-12-19 15:10:55'),
(78, 18, 'Indentors Registration Certificate', NULL, NULL, 13, NULL, 1, NULL, '2015-12-18 20:52:15', NULL, '2015-12-19 15:10:59'),
(79, 18, 'Import Registration Certificate', NULL, NULL, 14, NULL, 1, NULL, '2015-12-18 20:52:34', NULL, '2015-12-19 15:11:01'),
(80, 18, 'DCCI/Indenting Agents Association Membership Certificate', NULL, NULL, 15, NULL, 1, NULL, '2015-12-18 21:03:18', NULL, '2015-12-19 15:11:04'),
(81, 18, 'Agency Agreement Certificate', NULL, NULL, 16, NULL, 1, NULL, '2015-12-18 21:05:53', NULL, '2015-12-19 15:11:11'),
(82, 19, 'Warning', NULL, NULL, 0, NULL, 0, NULL, '2015-12-19 20:33:04', NULL, '2015-12-20 14:33:04'),
(83, 19, 'Temporary Embargo', NULL, NULL, 0, NULL, 1, NULL, '2015-12-19 20:34:58', NULL, '2015-12-20 14:37:10'),
(84, 19, 'Permanent Embargo', NULL, NULL, 0, NULL, 1, NULL, '2015-12-19 20:37:32', NULL, '2015-12-20 14:37:32'),
(85, 20, 'Local Agency', NULL, NULL, 0, NULL, 1, NULL, '2015-12-19 20:38:26', NULL, '2015-12-20 14:38:26'),
(86, 20, 'Foreign Agency', NULL, NULL, 0, NULL, 1, NULL, '2015-12-19 20:38:45', NULL, '2015-12-20 14:38:45'),
(87, 21, 'First Deposit', NULL, NULL, 0, NULL, 1, NULL, '2015-12-28 23:11:42', NULL, '2016-01-03 16:53:00'),
(88, 21, 'Renewal', NULL, NULL, 0, NULL, 1, NULL, '2015-12-28 23:11:58', NULL, '2016-01-03 16:52:56'),
(89, 21, 'Reissue of ID Card', NULL, NULL, 0, NULL, 1, NULL, '2015-12-28 23:12:44', NULL, '2015-12-29 17:12:44'),
(90, 21, 'Payment of form for Changing Representative', NULL, NULL, 0, NULL, 1, NULL, '2015-12-28 23:13:35', NULL, '2015-12-29 17:13:35'),
(91, 21, 'Enlistment fee for inclusion of another group', NULL, NULL, 0, NULL, 1, NULL, '2015-12-28 23:14:37', NULL, '2015-12-29 17:14:37'),
(92, 21, 'Enlistment fee for inclusion of another group', NULL, NULL, 0, NULL, 1, NULL, '2015-12-28 17:16:39', NULL, '2016-01-11 15:28:30'),
(93, 19, 'Black  Listing', NULL, NULL, 0, NULL, 1, NULL, '2016-01-02 13:54:33', NULL, '2016-01-11 15:28:30'),
(94, 21, 'Renew of ID Card', NULL, NULL, 0, NULL, 1, NULL, '2016-01-02 14:08:34', NULL, '2016-01-11 15:28:30'),
(95, 21, 'New Issue of ID Card', NULL, NULL, 0, NULL, 1, NULL, '2016-01-02 14:08:57', NULL, '2016-01-11 15:28:30'),
(96, 21, 'Payment of form for Enlistment', NULL, NULL, 0, NULL, 1, NULL, '2016-01-02 14:10:14', NULL, '2016-01-11 15:28:30'),
(97, 21, 'Payment of form for Inclusion of another Group', NULL, NULL, 0, NULL, 1, NULL, '2016-01-02 14:12:02', NULL, '2016-01-11 15:28:30'),
(127, 31, 'Male', NULL, NULL, 0, NULL, 1, NULL, '2016-01-28 00:42:06', NULL, NULL),
(128, 31, 'Female', NULL, NULL, 0, NULL, 1, NULL, '2016-01-28 00:42:14', NULL, NULL),
(129, 32, 'Certified Investment Management Analyst', NULL, NULL, 0, NULL, 1, NULL, '2016-01-28 17:05:18', NULL, NULL),
(130, 32, 'Certified Private Wealth Advisor', NULL, NULL, 0, NULL, 1, NULL, '2016-01-28 17:05:40', NULL, NULL),
(131, 32, 'Developer', NULL, NULL, 0, NULL, 1, NULL, '2016-01-28 17:06:28', NULL, NULL),
(132, 32, 'Programmer', NULL, NULL, 0, NULL, 1, NULL, '2016-01-28 17:06:36', NULL, NULL),
(133, 32, 'Designer ', NULL, NULL, 0, NULL, 1, NULL, '2016-01-28 17:06:56', NULL, NULL),
(134, 32, 'QA', NULL, NULL, 0, NULL, 1, NULL, '2016-01-28 17:07:05', NULL, NULL),
(135, 32, 'System Engineer', NULL, NULL, 0, NULL, 1, NULL, '2016-01-28 17:07:17', NULL, NULL),
(136, 33, 'Advanced level', NULL, NULL, 0, NULL, 1, NULL, '2016-01-28 17:08:58', NULL, NULL),
(137, 33, 'Mid Level', NULL, NULL, 0, NULL, 1, NULL, '2016-01-28 17:09:18', NULL, NULL),
(138, 33, 'Entry Level', NULL, NULL, 0, NULL, 1, NULL, '2016-01-28 17:09:34', NULL, NULL),
(139, 34, 'Army Wing-1', NULL, NULL, 0, NULL, 1, NULL, '2016-01-28 17:32:32', NULL, NULL),
(140, 34, 'Army Wing-2', NULL, NULL, 0, NULL, 1, NULL, '2016-01-28 17:32:38', NULL, NULL),
(141, 34, 'NAvy Wing', NULL, NULL, 0, NULL, 1, NULL, '2016-01-28 17:33:12', NULL, NULL),
(142, 34, 'Air Force Wing', NULL, NULL, 0, NULL, 1, NULL, '2016-01-28 17:33:37', NULL, NULL),
(143, 35, 'Married', 'M', NULL, 0, NULL, 1, NULL, '2016-01-28 17:42:21', NULL, NULL),
(144, 35, 'Unmarried', 'UM', NULL, 0, NULL, 1, NULL, '2016-01-28 17:42:35', NULL, NULL),
(179, 22, 'Brown', NULL, NULL, 0, NULL, 1, NULL, '2016-01-10 09:42:03', NULL, '2016-01-11 09:42:03'),
(180, 22, 'Black', NULL, NULL, 0, NULL, 1, NULL, '2016-01-10 09:42:22', NULL, '2016-01-11 09:42:22'),
(181, 22, 'White', NULL, NULL, 0, NULL, 1, NULL, '2016-01-10 09:42:32', NULL, '2016-01-11 09:42:32'),
(182, 23, 'Blue', NULL, NULL, 0, NULL, 1, NULL, '2016-01-11 04:01:32', NULL, '2016-01-12 04:01:32'),
(183, 23, 'Black', NULL, NULL, 0, NULL, 1, NULL, '2016-01-11 04:01:40', NULL, '2016-01-12 04:01:40'),
(184, 23, 'Brown', NULL, NULL, 0, NULL, 1, NULL, '2016-01-11 04:02:09', NULL, '2016-01-12 04:02:09'),
(185, 24, 'Tall', NULL, NULL, 0, NULL, 1, NULL, '2016-01-11 04:03:45', NULL, '2016-01-12 04:03:45'),
(186, 24, 'Medium', NULL, NULL, 0, NULL, 1, NULL, '2016-01-12 10:13:53', NULL, NULL),
(187, 24, 'Short', NULL, NULL, 0, NULL, 1, NULL, '2016-01-12 10:14:03', NULL, NULL),
(188, 26, 'Export', NULL, NULL, 0, NULL, 1, NULL, '2016-01-17 17:07:49', NULL, NULL),
(189, 26, 'Import', NULL, NULL, 0, NULL, 1, NULL, '2016-01-17 17:07:59', NULL, NULL),
(190, 26, 'Indenting', NULL, NULL, 0, NULL, 1, NULL, '2016-01-17 17:08:20', NULL, NULL),
(191, 26, 'Buying House', NULL, NULL, 0, NULL, 1, NULL, '2016-01-17 17:08:44', NULL, NULL),
(194, 15, 'Only Partner', 'OP', 0, 1, NULL, 1, NULL, '2016-02-08 06:00:00', NULL, '2016-02-09 03:01:04'),
(195, 15, 'Only Representative', 'OR', 0, 2, NULL, 1, NULL, '2016-02-08 06:00:00', NULL, '2016-02-09 17:18:04'),
(196, 15, 'Partner & Signatory', 'PS', 0, 3, NULL, 1, NULL, '2016-02-08 06:00:00', NULL, '2016-02-09 10:40:09'),
(197, 15, 'Representative & Signatory', 'RS', 0, 4, NULL, 1, NULL, '2016-02-08 22:59:32', NULL, '2016-02-09 19:12:18'),
(198, 15, 'Partner & Representative', 'PR', 0, 5, NULL, 1, NULL, '2016-02-08 22:59:57', NULL, '2016-02-09 19:12:43'),
(199, 15, 'Partner & Representative & Signatory', 'OS', 0, 6, NULL, 1, NULL, '2016-02-08 23:01:54', NULL, '2016-02-09 17:01:54'),
(200, 38, 'A', '', 1, 0, NULL, 0, NULL, '2016-02-09 22:43:37', NULL, NULL),
(201, 38, 'B', '', 2, 0, NULL, 1, NULL, '2016-02-09 22:43:45', NULL, NULL),
(202, 38, 'C', '', 3, 0, NULL, 1, NULL, '2016-02-09 22:43:54', NULL, NULL),
(203, 16, 'Husband', 'H', 0, 2, NULL, 1, NULL, '2016-02-10 16:42:51', NULL, NULL),
(204, 16, 'Brother', 'B', 0, 6, NULL, 1, NULL, '2016-02-10 16:43:03', NULL, NULL),
(205, 16, 'Sister', 'SI', 0, 7, NULL, 1, NULL, '2016-02-10 16:43:12', NULL, NULL),
(206, 39, 'package One', '', 1, 0, NULL, 1, NULL, '2016-03-21 22:18:42', NULL, NULL),
(207, 39, 'package Two', '', 2, 0, NULL, 1, NULL, '2016-03-21 22:19:01', NULL, NULL),
(208, 39, 'package Three', '', 3, 0, NULL, 1, NULL, '2016-03-21 22:19:19', NULL, NULL),
(209, 40, 'Controlled', 'C', 0, 0, NULL, 1, NULL, '2016-03-22 20:45:28', NULL, NULL),
(210, 40, 'Uncontrolled', 'U', 0, 0, NULL, 1, NULL, '2016-03-22 20:45:42', NULL, NULL),
(211, 41, 'Non Standardized', 'NS', 0, 0, NULL, 1, NULL, '2016-03-22 20:46:17', NULL, NULL),
(212, 41, 'Standardized', 'S', 0, 0, NULL, 1, NULL, '2016-03-22 20:46:32', NULL, NULL),
(213, 43, 'Organization', 'O', 0, NULL, NULL, 1, NULL, '2016-03-26 22:28:20', NULL, NULL),
(214, 43, 'Inspectorate', 'Ins', NULL, NULL, NULL, 1, NULL, '2016-03-26 22:28:36', NULL, NULL),
(215, 43, 'Section', 'Sec', NULL, NULL, NULL, 1, NULL, '2016-03-26 22:28:55', NULL, NULL),
(216, 43, 'Wing', 'W', NULL, NULL, NULL, 1, NULL, '2016-03-26 22:29:20', NULL, NULL),
(217, 43, 'User  Dte', 'U', NULL, NULL, NULL, 1, NULL, '2016-03-26 22:30:20', NULL, NULL),
(218, 43, 'Indenter', 'Ind', 0, NULL, NULL, 1, NULL, '2016-03-26 22:30:44', NULL, NULL),
(219, 42, 'General Procurement Meeting', 'GSPC', NULL, NULL, NULL, 1, NULL, '2016-03-27 16:41:05', NULL, NULL),
(220, 42, 'Navy procurement meeting', 'NSPC', NULL, NULL, NULL, 1, NULL, '2016-03-28 18:55:57', NULL, NULL),
(221, 42, 'Air Procurement Meeting', 'PCM', NULL, NULL, NULL, 1, NULL, '2016-03-28 18:56:35', NULL, NULL),
(222, 14, 'Driving License', 'DL', NULL, NULL, NULL, 1, NULL, '2016-03-30 22:08:08', NULL, NULL),
(223, 44, 'Text', 'Char', NULL, NULL, NULL, 1, NULL, '2016-04-11 18:31:28', NULL, NULL),
(224, 44, 'Number', 'int', NULL, NULL, NULL, 1, NULL, '2016-04-11 18:31:58', NULL, NULL),
(225, 45, 'Less than', '<', 1, NULL, NULL, 1, NULL, '2016-04-11 19:57:08', NULL, NULL),
(226, 45, 'Greater than', '>', 1, NULL, NULL, 1, NULL, '2016-04-11 19:57:56', NULL, NULL),
(227, 45, 'Equal', '=', 1, NULL, NULL, 1, NULL, '2016-04-11 19:58:28', NULL, NULL),
(228, 45, 'Less than or equal', '<=', 1, NULL, NULL, 1, NULL, '2016-04-11 19:59:07', NULL, NULL),
(229, 45, 'Greater than or equal', '>=', 1, NULL, NULL, 1, NULL, '2016-04-11 20:00:48', NULL, NULL),
(230, 46, 'Check Box', 'checkbox', NULL, NULL, NULL, 1, NULL, '2016-04-11 20:20:31', NULL, NULL),
(231, 46, 'Radio', 'radio', NULL, NULL, NULL, 1, NULL, '2016-04-11 20:20:49', NULL, NULL),
(232, 45, 'Between', 'between', 2, NULL, NULL, 1, NULL, '2016-04-11 21:11:37', NULL, NULL),
(233, 45, 'Or', 'or', 2, NULL, NULL, 1, NULL, '2016-04-11 21:12:11', NULL, NULL),
(234, 47, 'Arial', 'arial', NULL, NULL, NULL, 1, NULL, '2016-04-19 17:06:29', NULL, NULL),
(235, 47, 'Verdana', 'verdana', NULL, NULL, NULL, 1, NULL, '2016-04-19 17:06:53', NULL, NULL),
(236, 47, 'Times New Roman', 'Times New Roman', NULL, NULL, NULL, 1, NULL, '2016-04-19 17:07:43', NULL, NULL),
(237, 47, 'Tahoma', 'Tahoma', NULL, NULL, NULL, 1, NULL, '2016-04-19 17:08:03', NULL, NULL),
(238, 47, 'Georgia', 'Georgia', NULL, NULL, NULL, 1, NULL, '2016-04-19 17:08:25', NULL, NULL),
(239, 48, 'Bold', 'text-bold', 0, NULL, NULL, 1, NULL, '2016-04-19 17:08:38', NULL, NULL),
(240, 48, 'Italic', 'text-italic', NULL, NULL, NULL, 1, NULL, '2016-04-19 17:08:48', NULL, NULL),
(241, 48, 'Bold Italic', 'text-bold-italic', NULL, NULL, NULL, 1, NULL, '2016-04-19 17:29:42', NULL, NULL),
(242, 48, 'Bold Italic Underline', 'text-bold-italic-underline', NULL, NULL, NULL, 1, NULL, '2016-04-19 17:30:27', NULL, NULL),
(243, 48, 'Underline', 'text-underline', NULL, NULL, NULL, 1, NULL, '2016-04-19 17:31:12', NULL, NULL),
(244, 49, 'Limited', 'Ltd', 0, NULL, NULL, 1, NULL, '2016-04-19 21:21:37', NULL, NULL),
(245, 49, 'Secret', 'Secret', NULL, NULL, NULL, 1, NULL, '2016-04-19 21:36:59', NULL, NULL),
(246, 49, 'Restricted', 'Restricted', NULL, NULL, NULL, 1, NULL, '2016-04-19 21:37:14', NULL, NULL),
(247, 50, 'Open', 'Open', NULL, NULL, NULL, 1, NULL, '2016-04-19 21:38:11', NULL, NULL),
(248, 50, 'Limted', 'Ltd', NULL, NULL, NULL, 1, NULL, '2016-04-19 21:38:22', NULL, NULL),
(249, 51, 'Single Envelop', 'SE', NULL, NULL, NULL, 1, NULL, '2016-04-19 21:40:03', NULL, NULL),
(250, 51, 'Double Envelop', 'DE', NULL, NULL, NULL, 1, NULL, '2016-04-19 21:40:17', NULL, NULL),
(253, 31, 'Others', NULL, NULL, NULL, NULL, 1, NULL, '2016-04-27 00:02:55', NULL, NULL);

-- --------------------------------------------------------

--
-- Table structure for table `sa_lookup_grp`
--

CREATE TABLE IF NOT EXISTS `sa_lookup_grp` (
  `LOOKUP_GRP_ID` tinyint(3) NOT NULL AUTO_INCREMENT COMMENT 'Primary key of sa_lookup_grp table.',
  `LOOKUP_GRP_NAME` varchar(50) NOT NULL COMMENT 'Look up group name',
  `GRP_CATEGORY` tinyint(2) DEFAULT NULL COMMENT 'Group category',
  `USE_CHAR_NUMB` varchar(1) DEFAULT 'N' COMMENT 'Character Identification of the group',
  `SYSTEM_FG` tinyint(1) DEFAULT '0' COMMENT 'System Flag',
  `INSERT_FG` tinyint(1) DEFAULT '0',
  `UPDATE_FG` tinyint(1) DEFAULT '0',
  `DELETE_FG` tinyint(1) DEFAULT '0',
  `ORDER_SL_NO` tinyint(3) DEFAULT NULL COMMENT 'Ascending order',
  `UD_LKPGRP_ID` varchar(20) DEFAULT NULL COMMENT 'User Define Charge Head Id',
  `ACTIVE_FLAG` tinyint(1) NOT NULL DEFAULT '1' COMMENT 'It keeps boolean value representing Active/Inactive. e.g. 1 = Active, 0 = Inactive',
  `CRE_BY` int(10) unsigned DEFAULT NULL,
  `CRE_DT` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP,
  `UPD_BY` int(10) unsigned DEFAULT NULL,
  `UPD_DT` datetime DEFAULT NULL,
  PRIMARY KEY (`LOOKUP_GRP_ID`)
) ENGINE=InnoDB  DEFAULT CHARSET=utf8 COMMENT='All master data group entry i.e. Gender' AUTO_INCREMENT=53 ;

--
-- Dumping data for table `sa_lookup_grp`
--

INSERT INTO `sa_lookup_grp` (`LOOKUP_GRP_ID`, `LOOKUP_GRP_NAME`, `GRP_CATEGORY`, `USE_CHAR_NUMB`, `SYSTEM_FG`, `INSERT_FG`, `UPDATE_FG`, `DELETE_FG`, `ORDER_SL_NO`, `UD_LKPGRP_ID`, `ACTIVE_FLAG`, `CRE_BY`, `CRE_DT`, `UPD_BY`, `UPD_DT`) VALUES
(1, 'Type of the Company', NULL, 'C', 1, 0, 0, 0, 1, NULL, 1, NULL, '2015-05-13 22:18:19', NULL, '2015-05-14 17:17:29'),
(2, 'Type of Business', NULL, 'N', 0, 0, 0, 0, 0, NULL, 1, NULL, '2015-05-13 22:54:30', NULL, '2015-05-14 17:17:34'),
(3, 'Type of Account Type', NULL, 'N', 0, 0, 0, 0, 0, NULL, 1, NULL, '2015-05-15 20:16:35', NULL, '2015-05-16 14:30:33'),
(4, 'Religion', NULL, 'C', 0, 0, 0, 0, 0, NULL, 1, NULL, '2015-05-17 15:13:50', NULL, '2015-05-18 14:45:13'),
(5, 'Enlistment Groups', NULL, 'N', 0, 0, 0, 0, 0, NULL, 1, NULL, '2015-05-17 16:27:44', NULL, '2015-05-18 10:27:44'),
(6, 'Degree', NULL, 'N', 0, 0, 0, 0, 0, NULL, 1, NULL, '2015-05-18 17:26:36', NULL, '2015-05-19 11:26:36'),
(7, 'Education Type', NULL, 'N', 0, 0, 0, 0, 0, NULL, 1, NULL, '2015-05-18 17:29:01', NULL, '2015-05-19 11:29:01'),
(8, 'Bank Account Type', NULL, 'N', 0, 0, 0, 0, 0, NULL, 1, NULL, '2015-05-18 20:59:12', NULL, '2015-05-19 14:59:12'),
(9, 'Bank Brach Name', NULL, 'N', 0, 0, 0, 0, 0, NULL, 1, NULL, '2015-05-18 21:00:34', NULL, '2015-05-19 15:00:34'),
(10, 'Salutation', NULL, 'N', 0, 0, 0, 0, 0, NULL, 1, NULL, '2015-05-21 18:47:39', NULL, '2015-05-22 12:47:39'),
(11, 'Units', NULL, 'N', 0, 0, 0, 0, 0, NULL, 1, NULL, '2015-11-20 18:44:45', NULL, '2015-11-21 12:44:45'),
(12, 'DGFI Clearance Group', NULL, 'N', 0, 0, 0, 0, 0, NULL, 1, NULL, '2015-11-21 18:11:02', NULL, '2015-11-22 12:11:02'),
(13, 'Contract Status', NULL, 'N', 0, 0, 0, 0, 0, NULL, 1, NULL, '2015-11-22 22:12:31', NULL, '2015-11-23 16:12:31'),
(14, 'License Type', NULL, 'C', 0, 0, 0, 0, 0, NULL, 1, NULL, '2015-12-08 17:45:23', NULL, '2015-12-09 12:11:58'),
(15, 'Partner/Representative Type', NULL, 'C', 1, 0, 0, 0, 1, NULL, 1, NULL, '2015-05-13 22:18:19', NULL, '2015-05-14 17:17:29'),
(16, 'Relation Types', NULL, 'C', 0, 0, 0, 0, 0, NULL, 1, NULL, '2015-12-16 18:52:43', NULL, '2015-12-17 12:52:43'),
(17, 'Asset Types', NULL, 'N', 0, 0, 0, 0, 0, NULL, 1, NULL, '2015-12-16 20:14:50', NULL, '2015-12-17 14:14:50'),
(18, 'Attachment Types', NULL, 'N', 0, 0, 0, 0, 0, NULL, 1, NULL, '2015-12-18 20:34:31', NULL, '2015-12-19 14:34:31'),
(19, 'Embargo Types', NULL, 'N', 0, 0, 0, 0, 0, NULL, 1, NULL, '2015-12-19 20:31:57', NULL, '2015-12-20 14:31:57'),
(20, 'Agency Types', NULL, 'N', 0, 0, 0, 0, 0, NULL, 1, NULL, '2015-12-19 20:37:57', NULL, '2015-12-20 14:37:57'),
(21, 'Pay Order For', NULL, 'N', 0, 0, 0, 0, 0, NULL, 1, NULL, '2015-12-28 23:10:57', NULL, '2015-12-29 17:10:57'),
(22, 'Color or Race', NULL, 'N', 0, 0, 0, 0, 0, NULL, 1, NULL, '2016-01-10 09:41:49', NULL, '2016-01-11 09:41:49'),
(23, 'Eye Color', NULL, 'N', 0, 0, 0, 0, 0, NULL, 1, NULL, '2016-01-11 04:01:22', NULL, '2016-01-12 04:01:22'),
(24, 'Body Structure', NULL, 'N', 0, 0, 0, 0, 0, NULL, 1, NULL, '2016-01-11 04:02:29', NULL, '2016-01-12 04:03:04'),
(26, 'Category of License', NULL, 'N', 0, 0, 0, 0, 0, NULL, 1, NULL, '2016-01-17 17:07:34', NULL, NULL),
(31, 'Gender', NULL, 'N', 0, 0, 0, 0, 0, NULL, 0, NULL, '2016-01-28 00:41:50', NULL, NULL),
(32, 'Degisnation', NULL, 'N', 0, 0, 0, 0, 0, NULL, 0, NULL, '2016-01-28 17:02:42', NULL, NULL),
(33, 'Rank', NULL, 'N', 0, 0, 0, 0, 0, NULL, 0, NULL, '2016-01-28 17:03:24', NULL, NULL),
(34, 'Department', NULL, 'N', 0, 0, 0, 0, 0, NULL, 0, NULL, '2016-01-28 17:30:33', NULL, NULL),
(35, 'Marital Status', NULL, 'N', 0, 0, 0, 0, 0, NULL, 0, NULL, '2016-01-28 17:42:02', NULL, NULL),
(38, 'Country Category', NULL, 'N', 0, 0, 0, 0, 0, NULL, 0, NULL, '2016-01-28 23:41:28', NULL, NULL),
(39, 'Package', NULL, 'N', 0, 0, 0, 0, 0, NULL, 0, NULL, '2016-03-21 22:18:21', NULL, NULL),
(40, 'Item Category', NULL, 'C', 0, 0, 0, 0, 0, NULL, 0, NULL, '2016-03-22 20:45:06', NULL, NULL),
(41, 'Item Type', NULL, 'C', 0, 0, 0, 0, 0, NULL, 0, NULL, '2016-03-22 20:46:02', NULL, NULL),
(42, 'Meeting Name', NULL, 'C', 0, 0, 0, 0, NULL, NULL, 0, NULL, '2016-03-23 18:13:46', NULL, NULL),
(43, 'Organization Types', NULL, 'C', 0, 0, 0, 0, NULL, NULL, 0, NULL, '2016-03-26 22:27:46', NULL, NULL),
(44, 'Specs Attribute Value Type', NULL, 'C', 0, 0, 0, 0, NULL, NULL, 0, NULL, '2016-04-11 18:30:06', NULL, NULL),
(45, 'Operator Type', NULL, 'C', 0, 0, 0, 0, NULL, NULL, 0, NULL, '2016-04-11 19:53:02', NULL, NULL),
(46, 'VALUE ELEMENT', NULL, 'C', 0, 0, 0, 0, NULL, NULL, 0, NULL, '2016-04-11 20:20:09', NULL, NULL),
(47, 'Font Family', NULL, 'C', 0, 0, 0, 0, NULL, NULL, 0, NULL, '2016-04-19 17:04:44', NULL, NULL),
(48, 'Font Format', NULL, 'C', 0, 0, 0, 0, NULL, NULL, 0, NULL, '2016-04-19 17:05:48', NULL, NULL),
(49, 'Tender Security Level', NULL, 'C', 0, 0, 0, 0, NULL, NULL, 0, NULL, '2016-04-19 21:21:03', NULL, NULL),
(50, 'Tender Type', NULL, 'C', 0, 0, 0, 0, NULL, NULL, 0, NULL, '2016-04-19 21:37:52', NULL, NULL),
(51, 'Tender Method', NULL, 'C', 0, 0, 0, 0, NULL, NULL, 0, NULL, '2016-04-19 21:39:41', NULL, NULL),
(52, 'test-asif', NULL, 'N', 0, 0, 0, 0, NULL, NULL, 0, NULL, '2017-04-15 17:51:14', NULL, NULL);

-- --------------------------------------------------------

--
-- Table structure for table `sa_modules`
--

CREATE TABLE IF NOT EXISTS `sa_modules` (
  `MODULE_ID` int(11) NOT NULL AUTO_INCREMENT COMMENT 'Primary Key',
  `MODULE_NAME` varchar(70) NOT NULL COMMENT 'Name of the Module',
  `SHORT_NAME` char(10) NOT NULL COMMENT 'Short Name of the Module',
  `MODULE_NAME_BN` varchar(500) DEFAULT NULL COMMENT 'Bnagla Name of the Module',
  `SL_NO` tinyint(2) NOT NULL COMMENT 'Ascending Order',
  `ACTIVE_STATUS` tinyint(1) DEFAULT '1' COMMENT 'It keeps boolean value representing Active/Inactive. e.g. 1 = Active, 0 = Inactive',
  `CRE_BY` int(10) unsigned DEFAULT NULL,
  `CRE_DT` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP,
  `UPD_BY` int(10) unsigned DEFAULT NULL,
  `UPD_DT` datetime DEFAULT NULL,
  PRIMARY KEY (`MODULE_ID`)
) ENGINE=InnoDB  DEFAULT CHARSET=utf8 COMMENT='Modules list entry here ' AUTO_INCREMENT=6 ;

--
-- Dumping data for table `sa_modules`
--

INSERT INTO `sa_modules` (`MODULE_ID`, `MODULE_NAME`, `SHORT_NAME`, `MODULE_NAME_BN`, `SL_NO`, `ACTIVE_STATUS`, `CRE_BY`, `CRE_DT`, `UPD_BY`, `UPD_DT`) VALUES
(1, 'Access Control', 'AC', '???????????? ??????????', 1, 1, 1, '2017-09-09 00:49:22', 1, '2017-10-17 11:59:27'),
(2, 'All Setup', 'AS', '????? ????', 2, 1, 1, '2017-09-09 22:09:01', 1, '2017-09-10 04:09:19'),
(3, 'Medicine Setup', 'MS', '', 3, 1, 1, '2017-10-14 12:07:31', NULL, NULL),
(4, 'Global Oparetion', 'GP', '', 4, 1, 1, '2017-11-21 05:02:30', NULL, NULL),
(5, 'Photo Gallery', 'pg', '', 5, 1, 1, '2017-11-21 05:02:48', NULL, NULL);

-- --------------------------------------------------------

--
-- Table structure for table `sa_module_links`
--

CREATE TABLE IF NOT EXISTS `sa_module_links` (
  `LINK_ID` int(11) NOT NULL AUTO_INCREMENT COMMENT 'Primary Key',
  `LINK_NAME` varchar(60) NOT NULL COMMENT 'Link name will be stored',
  `LINK_NAME_BN` varchar(500) DEFAULT NULL COMMENT 'Link Name in Bangla',
  `MODULE_ID` int(2) DEFAULT NULL COMMENT 'Parent Module name Primary Key of sa_modules table',
  `URL_URI` varchar(200) DEFAULT NULL COMMENT 'URI location of the link ',
  `LINK_DESC` varchar(100) DEFAULT NULL COMMENT 'Link description',
  `SL_NO` tinyint(2) NOT NULL COMMENT 'Ascending order',
  `CREATE` tinyint(1) DEFAULT '0' COMMENT 'Flag for create action',
  `READ` tinyint(1) DEFAULT '0' COMMENT 'Flag for view action',
  `UPDATE` tinyint(1) DEFAULT '0' COMMENT 'Flag for update action',
  `DELETE` tinyint(1) DEFAULT '0' COMMENT 'Flag for Delete action',
  `STATUS` tinyint(4) DEFAULT NULL COMMENT 'Flag for Active/Inactive action',
  `SA_MLINK_PAGES` varchar(10) DEFAULT NULL COMMENT 'Each action first character is stored with comma seperation',
  `ACTIVE_STATUS` tinyint(1) DEFAULT '1' COMMENT 'It keeps boolean value representing Active/Inactive. e.g. 1 = Active, 0 = Inactive',
  `CRE_BY` int(10) unsigned DEFAULT NULL,
  `CRE_DT` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP,
  `UPD_BY` int(10) unsigned DEFAULT NULL,
  `UPD_DT` datetime DEFAULT NULL,
  PRIMARY KEY (`LINK_ID`),
  KEY `FK_MLINK_MODULE_ID` (`MODULE_ID`)
) ENGINE=InnoDB  DEFAULT CHARSET=utf8 COMMENT='All application pages link entry here ' AUTO_INCREMENT=20 ;

--
-- Dumping data for table `sa_module_links`
--

INSERT INTO `sa_module_links` (`LINK_ID`, `LINK_NAME`, `LINK_NAME_BN`, `MODULE_ID`, `URL_URI`, `LINK_DESC`, `SL_NO`, `CREATE`, `READ`, `UPDATE`, `DELETE`, `STATUS`, `SA_MLINK_PAGES`, `ACTIVE_STATUS`, `CRE_BY`, `CRE_DT`, `UPD_BY`, `UPD_DT`) VALUES
(1, 'Modules', '?????', 1, 'accessControl/index', NULL, 1, 1, 1, 1, 1, 1, 'I,V,U,D,S', 1, 1, '2017-09-09 00:54:28', NULL, NULL),
(2, 'Module Links', '????? ????', 1, 'accessControl/moduleLinks', NULL, 2, 1, 1, 1, 1, 1, 'I,V,U,D,S', 1, 1, '2017-09-09 00:55:14', 1, '2017-09-10 04:19:51'),
(3, 'Organization Modules', '????? ?????', 1, 'accessControl/orgModuleSetup', NULL, 3, 1, 1, 1, 1, 1, 'I,V,U,D,S', 1, 1, '2017-09-09 00:57:06', NULL, NULL),
(4, 'User Group', '????? ?????', 1, 'accessControl/allGroup', NULL, 4, 1, 1, 1, 1, 1, 'I,V,U,D,S', 1, 1, '2017-09-09 00:58:12', NULL, NULL),
(5, 'Assign Link To Group', '????? ???? ?????', 1, 'accessControl/assignModuleToGroup', NULL, 5, 1, 1, 1, 1, 1, 'I,V,U,D,S', 1, 1, '2017-09-09 01:00:32', NULL, NULL),
(6, 'User Setup', '????? ?????', 1, 'setup/user', NULL, 6, 1, 1, 1, 1, 1, 'I,V,U,D,S', 1, 1, '2017-09-09 01:01:22', NULL, NULL),
(7, 'Base Setup', '????? ?????', 2, 'accessControl/allGroup', NULL, 7, 1, 1, 1, 1, 1, 'I,V,U,D,S', 1, 1, '2017-09-09 22:19:41', 1, '2017-09-10 04:20:02'),
(9, 'Category Setup', '', 3, 'MedicineSetup/categories', NULL, 1, 1, 1, 1, 1, 1, 'I,V,U,D,S', 1, 1, '2017-10-14 12:10:07', 1, '2017-10-15 10:19:24'),
(10, 'Generic Setup', '', 3, 'MedicineSetup/generic', NULL, 3, 1, 1, 1, 1, 1, 'I,V,U,D,S', 1, 1, '2017-10-16 08:32:27', 1, '2017-10-16 12:04:15'),
(11, 'Therapeutic setup', '', 3, 'MedicineSetup/therapeutic', NULL, 2, 1, 1, 1, 1, 1, 'I,V,U,D,S', 1, 1, '2017-10-16 10:01:12', NULL, NULL),
(12, 'Medicine Setup', '', 3, 'MedicineSetup/medicine', NULL, 4, 1, 1, 1, 1, 1, 'I,V,U,D,S', 1, 1, '2017-10-18 08:54:58', NULL, NULL),
(13, 'Globa Achivement', '', 4, 'MedicineSetup/globalAchivement', NULL, 2, 1, 1, 1, 1, 1, 'I,V,U,D,S', 1, 1, '2017-11-21 05:04:26', NULL, NULL),
(14, 'photo Gallery', '', 5, 'MedicineSetup/photogallery', NULL, 6, 1, 1, 1, 1, 1, 'I,V,U,D,S', 1, 1, '2017-11-21 05:05:05', NULL, NULL),
(15, 'oncology department', '', 5, 'MedicineSetup/oncologyDepartment', NULL, 6, 1, 1, 1, 1, 1, 'I,V,U,D,S', 1, 1, '2017-11-21 05:05:40', NULL, NULL),
(16, 'Unit1', '', 5, 'MedicineSetup/photogalleryUnit1', NULL, 2, 1, 1, 1, 1, 1, 'I,V,U,D,S', 1, 1, '2017-11-21 06:49:12', 1, '2017-11-21 07:50:21'),
(17, 'Home Slider', '', 5, '	MedicineSetup/homeSlider', NULL, 4, 1, 1, 1, 1, 1, 'I,V,U,D,S', 1, 1, '2017-12-09 08:25:21', NULL, NULL),
(18, 'Specialized Department', '', 3, '	MedicineSetup/SpecializedDepartment', NULL, 6, 1, 1, 1, 1, 1, 'I,V,U,D,S', 1, 1, '2017-12-09 10:40:06', 1, '2017-12-09 13:02:24'),
(19, 'Specialized Product', '', 3, 'MedicineSetup/specializedProducts', NULL, 6, 1, 1, 1, 1, 1, 'I,V,U,D,S', 1, 1, '2017-12-09 12:02:06', 1, '2017-12-10 09:04:29');

-- --------------------------------------------------------

--
-- Table structure for table `sa_organizations`
--

CREATE TABLE IF NOT EXISTS `sa_organizations` (
  `ORG_ID` int(11) NOT NULL AUTO_INCREMENT COMMENT 'Primary Key',
  `ORG_NAME` varchar(100) NOT NULL COMMENT 'Organization Name',
  `ADDRESS` varchar(160) DEFAULT NULL COMMENT 'Address 2',
  `ZIP_CODE` varchar(8) DEFAULT NULL COMMENT 'Zip/Postal Code',
  `TEL` varchar(80) DEFAULT NULL COMMENT 'Contact Number',
  `PHONE` varchar(80) DEFAULT NULL COMMENT 'Mobile Number',
  `FAX` varchar(80) DEFAULT NULL COMMENT 'Fax Number',
  `EMAIL` varchar(40) DEFAULT NULL COMMENT 'Email Address',
  `WEBSITE` varchar(40) DEFAULT NULL COMMENT 'Organization Website',
  `LOGO` varchar(100) DEFAULT NULL COMMENT 'Organization Logo',
  `ACTIVE_STATUS` tinyint(1) DEFAULT '1' COMMENT 'It keeps boolean value representing Active/Inactive. e.g. 1 = Active, 0 = Inactive',
  `CRE_BY` int(10) unsigned DEFAULT NULL,
  `CRE_DT` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP,
  `UPD_BY` int(10) unsigned DEFAULT NULL,
  `UPD_DT` datetime DEFAULT NULL,
  PRIMARY KEY (`ORG_ID`)
) ENGINE=InnoDB  DEFAULT CHARSET=utf8 COMMENT='DGDP organizational basic information ' AUTO_INCREMENT=2 ;

--
-- Dumping data for table `sa_organizations`
--

INSERT INTO `sa_organizations` (`ORG_ID`, `ORG_NAME`, `ADDRESS`, `ZIP_CODE`, `TEL`, `PHONE`, `FAX`, `EMAIL`, `WEBSITE`, `LOGO`, `ACTIVE_STATUS`, `CRE_BY`, `CRE_DT`, `UPD_BY`, `UPD_DT`) VALUES
(1, 'Thikana', NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'Thikana.jpg', 1, NULL, '2017-09-08 22:22:52', NULL, NULL);

-- --------------------------------------------------------

--
-- Table structure for table `sa_org_mlinks`
--

CREATE TABLE IF NOT EXISTS `sa_org_mlinks` (
  `SA_MLINKS_ID` int(11) NOT NULL AUTO_INCREMENT COMMENT 'Primary Key',
  `SA_MODULE_ID` int(11) DEFAULT NULL COMMENT 'Primary Key of sa_modules table',
  `ORG_ID` int(11) DEFAULT NULL COMMENT 'Primary key of sa_organization table',
  `LINK_ID` int(7) DEFAULT NULL COMMENT 'Primary Key of sa_module_links table to assign previledge of module links',
  `CREATE` tinyint(1) DEFAULT '0' COMMENT 'Defined to assign previledge to particular organization for Insert action',
  `READ` tinyint(1) DEFAULT '0' COMMENT 'Defined to assign previledge to particular organization for View action',
  `UPDATE` tinyint(1) DEFAULT '0' COMMENT 'Defined to assign previledge to particular organization for Update action',
  `DELETE` tinyint(1) DEFAULT '0' COMMENT 'Defined to assign previledge to particular organization for Delete action',
  `STATUS` tinyint(4) DEFAULT NULL COMMENT 'Defined to assign previledge to particular organization for Active/Inactive action',
  `URL_URI` varchar(200) DEFAULT NULL COMMENT 'Keeps URL',
  `SA_MLINK_NAME` varchar(60) DEFAULT NULL,
  `SA_MLINK_PAGES` varchar(10) DEFAULT NULL,
  `ACTIVE_STATUS` tinyint(1) DEFAULT '1' COMMENT 'It keeps boolean value representing Active/Inactive. e.g. 1 = Active, 0 = Inactive',
  `CRE_BY` int(10) unsigned DEFAULT NULL,
  `CRE_DT` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP,
  `UPD_BY` int(10) unsigned DEFAULT NULL,
  `UPD_DT` datetime DEFAULT NULL,
  PRIMARY KEY (`SA_MLINKS_ID`),
  KEY `FK02_ORG_ID` (`ORG_ID`),
  KEY `FK01_SA_MODULE_ID` (`SA_MODULE_ID`)
) ENGINE=InnoDB  DEFAULT CHARSET=utf8 COMMENT='organizational modules wise link assign ' AUTO_INCREMENT=20 ;

--
-- Dumping data for table `sa_org_mlinks`
--

INSERT INTO `sa_org_mlinks` (`SA_MLINKS_ID`, `SA_MODULE_ID`, `ORG_ID`, `LINK_ID`, `CREATE`, `READ`, `UPDATE`, `DELETE`, `STATUS`, `URL_URI`, `SA_MLINK_NAME`, `SA_MLINK_PAGES`, `ACTIVE_STATUS`, `CRE_BY`, `CRE_DT`, `UPD_BY`, `UPD_DT`) VALUES
(1, 1, 1, 1, 1, 1, 1, 1, 1, NULL, NULL, NULL, 1, 1, '2017-09-09 02:31:55', 1, '2017-09-09 08:32:00'),
(2, 1, 1, 2, 1, 1, 1, 1, 1, NULL, NULL, NULL, 1, 1, '2017-09-09 02:32:02', 1, '2017-09-09 08:32:07'),
(3, 1, 1, 3, 1, 1, 1, 1, 1, NULL, NULL, NULL, 1, 1, '2017-09-09 02:32:08', 1, '2017-09-09 08:32:12'),
(4, 1, 1, 4, 1, 1, 1, 1, 1, NULL, NULL, NULL, 1, 1, '2017-09-09 02:32:13', 1, '2017-09-09 08:32:17'),
(5, 1, 1, 5, 1, 1, 1, 1, 1, NULL, NULL, NULL, 1, 1, '2017-09-09 02:32:18', 1, '2017-09-09 08:32:21'),
(6, 1, 1, 6, 1, 1, 1, 1, 1, NULL, NULL, NULL, 1, 1, '2017-09-09 02:32:23', 1, '2017-09-09 08:32:26'),
(7, 2, 1, 7, 1, 1, 1, 1, 1, NULL, NULL, NULL, 1, 1, '2017-09-10 04:07:45', 1, '2017-09-10 10:07:48'),
(8, 2, 1, 8, 1, 1, 1, 1, 1, NULL, NULL, NULL, 1, 1, '2017-10-14 11:51:32', 1, '2017-10-14 13:54:28'),
(9, 3, 1, 9, 1, 1, 1, 1, 1, NULL, NULL, NULL, 1, 1, '2017-10-14 12:10:27', 1, '2017-10-14 14:13:23'),
(10, 3, 1, 10, 1, 1, 1, 1, 1, NULL, NULL, NULL, 1, 1, '2017-10-16 08:35:02', 1, '2017-10-16 10:37:53'),
(11, 3, 1, 11, 1, 1, 1, 1, 1, NULL, NULL, NULL, 1, 1, '2017-10-16 10:02:02', 1, '2017-10-16 12:04:52'),
(12, 3, 1, 12, 1, 1, 1, 1, 1, NULL, NULL, NULL, 1, 1, '2017-10-18 08:55:29', 1, '2017-10-18 10:58:32'),
(13, 4, 1, 13, 1, 1, 1, 1, 1, NULL, NULL, NULL, 1, 1, '2017-11-21 05:06:31', 1, '2017-11-21 06:06:38'),
(14, 5, 1, 14, 1, 1, 1, 1, 1, NULL, NULL, NULL, 1, 1, '2017-11-21 05:06:32', 1, '2017-11-21 06:06:41'),
(15, 5, 1, 15, 1, 1, 1, 1, 1, NULL, NULL, NULL, 1, 1, '2017-11-21 05:06:33', 1, '2017-11-21 06:06:44'),
(16, 5, 1, 16, 1, 1, 1, 1, 1, NULL, NULL, NULL, 1, 1, '2017-11-21 06:49:29', 1, '2017-11-21 07:49:32'),
(17, 5, 1, 17, 1, 1, 1, 1, 1, NULL, NULL, NULL, 1, 1, '2017-12-09 08:25:54', 1, '2017-12-09 09:25:59'),
(18, 3, 1, 18, 1, 1, 1, 1, 1, NULL, NULL, NULL, 1, 1, '2017-12-09 10:40:15', 1, '2017-12-09 11:40:20'),
(19, 3, 1, 19, 1, 1, 1, 1, 1, NULL, NULL, NULL, 1, 1, '2017-12-09 12:09:15', 1, '2017-12-09 13:09:19');

-- --------------------------------------------------------

--
-- Table structure for table `sa_org_modules`
--

CREATE TABLE IF NOT EXISTS `sa_org_modules` (
  `SA_MODULE_ID` int(7) NOT NULL AUTO_INCREMENT COMMENT 'Primary Key',
  `SA_MODULE_NAME` varchar(70) NOT NULL COMMENT 'Name of the Module',
  `ORG_ID` int(11) DEFAULT NULL COMMENT 'Primary key of sa_organization table',
  `DEFAULT_FLAG` tinyint(1) DEFAULT NULL COMMENT 'Keeps Deafult Flag Boolean value',
  `MODULE_ID` int(11) DEFAULT NULL COMMENT 'Primary key of sa_modules Table',
  `ACTIVE_STATUS` tinyint(1) DEFAULT '1' COMMENT 'It keeps boolean value representing Active/Inactive. e.g. 1 = Active, 0 = Inactive',
  `CRE_BY` int(10) unsigned DEFAULT NULL,
  `CRE_DT` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP,
  `UPD_BY` int(10) unsigned DEFAULT NULL,
  `UPD_DT` datetime DEFAULT NULL,
  PRIMARY KEY (`SA_MODULE_ID`),
  KEY `FK01_ORG_ID` (`ORG_ID`)
) ENGINE=InnoDB  DEFAULT CHARSET=utf8 COMMENT='organizational wise existing modules assign ' AUTO_INCREMENT=6 ;

--
-- Dumping data for table `sa_org_modules`
--

INSERT INTO `sa_org_modules` (`SA_MODULE_ID`, `SA_MODULE_NAME`, `ORG_ID`, `DEFAULT_FLAG`, `MODULE_ID`, `ACTIVE_STATUS`, `CRE_BY`, `CRE_DT`, `UPD_BY`, `UPD_DT`) VALUES
(1, 'Access Control', 1, NULL, 1, 1, NULL, '2017-09-09 02:30:50', NULL, NULL),
(2, 'All Setup', 1, NULL, 2, 1, NULL, '2017-09-10 04:07:40', NULL, NULL),
(3, 'Medicine Setup', 1, NULL, 3, 1, NULL, '2017-10-14 12:10:22', NULL, NULL),
(4, 'Global Oparetion', 1, NULL, 4, 1, NULL, '2017-11-21 05:06:27', NULL, NULL),
(5, 'Photo Gallery', 1, NULL, 5, 1, NULL, '2017-11-21 05:06:27', NULL, NULL);

-- --------------------------------------------------------

--
-- Table structure for table `sa_uglw_mlink`
--

CREATE TABLE IF NOT EXISTS `sa_uglw_mlink` (
  `SA_UGLWM_LINK` int(11) NOT NULL AUTO_INCREMENT COMMENT 'Primary Key',
  `SA_MLINKS_ID` int(11) DEFAULT NULL COMMENT 'Primary key of sa_org_mlinks table. Only permitted link ids for org will be stored ',
  `ORG_ID` int(11) DEFAULT NULL COMMENT 'Primary key of sa_organization table',
  `USER_ID` bigint(14) DEFAULT NULL COMMENT 'Primary key of sa_users table. Assign priveledge by user id.',
  `USERGRP_ID` int(11) DEFAULT NULL COMMENT 'Primary key of sa_user_group table. Assigning priveledge agains group id',
  `UG_LEVEL_ID` int(11) DEFAULT NULL COMMENT 'Primary key of sa_ug_level table. Assigning priveledge agains level id',
  `SA_MODULE_ID` int(7) DEFAULT NULL COMMENT 'Primary key of sa_module table',
  `LINK_ID` int(7) DEFAULT NULL COMMENT 'primary key of sa_org_mlinks table ',
  `CREATE` tinyint(1) DEFAULT '0' COMMENT 'Defined to assign previledge for Insert action',
  `READ` tinyint(1) DEFAULT '0' COMMENT 'Defined to assign previledge for View action',
  `UPDATE` tinyint(1) DEFAULT '0' COMMENT 'Defined to assign previledge for Update action',
  `DELETE` tinyint(1) DEFAULT '0' COMMENT 'Defined to assign previledge for Delete action',
  `STATUS` tinyint(4) DEFAULT NULL COMMENT 'Defined to assign previledge for Active/Inactive action',
  `URL_URI` varchar(200) DEFAULT NULL COMMENT 'URL for query enhencement',
  `ACTIVE_STATUS` tinyint(1) DEFAULT '1' COMMENT 'It keeps boolean value representing Active/Inactive. e.g. 1 = Active, 0 = Inactive',
  `CRE_BY` int(10) unsigned DEFAULT NULL,
  `CRE_DT` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP,
  `UPD_BY` int(10) unsigned DEFAULT NULL,
  `UPD_DT` datetime DEFAULT NULL,
  PRIMARY KEY (`SA_UGLWM_LINK`),
  KEY `FK01_USER_ID` (`USER_ID`),
  KEY `FK02_SA_MODULE_ID` (`SA_MODULE_ID`),
  KEY `FK01_SA_MLINKS_ID` (`SA_MLINKS_ID`),
  KEY `FK02_USERGRP_ID` (`USERGRP_ID`),
  KEY `FK01_UG_LEVEL_ID` (`UG_LEVEL_ID`),
  KEY `FK05_ORG_ID` (`ORG_ID`)
) ENGINE=InnoDB  DEFAULT CHARSET=utf8 COMMENT='User level wise module link define ' AUTO_INCREMENT=20 ;

--
-- Dumping data for table `sa_uglw_mlink`
--

INSERT INTO `sa_uglw_mlink` (`SA_UGLWM_LINK`, `SA_MLINKS_ID`, `ORG_ID`, `USER_ID`, `USERGRP_ID`, `UG_LEVEL_ID`, `SA_MODULE_ID`, `LINK_ID`, `CREATE`, `READ`, `UPDATE`, `DELETE`, `STATUS`, `URL_URI`, `ACTIVE_STATUS`, `CRE_BY`, `CRE_DT`, `UPD_BY`, `UPD_DT`) VALUES
(1, 1, 1, NULL, 1, 1, 1, NULL, 1, 1, 1, 1, 1, NULL, 1, 1, '2017-09-09 02:34:49', 1, '2017-09-09 08:34:53'),
(2, 2, 1, NULL, 1, 1, 1, NULL, 1, 1, 1, 1, 1, NULL, 1, 1, '2017-09-09 02:34:54', 1, '2017-09-09 08:34:58'),
(3, 3, 1, NULL, 1, 1, 1, NULL, 1, 1, 1, 1, 1, NULL, 1, 1, '2017-09-09 02:34:59', 1, '2017-09-09 08:35:03'),
(4, 4, 1, NULL, 1, 1, 1, NULL, 1, 1, 1, 1, 1, NULL, 1, 1, '2017-09-09 02:35:04', 1, '2017-09-09 08:35:08'),
(5, 5, 1, NULL, 1, 1, 1, NULL, 1, 1, 1, 1, 1, NULL, 1, 1, '2017-09-09 02:35:09', 1, '2017-09-09 08:35:11'),
(6, 6, 1, NULL, 1, 1, 1, NULL, 1, 1, 1, 1, 1, NULL, 1, 1, '2017-09-09 02:35:13', 1, '2017-09-09 08:35:17'),
(7, 7, 1, NULL, 1, 1, 2, NULL, 1, 1, 1, 1, 1, NULL, 1, 1, '2017-09-10 04:08:44', 1, '2017-09-10 10:08:47'),
(8, 8, 1, NULL, 1, 1, 2, NULL, 1, 1, 1, 1, 1, NULL, 1, 1, '2017-10-14 11:52:02', 1, '2017-10-14 13:54:57'),
(9, 9, 1, NULL, 1, 1, 3, NULL, 1, 1, 1, 1, 1, NULL, 1, 1, '2017-10-14 12:10:49', 1, '2017-10-14 14:13:42'),
(10, 10, 1, NULL, 1, 1, 3, NULL, 1, 1, 1, 1, 1, NULL, 1, 1, '2017-10-16 08:35:26', 1, '2017-10-16 10:38:14'),
(11, 11, 1, NULL, 1, 1, 3, NULL, 1, 1, 1, 1, 1, NULL, 1, 1, '2017-10-16 10:02:24', 1, '2017-10-16 12:05:15'),
(12, 12, 1, NULL, 1, 1, 3, NULL, 1, 1, 1, 1, 1, NULL, 1, 1, '2017-10-18 08:56:01', 1, '2017-10-18 10:59:04'),
(13, 13, 1, NULL, 1, 1, 4, NULL, 1, 1, 1, 1, 1, NULL, 1, 1, '2017-11-21 05:06:57', 1, '2017-11-21 06:07:00'),
(14, 14, 1, NULL, 1, 1, 5, NULL, 1, 1, 1, 1, 1, NULL, 1, 1, '2017-11-21 05:07:01', 1, '2017-11-21 06:07:08'),
(15, 15, 1, NULL, 1, 1, 5, NULL, 1, 1, 1, 1, 1, NULL, 1, 1, '2017-11-21 05:07:02', 1, '2017-11-21 06:07:08'),
(16, 16, 1, NULL, 1, 1, 5, NULL, 1, 1, 1, 1, 1, NULL, 1, 1, '2017-11-21 06:49:47', 1, '2017-11-21 07:49:51'),
(17, 17, 1, NULL, 1, 1, 5, NULL, 1, 1, 1, 1, 1, NULL, 1, 1, '2017-12-09 08:26:23', 1, '2017-12-09 09:26:27'),
(18, 18, 1, NULL, 1, 1, 3, NULL, 1, 1, 1, 1, 1, NULL, 1, 1, '2017-12-09 10:40:35', 1, '2017-12-09 11:40:39'),
(19, 19, 1, NULL, 1, 1, 3, NULL, 1, 1, 1, 1, 1, NULL, 1, 1, '2017-12-09 12:09:41', 1, '2017-12-09 13:09:46');

-- --------------------------------------------------------

--
-- Table structure for table `sa_ug_level`
--

CREATE TABLE IF NOT EXISTS `sa_ug_level` (
  `UG_LEVEL_ID` int(11) NOT NULL AUTO_INCREMENT COMMENT 'Primary Key',
  `USERGRP_ID` int(11) DEFAULT NULL COMMENT 'Primary key of sa_user_group table',
  `ORG_ID` int(11) DEFAULT NULL COMMENT 'Primary key of sa_organization table',
  `UGLEVE_NAME` varchar(50) DEFAULT NULL COMMENT 'Name of the Level',
  `ORDER_SL` tinyint(2) DEFAULT NULL COMMENT 'Ascending Order',
  `ACTIVE_STATUS` tinyint(1) DEFAULT '1' COMMENT 'It keeps boolean value representing Active/Inactive. e.g. 1 = Active, 0 = Inactive',
  `CRE_BY` int(10) unsigned DEFAULT NULL,
  `CRE_DT` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP,
  `UPD_BY` int(10) unsigned DEFAULT NULL,
  `UPD_DT` datetime DEFAULT NULL,
  PRIMARY KEY (`UG_LEVEL_ID`),
  KEY `FK04_ORG_ID` (`ORG_ID`),
  KEY `FK01_USERGRP_ID` (`USERGRP_ID`)
) ENGINE=InnoDB  DEFAULT CHARSET=utf8 COMMENT='Organization wise user level define for access application ' AUTO_INCREMENT=3 ;

--
-- Dumping data for table `sa_ug_level`
--

INSERT INTO `sa_ug_level` (`UG_LEVEL_ID`, `USERGRP_ID`, `ORG_ID`, `UGLEVE_NAME`, `ORDER_SL`, `ACTIVE_STATUS`, `CRE_BY`, `CRE_DT`, `UPD_BY`, `UPD_DT`) VALUES
(1, 1, 1, 'Admin', NULL, 1, 1, '2017-09-09 00:44:30', 1, '2017-09-09 06:44:46'),
(2, 2, 1, 'Admin', NULL, 1, 1, '2017-09-09 22:47:50', NULL, NULL);

-- --------------------------------------------------------

--
-- Table structure for table `sa_users`
--

CREATE TABLE IF NOT EXISTS `sa_users` (
  `FLD_USER_ID` bigint(20) NOT NULL AUTO_INCREMENT COMMENT 'Primary Key',
  `ORG_ID` int(11) DEFAULT NULL COMMENT 'Primary Key of sa_organization table.',
  `USERGRP_ID` int(11) DEFAULT NULL COMMENT 'Primary Key of sa_user_group table. This will be used for Access Control',
  `USERLVL_ID` int(11) DEFAULT NULL COMMENT 'Primary Key of sa_ug_level. This will be used for user Access Control',
  `USERNAME` varchar(16) DEFAULT NULL COMMENT 'User username will be stored. This will be used while login as iser',
  `USERPW` varchar(60) NOT NULL COMMENT 'Password of user to be used while login',
  `FULL_NAME` varchar(250) DEFAULT NULL COMMENT 'User Full Name',
  `DESIG_ID` int(11) DEFAULT NULL COMMENT 'Come from sa_designation',
  `FATHER_NAME` varchar(250) DEFAULT NULL COMMENT 'Father Name of user',
  `MOTHER_NAME` varchar(250) DEFAULT NULL COMMENT 'Mother Name of User',
  `MOBILE` varchar(40) DEFAULT NULL COMMENT 'User Mobile Number',
  `EMAIL` varchar(40) NOT NULL COMMENT 'User Email Address',
  `NID` varchar(30) DEFAULT NULL COMMENT 'National ID of User',
  `GENDER` varchar(5) DEFAULT 'M' COMMENT 'M= Male, F= Female, O=Others',
  `RELIGION` int(11) DEFAULT NULL COMMENT 'Come from lookup',
  `MARITAL_STATUS` int(11) DEFAULT NULL COMMENT 'Come from lookup',
  `USERIMG` varchar(100) DEFAULT NULL COMMENT 'User Photo',
  `USER_ENTITY` varchar(20) DEFAULT NULL COMMENT 'Define whether a user is Org user/ Doctor/ Patients/ Guardian',
  `USERTYPE` int(11) DEFAULT NULL,
  `ACTIVE_STATUS` tinyint(1) DEFAULT '1' COMMENT 'It keeps boolean value representing Active/Inactive. e.g. 1 = Active, 0 = Inactive',
  `CRE_DT` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP,
  `CRE_BY` int(10) unsigned DEFAULT NULL,
  `UPD_DT` datetime DEFAULT NULL,
  `UPD_BY` int(10) unsigned DEFAULT NULL,
  PRIMARY KEY (`FLD_USER_ID`),
  KEY `sa_users_ibfk_1` (`USERLVL_ID`),
  KEY `sa_users_ibfk_2` (`USERGRP_ID`),
  KEY `sa_users_ibfk_3` (`ORG_ID`)
) ENGINE=InnoDB  DEFAULT CHARSET=utf8 COMMENT='Basic information of All user' AUTO_INCREMENT=3 ;

--
-- Dumping data for table `sa_users`
--

INSERT INTO `sa_users` (`FLD_USER_ID`, `ORG_ID`, `USERGRP_ID`, `USERLVL_ID`, `USERNAME`, `USERPW`, `FULL_NAME`, `DESIG_ID`, `FATHER_NAME`, `MOTHER_NAME`, `MOBILE`, `EMAIL`, `NID`, `GENDER`, `RELIGION`, `MARITAL_STATUS`, `USERIMG`, `USER_ENTITY`, `USERTYPE`, `ACTIVE_STATUS`, `CRE_DT`, `CRE_BY`, `UPD_DT`, `UPD_BY`) VALUES
(1, 1, 1, 1, 'admin', 'e10adc3949ba59abbe56e057f20f883e', 'Super Admin', NULL, NULL, NULL, NULL, 'admin@gmail.com', NULL, 'M', NULL, NULL, NULL, NULL, NULL, 1, '2017-09-08 16:04:05', NULL, NULL, NULL),
(2, 1, 2, 2, 'admin', 'e10adc3949ba59abbe56e057f20f883e', 'Full Name', 129, 'Father''s Name', 'Mother''s Name', 'Phone', 'dgdfg@mail.com', 'National ID', '127', 12, 143, '2017_09_10_b0bef4c.png', NULL, NULL, 1, '2017-09-10 06:53:21', 1, NULL, NULL);

-- --------------------------------------------------------

--
-- Table structure for table `sa_user_group`
--

CREATE TABLE IF NOT EXISTS `sa_user_group` (
  `USERGRP_ID` int(11) NOT NULL AUTO_INCREMENT COMMENT 'Primary Key',
  `ORG_ID` int(11) DEFAULT NULL COMMENT 'Primary Key of sa_user_group table. Group may be created against org',
  `USERGRP_NAME` varchar(50) DEFAULT NULL COMMENT 'Name of the Group',
  `ACTIVE_STATUS` tinyint(1) DEFAULT '1' COMMENT 'It keeps boolean value representing Active/Inactive. e.g. 1 = Active, 0 = Inactive',
  `CRE_BY` int(10) unsigned DEFAULT NULL,
  `CRE_DT` timestamp NOT NULL DEFAULT CURRENT_TIMESTAMP,
  `UPD_BY` int(10) unsigned DEFAULT NULL,
  `UPD_DT` datetime DEFAULT NULL,
  PRIMARY KEY (`USERGRP_ID`),
  KEY `FK03_ORG_ID` (`ORG_ID`)
) ENGINE=InnoDB  DEFAULT CHARSET=utf8 COMMENT='Application user divided into multiple group ' AUTO_INCREMENT=4 ;

--
-- Dumping data for table `sa_user_group`
--

INSERT INTO `sa_user_group` (`USERGRP_ID`, `ORG_ID`, `USERGRP_NAME`, `ACTIVE_STATUS`, `CRE_BY`, `CRE_DT`, `UPD_BY`, `UPD_DT`) VALUES
(1, 1, 'Administrative', 1, 1, '2017-09-09 00:42:28', NULL, NULL),
(2, 1, 'Thikana Admin', 1, 1, '2017-09-09 22:47:42', NULL, NULL),
(3, 1, 'Test Group', 1, 1, '2017-09-09 23:28:19', NULL, NULL);

--
-- Constraints for dumped tables
--

--
-- Constraints for table `drg_generic_group`
--
ALTER TABLE `drg_generic_group`
  ADD CONSTRAINT `FK_drg_gereric_group_1` FOREIGN KEY (`TH_GRP_ID`) REFERENCES `drg_therapeutic_group` (`TH_GRP_ID`) ON DELETE CASCADE ON UPDATE CASCADE;

--
-- Constraints for table `drg_medicine_img`
--
ALTER TABLE `drg_medicine_img`
  ADD CONSTRAINT `FK_drg_medicine_img_1` FOREIGN KEY (`MEDICINE_ID`) REFERENCES `drg_medicine_info` (`MEDICINE_ID`) ON DELETE CASCADE ON UPDATE CASCADE;

--
-- Constraints for table `drg_medicine_info`
--
ALTER TABLE `drg_medicine_info`
  ADD CONSTRAINT `FK_drg_medicine_info_1` FOREIGN KEY (`GN_GRP_ID`) REFERENCES `drg_generic_group` (`GN_GRP_ID`),
  ADD CONSTRAINT `FK_drg_medicine_info_2` FOREIGN KEY (`CAT_ID`) REFERENCES `drg_medicine_cat` (`CAT_ID`);

--
-- Constraints for table `drg_medicine_strength`
--
ALTER TABLE `drg_medicine_strength`
  ADD CONSTRAINT `FK_drg_medicine_strength_1` FOREIGN KEY (`MEDICINE_ID`) REFERENCES `drg_medicine_info` (`MEDICINE_ID`) ON DELETE CASCADE ON UPDATE CASCADE,
  ADD CONSTRAINT `FK_drg_medicine_strength_2` FOREIGN KEY (`TYPE_ID`) REFERENCES `drg_medicine_type` (`TYPE_ID`) ON DELETE CASCADE ON UPDATE CASCADE,
  ADD CONSTRAINT `FK_drg_medicine_strength_3` FOREIGN KEY (`UOM_ID`) REFERENCES `drg_uom` (`UOM_ID`) ON DELETE CASCADE ON UPDATE CASCADE;

--
-- Constraints for table `drg_special_medicine`
--
ALTER TABLE `drg_special_medicine`
  ADD CONSTRAINT `FK_drg_special_medicine_1` FOREIGN KEY (`MEDICINE_ID`) REFERENCES `drg_medicine_info` (`MEDICINE_ID`) ON DELETE CASCADE ON UPDATE CASCADE,
  ADD CONSTRAINT `FK_drg_special_medicine_2` FOREIGN KEY (`SPECIAL_ID`) REFERENCES `drg_special_prod_cat` (`SPECIAL_ID`) ON DELETE CASCADE ON UPDATE CASCADE;

--
-- Constraints for table `drg_therapeutic_group`
--
ALTER TABLE `drg_therapeutic_group`
  ADD CONSTRAINT `FK_drg_therapeutic_group_1` FOREIGN KEY (`CAT_ID`) REFERENCES `drg_medicine_cat` (`CAT_ID`) ON DELETE CASCADE ON UPDATE CASCADE;

--
-- Constraints for table `sa_lookup_data`
--
ALTER TABLE `sa_lookup_data`
  ADD CONSTRAINT `FK01_LOOKUP_GRP_ID` FOREIGN KEY (`LOOKUP_GRP_ID`) REFERENCES `sa_lookup_grp` (`LOOKUP_GRP_ID`);

--
-- Constraints for table `sa_module_links`
--
ALTER TABLE `sa_module_links`
  ADD CONSTRAINT `FK_MLINK_MODULE_ID` FOREIGN KEY (`MODULE_ID`) REFERENCES `sa_modules` (`MODULE_ID`);

--
-- Constraints for table `sa_org_mlinks`
--
ALTER TABLE `sa_org_mlinks`
  ADD CONSTRAINT `FK01_SA_MODULE_ID` FOREIGN KEY (`SA_MODULE_ID`) REFERENCES `sa_org_modules` (`SA_MODULE_ID`),
  ADD CONSTRAINT `FK02_ORG_ID` FOREIGN KEY (`ORG_ID`) REFERENCES `sa_organizations` (`ORG_ID`);

--
-- Constraints for table `sa_org_modules`
--
ALTER TABLE `sa_org_modules`
  ADD CONSTRAINT `FK01_ORG_ID` FOREIGN KEY (`ORG_ID`) REFERENCES `sa_organizations` (`ORG_ID`);

--
-- Constraints for table `sa_uglw_mlink`
--
ALTER TABLE `sa_uglw_mlink`
  ADD CONSTRAINT `FK01_SA_MLINKS_ID` FOREIGN KEY (`SA_MLINKS_ID`) REFERENCES `sa_org_mlinks` (`SA_MLINKS_ID`),
  ADD CONSTRAINT `FK01_UG_LEVEL_ID` FOREIGN KEY (`UG_LEVEL_ID`) REFERENCES `sa_ug_level` (`UG_LEVEL_ID`),
  ADD CONSTRAINT `FK01_USER_ID` FOREIGN KEY (`USER_ID`) REFERENCES `sa_users` (`FLD_USER_ID`),
  ADD CONSTRAINT `FK02_SA_MODULE_ID` FOREIGN KEY (`SA_MODULE_ID`) REFERENCES `sa_org_modules` (`SA_MODULE_ID`),
  ADD CONSTRAINT `FK02_USERGRP_ID` FOREIGN KEY (`USERGRP_ID`) REFERENCES `sa_user_group` (`USERGRP_ID`),
  ADD CONSTRAINT `FK05_ORG_ID` FOREIGN KEY (`ORG_ID`) REFERENCES `sa_organizations` (`ORG_ID`);

--
-- Constraints for table `sa_ug_level`
--
ALTER TABLE `sa_ug_level`
  ADD CONSTRAINT `FK01_USERGRP_ID` FOREIGN KEY (`USERGRP_ID`) REFERENCES `sa_user_group` (`USERGRP_ID`),
  ADD CONSTRAINT `FK04_ORG_ID` FOREIGN KEY (`ORG_ID`) REFERENCES `sa_organizations` (`ORG_ID`);

--
-- Constraints for table `sa_users`
--
ALTER TABLE `sa_users`
  ADD CONSTRAINT `sa_users_ibfk_1` FOREIGN KEY (`USERLVL_ID`) REFERENCES `sa_ug_level` (`UG_LEVEL_ID`),
  ADD CONSTRAINT `sa_users_ibfk_2` FOREIGN KEY (`USERGRP_ID`) REFERENCES `sa_user_group` (`USERGRP_ID`),
  ADD CONSTRAINT `sa_users_ibfk_3` FOREIGN KEY (`ORG_ID`) REFERENCES `sa_organizations` (`ORG_ID`);

--
-- Constraints for table `sa_user_group`
--
ALTER TABLE `sa_user_group`
  ADD CONSTRAINT `FK03_ORG_ID` FOREIGN KEY (`ORG_ID`) REFERENCES `sa_organizations` (`ORG_ID`);

/*!40101 SET CHARACTER_SET_CLIENT=@OLD_CHARACTER_SET_CLIENT */;
/*!40101 SET CHARACTER_SET_RESULTS=@OLD_CHARACTER_SET_RESULTS */;
/*!40101 SET COLLATION_CONNECTION=@OLD_COLLATION_CONNECTION */;
